ࡱ>    y  bjbj ' {{H((55555`6`6`6@7$>`6}TfpBgBgBght{d؀$-5hh55BgBgH7ͪͪͪ 5Bg5BgͪͪͪN0 Bg3muߧF 0|M0}P%` 6B5x*^ͪnLA}( 4:  INCLUDEPICTURE "http://vaww.vhaco.va.gov/vhacio/images/OILogos/VistA.gif" \* MERGEFORMAT  OncoTraX: Cancer Registry User Manual June 2012 Department of Veterans Affairs Health Systems Design & Development Revision History DateDescriptionAuthorMay 2007Initial Publication of OncoTraX: Cancer Registry User ManualChristine Beynon This page intentionally left blank for double-sided printing. Table of Contents TOC \o "3-3" \h \z \t "Heading 1,1,Heading 2,2"   HYPERLINK \l "_Toc173658689" Introduction  PAGEREF _Toc173658689 \h 1  HYPERLINK \l "_Toc173658690" Recommended Users  PAGEREF _Toc173658690 \h 2  HYPERLINK \l "_Toc173658691" Related Manuals  PAGEREF _Toc173658691 \h 2  HYPERLINK \l "_Toc173658692" Recommended Websites  PAGEREF _Toc173658692 \h 3  HYPERLINK \l "_Toc173658693" OncoTraX Conventions  PAGEREF _Toc173658693 \h 4  HYPERLINK \l "_Toc173658694" OncoTraX Menu  PAGEREF _Toc173658694 \h 7  HYPERLINK \l "_Toc173658695" Getting Started  PAGEREF _Toc173658695 \h 8  HYPERLINK \l "_Toc173658696" Define Cancer Registry Parameters  PAGEREF _Toc173658696 \h 9  HYPERLINK \l "_Toc173658697" SUS Case Finding and Suspense Module  PAGEREF _Toc173658697 \h 11  HYPERLINK \l "_Toc173658698" CF Automatic Case Finding - Lab Search  PAGEREF _Toc173658698 \h 11  HYPERLINK \l "_Toc173658699" LR Print Case Finding - Lab Report  PAGEREF _Toc173658699 \h 12  HYPERLINK \l "_Toc173658700" RA Automatic Case Finding - Radiology Search  PAGEREF _Toc173658700 \h 13  HYPERLINK \l "_Toc173658701" PT Automatic Case Finding - PTF Search  PAGEREF _Toc173658701 \h 14  HYPERLINK \l "_Toc173658702" SE Add/Edit/Delete from Suspense  PAGEREF _Toc173658702 \h 14  HYPERLINK \l "_Toc173658703" Adding a VA Patient to Suspense  PAGEREF _Toc173658703 \h 14  HYPERLINK \l "_Toc173658704" Editing a VA Patient in Suspense  PAGEREF _Toc173658704 \h 15  HYPERLINK \l "_Toc173658705" Deleting a VA Patient from Suspense  PAGEREF _Toc173658705 \h 15  HYPERLINK \l "_Toc173658706" SP Print Suspense List by Suspense Date (132c)  PAGEREF _Toc173658706 \h 15  HYPERLINK \l "_Toc173658707" NP Patients in Suspense with No Primaries  PAGEREF _Toc173658707 \h 16  HYPERLINK \l "_Toc173658708" ABS Abstract Entry and Printing Module  PAGEREF _Toc173658708 \h 17  HYPERLINK \l "_Toc173658709" AI Complete Abstract  PAGEREF _Toc173658709 \h 17  HYPERLINK \l "_Toc173658710" Abstracting a Case  PAGEREF _Toc173658710 \h 18  HYPERLINK \l "_Toc173658711" Completing an Abstract  PAGEREF _Toc173658711 \h 24  HYPERLINK \l "_Toc173658712" EE Abstract Edit Primary  PAGEREF _Toc173658712 \h 25  HYPERLINK \l "_Toc173658713" NC Print Abstract NOT Complete List  PAGEREF _Toc173658713 \h 25  HYPERLINK \l "_Toc173658714" IR Patient Summary  PAGEREF _Toc173658714 \h 25  HYPERLINK \l "_Toc173658715" QA Print Abstract QA (80c)  PAGEREF _Toc173658715 \h 26  HYPERLINK \l "_Toc173658716" EX Print Abstract-Extended (80c)  PAGEREF _Toc173658716 \h 26  HYPERLINK \l "_Toc173658717" PA Print Complete Abstract (132c)  PAGEREF _Toc173658717 \h 26  HYPERLINK \l "_Toc173658718" MA Print QA/Multiple Abstracts  PAGEREF _Toc173658718 \h 26  HYPERLINK \l "_Toc173658719" AS Abstract Screens Menu (80c)  PAGEREF _Toc173658719 \h 26  HYPERLINK \l "_Toc173658720" FOL Follow-up Module  PAGEREF _Toc173658720 \h 27  HYPERLINK \l "_Toc173658721" PF Post/Edit Follow-up  PAGEREF _Toc173658721 \h 27  HYPERLINK \l "_Toc173658722" RF Recurrence/Sub Tx Follow-up  PAGEREF _Toc173658722 \h 28  HYPERLINK \l "_Toc173658723" FH Patient Follow-up History  PAGEREF _Toc173658723 \h 29  HYPERLINK \l "_Toc173658724" DF Print Due Follow-up List by Month Due  PAGEREF _Toc173658724 \h 29  HYPERLINK \l "_Toc173658725" LF Print Delinquent (LTF) List  PAGEREF _Toc173658725 \h 29  HYPERLINK \l "_Toc173658726" FP Follow-up Procedures Menu  PAGEREF _Toc173658726 \h 30  HYPERLINK \l "_Toc173658727" Follow-up Letter  PAGEREF _Toc173658727 \h 30  HYPERLINK \l "_Toc173658728" LIS Registry Lists Module  PAGEREF _Toc173658728 \h 37  HYPERLINK \l "_Toc173658729" AA Accession Register-ACoS (80c)  PAGEREF _Toc173658729 \h 37  HYPERLINK \l "_Toc173658730" AS Accession Register-Site (80c)  PAGEREF _Toc173658730 \h 38  HYPERLINK \l "_Toc173658731" AE Accession Register-EOVA (132c)  PAGEREF _Toc173658731 \h 38  HYPERLINK \l "_Toc173658732" PA Patient Index-ACoS (132c)  PAGEREF _Toc173658732 \h 38  HYPERLINK \l "_Toc173658733" PS Patient Index-Site (80c)  PAGEREF _Toc173658733 \h 38  HYPERLINK \l "_Toc173658734" PE Patient Index-EOVA (132c)  PAGEREF _Toc173658734 \h 38  HYPERLINK \l "_Toc173658735" IN Primary ICDO Listing (80c)  PAGEREF _Toc173658735 \h 39  HYPERLINK \l "_Toc173658736" SG Primary Site/GP Listing (80c)  PAGEREF _Toc173658736 \h 39  HYPERLINK \l "_Toc173658737" IW Primary ICDO Listing (132c)  PAGEREF _Toc173658737 \h 39  HYPERLINK \l "_Toc173658738" ANN Annual Reporting Module  PAGEREF _Toc173658738 \h 41  HYPERLINK \l "_Toc173658739" AAR Annual ACoS Accession Register (80c)  PAGEREF _Toc173658739 \h 41  HYPERLINK \l "_Toc173658740" API Annual ACoS Patient Index (132c)  PAGEREF _Toc173658740 \h 41  HYPERLINK \l "_Toc173658741" ASL Annual Primary Site/GP Listing (132c)  PAGEREF _Toc173658741 \h 42  HYPERLINK \l "_Toc173658742" ACL Annual Patient List by Class of Case (80c)  PAGEREF _Toc173658742 \h 42  HYPERLINK \l "_Toc173658743" SST Annual Primary Site/Stage/Tx (132c)  PAGEREF _Toc173658743 \h 42  HYPERLINK \l "_Toc173658744" TST Annual ICDO Topography/Stage/Tx (132c)  PAGEREF _Toc173658744 \h 43  HYPERLINK \l "_Toc173658745" SDX Annual Status/Site/Dx-Age (132c)  PAGEREF _Toc173658745 \h 44  HYPERLINK \l "_Toc173658746" HIS Annual Histology/Site/Topography (80c)  PAGEREF _Toc173658746 \h 44  HYPERLINK \l "_Toc173658747" ACT Annual Cross Tabs (80c)  PAGEREF _Toc173658747 \h 45  HYPERLINK \l "_Toc173658748" CPR PRINT Custom Reports  PAGEREF _Toc173658748 \h 45  HYPERLINK \l "_Toc173658749" STA Statistical Reporting Module  PAGEREF _Toc173658749 \h 47  HYPERLINK \l "_Toc173658750" DS Define Search Criteria  PAGEREF _Toc173658750 \h 47  HYPERLINK \l "_Toc173658751" SP Survival by Site  PAGEREF _Toc173658751 \h 49  HYPERLINK \l "_Toc173658752" SS Survival by Stage  PAGEREF _Toc173658752 \h 49  HYPERLINK \l "_Toc173658753" TX Survival by Treatment  PAGEREF _Toc173658753 \h 49  HYPERLINK \l "_Toc173658754" TS Treatment by Stage - Cross Tabs  PAGEREF _Toc173658754 \h 49  HYPERLINK \l "_Toc173658755" UTL Utility Options Module  PAGEREF _Toc173658755 \h 51  HYPERLINK \l "_Toc173658756" RS Registry Summary Reports  PAGEREF _Toc173658756 \h 51  HYPERLINK \l "_Toc173658757" DP Delete OncoTraX Patient  PAGEREF _Toc173658757 \h 53  HYPERLINK \l "_Toc173658758" DS Delete Primary Site/Gp Record  PAGEREF _Toc173658758 \h 53  HYPERLINK \l "_Toc173658759" EA Edit Site/AccSeq# Data  PAGEREF _Toc173658759 \h 53  HYPERLINK \l "_Toc173658760" AR Create a Report to Preview ACoS Output  PAGEREF _Toc173658760 \h 53  HYPERLINK \l "_Toc173658761" CT Create ACoS Data Download  PAGEREF _Toc173658761 \h 53  HYPERLINK \l "_Toc173658762" SR Create a Report to Preview State/VACCR Output  PAGEREF _Toc173658762 \h 53  HYPERLINK \l "_Toc173658763" CC Create State/VACCR Data Download  PAGEREF _Toc173658763 \h 53  HYPERLINK \l "_Toc173658764" TR Define Cancer Registry Parameters  PAGEREF _Toc173658764 \h 54  HYPERLINK \l "_Toc173658765" AC Enter/Edit Facility File  PAGEREF _Toc173658765 \h 54  HYPERLINK \l "_Toc173658766" CDD1 Print Condensed DD--OncoTraX Patient file  PAGEREF _Toc173658766 \h 54  HYPERLINK \l "_Toc173658767" CDD2 Print Condensed DD--OncoTraX Primary file  PAGEREF _Toc173658767 \h 54  HYPERLINK \l "_Toc173658768" PSR Purge Suspense Records  PAGEREF _Toc173658768 \h 54  HYPERLINK \l "_Toc173658769" SP Purge Patient Records with No Suspense/Primaries  PAGEREF _Toc173658769 \h 54  HYPERLINK \l "_Toc173658770" CS Restage CS Cases  PAGEREF _Toc173658770 \h 54  HYPERLINK \l "_Toc173658771" TNM Compute Percentage of TNM Forms Completed  PAGEREF _Toc173658771 \h 54  HYPERLINK \l "_Toc173658772" TIME Timeliness Report  PAGEREF _Toc173658772 \h 55  HYPERLINK \l "_Toc173658773" Reporting to VA Central Cancer Registry  PAGEREF _Toc173658773 \h 57  HYPERLINK \l "_Toc173658774" Utility Tools  PAGEREF _Toc173658774 \h 59  HYPERLINK \l "_Toc173658775" PC Capture Program  PAGEREF _Toc173658775 \h 59  HYPERLINK \l "_Toc173658776" KEA Term - Illustrated Directions  PAGEREF _Toc173658776 \h 59  HYPERLINK \l "_Toc173658777" Emailing the VACCR file  PAGEREF _Toc173658777 \h 60  HYPERLINK \l "_Toc173658778" State Reporting  PAGEREF _Toc173658778 \h 60  HYPERLINK \l "_Toc173658779" PC Capture Program  PAGEREF _Toc173658779 \h 62  HYPERLINK \l "_Toc173658780" Downloading Your Data from VistA for the ACoS  PAGEREF _Toc173658780 \h 62  HYPERLINK \l "_Toc173658781" Downloading and Installing Genedits  PAGEREF _Toc173658781 \h 63  HYPERLINK \l "_Toc173658782" Running Genedits for ACoS Call for Data  PAGEREF _Toc173658782 \h 65  HYPERLINK \l "_Toc173658783" Sending Your File to ACoS  PAGEREF _Toc173658783 \h 66  HYPERLINK \l "_Toc173658784" VistA Setup  PAGEREF _Toc173658784 \h 67  HYPERLINK \l "_Toc173658785" Line Editor  PAGEREF _Toc173658785 \h 67  HYPERLINK \l "_Toc173658786" Screen Editor  PAGEREF _Toc173658786 \h 68  HYPERLINK \l "_Toc173658787" Menu Options  PAGEREF _Toc173658787 \h 72  HYPERLINK \l "_Toc173658788" Edits within OncoTraX  PAGEREF _Toc173658788 \h 75  HYPERLINK \l "_Toc173658789" Edits within Genedits  PAGEREF _Toc173658789 \h 79  HYPERLINK \l "_Toc173658790" Glossary  PAGEREF _Toc173658790 \h 95  This page intentionally left blank for double-sided printing. Introduction OncoTraX: Cancer Registry is an integrated collection of computer programs and routines, which work together in assisting the Cancer Registrars to create and maintain a cancer patient database. The software creates case listings and registry reports for Cancer Boards (Cancer Conferences), special studies, and the Annual Report recommended by the American College of Surgeons (ACoS). The software allows the Cancer Registrars to: Perform case finding. Identify potential cases to include in your registry, enter the pertinent data directly into the computer system, and maintain patient follow-up information on an annual basis. Enter abstracts. Download and transmit data electronically to the VA Central Cancer Registry, state central registries, the National Cancer Database for the ACoS Call for Data. Produce several reports by using an option in the Utility menu. Note: Several reports within the software provide basic information; however, for more specific reports, you need to know basic FileMan functions. Any and all data collected within an abstract can be pulled back into reports. Print out by year the number of cases by site, including sex, race, and stages. Generate follow-up reports as required by the ACoS Note: OncoTraX is in complete compliance with all ACoS required data elements, and is updated as changes occur. OncoTraX is used by cancer registrars and meets all requirements set forth by the American College of Surgeons for approved cancer programs. Note: OncoTraX makes extensive use of Help screens, but it does not replace the use of your reference manuals. This manual deals with the three most commonly used areas of the software. These are the main functions of registry work used to maintain the cancer registry. Case Finding/Suspense Module allows you to perform an automated case finding search of relevant hospital databases (pathology, radiology, and patient treatment files) for cases meeting specific criteria for inclusion in the registry. Abstracting/Printing allows you to enter coded data into the database directly or by utilizing auto-coding techniques. The software is site-specific prompt driven; the only data elements presented are those pertinent to the site you are abstracting. Follow-Up in OncoTraX assists you in following your patients. The database automatically reminds you when it is time to do a follow-up on a patient. You can update each patients record with new follow-up information. The software comes with a variety of follow-up letters, which may be customized to fit the needs of individual facilities. When using the electronic version of the manual to search for information, click Edit on the menu bar and select Find (binoculars icon). Enter the word or words for which you are looking and Microsoft Word searches the document. Recommended Users This manual is intended for VA registrars using the OncoTraX: Cancer Registry software. Related Manuals XE "Related manuals"  Every cancer registry office should have the following reference material. Note: Use the older editions of the reference materials when entering old cases. Facility Oncology Registry Data Standards (FORDS), 2011 and after Registry Operations and Data Standards (ROADS), prior to 2003 cases Facility Oncology Registry Data Standards (FORDS), 2003 and after Collaborative Staging Manual and Coding Instructions Collaborative Staging was added to OncoTraX in July 2004. Use the Collaborative Staging Manual and Coding Instructions for all cases diagnosed in 2004 and after. AJCC Cancer Staging Manual, 7th Edition on cancer cases diagnosed beginning January 1, 2010 AJCC Cancer Staging Manual, 6th Edition on cancer cases diagnosed beginning January 1, 2003 AJCC Cancer Staging Manual, 5th edition, for entering older cases SEER Summary Staging Manual, 2000 Summary Staging Guide, 1977 SEER Extent of Disease, 1988; Codes and Coding Instructions, 2nd edition, 1994 SEER Extent of Disease, 1998; Codes and Coding Instructions, 3rd edition, 1998 SEER Program Coding and Staging Manual, 2004 (on CD) SEER*Rx - Interactive Antineoplastic Drugs Database The interactive antineoplastic drugs database (helpful when abstracting) is available from SEER on the following website:  HYPERLINK "http://www.seer.cancer.gov/tools/seerrx/" http://www.seer.cancer.gov/tools/seerrx/ SEER Self Instructional Manuals for Tumor Registrars SEER self instructional manuals are available for download on the following website:  HYPERLINK "http://www.seer.cancer.gov/training/manuals/" http://www.seer.cancer.gov/training/manuals/ ICD-O-3, International Classification of Diseases for Oncology (ICD-O), 3rd edition ICD-O-2, International Classification of Diseases for Oncology (ICD-O), 2nd edition Cancer Registry Management Principles and Practice, 3nd edition Recommended Websites XE "Recommended websites"   HYPERLINK "http://cancer.gov/" http://cancer.gov/ Website for the National Cancer Institute  HYPERLINK "http://www.facs.org/cancer/index.html" http://www.facs.org/cancer/index.html Home page for the Commission on Cancer, American College of Surgeons, Cancer Programs  HYPERLINK "http://www.facs.org/cancer/cocflash/june02.html" http://www.facs.org/cancer/cocflash/ Highlights for the month from the Commission on Cancer, American College of Surgeons, Cancer Programs  HYPERLINK "http://web.facs.org/coc/default.htm" http://web.facs.org/coc/default.htm American College of Surgeons, Commission on Cancer: Inquiry and Response System (I & R) Available to all cancer care professionals. It is a repository of thousands of questions and answers related to the Approvals and Accreditation Program, the National Cancer Data Base (NCDB), the American Joint Committee on Cancer (AJCC), and the Facility Oncology Registry Data Standards (FORDS).  HYPERLINK "http://www.ncra-usa.org/" http://www.ncra-usa.org/ Website for the National Cancer Registrars Association  HYPERLINK "http://www.cancerstaging.org/" http://www.cancerstaging.org/ Website for the American Joint Committee on Cancer (AJCC)  HYPERLINK "http://cancerstaging.org/cstage/manuals.html" http://cancerstaging.org/cstage/manuals.html Website for Collaborative Staging  HYPERLINK "http://vaww.medicalsurgical.va.gov/cancer/index.asp" http://vaww.medicalsurgical.va.gov/cancer/index.asp All links for the Veterans Health Administration Cancer Program  HYPERLINK "http://www.training.seer.cancer.gov/" http://www.training.seer.cancer.gov SEERs Training Web Site provides web-based training modules for cancer registration and surveillance. When the site is complete, it will comprise about 30 training modules, each covering a particular cancer registration training subject.  HYPERLINK "http://www.seer.cancer.gov/tools/seerrx/" http://www.seer.cancer.gov/tools/seerrx/ Download the SEER*Rx - Interactive Antineoplastic Drugs Database, version 1.1.1 (replaces Book 8)  HYPERLINK "http://www.cancerstaging.org/cstage/csmanualpart1.pdf" http://www.cancerstaging.org/cstage/csmanualpart1.pdf Collaborative Staging Manual and Coding Instructions Part I  HYPERLINK "http://cancerstaging.org/cstage/CSPart2Manual.pdf" http://cancerstaging.org/cstage/CSPart2Manual.pdf Collaborative Staging Manual and Coding Instructions Part II  HYPERLINK "http://seer.cancer.gov/manuals/codeman.pdf" http://seer.cancer.gov/manuals/codeman.pdf The SEER Program Code Manual, Third Edition, 1998  HYPERLINK "http://seer.cancer.gov/manuals/EOD10Dig.pub.pdf" http://seer.cancer.gov/manuals/EOD10Dig.pub.pdf SEER Extent of Disease - 1988, Codes and Coding Instructions, Third Edition, .January 1998  HYPERLINK "http://www.facs.org/cancer/coc/cocprogramstandards.pdf" http://www.facs.org/cancer/coc/cocprogramstandards.pdf Commission on Cancer: Cancer Program Standards 2011 Revised Edition, ACoS required standards for approved cancer programs  HYPERLINK "http://www.facs.org/cancer/coc/fordsmanual.html" http://www.facs.org/cancer/coc/fordsmanual.html Facility Oncology Registry Data Standards (FORDS): Revised for 2011 OncoTraX Conventions XE "OncoTraX conventions"  You must have a working knowledge of VistA XE "VistA conventions"  conventions, in order to maneuver easily in OncoTraX. The table contains frequently used characters and their descriptions with examples. CharacterDescription XE "Character:"  is the symbol for the Return or Enter key. Type after every response, or to bypass a prompt or accept a default. Note: Do not press it more than necessary; you do not want to bypass an opportunity to enter valuable information.? XE "Character:?" ? (one question mark) Type ? at any prompt to view a message explaining the requested information or how to enter it.?? XE "Character:??" ?? (two question marks) Type ?? at any prompt to view detailed instructions and/or a list of choices.// XE "Character://" // (two slash marks) Type // after text for the default response. If you accept the default answer, press to continue to the next prompt. For a different choice, type the choice and press . Press Enter at // and the word before the slashes becomes the default response. Type ? at // and a list of choices displays. Example PREVIOUS HISTORY OF CANCER: No// ? Choose from: 0 No 1 Yes 9 Unknown^  XE "Character:^" ^ (caret) is Shift + 6 on the keyboard and is also called the up-caret symbol. Type ^ to exit an option and return to the menu; Type ^ to jump to another field. Example Type ^ DATE DX at the field prompt to jump to the DATE DX field. DATE DX: 04/05/2005// DX FACILITY: BUFFALO VA MEDICAL CENTER// PRIMARY SITE: PROSTATE// TEXT-PRIMARY SITE TITLE: PROSTATE// LATERALITY: Not a paired site// HISTOLOGY (ICD-O-3): ADENOCARCINOMA, NOS// HISTOLOGY CODE: 8140/3 TEXT-HISTOLOGY TITLE: ADENOCARCINOMA, NOS// ^DATE DX DATE DX: 04/05/2005// Type a new date after DATE DX: In the Abstract Go from one field to another in most areas of an abstract type ^ Go completely out of the abstract type ^ without a field name Edit a field already completed type ^ to return to the field and then edit. Example CLASS OF CASE: 1 Dx here, 1st tx here FACILITY REFERRED FROM: NONE/ ^CLASS OF CASE CLASS OF CASE: Dx here, 1st tx here//@ XE "Character:@" @ (at symbol) is Shift + 2 on the keyboard. Type @ to delete data values stored in fields.  XE "Character:..."  (three dots) Type to replace all data in a field. Example TX Primary Cancer cannot be assessed Replace With At the Replace prompt, type and press Enter. When With displays, type new data. Example CLINICAL T: T3 Chest wall/diaphragm/mediastinal pleura etc Replace ... With There is a submenu when ... displays after a menu option. Example ANN *Annual Reports ... Select ANN and the following displays. AAR Annual ACoS Accession Register (80c) API Annual ACoS Patient Index (132c) ASL Annual Primary Site/GP Listing (132c) ACL Annual Patient List by Class of Case (80c) SST Annual Primary Site/Stage/Tx (132c) TST Annual ICDO Topography/Stage/Tx (132c) SDX Annual Status/Site/Dx-Age (132c) HIS Annual Histology/Site/Topography (80c) ACT Annual Cross Tabs (80c) CPR Print Custom ReportsDates XE "Dates"  XE "Device prompt" Several date formats are acceptable. Examples 010102, 1-1-02, 1/1/02, 01/01/2002, January 1, 2002 If the year is omitted, the computer uses Current Year.Device promptTo send a report to a printer, type the name of the printer at the Device prompt. If the printer is shared, queue your report by entering Q at the Device prompt and then the name of the printer at the next prompt. To view a report on your computer screen, press the key at the Device prompt. When capturing a file, type 0;269;9999999 at the Device prompt. Note: When you learn to capture files from the software, you can also learn many ways to display data.Space bar return XE "Character:Space bar" Press the space bar to re-enter the last selection made at a particular level. (This feature may be limited for some options.) Example At a submenu, the space bar enters the last submenu option accessed. At a field, the space bar re-enters whatever was last entered, to any other field within the same option. Note: Press the space bar, and then press the Return key, not both at the same time.Report options XE "Report options" Report options with 80c in the name; require an 80-character line printer. Report options with 80c in the name; look correct when viewed on your monitor. Report options with 132c in the name; require a 132-character line printer. Reports with 132c in the name do not look correct when viewed on your monitorthe text wraps. Note: A printer that can print both 80c and 132c is recommended.OncoTraX Menu XE "Oncology menu"  XE "OncoTraX menu"  The main OncoTraX menu is the first screen that displays when you sign on to the program. The OncoTraX menu displays the version number of the OncoTraX: Cancer Registry software running on your system. Example ONCOTRAX CANCER REGISTRY V2.11 PATCH ONC*2.11*54 The functions on the OncoTraX Option list also display. SUS *..Case Finding/Suspense ... ABS *..Abstracting/Printing ... FOL *..Follow-up Functions ... LIS *..Registry Lists ... ANN *..Annual Reports ... STA *..Statistical Reports ... UTL *..Utility Options ... The Select OncoTraX Option: prompt is the starting point for all of the modules within the software. At the prompt, type in an option/module three-letter abbreviation. The group of related submenu options displays. Example Select OncoTraX Option: SUS *..Case Finding/Suspense *********** Suspense Cases *********** CF Automatic Case Finding-Lab Search LR Print Case Finding-Lab Report RA Automatic Case Finding-Radiology Search PT Automatic Case Finding-PTF Search SE Add/Edit/Delete 'Suspense' Case SP Print Suspense List by Suspense Date (132c) NP Patients in Suspense with no primaries DI Disease Index Getting Started Before using OncoTraX for the first time, you must define your registrys parameters.  XE "Define parameters"  If OncoTraX is already being used by the registry and you are a new registrar, review the registrys parameters because you may need to update them. To access the registrys parameters: From the main OncoTraX menu, select UTL *..Utility Options From the Utility Options, select TR Define Cancer Registry Parameters Example SUS *..Case Finding/Suspense ... ABS *..Abstracting/Printing ... FOL *..Follow-up Functions ... LIS *..Registry Lists ... ANN *..Annual Reports ... STA *..Statistical Reports ... UTL *..Utility Options ... Select OncoTraX Option: UTL *..Utility Options *************UTILITY OPTIONS************* DP Delete OncoTraX Patient DS Delete Primary Site/GP Record EA Edit Site/AccSeq# Data LG List Topographic Site Groups LT List Topography Codes by Site Group AR Create a report to preview ACoS output CT Create ACoS Data Download SR Create a report to preview State/VACCR output CC Create State/VACCR Data Download TR Define Cancer Registry Parameters AC Enter/Edit Facility file CDD1 Print Condensed DD--OncoTraX Patient file CDD2 Print Condensed DD--OncoTraX Primary file PSR Purge Suspense Records SP Purge Patient Records with No Suspense/Primaries CS Restage CS cases using latest version TIME Timeliness Report Define Cancer Registry Parameters XE "Define cancer registry parameters"  Use Define Cancer Registry Parameters to update/change parameters, such as the name of the Cancer Registrar. You are required to put in information for the following fields. Select ONCOLOGY SITE PARAMETERS HOSPITAL NAME: HOSPITAL NAME: Type the name of your medical center as you want it to display. STREET ADDRESS: Type the street address of your medical center. ZIP CODE: Type the zip code for your medical center. REFERENCE DATE: Type the year: first day of the first month of the year the registry first starts capturing data. CANCER REGISTRAR: Type the name of the cancer registrar (3 - 30 characters in length) as you want it to display on letters and reports. PHONE NUMBER: Type the phone number of the cancer registrar's office. STATE HOSPITAL #: Type the number assigned by the state to your medical center. INSTITUTION ID #: Type the registry number assigned by the American College of Surgeons. Use the ID to define the registry in the ACoS Call for Data. CENTRAL REGISTRY #: Type the registry number assigned by the state central registry, where applicable. Note: This field may be left blank. VISN: Type the Veterans Integrated Service Network number. CS URL: Type the URL address for the Collaborative Staging computer algorithms:  HYPERLINK "http://vaww.va.gov/cstage/cgi-bin/cstage.exe" http://vaww.va.gov/cstage/cgi-bin/cstage.exe Note: Copy and paste the address, so as not to make a mistake when typing. DIVISION: Type in your division or site number. It is a required field, even for a single division site. Note: Case finding does not work when Division is blank; type in the name of the hospital or the division. Select AFFILIATED DIVISION: Type the name of the division that is associated with the primary division for purposes of the cancer registry. If you are not an integrated site, bypass the Define Cancer Registry Parameters prompt by pressing . If you are an integrated site and each site/division manages its own cancer registry, bypass the Define Cancer Registry Parameters prompt by pressing . If you are an integrated site and one or more sites/divisions do not have a cancer registry and you are responsible for tracking patients from one or more of those sites in your cancer registry, type the name of each in Select AFFILIATED DIVISION. Select QA USER: Type the name of the cancer registrar. Example REFERENCE DATE: ?? Record the reference date for the registry. This date is listed as the first day of the first month of the year the registry first starts keeping data. Enter the date in format: 010106. SUS Case Finding and Suspense Module XE "SUS"  The SUS Case Finding and Suspense module provides a way to automatically find eligible cases or manually add the patients to Suspense.  XE "Module:Case finding and suspense"  Case finding is a systematic method of locating all eligible cases to enter (accession for abstracting) into your database. One of the unique features of the OncoTraX software is Automatic Case Finding. Enter a range, start date and end date, and the computer searches pathology (CF), radiology (RA) and the Patient Treatment File (PT) for eligible cases in that date range. Each search is run separately according to your input. Cases meeting the defined criteria are captured electronically and added to Suspense. The Suspense Date field, the cases are held in Suspense until they are accessioned for abstracting or manually deleted.  XE "Suspense date"  The suspense date is pulled into the abstract as the DATE DX. The date can be changed, if necessary. After reviewing the Suspense cases, you may find some that are not required in the registry. You can manually delete them; refer to  HYPERLINK \l "_Deleting_a_VA" Deleting a VA Patient from Suspense, page  PAGEREF _Ref164474433 \h 15. You may find some cases that are recurrences of an already documented primary. Recurrences require a follow up. The recurrences must be updated using  HYPERLINK \l "_RF__Recurrence/Sub" RF Recurrence/Sub Tx Follow-up, page  PAGEREF _Ref164475161 \h 28 in the Follow-up Module. Update the follow-up using  HYPERLINK \l "_PF__Post/Edit" PF Post/Edit Follow-up, page  PAGEREF _Ref164475280 \h 27. After you do a follow up for a patient, you must manually delete the patient from the Suspense file; refer to  HYPERLINK \l "_Deleting_a_VA" Deleting a VA Patient from Suspense, page  PAGEREF _Ref164474433 \h 15. Cases that are accessioned are automatically deleted from Suspense. Case Finding/Suspense Menu CF Automatic Case Finding-Lab Search LR Print Case Finding-Lab Report RA Automatic Case Finding-Radiology Search PT Automatic Case Finding-PTF Search SE Add/Edit/Delete from Suspense SP Print Suspense List by Suspense Date (132c) NP Patients in Suspense with no primaries DI Disease Index Note: For your date range, run CF, RA, and PT only once. If you repeat the search for your date range, cases already reviewed end up in your Suspense file. CF Automatic Case Finding - Lab Search XE "CF"  Use this option to search the Lab files to build a Suspense list of cases. When the search is complete, you can print the Suspense list on a selected device/printer. XE "Case Finding:Lab search"  Start with Date:. . Go to Date: Type the end date of the search, such as 1/31/04 If the year is omitted, the computer uses Current Year. Device: Type the name of your printer. ************ LAB CASE FINDING ************ This option will search the LAB DATA file for cases to add to the Suspense List. Start Date: Type the begin date of the search. If this option was used previously, the previous end date is the begin date, such as JUL 1, 2005 End Date: JUL 31, 2005 Dates OK? Y// Press Enter. Note: The option searches for ICD-O morphology codes 800-998, excluding Behavior Code /0 (Benign) codes. Exceptions to the search criteria: Benign Cancers of the central nervous system will be included. Squamous cell neoplasms (805-808) of the skin will be excluded. Basal cell neoplasms (809) will be excluded. DEVICE: HOME// Your report shows the total number of patients identified. Example CASE FINDING LIST your hospital VAMC 03/10/2004 Patient Name PtID# Lab Test Organ/Tissue Morph/Disease-SNOMED SUSPENSE DATE: 7-5-2005 ONCOPATIENT1 O9999 07/15/2005-SP LUNG, UPPER 80703-SQUAMOUS CELL LR Print Case Finding - Lab Report XE "LR"  Use this option to generate a list of patients from Suspense, identified in Pathology with reportable malignancies in the CF Automatic Case Finding - Lab Search. You can print all lab cases in Suspense by entering at the start date prompt or print only those cases within a specified date range. XE "Case Finding:Print lab report"  Start with Suspense Date: First//: Type the begin date for the search or press Enter to print all cases. Go to Suspense Date Last: Type the end date for the search or press the key to accept the last date available. Device: Type the name of your printer. Example Select *..Case finding/Suspense Option: lr Print Case finding-Lab Report START WITH SUSPENSE DATE: FIRST// DEVICE: UCX REMOTE TCPIP --------------------------------------------------------------------------- CASE FINDING LIST WASHINGTON DC VAMC 03/10/2004 Patient Name PtID# Lab Test Organ/Tissue CODE-Morphology ---------------------------------------------------------------------------SOURCE: CYTOPATHOLOGY ONCOPATIENT1 L9999 07/08/2005-CY BRONCHIAL WAS 69760-USPICIOUS SOURCE: SURGICAL PATHOLOGY ONCOPATIENT2 N9999 07/10/2005-SP SKIN OF UPPER 87203-MELANOMA,NOS Last Contact: 04/03/1998 Acc/Sequence Primary Site Last Cancer Status Date DX Status ------------ ---------------- ------------------- -------- ----- 1998-00139/00 SKIN, FACE NOS Unknown 04/03/1998 Complete Note: Patient N999 has a primary from 1998; so that information also displays. When the patient has a history of malignancy, you must verify whether this new finding is a recurrence or a new primary. If it is a recurrence, Document this recurrence using the FOL Follow-up module. Manually delete the case from the Suspense, using  HYPERLINK \l "_SE__Add/Edit/Delete" SE Add/Edit/Delete Suspense Case, page  PAGEREF _Ref164476214 \h 14 in the SUS Case Finding/Suspense module. RA Automatic Case Finding - Radiology Search XE "RA"  XE " Case Finding:Radiology search"  Use this option to search the Rad/Nuc Med (Radiology/Nuclear Medicine) Patient file for suspicious malignancies and add the cases to your Suspense list in the OncoTraX Patient file. Select Start Date: Type the begin date for the search or use the default date. Select Ending Date: Type the end date for the search. Device: Type the name of your printer. ----------------------------------------------------------------------- -----------------------------------------------------------------------RADIOLOGY CASE FINDING LIST WASHINGTON DC VAMC 07/18/2005 Patient Name PtID# Exam Date Procedure -----------------------------------------------------------------------ONCOPATIENT1 B1111 07/18/2005 CT THORAX W/O CONTRAST ONCOPATIENT2 D9999 07/18/2005 ULTRASOUND ABDOMEN LTD Note: This option only yields results if Radiology is entering internal Code 8 or Code 9, not an ICD-9 Code for Radiology. Many patients identified through these options may not actually have cancer and need to be manually deleted from Suspense. To delete, refer to  HYPERLINK \l "_Deleting_a_VA" Deleting a VA Patient from Suspense, page  PAGEREF _Ref164474433 \h 15. PT Automatic Case Finding - PTF Search XE "PT"  Use this option to search the PTF (Patient Treatment File) and add the cases to your Suspense list in the OncoTraX Patient file. After you enter the dates for your search, the program lists the codes to capture during this search. XE "Case Finding:PTF search"  Note: Suspense date = Admission day +1. Select Start Date: Type the begin date for the search or use the default date. Select Ending Date: Type the end date for the search. Device: Type the name of your printer. Example Start Date: 02-01-2004// FEB 01, 2004 Go to Date: 2-10 FEB 10, 2004 Dates ok? Y// ES We will capture codes 140.0 to 239.9 From: FEB 01, 2004 To: FEB 10, 2004 Including codes: 042.2,259.2,273.1,273.2,273.3,273.9,284.9,288.3 & 289.8 V-Codes: 07.3,07.8,10.0-9,58.0-1,66.1,66.2,67.1-2,76,77.1 Note: These are the codes searched for and added to your Suspense file. (Eliminating BENIGN 209.0-229.9) ---------------------------------------------------------------------------PTF-CASE FINDING LIST WASHINGTON DC VAMC 03/10/2004 Patient Name PtID# Admit Disch Level/ICD9-Description --------------------------------------------------------------------------- ONCOPATIENT1 A9999 02/03/2004-02/04/2004 ICD-6/0-HX-PROSTATIC MALIGNA ONCOPATIENT2 G9999 02/06/2004-02/06/2004 ICD-8/0-HX OF BLADDER MALIGN PTF CASE FINDING RESULTS 38 Cases found 2 New Patients added 2 New cases added Note: Although there were 38 cases found during this time period, only 2 of the 38 were not already in Suspense. SE Add/Edit/Delete from Suspense  XE "SE"  Use this option to manually add patients to the Suspense file, to modify patient information in the file, or to manually delete patients from Suspense. Adding a VA Patient to Suspense XE "Suspense:Add a VA patient"  To enter a patient in the Suspense file: Type the patient PID#; refer to the Glossary on page  PAGEREF _Ref165274786 \h 95. The program asks: do you want to add the patient as a New OncoTraX Patient? Response is YES. At the Suspense Date: prompt, type the provisional date of the diagnosis. You can edit the date when the abstract is complete. Note: You must enter a date; this date becomes the Date of Diagnosis in the abstract. Editing a VA Patient in Suspense XE "Suspense:Edit a VA patient"  To modify patient information in the Suspense file: Type the patient PID#; refer to the Glossary on page  PAGEREF _Ref165274852 \h 95. At the Suspense Date: prompt, change the date. Deleting a VA Patient from Suspense XE "Suspense:Delete a VA patient"  To remove a patient from the Suspense file: Type the patient PID#; refer to the Glossary on page  PAGEREF _Ref165274885 \h 95. Press @ (shift + 2) to delete the patient. Example Select ONCOTRAX PATIENT NAME: 19999 Searching for a VA Patient, (pointed-to by NAME) ONCOPATIENT1 12-21-99 999999999 NO NSC VETERAN Enrollment Priority: GROUP 8c Category: ENROLLED End Date: ...OK? Yes// (Yes) Patient Name: ONCOPATIENT Date of Last Contact or Death: Vital Status: Follow-Up Status: SUSPENSE DATE: FEB 10,2004// @ SURE YOU WANT TO DELETE THE ENTIRE SUSPENSE DATE? y (Yes) This patient is not on suspense and has no primaries. This patient's record has been deleted. SP Print Suspense List by Suspense Date (132c) XE "SP"  XE "Suspense:Print list by suspense date"  Use this option to print a list of patients currently in Suspense by the suspense date. The printout lists patients according to how they are identified; first by the source (through Surgical Pathology, Cytopathology, Electron Microscopy, Autopsy, PTF, Radiology, or manual entry) and then in the order of the suspense date. The printout lists the patient's name, the patient's SSN or identifier, Organ/Tissue, Lab Morphology, and Suspense, Admission and Discharge Dates. Note: 132c (132 columns) does not present an easy-to-read display on the computer screen because the text wraps; select a device that can print 132 columns. Start with Suspense Date: FIRST//: Press the key to accept FIRST. All the cases with suspense dates display. or type a date for a Go to Suspense Date prompt. Go to Suspense Date: Type the end date of the range for the printout. Example START WITH SUSPENSE DATE: FIRST// Patient Name SSN Organ/Tissue Lab Morphology Suspense Dt Admission Discharge SOURCE: SURGICAL PATHOLOGY ONCOPATIENT1 999-99-9999 LOBE OF LUNG LIGNANT MELANOMA JAN 6,2006 JAN 6,2006 JAN 10,2006 ONCOPATIENT2 999-99-9999 SIGMOID COLON ENOCARCINOMA,MODERATEL JAN 6,2006 JAN 6,2006 JAN 10,2006 NP Patients in Suspense with No Primaries XE "NP"  XE "Suspense:Patients with no primaries"  This option prints a list of OncoTraX patients that are in Suspense, but do not have a primary. Example ONCOTRAX PATIENT ONLY Patient Name SSN Suspense Last Admit Last Disch --------------------------------------------------------------------ONCOPATIENT1 999-99-9999 FEB 3, 2004 03/07/2004 03/09/2004 ONCOPATIENT2 999-99-9999 FEB 2, 2004 01/30/2004 02/04/2004 ABS Abstract Entry and Printing Module XE "ABS"  XE "Module:Abstract entry and printing"  The Abstract Entry and Printing module is used for abstracting cases. An abstract is a summary of pertinent information about the patient, the cancer, the treatment, and the outcome. Components include patient demographic information, cancer identification, extent of disease, stage at diagnosis, first course of treatment, recurrence, and subsequent therapies or progression and follow-up. An abstract must be completed for all cases that meet the criteria for inclusion in the registry. (The standards are set forth by the American College of Surgeons and VACCR reportable lists.) If a patient has multiple primary malignancies, an abstract must be prepared for each additional primary. An abstract must be completed within six months from the date of first contact. Abstract Entry/Print Menu ************** ABSTRACT ENTRY/PRINT ************** AI Complete Abstract EE Abstract Edit Primary NC Print Abstract NOT Complete List IR Patient Summary QA Print Abstract QA (80c) EX Print Abstract-Extended (80c) PA Print Complete Abstract (132c) MA Print QA/Multiple Abstracts AS Abstract Screens Menu (80c) ... AI Complete Abstract XE "AI"  XE "Abstract:Complete"  Note: To complete an abstract, you need the Facility Oncology Registry Data Standards (FORDS), which describe every field in the abstract and the selections for those fields. Keep a copy of FORDS close at hand for reference. The Complete Abstract option is the main entry point for abstracting new cases or editing existing abstracted cases. OncoTraX is prompt driven. Once a specific Topography Code is selected, all successive prompts displayed are specific. Some of the data captured in the case finding and suspense process, as well as demographic data, are automatically transferred and inserted into the appropriate fields within the abstract; however you can edit the data if necessary. Note: The  HYPERLINK \l "_VistA" OncoTrax Conventions on page  PAGEREF _Ref162679760 \h 4 are helpful in maneuvering around an abstract. Abstracting a Case XE "Abstract:Start"  You begin an abstract by searching for the patient to determine if the patient is new to the VA. If you do not enter data in all required fields, you cannot change the status of the abstract to Complete (3). Adding a New Patient XE "Abstract:Add new patient"  At the prompt, type the patient PID#; refer to the Glossary on page  PAGEREF _Ref165275024 \h 95. Respond YES to the prompt: Are you adding 'LAST,FIRST' as a new ONCOTRAX PATIENT (the 24673RD)? No// Example Enter patient name: h9999 Searching for a VA Patient, (pointed-to by NAME) Searching for a Non-VA or Ambiguous Patient, (pointed-to by NAME) Searching for a VA Patient 1 H3315 LAST,FIRST *SENSITIVE* *SENSITIVE* NO EMPLOYEE 2 H3315 LAST,FIRST1 7-7-15 095093315 NO COLLATERAL SY/ 3 H3315 LAST,FIRST2 11-9-58 118483315 NO NON-VET(OTHER) SY/ 4 H3315 LAST,FIRST3 10-4-48 069423315 YES SC VETERAN 5 H3315 LAST,FIRST4 6-4-22 096123315 NO NSC VETERAN ENTER '^' TO STOP, OR CHOOSE 1-5: 1 LAST,FIRST *SENSITIVE* *SENSITIVE* NOEMPLOYEE ...OK? Yes// (Yes) Are you adding 'LAST,FIRST' as a new ONCOTRAX PATIENT (the 24673RD)? No// y (Yes) The following information is contained in the Patient file NOT editable - See your MAS department IF in error Name: LAST,FIRST DOB: DEC 24, 1953 Address: 1111 THIRD AVENUE SSN: 999-00-9999 Washingon DC 20422 SEX: Female POB: Not Stated 888-8888, EXT. 1111 NOK: ************* OncoTraX Patient file DATA ************** Place of birth.............: UNKNOWN Race 1.....................: Race 2.....................: Race 3.....................: Race 4.....................: Race 5.....................: Spanish origin.............: Sex........................: FEMALE Agent Orange exposure......: Ionizing radiation exposure: Chemical exposure..........: Asbestos exposure..........: Persian Gulf service.......: Middle East service........: Somalia service............: Edit patient data? YES// n NO Continue with Patient History? Yes// n NO Register a Primary for this patient? Yes// YES Editing an Existing Patient XE "Abstract:Edit existing patient"  Respond NO to the prompt: Are you adding 'LAST,FIRST' as a new ONCOTRAX PATIENT (the 24673RD)? No// At the prompt: Edit patient data? YES// y YES Type in the patients remaining demographic information. Some information is automatically imported from the patients electronic record; and some information is taken from the patients chart Example Edit patient data? YES// y YES Note: Answer No to Edit patient data?, if you are not going to complete this section now; such as when accessioning a patient to remove from Suspense. PLACE OF BIRTH: New York// RACE 1: White// RACE 2: NA// RACE 3: NA RACE 4: NA RACE 5: NA SPANISH ORIGIN: Non-Spanish, non-Hispanic SEX: Male// Note: These fields are automatically brought into the abstract from information in the patients electronic record. Enter 99 for Unknown. AGENT ORANGE EXPOSURE : No// IONIZING RADIATION EXPOSURE: No// CHEMICAL EXPOSURE: ASBESTOS EXPOSURE: Note: These two fields are not automatically populated. This information is found in the patients chart. Leave no blanks. PERSIAN GULF SERVICE: No// MIDDLE EAST SERVICE: No// SOMALIA SERVICE: No// Would you like to see a PROBLEM LIST for this patient to assist you in entering the COMORBIDITY/COMPLICATION #1-6 prompts? Yes// YES Note: All problems from the cover sheet display. Select them as required by ACoS. DATE OF ONSET ICD DIAGNOSIS ------------- --------- -------------------------------------------- 2003 266.2 B-COMPLEX DEFIC NEC 2003 110.4 DERMATOPHYTOSIS OF FOOT 2001 401.9 HYPERTENSION NOS UNKNOWN 780.79 OTHER MALAISE AND FATIGUE UNKNOWN 110.1 DERMATOPHYTOSIS OF NAIL UNKNOWN 414.9 CHR ISCHEMIC HRT DIS NOS  XE "Abstract:Occupations not included"  A registrar often finds that a patients occupation is not in the list. When ?? (two question marks) display after the occupation, it means the occupation is not in the list. You can add an occupation. Continue with Patient History? Yes// YES Select USUAL OCCUPATION: DOG TRAINER ?? Type an existing occupation. When it is echoed back, type in the new occupation. At the prompt: Are you adding DOG TRAINER as a new ., type YES with the suggested SNOMED code. Example Select USUAL OCCUPATION: TEACHER IN EDUCATION (THIRD LEVEL) USUAL OCCUPATION...........: TEACHER IN AGRICULTURAL SCIENCE (THIRD LEVEL) // DOG TRAINER Are you adding 'DOG TRAINER' as a new OCCUPATION FIELD (the 1750TH)? No// Y (Yes) OCCUPATION FIELD SNOMED CODE: 1750 Note: This SNOMED code is specific to your facility, however you can enter free text into these fields. Entering a First Primary for a Patient XE "Abstract:Enter first primary"  Press Enter at the prompt default. Register a Primary for this patient? Yes// Select (first) Primary 'SITE/GP': At the prompt, Primary 'SITE/GP': type the site group name or the ICDO Topography code (C code). The case is assigned to the appropriate group and all subsequent fields display only the information relating to the selected site.  XE "Abstract:Enter a primary"  ******** CREATE FIRST PRIMARY RECORD FOR THIS PATIENT******* PATIENT: LAST,FIRST Select first Primary SITE/GP: BREAST Ok to ADD:? Yes// YES Creating a new Primary record for LAST,FIRST ACCESSION YEAR: 2007// ACCESSION NUMBER: 200700224// SEQUENCE NUMBER: 00// LAST,FIRST BREAST 999-00-9999 -------------------------------------------------------------------------- Primary Menu Options -------------------------------------------------------------------------- 1. Patient Identification 2. Cancer Identification 3. Stage of Disease at Diagnosis Collaborative Staging (2004+ cases) 4. First Course of Treatment 5. Patient Care Evaluation 6. Over-ride Flags A All - Complete Abstract Enter option: All// -------------------------------------------------------------------------- LAST,FIRST Patient Identification BREAST 999-00-9999 -------------------------------------------------------------------------- Reporting Hospital...........: Marital status at Dx.........: MARRIED/COMMON LAW Patient address at Dx........: 1111 FIRST AVENUE A new primary record is created for this patient and you are prompted for: Accession Year: Type the year the case was added to the registry. Note: The current year is the default, but you can type in any year. Accession No.: Press Enter to accept the accession number. Note: The next available accession number for the accession year displays. Sequence No.: If this is the first primary for the patient, press Enter to accept the sequence number 00. If this is not the first primary for the patient, all the primaries for the patient are listed, and you can edit any of the primaries or add another. If the sequence number is not correct, such as when a patient had a previous cancer diagnosis and was treated elsewhere, type 02. Editing a New or an Existing Primary XE "Abstract:Enter a new primary"  XE "Abstract:Edit an existing primary"  Type a new primary SITE/GP. The program takes you to the body of the abstract. E EDIT existing Primary A ADD another Primary F Follow-Up Q Quit Patient EDIT/ADD primary for this patient: Edit// Select A to edit all the information or select the portion of the abstract you want to edit. --------------------------------------------------------------------------Primary Sub-menu Options -------------------------------------------------------------------------- 1. Patient Identification 2. Cancer Identification 3. Stage of Disease at Diagnosis 4. First Course of Treatment 5. Patient Care Evaluation A All - Complete Abstract Note: If you only want to edit one section of the abstract, select that number. Adding a Second Primary XE "Abstract:Add a second primary"  Select AI, the Abstract/Printing option. Select *..Abstracting/Printing Option: AI Complete Abstract Enter patient name: LAST, FIRST Place of birth.............: NEW YORK Race 1.....................: WHITE Race 2.....................: NA Race 3.....................: NA Race 4.....................: NA Race 5.....................: NA Spanish origin.............: NON-SPANISH, NON-HISPANIC Sex........................: MALE Agent Orange exposure......: NO Ionizing radiation exposure: NO Chemical exposure..........: UNKNOWN Asbestos exposure..........: UNKNOWN Persian Gulf service.......: NO Middle East service........: NO Somalia service............: NO Comorbidity/Complication #1: 401.9 HYPERTENSION NOS Comorbidity/Complication #2: 724.2 LUMBAGO Comorbidity/Complication #3: Comorbidity/complication #4: Comorbidity/Complication #5: Comorbidity/Complication #6: Note: The personal information entered for the first primary displays and you can edit it or accept it as it is. Edit patient data? YES// NO Continue with Patient History? Yes// NO Acc/Sequence Primary Site Last Cancer Status Date DX Status ------------- ------------- ------------------ --------- --------- 2004-00898/00 BONE MARROW Evidence this CA 06/23/2004 Complete Select one of the following: E EDIT existing Primary A ADD another Primary F Follow-Up Q Quit Patient To add another primary for the patient select ADD another Primary. EDIT/ADD primary for this patient: Edit// ADD another Primary ********************* ADD PRIMARY ********************* LAST, FIRST ACCESSION NUMBER: 2004-00898 SEQUENCE NUMBER: 02// Note: The sequence number is updated. The first sequence number is changed from 00 to 01 and the additional one is 02. Type the site or topography code and press Enter. Select another Primary 'SITE/GP': LUNG NOS Continue following the prompts. Completing an Abstract XE "Abstract:Status"  After you finish an abstract, you must change the abstract status to Complete (3). OncoTraX reviews all mandatory fields and if any are not filled in, you are unable to code the abstract status as Complete. When an abstract is not complete and you have a large amount of data, you can change the status to partial or minimal. An incomplete abstract generates a list of empty required fields. Go back into the abstract and fill in the empty required fieldsleave no blanks. In Abstract Status, you decide when to call an incomplete abstract. You can leave it as incomplete and do nothing more. To change the status, type the number, the first letter, or the entire word. Note: You cannot set the abstract to Complete, if any of the required fields are left blank. Example ABSTRACT STATUS ABSTRACT STATUS: Incomplete// ? Choose from: 0 Incomplete 1 Minimal data 2 Partial 3 Complete ABSTRACT STATUS: Incomplete// c Complete?? Abstract Status may not be set to COMPLETE unless ALL REQUIRED DATA FIELDS HAVE BEEN ENTERED. The following REQUIRED fields have not been entered for this primary: ALCOHOL HISTORY DATE OF SURGICAL DISCHARGE DATE RADIATION STARTED DIAGNOSTIC CONFIRMATION EXTENSION Note: Alcohol History, Tobacco History, Family History, and Occupation Information are considered patient demographic fields. You cannot ^ from these fields back to the patient .You must exit out of the abstract and go back into AI. You can ^ to any primary field, such as Date of Surgical Discharge, Date Radiation Started, Diagnostic Confirmation, and Extension , and so on. Example: ^Date of Surgical Discharge. EE Abstract Edit Primary XE "EE"  XE "Abstract:Edit a primary"  The Abstract Edit Primary option allows you to edit only information related to the cancer and not to a patients demographics. Only the primary fields of the abstract are brought up. This option allows you to pull up a patient using only the Accession/Sequence Number. Note: The Accession/Sequence Number must be typed exactly as in the example. Select *..Abstracting/Printing Option: EE Abstract Edit Primary Select primary or patient name: 2000-00163/00 PROSTATE Last, First Note: The site and patients name are echoed back to you. NC Print Abstract NOT Complete List XE "NC"  XE "Abstract:Print not complete list"  The Print Abstract NOT Complete List option allows you to print a list of records with an Abstract Status of Incomplete, Minimal, and Partial. The report shows the accession/sequence number, patient name, SSN, ICDO topography, and the date of diagnosis. Records are sorted according to the Status and Patient Name. Example ACC/SEQ NAME SSN NUMBER PRIMARY SITE COC DATE DX ABSTRACT STATUS: Incomplete ONCOPatient1 999-99-9999 2005-00537/00 UNKNOWN PRIMAR 1 07/29/2005 ABSTRACT STATUS: Minimal data ONCOPatient2 999-99-9999 1995-00136/01 SKIN, TRUNK 1 03/02/1995 ABSTRACT STATUS: Partial ONCOPatient3 999-99-9999 2005-00752/01 RECTOSIGMOID J 1 10/18/2005 ONCOPatient4 999-99-9999 2005-00763/00 ESOPHAGUS, LOW 1 10/27/2005 Note: Only AI and EE allow you to enter data into an abstract. IR Patient Summary  XE "IR"  XE "Abstract:Patient summary"  The Patient Summary option allows you to produce a brief summary of the data found in a patients abstract. QA Print Abstract QA (80c)  XE "Abstract:Print QA"  XE "QA"  The Print Abstract QA option allows you to print a user-friendly abstract, which physicians can use when doing the ACoS required QA portion of registry abstracts. Note: 80c (80 columns) presents an easy-to-read display on the computer screen. EX Print Abstract-Extended (80c)  XE "EX"  XE "Abstract:Print extended"  The Print Abstract Extended option allows you to print a condensed version of a complete abstract. Note: 80c (80 columns) presents an easy-to-read display on the computer screen. PA Print Complete Abstract (132c) The Print Complete Abstract option allows you to print a complete abstract, which includes capturing the extended data set or to print without personal identifiers (sensitive information), specifically name and SSN. Note: 132c (132 columns) does not present an easy-to-read display on the computer screen because the text wraps; select a device that can print 132 columns. XE "PA"  XE "Abstract:Print complete"  MA Print QA/Multiple Abstracts XE "MA"  XE "Abstract:Print QA/multiple"  The Print QA/Multiple Abstracts option allows you to print quality assurance/multiple abstracts. AS Abstract Screens Menu (80c) XE "AS"  XE "Abstract:Screens menu"  The Abstract Screens Menu option allows you to print or view on your screen, various portions of a patients abstract. Note: 80c (80 columns) presents an easy-to-read display on the computer screen. FOL Follow-up Module XE "FOL"  XE "Module:Follow-up"  The Follow-up module provides follow up information based on the date of last contact. A patient is considered delinquent or lost to follow-up when no contact is made within 15 months after the date of last contact. Lost cases remain delinquent in follow-up until further information is obtained. ************ FOLLOW-UP FUNCTIONS ********** PF Post/Edit Follow-up RF Recurrence/Sub Tx Follow-up FH Patient Follow-up History DF Print Due Follow-up List by Month Due LF Print Delinquent (LTF) List FP Follow-up Procedures Menu ... Note: The first screen contains the information from the last posted follow-up note. The system prompts you to enter new follow-up information, beginning with Date of Last Contact or Death. PF Post/Edit Follow-up XE "PF"  XE "Follow-up:Post/edit"  The Post Follow-up option allows you to post and edit follow-up information. PF Post/Edit Follow-up: Type the patient's PID#; refer to the Glossary on page  PAGEREF _Ref165275074 \h 95. Date of Last Contact or Death:Date of last contact with the patient and not the date you are entering the patient information. To edit the date of contact, select the date and press Enter. To add new follow-up information, type a new date. DATE ENTERED, REGISTRAR: The system automatically enters the date you are entering the follow-up and the registrars name. VITAL STATUS: Type A for Alive or D for Dead. FOLLOW-SOURCE: From the FORDS manual, select allowable fields. COMMENTS: Type information from the patients last contact. Example Patient seen in Oncology clinic, no evidence of disease recurrence. or Patient seen in urology clinic, PSA <0.05. CANCER STATUS: Choose from the following: 1 No evidence of this tumor 2 Evidence of this tumor 9 Unknown/not stated if this tumor present Note: Every Complete abstract must have follow-up posted. RF Recurrence/Sub Tx Follow-up XE "RF"   XE "Follow-up:Recurrence/sub tx" The Recurrence/Sub Tx Follow-up option allows you to document the first recurrence and/or subsequent treatment. Date of first recurrence is the date a medical practitioner diagnoses a recurrence of a cancer after a disease-free period. Recurrence means the return or reappearance of the cancer after a disease-free period. Select Initiation Date: Recurrence/Sub Tx Follow-up: Type the patient's or PID#; refer to the Glossary on page  PAGEREF _Ref165275118 \h 95. Type of First Recurrence: Enter the appropriate code for the first recurrence for this primary. Note: To bring up a list of selections, type ?? at the prompt. Select Subsequent Course of Treatment If the patient did not receive subsequent treatment, press Enter. If the patient did receive subsequent treatment, type the date treatment began. Treatment fields display: SURGERY OF PRIMARY SITE: SURGERY OF PRIMARY SITE DATE: RADIATION: RADIATION DATE: CHEMOTHERAPY: CHEMOTHERAPY DATE: HORMONE THERAPY: HORMONE THERAPY DATE: IMMUNOTHERAPY: IMMUNOTHERAPY DATE: HEMA TRANS/ENDOCRINE PROC: HEMA TRANS/ENDOCRINE PROC DATE: OTHER TREATMENT: OTHER TREATMENT START DATE: PLACE: SUBSEQUENT THERAPY COMMENTS: No existing text Edit? NO// To enter a comment, type Y. Initiation Date: For each recurrence for this primary, type the date the course of treatment began. *************************** POST/EDIT FOLLOW-UP ************************** Update the follow-up now. Note: The subsequent course of treatment may consist of multiple treatments. If a patient did not receive a particular treatment, be sure to code it 00 for no treatment. Do not leave any treatment fields blank. FH Patient Follow-up History XE "FH"  XE "Follow-up:History"  The Patient Follow-up History allows you to print the patient's follow-up history, including when the next follow-up is due. Type the patient's name and a device, or print to your screen. DF Print Due Follow-up List by Month Due XE "DF"  XE "Follow-up:Print list by month due"  The Print Due Follow-up List by Month Due option allows you to print a list of follow-ups that are due for a selected date range. They display by month due, along with the SSN, primary site, last date of contact, and date of diagnosis. Your previous date range selection displays automatically. You want to be current by doing a patient due for follow-up in the month that the follow-up is scheduled; however, with other duties to perform, you may not be able to do this. In this case, work on the Lost To Follow-up list. Example START WITH DUE FOLLOW-UP: // 12-2005 (DEC 2005) GO TO DUE FOLLOW-UP: LAST// 12-31-05 (DEC 31 2005) ********************************************************************************* TUMOR REGISTRY - DUE FOLLOW-UP Washington DC VAMC DEC 21, 2005 PAGE: 1 Patient Name Med Rec# Contact Primary Site/Gp Date Dx ********************************************************************************* DUE FOLLOW-UP: DEC 2005 ONCOPATIENT1 999-99-9999 12/1/2004 TESTIS 03/13/1986 TESTIS 07/27/1999 ONCOPATIENT2 999-99-9999 12/31/2004 MELANOMA 11/05/2004 ONCOPATIENT3 999-99-9999 12/14/2004 SOFT TISSUE 04/19/2002 ------------------------------------------- COUNT 3 LF Print Delinquent (LTF) List XE "LF"  XE "Follow-up:Print delinquent list"  The Print Delinquent (LTF) List option allows you to print a list of all patients whose Due Follow-up date is over 3 months (are not seen/contacted for over 15 months). These patients are considered lost to follow-up. The report is sorted by the month and year the follow-up was due and prints the SSN, date of last contact, Site/Gp, and date of diagnosis. Note: You may want to use this option frequently; if you are in a crunch, run only this list and work to reduce these numbers. Example ONCOLOGY DELINQUENT (LTF) LIST DATE LAST NAME SSN CONTACT SITE/GP DATE DX ------------------------------------------------------------------------------------------------ DUE FOLLOW-UP: MAY 1997 ONCOPATIENT1 999-99-9999 5/03/1996 BLADDER 10/25/1993 DUE FOLLOW-UP: JUN 2005 ONCOPATIENT2 999-99-9999 06/07/2004 PROSTATE 05/14/1998 DUE FOLLOW-UP: AUG 2005 ONCOPATIENT3 999-99-9999 08/19/2004 PROSTATE 02/06/1985 DUE FOLLOW-UP: SEP 2005 ONCOPATIENT4 999-99-9999 09/01/2004 ENDOCRINE, OTHER 06/24/1996 ONCOPATIENT5 999-99-9999 09/13/2004 BREAST 03/22/2000 COUNT 5 FP Follow-up Procedures Menu XE "FP"  XE "Follow-up:Procedures menu"  The Follow-up Procedures Menu option allows you to manage follow-up by providing a list of contacts for the patient, follow-up letters, and a summary report of the patient follow-up. PI Patient Follow-up Inquiry AC Add Patient Contact AF Attempt a Follow-up PL Print Follow-up Letter EL Add/Edit Follow-up Letter FR Individual Follow-up Report UP Update Contact File Type a patient name at the prompt. PI Patient Follow-up Inquiry view the last time a patient had follow-up and the status of the cancer at that time. AC Add Patient Contact view contacts for a specific patient and add other contacts. Additional contacts may be useful when doing follow-up on a patient. AF Attempt a Follow-up document the date for which you want a patient follow-up and the method you used. PL Print Follow-up Letter print a follow-up form letter to send to obtain follow-up. EL Add/Edit Follow-up Letter edit or create other follow-up letters specific to your facility. Follow-up Letter XE "Follow-up:Letter"  To send a letter to a patient, use the AC, AF, and PL options, in this sequence. To generate a follow up letter: XE "Follow-up:Generate letter"  Select OncoTraX Cancer Registry Option: fol *..Follow-up Functions ************ FOLLOW-UP FUNCTIONS ********** PF Post/Edit Follow-up RF Recurrence/Sub Tx Follow-up FH Patient Follow-up History DF Print Due Follow-up List by Month Due LF Print Delinquent (LTF) List SR Follow-up Status Report by Patient (132c) FP Follow-up Procedures Menu ... Select *..Follow-up Functions Option: FP Follow-up Procedures Menu PI Patient Follow-up Inquiry AC Add Patient Contact AF Attempt a Follow-up PL Print Follow-up Letter EL Add/Edit Follow-up Letter FR Individual Follow-up Report UP Update Contact File Select Follow-up Procedures Menu Option: AC Add Patient Contact ********* DISPLAY CONTACTS ********** Select Patient: T9999 (Type the PID# to bring up patient or patients name) Searching for a VA Patient, (pointed-to by NAME) LAST,FIRST 10-23-26 000129999 All of the contacts for this patient are displayed AVAILABLE CONTACTS ================== Patient LAST,FIRST 000 999-0000 1269 STREETNAME ST City, ST 00000 Next of Kin LAST,FIRST1, NEXT OF KIN 000 999-0000 0000 STREETNAME ST City,ST 00000 ********** ADD/EDIT CONTACTS ********** for: Last,First To send a letter to a patient: XE "Follow-up:Send letter"  Select TYPE OF FOLLOW-UP CONTACT: Guardian// PT Type PT. TYPE OF FOLLOW-UP CONTACT: Patient// CONTACT NAME: LAST,FIRST1// Go to the Contact File to edit the contact's name and address. CONTACT: LAST,FIRST1// STREET ADDRESS 1: 0000 STREETNAME ST// STREET ADDRESS 2: STREET ADDRESS 3: ZIP CODE: City,ST 00000 Note: Always check the Zip Code field. The first town alphabetically with the zip code is selected. Compare it with the address in CPRS and select the correct town. PHONE: 000 999-0000// TITLE: Mr// Type a title without a period (Mr Mrs Ms and so on) COMMENTS: Select one of the following: 1 Display Contacts 2 Edit Contact 3 Attempt a Follow-up Select 3 Attempt a Follow-up. 4 Another Patient 5 Exit Option Select Action: 3// Attempt a Follow-up ********** ATTEMPT A FOLLOW-UP ********** for Last,First Select FOLLOW-UP ATTEMPT DATE: JUL 5,2005// FOLLOW-UP ATTEMPT DATE: JUL 5,2005// TYPE: ? How will you be obtaining follow-up information? Choose from: 1 Chart Review 2 Phone Contact 3 Letter Contact Select 3 Letter Contact 8 Other THE CONTACT: LAST,First1,// Type the patients last name. RESULT: Pending// REMARKS: Generate Letter...!! Specify TYPE Contact letter: ?? ?? (two question marks) brings up a list from which to select a type. Choose from: 1 PATIENT *Washington LETTER* 2 PATIENT *Washington 2* DOT MATRIX 3 PATIENT *Washington 3 LETTER* 4 PATIENT *Washington NEW* 5 PATIENT TESTING LETTER CHOOSE 1-5: 1 PATIENT *Washington LETTER* DEVICE: (ENTER YOUR PRINTER) To edit the follow-up letter: XE "Follow-up:Edit letter"  Follow-up Procedures Menu PI Patient Follow-up Inquiry AC Add Patient Contact AF Attempt a Follow-up PL Print Follow-up Letter EL Add/Edit Follow-up Letter Select EL Add/Edit Follow-up Letter. FR Individual Follow-up Report UP Update Contact File EL Add/Edit Follow-up Letter Select letter to Add/Edit: PAT Type PAT. 1 PATIENT *Washington LETTER* 2 PATIENT *Washington DOT MATRIX 3 PATIENT *Washington 2 LETTER* 4 PATIENT *Washington NEW* 5 PATIENT TESTING LETTER Press to see more, '^' to exit this list, OR CHOOSE 1-5: 1 PATIENT *Washington LETTER* NAME: PATIENT *Washington LETTER* Replace To change the name, type and press Enter. Type the name change for the letter. FORM TYPE: PATIENT// ? DESCRIPTION: No existing text Edit? NO// MAIN FORM BODY:. . . Our hospital has a clinical program engaged in following the progress of our former patients. We are interested in knowing how you are doing. Edit? NO// YES Respond YES to edit the letter. This takes you into the text editor (like VistA E-MAIL), where you can make changes to the wording of the letter. Do not change anything that is between the upright characters. Example |PATIENT NAME| This information is automatically pulled from other parts in VistA. If you delete an upright or alter the text in the upright, the information is not placed into your letter. Edit? NO// YES Example of the editing screen XE "Follow-up:Letter edit screen"  DO NOT CHANGE ANYTHING WITHIN THE UPRIGHTS OR DELETE THEM |INDENT(10)| DEPARTMENT OF VETERANS AFFAIRS |HOSPITAL NAME| |HOSPITAL STREET ADDRESS| |HOSPITAL CITY,ST ZIP| |LAST(FOLLOW-UP ATTEMPTS:FOLLOW-UP ATTEMPT DATE)| |SSN| 528/111H |LOWERCASE(ONCOFIRSTNAME LASTNAME(LAST FOLLOW-UP CONTACT))||TAB| |LAST FOLLOW-UP CONTACT:STREET ADDRESS 1| |WRAP| |LAST FOLLOW-UP CONTACT:STREET ADDRESS 2| |LAST FOLLOW-UP CONTACT:STREET ADDRESS 3| |NOWRAP| |LAST FOLLOW-UP CONTACT:ZIP CODE| Dear |LAST FOLLOW-UP CONTACT:TITLE|. |LOWERCASE(LAST NAME)|, Text below this line may be changed. Example of a follow-up letter to a patient XE "Follow-up:Letter example"  Our hospital has a clinical program engaged in following the progress of our former patients. We are interested in knowing how you are doing. Would you be kind enough to answer the questions listed below? Your assistance will add to the success of this program and help us achieve better patient care in our hospital. A self-addressed stamped envelope is enclosed for your convenience. Thank you for your participation. Sincerely, |Cancer Registrar| Cancer Registrar Today's date: ______________ What is your present status? _____ Free of cancer _____ Not free of cancer Are you able to work or carry on normal activity? ____ YES, Normal _____ Limited _____ Capable, but limited _____ Incapable _____ Bedridden Have you seen a doctor outside of the VA Medical Center? _____ Yes _____ No If "Yes", who and where: _________________________________________________________ IF THE PATIENT IS DECEASED, Please give date and place of death: _________________________________________________________ What was the cause of death? _______Cancer ________Not Cancer _____ Other causes (specify) ___________________________ Please list any other symptoms relating to your condition not covered in the above items on the back of this sheet. This page intentionally left blank for double-sided printing. LIS Registry Lists Module XE "LIS"  XE "Module:Registry lists"  The Registry Lists module is a menu of registry listings containing various accession registers, and patient and site reports. Any 132c report requires a printer that prints 132 columns. Any 80c report requires a printer that prints 80 columns. The majority of the reports produce information that includes the entire database. If you have 20 years of data in your registry, the report contains all 20 years of data. For data from a specific year, use the options in the ANN *..Annual Reports ...module. ************Cancer Registry Lists************ AA Accession Register-ACoS (80c) AS Accession Register-Site (80c) AE Accession Register-EOVA (132c) PA Patient Index-ACoS (132c) PS Patient Index-Site (80c) PE Patient Index-EOVA (132c) IN Primary ICDO Listing (80c) SG Primary Site/GP Listing (80c) IW Primary ICDO Listing (132c) AA Accession Register-ACoS (80c) XE "AA"  XE "Registry:Accession Register-ACoS"  The Accession Register-ACoS list allows you to print all records. This contains the ACoS required Accession Register data items. Note: 80c (80 columns) presents an easy-to-read display on the computer screen. Press Enter at the START WITH prompt. For a complete register: START WITH ACC/SEQ NUMBER: FIRST// To get all records beginning with the same year: For a single accession year (e.g. 2003): START WITH ACC/SEQ NUMBER: FIRST// 2003-00000 GO TO ACC/SEQ NUMBER: LAST// 2003-99999 To get a Specific range of records: START WITH ACC/SEQ NUMBER: 2004-00400 -00// GO TO ACC/SEQ NUMBER: 2004-00500 ACC/SEQ# PATIENT NAME ICDO TOPOGRAPHY DATE DX YEAR 2004-00400/00 ONCOPATIENT1 C42.0 BLOOD 06/03/2004 2004 2004-00408/00 ONCOPATIENT2 C02.9 TONGUE NOS 06/24/2004 2004 2004-00409/00 ONCOPATIENT3 C18.7 COLON, SIGMOID 06/24/2004 2004 AS Accession Register-Site (80c) XE "Registry:Accession Register-Site"  XE "AS"  The Accession Register Site list allows you to select a range of accession years or a range of accession numbers. Note: 80c (80 columns) presents an easy-to-read display on the computer screen. You are provided with the following data: ACC/SEQ # PATIENT NAME SSN PRIMARY SITE/GP DATE DX YEAR AE Accession Register-EOVA (132c)  XE "AE"  XE "Registry:Accession Register-EOVA"  The Accession Register-EOVA list is similar to AA Accession Register-ACoS, but displays more fields. Note: 132c (132 columns) does not present an easy-to-read display on the computer screen because the text wraps; select a device that can print 132 columns. PA Patient Index-ACoS (132c) XE "Registry:Patient index-ACoS"   XE "PA" The Patient Index-ACoS allows you to print the Patient Index, which contains all elements required by the ACoS Cancer Program, for all the patients in the registry. The list is very long. Note: 132c (132 columns) does not present an easy-to-read display on the computer screen because the text wraps; select a device that can print 132 columns. Example PATIENT NAME MED RECORD# S DT-BIRTH DT-DEATH ACC/SEQ-NO DATE DX ICDTOPOGRAPHY L ICDOMORPHOLOGY ----------------------------------------------------------------------------------------------- ONCOPATIENT1 000-00-0000 M 07/25/1940 07/25/2000 2000-00371/00 09/25/1992 C18.5COLON, SPLENIC PS Patient Index-Site (80c) XE "PS"  XE "Registry:Patient index-site"  The Patient Index Site list provides an alphabetical list of the entire registry. Note: 80c (80 columns) presents an easy-to-read display on the computer screen. PATIENT NAME SSN SX ACC/SEQ # PRIMARY SITE/GP DATE DX PE Patient Index-EOVA (132c)  XE "PE"  XE "Registry:Patient index-EOVA"  The Patient Index-EOVA is similar to PA Patient Index Site, but provides slightly different information. Note: 132c (132 columns) does not present an easy-to-read display on the computer screen because the text wraps; select a device that can print 132 columns. IN Primary ICDO Listing (80c)  XE "IN"  XE "Registry:Primary ICDO listing"  The Primary ICDO Listing provides a list of all cases in the entire registry by the ICDO codes. The list begins with ICDO-SITE: C00-LIP. The list is very long. Note: 80c (80 columns) presents an easy-to-read display on the computer screen. PATIENT NAME SSN YEAR ACC/SEQ # TOPOGRAPHY DATE DX SG Primary Site/GP Listing (80c) XE "Registry:Primary site/GP listing"  XE "SG"  The Primary Site/GP Listing provides a list of all cases in the entire registry by requested site/gp. The previous selection displays as the default. Note: 80c (80 columns) presents an easy-to-read display on the computer screen. * Previous selection: SITE/GP equals LUNG START WITH SITE/GP: LUNG// PANCREAS Type PANCREAS. GO TO SITE/GP: LAST// PANCREAS Previous selection: ICDO TOPOGRAPHY-CODE from C34.0 to C34.9 START WITH PRIMARY SITE CODE: C34.0// C25 For a specific primary site use only that code GO TO PRIMARY SITE CODE: C34.9// C25.9 Example List for an ICDO Code, sorted alphabetically. PATIENT NAME SSN YEAR ACC/SEQ # TOPOGRAPHY DATE DX --------------------------------------------------------------------------- ICDO CODE: C25.0 LAST,FIRST A 000-00-0000 2002 2002-00072/00 PANCREAS HEAD 02/20/2002 ICDO CODE: C25.1 LAST,FIRST B 000-00-0000 1978 1978-00089/00 PANCREAS BODY 05/01/1978 LAST,FIRST C 000-00-0000 2005 2005-00143/02 PANCREAS BODY 03/23/2005 ICDO CODE: C25.2 LAST,FIRST D 000-00-0000 2006 2006-00001/00 PANCREAS TAIL 01/01/2006 LAST,FIRST E 000-00-0000 1985 1985-00347/03 PANCREAS TAIL 07/17/1985 ICDO CODE: C25.9 LAST,FIRST F 000-00-0000 2005 2005-00089/00 PANCREAS NOS 05/01/2005 LAST,FIRST G 000-00-0000 1998 1998-00019/00 PANCREAS NOS 02/01/1998 IW Primary ICDO Listing (132c)  XE "IW"  XE "Registry:Primary ICDO listing"  The Primary ICDO Listing provides a list of all patients by all primary site codes in the entire registry. PRIMARY SITE: C00.0-LIP, EXTERNAL UPPER PATIENT NAME SSN DOB DOD YEAR ACC/SEQ# DATE DX TOPOGRAPHY MORPHOLOGY Note: If you have time, experiment with this listing to see all that it can provide. This page intentionally left blank for double-sided printing. ANN Annual Reporting Module XE "ANN"  XE "Module:Annual reporting"  The Annual Reporting module is a menu of annual reports. Annual Reports AAR Annual ACoS Accession Register (80c) API Annual ACoS Patient Index (132c) ASL Annual Primary Site/GP Listing (132c) ACL Annual Patient List by Class of Case (80c) SST Annual Primary Site/Stage/Tx (132c) TST Annual ICDO Topography/Stage/Tx (132c) SDX Annual Status/Site/Dx-Age (132c) HIS Annual Histology/Site/Topography (80c) AST Annual Site/ICDO Topography/Histology (80c) ACT Annual Cross Tabs (80c) CPR Print Custom Reports The Annual ACoS Accession Register and Annual ACoS Patient Index are required for ACoS approval. Print Custom Reports allows you to retrieve data requested by your staff from your database. It requires knowledge of basic FileMan functions. AAR Annual ACoS Accession Register (80c) XE "AAR"  XE "Annual reporting:ACoS Accession Register"  The ACoS Annual Accession Register is an annual report required by ACoS. The report is sorted by accession /sequence number within a specific accession year and a count of the records prints at the end. Note: 80c (80 columns) presents an easy-to-read display on the computer screen. Select year: 2005 Type specific year. Example of the report ******************************************************************************************************************* ACC/SEQ-No Patient Name ICDO Topography Date Dx C L 1975-00334/04 ONCOPATIENT1 C44.1 SKIN, EYELID 01/19/2005 1 1 1987-00118/03 ONCOPATIENT2 C80.9 UNKNOWN PRIMARY 05/10/2005 1 0 2005-00055/00 ONCOPATIENT3 C61.9 PROSTATE 02/08/2005 1 0 API Annual ACoS Patient Index (132c) XE "API"  XE "Annual reporting:ACoS patient index"  The Annual ACoS Patient Index is an annual report of the required ACoS items for an accession year. A count of the records prints at the end. Note: 132c (132 columns) does not present an easy-to-read display on the computer screen because the text wraps; select a device that can print 132 columns. Select year: Type specific year. Example fields in this report *************************************************************************************************************************************************** PATIENT NAME MED RECORD# DT-BIRTH DT-DEATH ACC/SEQ-NO ICDO TOPOGRAPHY MORPHOLOGY L ASL Annual Primary Site/GP Listing (132c) Note: 132c (132 columns) does not present an easy-to-read display on the computer screen because the text wraps; select a device that can print 132 columns. XE "ASL"  XE "Annual reporting:Primary site/GP listing"  The Annual Primary Site/GP Listing is an annual report sorted first by accession year and then by the primary site/group. Example START WITH ACCESSION YEAR: FIRST// 2003 GO TO ACCESSION YEAR: LAST// 2003 START WITH SITE/GP: FIRST// BLADDER Note: Type the SITE/GP in capital letters. GO TO SITE/GP: LAST// BLADDER Example fields in this report A list of all patients from the year 2003 with a primary Bladder cancer displays. PATIENT NAME MED RECORD# S DT-BIRTH DT-DEATH ACC/SEQ DATE DX ICDO TOPOGRAPHY ICDO MORPHOLOGY ACL Annual Patient List by Class of Case (80c) XE "ACL"   XE "Annual reporting:Patient list by class of case" The Annual Patient List by Class of Case is an annual report listing all patients alphabetically, for a specific year for each class of case. Note: 80c (80 columns) presents an easy-to-read display on the computer screen. Example fields in this report Patient Name Med Rec# Sx Acc/Seq# Site/Group Date Dx SST Annual Primary Site/Stage/Tx (132c) XE "SST"  XE "Annual reporting:Primary site/stage/tx"  The Annual Primary Site/Stage/Tx is an annual report listing patients for a specific year and specific site and stage. Note: 132c (132 columns) does not present an easy-to-read display on the computer screen because the text wraps; select a device that can print 132 columns. START WITH ACCESSION YEAR: 2005// GO TO ACCESSION YEAR: LAST// 2005 * Previous selection: SITE/GP equals PHARYNX START WITH SITE/GP: PHARYNX// GO TO SITE/GP: PHARYNX// Example fields in this report PT ID TX TREATMENT SURG DATE SURGERY RAD DATE RADIATION CHEMO DT CHEMOTHERAPY HT DATE HORMONE TPY TST Annual ICDO Topography/Stage/Tx (132c) XE "TST"  XE "Annual reporting:ICDO topography/stage/tx"  The Annual ICDO Topography/Stage/Tx is an annual report listing cases by stage and site for a selected accession year and selected ICDO-topography. Note: 132c (132 columns) does not present an easy-to-read display on the computer screen because the text wraps; select a device that can print 132 columns. START WITH ACCESSION YEAR: 2006// 2005 Define the year. GO TO ACCESSION YEAR: 2006// 2005 * Previous selection: ICDO-SITE CODE from C00 to C90 START WITH PRIMARY SITE CODE PREFIX: C00// Define the ICDO-SITE CODE (S). GO TO PRIMARY SITE CODE PREFIX: C90// C02 Example -------------------------------------------------------------------------- ICDO-SITE CODE: C32 STAGE GROUPING-AJCC: I W5321 C32.0 NONE ------- SUBCOUNT 1 R3493 C32.0 XRT 00/00/0000 06/13/2005 Beam radiation 00/00/0000 None 00/00/0000 None ------- SUBCOUNT 1 ------- SUBCOUNT 2 STAGE GROUPING-AJCC: II B4704 C32.0 XRT 00/00/0000 03/03/2005 Beam radiation 00/00/0000 None 00/00/0000 None ------- SUBCOUNT 1 ------- SUBCOUNT 1 STAGE GROUPING-AJCC: IV B6985 C32.0 NONE ------- SUBCOUNT 1 P7689 C32.1 SUR 09/02/2005 ------- SUBCOUNT H7872 C32.1 XRT/CMX 00/00/0000 07/13/2005 Beam radiation 07/18/2005 Multiagent00/00/0000 None ------- SUBCOUNT 1 ------- SUBCOUNT 3 ------- COUNT 6 SDX Annual Status/Site/Dx-Age (132c) XE "SDX"  XE "Annual reporting:Status/site/dx-age"  The Annual Status/Site/Dx-Age is an annual report listing patients for a specific accession year. Note: 132c (132 columns) does not present an easy-to-read display on the computer screen because the text wraps; select a device that can print 132 columns. Annual report - sorted first by Accession year Then by Class Category (Non-analytic/Analytic) Then by Status, Site/GP, and Diagnosis Age Gp. Enter four digit ACCESSION YEAR, For Class category: either 'A' for Analytic, or first to last. Example START WITH ACCESSION YEAR: 2005 GO TO ACCESSION YEAR: LAST// 2005 . * Previous selection: CLASS CATEGORY equals 1 (ANALYTIC) START WITH CLASS CATEGORY: 1// ANALYTIC GO TO CLASS CATEGORY: 1// ANALYTIC DEVICE: PRIMARY LIST DX AGE-GP: 60-69 ONCOPATIENT1 999-99-9999 2005-00054/00 02/02/2005 ANUS NOS SQUAM CELL CARC T1 N0 M0 I SUR ONCOPATIENT2 999-99-9999 2005-00272/00 03/22/2005 ANUS NOS SQUAM CELL CARC TX NX MX Unkno UR/CMX HIS Annual Histology/Site/Topography (80c) XE "HIS"  XE "Annual reporting:Histology/site/topography"  The Annual Histology/Stage/Topography is an annual report listing. Note: 80c (80 columns) presents an easy-to-read display on the computer screen. START WITH ACCESSION YEAR: 2005// GO TO ACCESSION YEAR: LAST// 2005 START WITH SITE/GP: PHARYNX// GO TO SITE/GP: PHARYNX// Example *********************************************************************************************** 2005 - ANALYTIC Washington DC VAMc DEC 21,2005 PAGE: 1 Patient Name Med Rec# Sx Acc/Seq# ICDO-Topography Date Dx *********************************************************************************************** ICDO HISTOLOGY-CODE: 8070/3 SITE/GP: PHARYNX ICDO-SITE CODE: C01 PATIENT NAME: ONCOPATIENT1 ONCOPATIENT1 999-99-9999 M 2005-00096/00 TONGUE BASE 03/14/2005 ICDO-SITE CODE: C09 PATIENT NAME: ONCOPATIENT2 ONCOPATIENT2 999-99-9999 M 2005-00494/00 TONSILLAR FOSSA 07/12/2005 ICDO-SITE CODE: C10 PATIENT NAME: ONCOPATIENT3 ONCOPATIENT3 999-99-9999 M 2005-00029/00 OROPHARYNX NOS 01/27/2005 COUNT 4 ------------- SUBCOUNT 3 ACT Annual Cross Tabs (80c) XE "Annual reporting:Cross tabs"   XE "ACT" The Annual Cross Tabs is an annual report that is very long. Queue this report after hours. Note: 80c (80 columns) presents an easy-to-read display on the computer screen. CPR PRINT Custom Reports XE "Annual reporting:Print custom reports"   XE "CPR" The PRINT Custom Reports option allows you to create custom reports using VA FileMan. Note: It is very helpful to have some FileMan training from the computer department at your facility. Also, with knowledge of capturing files and opening them in Microsoft Excel, you can create a very usable and professional document. You can retrieve any data that you enter into an abstract. Create a report by specifying: file from which the information is coming, OncoTraX Primary (#165.5), OncoTraX Patient (#160), or OncoTraX Contact (#165); fields that contain the data; how to separate/sort the data; and information to be printed. This page intentionally left blank for double-sided printing. STA Statistical Reporting Module XE "STA"  XE "Module:Statistical reporting"  The Statistical Reporting module allows you to obtain 5-year survival information on your data. You can search for user-defined criteria. ****************STATISTICAL REPORTS************** TS Treatment by Stage - Cross tabs SP Survival by Site SS Survival by Stage TX Survival by Treatment SU Survival Routines DS Define Search Criteria DS Define Search Criteria XE "DS"  XE "Statistical reporting:Define search criteria"  The Define Search Criteria option allows you to define criteria to obtain 5-year survival information from: SP Survival by Site SS Survival by Stage TX Survival by Treatment In order to use SP, SS, TX, or SU (Survival Routines), you must first create a template using DS Define Search Criteria. Use DS to create search templates for Survival Analysis. Note: Name templates beginning with ONCOZ for user-defined templates rather than software-distributed names, ONCOS. Select one of the following: 1 ONCOTRAX PRIMARY 2 ONCOTRAX PATIENT 3 ONCOTRAX CONTACT Select File: 1 ONCOTRAX PRIMARY We will search entries in ONCOTRAX PRIMARY file... -A- SEARCH FOR ONCOTRAX PRIMARY FIELD: SITE/GP -A- CONDITION: ? Type ? to view choices. Answer with CONDITION NUMBER, or NAME Type a condition. Choose from 1 NULL 2 CONTAINS 3 MATCHES 4 LESS THAN 5 EQUALS 6 GREATER THAN YOU CAN NEGATE ANY OF THESE CONDITIONS BY PRECEDING THEM WITH OR "-" SO THAT "'NULL'" MEANS "NOT NULL" -A- CONDITION: CONTAINS -A- CONTAINS: LUNG NOS -B- SEARCH FOR ONCOTRAX PRIMARY FIELD: ACCESSION YEAR -B- CONDITION: GREATER THAN -B- GREATER THAN: 1995 -C- SEARCH FOR ONCOTRAX PRIMARY FIELD: ACCESSION YEAR -C- CONDITION: LESS THAN -C- LESS THAN: 2001 -D- SEARCH FOR ONCOTRAX PRIMARY FIELD: CLASS CATEGORY -D- CONDITION: EQUALS -D- EQUALS: ANALYTIC Use only analytic cases for survival data. -E- SEARCH FOR ONCOTRAX PRIMARY FIELD: Note: If you want to include more data, continue with E. If not, press Enter and at IF, type the letters of your search criteria. The screen echoes back your selections. IF: ABCD SITE/GP CONTAINS (case-insensitive) "LUNG NOS" and ACCESSION YEAR GREATER THAN 1995 and ACCESSION YEAR LESS THAN 2001 and CLASS CATEGORY EQUALS "1" (ANALYTIC) or STORE RESULTS OF SEARCH IN TEMPLATE: ONCOZ LUNG NOS SURVIVAL Name the template beginning with ONCOZ. Press Enter to start the sort. Note: You do a sort make sure that data is available. You can sort and print any data you want to view. SORT BY: NUMBER// AJCC STAGE START WITH AJCC STAGE: FIRST// WITHIN AJCC STAGE, SORT BY: FIRST PRINT FIELD: !PID# THEN PRINT FIELD: DATE DX THEN PRINT FIELD: TREATMENT PLAN THEN PRINT FIELD: Heading (S/C): ONCOTRAX PRIMARY STATISTICS Replace Running Survival Options. SP Survival by Site SS Survival by Stage TX Survival by Treatment SP Survival by Site XE "Search criteria:Survival by site"  XE "Search criteria:SP"  Survival by Site produces a 5-year survival by site, from the criteria you set in the DS Define Search Criteria. SS Survival by Stage XE "Search criteria:Survival by stage"  XE "Search criteria:SS"  Survival by stage produces a 5-year survival by AJCC Stage, from the criteria you set in the DS Define Search Criteria. TX Survival by Treatment XE "Search criteria:Survival by treatment"  XE "Search criteria:TX"  Survival by Treatment produces a 5-year survival by the treatment, from the criteria you set in the DS Define Search Criteria. Each of the three options also generates a list of patients who are dropped from the search and why. Example including reason Cases dropped: 4 PATIENT REASON FOR BEING DROPPED ---------------------- -------------------------------- L9999 ONCOPATIENT1 SURVIVAL MONTHS 0 Y1111 ONCOPATIENT2 SURVIVAL MONTHS 0 Example of the survival information for the template ONCOTRAX PRIMARY Template ONCOZ LUNG NOS SURVIVAL 96-99 Life Table Yrs % Alive # Left Deaths Losses ----------------------------------------------------------------------- 0 100.0 416 259 0 1 37.7 157 73 0 2 20.2 84 17 0 3 16.1 67 18 0 4 11.8 49 6 10 5 10.2 33 3 5 TS Treatment by Stage - Cross Tabs XE "TS"  XE "Statistical reporting:Treatment by stage-cross tabs"  The Treatment by Stage Cross tabs option allows you to print cross-tabs for all analytic cases for treatment by stage groups (I, II, III, IV). It is a large report and not user-friendly to view. This page intentionally left blank for double-sided printing. UTL Utility Options Module XE "Module:Utility options"  XE "UTL"  The Utility Options module allows you to manage the information in your OncoTraX database. You can correct errors, delete records, and create data disks to send to national and state databases. RS Registry Summary Reports DP Delete OncoTraX Patient DS Delete Primary Site/GP Record EA Edit Site/AccSeq# Data LG List Topographic Site Groups LT List Topography Codes by Site Group AR Create a report to preview ACoS output CT Create ACoS Data Download SR Create a report to preview State/VACCR output CC Create State/VACCR Data Download TR Define Cancer Registry Parameters AC Enter/Edit Facility file CDD1 Print Condensed DD--OncoTraX Patient file CDD2 Print Condensed DD--OncoTraX Primary file PSR Purge Suspense Records SP Purge Patient Records with No Suspense/Primaries CS Restage CS cases using latest version TNM Compute percentage of TNM forms completed TIME Timeliness Report RS Registry Summary Reports XE "RS"  XE "Utility options:Registry summary reports"  The Registry Summary Reports provide a quick count for: TToday AAnnual (132c) FFollow-up The Today report gives you an overview of the entire registry on the day and time you run the report. Analytical: 10144 Non-Analytical: 1515 Total: 11659 WORKLOAD STATISTICS Suspense: 4 Incomplete: 68 Minimal: 4 Partial: 35 Complete: 1311 The Annual report gives you the number of cases for the selected year by site, race, sex, and the AJCC Stage. There are two options to choose from after you select the year. Select year for summary: (1952-2006): 2005// Analytic cases only? YES// m Answer 'YES' if you want only analytic cases (CLASS OF CASE 0-2) displayed. Answer 'NO' if you want all cases (analytic and non-analytic) displayed. The Follow-up report offers two options that meet the ACoS requirements. Follow-up rate calculation parameters (select 1 or 2): 1) All analytic patients from the cancer registry reference date 2) All analytic patients diagnosed within the last five years, or from the cancer registry reference date, whichever is shorter Example of selection 1 FOLLOW-UP RATE FOR ALL PATIENTS (LIVING AND DEAD) NUMBER PERCENT Total patients from registry reference date 11808 100% 1. Less benign/borderline (behavior code 0/1) - 183 2. Less Carcinoma in situ CERVIX cases - 9 3. Less cases of in situ/localized basal and - 1068 squamous cell carcinoma of skin 4. Less foreign residents - 0 5. Less nonanalytic (includes recurrent cases - 1234 class of case 3,4,5, 8 & 9) SUBTOTAL CASES = ANALYTIC CASES (A) 9314 100% (class of case 0, 1, 2) 1. Less number dead (B) 6881 74% SUBTOTAL CASES (NUMBER LIVING) (C) 2433 26% 1. Less number current (known to be alive in the last 15 months) (D) 2380 26% TOTAL (LOST TO FOLLOW UP OR NOT CURRENT) (E) 53 * 1% (* should be 20%) Note: Percent should be 20% or less. Successful follow-up currency (all patients) (F) 9261 ** 99% (** should be 80%) Note: Percent should be 80% or greater. ======================================================================== FOLLOW UP RATE FOR LIVING PATIENTS ONLY NUMBER PERCENT Enter the total number from Line C 2433 100% Subtract the total number from Line D - 2380 *** 98% Total lost/not current of living patients - 53 2% *** DP Delete OncoTraX Patient XE "Delete Oncology Patient"  XE "DP"  XE "Utility options:Delete patient"  The Delete OncoTraX Patient option allows you to delete an OncoTraX patient from the OncoTraX Patient file. You can also delete any associated records in the OncoTraX Primary file. Note: Once you delete an abstract, you cannot undelete it. If you delete a patient by mistake, you have to manually re-enter the patients abstract. DS Delete Primary Site/Gp Record XE "Utility options:Delete primary site/Gp record"  XE "DS"  The Delete Primary Site/Gp Record option allows you to delete a selected primary record for a specific OncoTraX patient. EA Edit Site/AccSeq# Data XE "EA"  XE "Utility options:Edit site/AccSeq# data"  The Edit Site/AccSeq# Data option allows you to edit/correct accession numbers, sequence numbers, diagnosis dates, and so on. AR Create a Report to Preview ACoS Output XE "AR"  XE "Utility options:Create a report to preview ACoS output"  The Create a Report to Preview ACoS Output option allows the cancer registrar to preview the contents of the specified accessions intended as output for the ACoS. CT Create ACoS Data Download XE "CT"  XE "Utility options:Create ACoS data download"  The Create ACoS Data Download option allows you to create the file for submission to the American College of Surgeons (ACoS), in response to the annual call for data. SR Create a Report to Preview State/VACCR Output XE "SR"  XE "Utility options:Create a report to preview state/VACCR output"  The Create a Report to Preview State/VACCR Output option allows you to print the state extract data in a report format. CC Create State/VACCR Data Download XE "CC"   XE "Utility options:Create state VACCR data download" The Create State /VACCR Data Download option allows you to create a file for the transmission of cancer registry information, including confidential patient identity data to the State collecting agencies. This extraction routine includes/downloads only patients from your state based on ZIPCODE and COUNTY AT DIAGNOSIS. It also blanks out communicable diseases and substance abuse, which are protected by federal law. TR Define Cancer Registry Parameters XE "TR"  XE "Utility options:Define cancer registry parameters"  The Define Cancer Registry Parameters option allows you to set up the OncoTraX: Cancer Registry software. You must use this option first, in order to make several of the follow-up options work. For more information, refer to software implementation in the Oncology Technical Manual and Software Security Guide at  HYPERLINK "http://www.va.gov/vdl/documents/Clinical/Oncology/onc211_tm.doc" http://www.va.gov/vdl/documents/Clinical/Oncology/onc211_tm.doc. AC Enter/Edit Facility File XE "AC"  XE "Utility options:Enter/edit facility file"  The Enter/Edit Facility File option allows you to enter new facilities in the Facility file or change the data for a facility. CDD1 Print Condensed DD--OncoTraX Patient file XE "CDD1"  XE "Utility options:Print condensed DD-patient file"  The Print Condensed DD-OncoTraX Patient file option allows you to view the data dictionary, which lists all patient information files in the abstract. Use this option when doing custom reports. CDD2 Print Condensed DD--OncoTraX Primary file XE "Utility options:Print condensed DD-primary file"  XE "CDD2"  The Print Condensed DD-OncoTraX Primary file option allows you to view the data dictionary, which lists all primary information files in the abstract. Use this option when doing custom reports. PSR Purge Suspense Records XE "PSR"  XE "Utility options:Purge suspense records"  The Purge Suspense Records option allows you to enter multiple dates in the suspense file when deleting. Use this option with caution. SP Purge Patient Records with No Suspense/Primaries XE "SP"  XE "Utility options:Purge patient records with no suspense/primaries"  The Purge Patient Records with No Suspense/Primaries option allows you to purge OncoTraX Patient records with no suspense records and no primaries CS Restage CS Cases XE "CS"  XE "Utility options:Restage CS cases using latest version"  The Restage CS Cases option allows you to correct a problem in Collaborative Staging; use the most current version of collaborative staging. Run it only once. TNM Compute Percentage of TNM Forms Completed XE "TNM"  XE "Utility options:Compute percentage of TNM forms completed"  The Compute Percentage of TNM Forms Completed option allows you to compute the percentage of Primary Tumor, Regional Lymph Nodes, and Distant Metastasis forms completed. TIME Timeliness Report XE "TIME"  XE "Utility options:Timeliness report"  The Timeliness Report computes the percentage of cases within the selected date range, which have an ELAPSED DAYS TO COMPLETION value less than 180 days. This page intentionally left blank for double-sided printing. Reporting to VA Central Cancer Registry XE "VACCR:Reporting to"  You must report data to the VA Central Cancer Registry once a month. Select *..Utility Options Option: cc Create State/VACCR Data Download DISPLAY/PRINT on-line instructions? No// NO Available record layouts: 1) VACCR Record Layout v11.1 (VA Registry) 2) NAACCR State Record Layout v11.1 Select record layout: 1 VACCR Record Layout v11.1 Facility Identification Number (FIN): 6211145// Select date field to be used for Start/End range: ? Select the date field you wish to use for this download's Start/End range prompts. Select one of the following: 1 Date Case Completed <<<<<<<<< USE TO REPORT NEW CASES 2 Date Case Last Changed<<<<<<<>NEED LATEST<<<< XE "Downloading:Genedits"  XE "Installing:Genedits"  XE "Genedits:Downloading"   XE "Genedits:Installing" Create a folder on your drive (like M: drive) and name it Genedits. Use your network drive for this and if you should receive a new computer, you will not have to do this again. Go the ACoS website:  HYPERLINK "http://www.facs.org/cancer/index.html" http://www.facs.org/cancer/index.html On the ACS menu on the left side of the page, click National Cancer Data Base (NCDB). Under Data Submission Information, click  HYPERLINK "http://www.facs.org/cancer/ncdb/edits.html" \o "Downloading, Installing, and Running GenEDITS with the Current NCDB Edit Metafile" Downloading, Installing, and Running GenEDITS with the Current NCDB Edit Metafile Click  HYPERLINK "http://www.facs.org/cancer/ncdb/install_1985_1990_1995_2000_2005.pdf" \o "Instructions for Downloading and Installing the NCDB Metafiles and EDITS Software Beginning October 2005 (315K PDF)" Instructions for Downloading and Installing the NCDB Metafile and EDITS Software Beginning October 2006 (850K PDF) to print the instructions. Click Back in your browser, to return to the ACoS site. Under NCDB Submission Metafiles, click the  HYPERLINK "http://www.facs.org/cancer/ncdb/NCD_110B_09202006.exe" \o "NCD_110B (740K EXE)" NCD_110B (740K EXE) file to download it to the Genedits folder you created in step 1. Click Save and navigate to the Genedits folder. Click Close. Click  HYPERLINK "http://www.naaccr.org/index.asp?Col_SectionKey=7&Col_ContentID=136" \o "Download Software" Download Software and automatically go to the NAACCR website, Centers for Disease Control and Prevention (CDC). Under Installation Instructions, click Download  HYPERLINK "ftp://ftp.cdc.gov/pub/Software/RegistryPlus/EDITS/Program/edits11152001.exe" EDITS Version 1.0 (4.7M) released November 2001. Click Save and navigate to the Genedits folder. Click Close. Go to page 5 of your printed instructions and follow them. Running Genedits for ACoS Call for Data XE "Genedits:Running"  XE "Running:Genedits"  To open Genedits, double-click the icon,  In the Open Configuration File list box (pink box), double-click NCDB110B. Depending on where you installed the Genedits program, the first line is similar to: Configuration File: M:\GENEDITS\NCDB110B.GCF The second line is: EDITS Runtime Metafile <.RMF>: NCD_110B.RMF Type the path to your file. Input Data File: M:\NCDB\2005.TXT Note: It is important to include the file extension in lower case (.txt) or upper case (.TXT).  Type the path for saving your edits report. Error Message: M:\NCDB.2005.rpt On line 3, delete Use Picker Dialog, and type the path to your file. Example: M:\2005buf.txt At Error Message, type the location to save your edits for printing. Example: M:\2005ed.rpt When all lines are filled in correctly, click Run! at the top of the window. The edits report is sent to your location; as in the example: M:\2005ed.rpt. Go to Microsoft Word (or whatever Word Processing Software you use). Open the file and correct your errors. When your errors are corrected, download the data again and re-run the data through the edits. Note: If you still have errors, correct those and keep doing this until you have no errors. Then proceed to the ACoS website and submit your data to the college. You are ready to send the data to the NCDB. Go to the ACoS website:  HYPERLINK "http://www.facs.org/cancer/index.html" http://www.facs.org/cancer/index.html Sending Your File to ACoS XE "Send file to ACoS"  Log on to the website,  HYPERLINK "https://web.facs.org/datalinks/" https://web.facs.org/datalinks/ with your User ID and password. Select Submit Patient Level Data and Direct submission from my registry. Click Continue. Click Browse and find your data file; as in the example: M:\2003buf.txt. Click Submit. VistA Setu XE "VistA setup" p VistA can be set up in different ways. Line Editor XE "VistA setup:Line editor"  If you are set up with Line Editor in VistA, your screen for entering text can look like the example, TEXT-DX PROC-PE:. The number lines make editing a little difficult. Example of the Line Editor Screen  XE "Line editor example"   Screen Editor XE "VistA setup:Screen editor"  You can change to a more user-friendly word processing screen. Using the Screen Editor, you are able to move around easily, format your text, and do many things that are impossible with the line editor. To change to the Screen Editor, type ^EDIT USER CHARACTERISTICS. XE "Edit user characteristics" . Tab or arrow down to PREFERRED EDITOR: LINE EDITOR VA FILEMAN.  Change LINE to SCREEN. Example of the Screen Editor Screen XE "Screen editor example"   You can type in this screen, just like in Microsoft Word or Word Perfect. You are able to change margins, format text, join lines together, cut and paste text, easily delete text, and so on. Type F1H (H for help) to access word processing Help commands for the Screen Editor. There are four Help screens XE "Help screens"  to which you can navigate. Use the Arrow keys (to the left of the number pad) to move around the Help screens. Help Screen 3 of 4 is the most useful of the Help screens. Example of Help Screen 3 of 4  Example of Help Screen 2 of 4  Menu Options XE "Menu options"  When you sign on to VistA, your screen may be set up not to display menus. You may want to change your set up options, so that you can see your menu choices.  At Select OncoTraX: Cancer Registry Option, type ^EDIT USER CHARACTERISTICS. Arrow down to AUTO MENU: and type ? Your options display.  Select 1 YES, MENUS GENERATED. Your menu choices display when you access VistA.  BeforeAfter Edits within OncoTraX XE "Edits:OncoTraX"  If there are inter-field problems, warning messages display when you attempt to change the  XE "Edits:Interfield problems" ABSTRACT STATUS (165.5,91) to Complete These warning messages are the VistA inter-field edit checks. You can override these warnings. XE "Edits:Warning messages"  1WARNING: REPORTING HOSPITAL = REFERRING FACILITY2WARNING: REPORTING HOSPITAL = TRANSFER FACILITY3WARNING: CLASS OF CASE = 2 (Dx ew, 1st rx here) -REFERRING FACILITY may not be blank4WARNING: CLASS OF CASE = 3 (Dx ew, 1st rx ew) REFERRING FACILITY may not be blank5WARNING: CLASS OF CASE = 0 (Dx here, 1st rx ew)-DATE OF FIRST CONTACT..: later than SURGERY OF PRIMARY SITE DATE.:6WARNING: CLASS OF CASE = 0 (Dx here, 1st rx ew) DATE OF FIRST CONTACT. later than RADIATION DATE...............: 7WARNING: CLASS OF CASE = 0 (Dx here, 1st rx ew) DATE OF FIRST CONTACT..:later than RADIATION THERAPY TO CNS DATE: 8WARNING: CLASS OF CASE = 0 (Dx here, 1st rx ew) DATE OF FIRST CONTACT..: later than CHEMOTHERAPY DATE............:9WARNING: CLASS OF CASE = 0 (Dx here, 1st rx ew) DATE OF FIRST CONTACT..: 10WARNING: CLASS OF CASE = 0 (Dx here, 1st rx ew) DATE OF FIRST CONTACT..: later than IMMUNOTHERAPY DATE...........:11WARNING: CLASS OF CASE = 0 (Dx here, 1st rx ew) DATE OF FIRST CONTACT..: later than OTHER TREATMENT DATE.........:12WARNING: CLASS OF CASE = 2 (Dx ew, 1st rx here) DATE OF FIRST CONTACT..: earlier than DATE DX......................: 13WARNING: TYPE OF REPORTING SOURCE = 6 (Autopsy only) CLASS OF CASE must be 5 (Dx at autopsy)14WARNING: CLASS OF CASE = 5 (Dx at autopsy) TYPE OF REPORTING SOURCE must be 6 (Autopsy only)15WARNING: TYPE OF REPORTING SOURCE = 6 (Autopsy only) DIAGNOSTIC CONFIRMATION must be 1 (Pos histology) or 6 (Direct visualization)16WARNING: TYPE OF REPORTING SOURCE = 7 (Death certificate only) DIAGNOSTIC CONFIRMATION must be 9 (Unk if microscopically confirmed)17WARNING: XXX is a paired site LATERALITY may not be 0 (Not a paired site)18WARNING: XXX is an unpaired site LATERALITY must be 0 (Not a paired site)19WARNING: BONES, PELVIS, SACRUM, COCCYX is a paired site20WARNING: BEHAVIOR CODE = 2 (In situ) SUMMARY STAGE must be 0 (In situ)21WARNING: BEHAVIOR CODE = 3 (Malignant) SUMMARY STAGE may not be 0 (In situ)22WARNING:HISTOLOGY = 8331 FOLLICULAR ADENOCA, WELL DIFF GRADE/DIFFERENTIATION must be 1 (Grade I)23WARNING: HISTOLOGY = 8851 LIPOSARCOMA, WELL DIFFGRADE/DIFFERENTIATION must be 1 (Grade I)24WARNING: HISTOLOGY = 9511 RETINOBLASTOMA, DIFFERENTIATED GRADE/DIFFERENTIATION must be 1 (Grade I)25WARNING: HISTOLOGY = 9083 TERATOMA, INTERMEDIATE GRADE/DIFFERENTIATION must be 2 (Grade II)26WARNING: HISTOLOGY = 8020 CARCINOMA, UNDIFFERENTIATED GRADE/ DIFFERENTIATION must be 4 (Grade IV)27WARNING: HISTOLOGY = 8021 CARCINOMA, ANAPLASTIC NOS GRADE/DIFFERENTIATION must be 4 (Grade IV)28WARNING: HISTOLOGY = 9062 SEMINOMA, ANAPLASTIC TYPE GRADE/DIFFERENTIATION must be 4 (Grade IV)29WARNING: HISTOLOGY = 9082 TERATOMA, ANAPLASTIC GRADE/DIFFERENTIATION must be 4 (Grade IV)30WARNING: HISTOLOGY = 9390 CHOROID PLEXUS PAPILLOMA GRADE/DIFFERENTIATION must be 4 (Grade IV)31WARNING: HISTOLOGY = 9401 ASTROCYTOMA, ANAPLASTIC GRADE/DIFFERENTIATION must be 4 (Grade IV)32WARNING: HISTOLOGY = 9451 OLIGODENDROGLIOMA, ANAPLASTIC GRADE/DIFFERENTIATION must be 4 (Grade IV)33WARNING: HISTOLOGY = 9512 RETINOBLASTOMA, UNDIFFGRADE/DIFFERENTIATION must be 4 (Grade IV)34WARNING: HISTOLOGY = 9696 LYMPHOMA, LYMPH. POOR DIFF. NOD GRADE/DIFFERENTIATION must be: 3 (Grade III) or 5 (T-cell) or 6 (B-cell) or 7 (Null cell)35WARNING: HISTOLOGY = 9694 LYMPHOMA, LYMPH. INT. DIFF. NOD GRADE/DIFFERENTIATION must be:-2 (Grade II) or 5 (T-cell) or 6 (B-cell) or7 (Null cell) or 9 (Unknown)36WARNING: HISTOLOGY = 9683 LYMPHOMA CENTROBLASTIC DIFFGRADE/DIFFERENTIATION must be:4 (Grade IV) or5 (T-cell) or 6 (B-cell) or7 (Null cell)37WARNING: GRADE/DIFFERENTIATION = 5 (T-cell) HISTOLOGY must be leukemia or lymphoma (9590-9941)38WARNING: GRADE/DIFFERENTIATION = 6 (B-cell) HISTOLOGY must be leukemia or lymphoma (9590-9941)39WARNING: GRADE/DIFFERENTIATION = 7 (Null cell) HISTOLOGY must be leukemia or lymphoma (9590-9941)40WARNING: GRADE/DIFFERENTIATION = 8 (Natural killer cell) HISTOLOGY must be leukemia or lymphoma (9590-9941)41WARNING: No TNM classification is available for LYMPHOMA SUMMARY STAGE cannot be blank41WARNING: No TNM classification is available for KAPOSI'S SARCOMA SUMMARY STAGE cannot be blank43WARNING: BEHAVIOR CODE = 3 (Malignant) EXTENSION may not be 00 (In situ)44WARNING: ICDO-TOPOGRAPHY = XXX PATHOLOGIC EXTENSION = XXX45PATHOLOGIC EXTENSION may only be coded for PROSTATE (C61.9) cases46WARNING: NODES POSITIVE (REGIONAL) = 01-97 LYMPH NODES may not be 0 (No lymph nodes)47WARNING: ICDO-TOPOGRAPHY = XXX HORMONE THERAPY = 2 (Endocrine surgery and/or radiation) Only BREAST and PROSTATE cases may be coded as receiving endocrine surgery or endocrine radiation48WARNING: STATUS = Dead PLACE OF DEATH may not be blank49WARNING: STATUS = Dead CAUSE OF DEATH and STATE DEATH CERT may not both be blank50WARNING: For race combinations RACE 1 may not be 'White'51WARNING: A specific race code may not occur more than once52If REGIONAL NODES EXAMINED is 99 (Unknown if nodes examined, NA), REGIONAL NODES POSITIVE must be 99 (Unk if nodes + or -, NA) This page intentionally left blank for double-sided printing. Edits within Genedits XE "Edits:Genedits"  Messages display for the NAACCR edits (Genedits version) - NAACR110VC (Version 11.0 C). The edit set is Veterans Administration; the cross-field edits are skipped when a single-field edit fails. Name of EditErrorsWarnSkippedAddr at DX--City (NAACCR) Addr at DX--Postal Code (NAACCR)Addr at DX--State (NAACCR) Age at Diagnosis (SEER AGEDX)Birth Date (NAACCR DATEEDIT)Birthplace (COC) Cause of Death (SEER COD)Census Cod Sys 1970/80/90 (SEER RESSYST) Census Tr Cert 1970/80/90 (SEER CENSCERT)Census Tr Certainty 2000 (SEER)Census Tract 1970/80/90 (SEER TRACT)Census Tract 2000 (SEER)County at DX (NAACCR) CS Extension (CS)CS Lymph Nodes (CS)CS Mets at DX (CS)CS Site-Specific Factor 1 (CS)CS Site-Specific Factor 3 (CS)CS Version 1st (CS)Date of 1st Crs RX--COC (NPCR)Date of Diagnosis (NAACCR DATEEDIT)Date of Initial RX--SEER (NPCR)Date of Last Contact (NAACCR DATEEDIT)Derived SS2000 (CS)Derived SS2000--Flag (CS)Diagnostic Confirmation (SEER DXCONF)Follow-up Source Central (NAACCR)Grade (COC)Histologic Type ICDO3 Conversion (NAACCR)ICD Revision Number (NPCR) ICD-O-3 Conversion Flag (NAACCR)Laterality (SEER LATERAL)Name--First (NAACCR)Name--Last (NAACCR) Name--Middle (NAACCR)Patient ID Number (SEER CASENUM)Primary Payer at DX (NPCR)Primary Site (SEER SITE)Race 1 (SEER RACE)Race 2 (NAACCR)Race 3 (NAACCR)Race 4 (NAACCR)Race 5 (NAACCR)Rad--Regional RX Modality (NPCR) Reason for No Surgery (NPCR)RX Summ--BRM (NPCR)RX Summ--Chemo (NPCR)RX Summ--Hormone (NPCR)RX Summ--Other (NPCR)RX Summ--Surg/Rad Seq (NPCR)RX Summ--Systemic/Sur Seq (COC)RX Summ--Transplnt/Endocr (NPCR)Sex (SEER Sex)Social Security Number (NAACCR)Spanish/Hispanic Origin (SEER SPANORIG)Summary Stage 1977 (NAACCR)Summary Stage 2000 (NAACCR)Type of Reporting Source (SEER RPRTSRC)Vital Status (COC)Ambiguous Terminology DX (SEER)Behavior ICDO2 (COC)Behavior ICDO3 (COC) CS Version Latest (CS)Date of Conclusive DX (SEER)Date of Multiple Tumors (SEER)Histologic Type ICDO2 (COC)Histologic Type ICDO3 (SEER)Mult Tum Rpt As One Prim (SEER)Multiplicity Counter (SEER)RX Summ--Scope Reg LN Sur (COC)RX Summ--Surg Oth Reg/Dis (COC)RX Summ--Surg Prim Site (COC)Abstracted By (COC)Accession Number--Hosp (COC)Archive FIN (COC) COC Coding Sys--Current (COC)COC Coding Sys--Original (COC)CS Mets Eval (CS)CS Reg Nodes Eval (CS)CS Site-Specific Factor 2 (CS)CS Site-Specific Factor 4 (CS)CS Site-Specific Factor 5 (CS)CS Site-Specific Factor 6 (CS)CS Tumor Size (CS)CS Tumor Size/Ext Eval (CS)Cancer Status (COC)Class of Case (COC)Comorbid/Complication 1 (COC)Comorbid/Complication 10 (COC)Comorbid/Complication 2 (COC)Comorbid/Complication 3 (COC)Comorbid/Complication 4 (COC)Comorbid/Complication 5 (COC)Comorbid/Complication 6 (COC)Comorbid/Complication 7 (COC)Comorbid/Complication 8 (COC)Comorbid/Complication 9 (COC)County at DX (COC)Date Case Completed (NAACCR DATEEDIT)Date of 1st Contact (COC)Derived AJCC M (CS)Derived AJCC M Descriptor (CS)Derived AJCC N (CS)Derived AJCC N Descriptor (CS) Derived AJCC Stage Group (CS)Derived AJCC T (CS)Derived AJCC T Descriptor (CS)Derived AJCC--Flag (CS)Derived SS1977 (CS)Derived SS1977--Flag (CS)EOD--Tumor Size (COC)Follow-Up Source (COC)Morph Coding Sys--Current (NAACCR)Morph Coding Sys--Originl (NAACCR)NPI--Archive FIN (NAACCR)NPI--Reporting Facility (NAACCR)Next Follow-Up Source (COC)Primary Payer at DX (COC)RX Coding System--Current (COC)RX Date--DX/Stg Proc (COC) RX Date--Most Defin Surg (COC)RX Date--Other (COC)RX Date--Radiation (COC)RX Date--Radiation Ended (COC)RX Date--Surgery (COC)RX Date--Surgical Disch (COC)RX Date--Systemic (COC)RX Hosp--BRM (COC) RX Hosp--Chemo (COC)RX Hosp--DX/Stg Proc (COC)RX Hosp--Hormone (COC)RX Hosp--Other (COC)RX Hosp--Palliative Proc (COC)RX Hosp--Reg LN Examined (COC)RX Hosp--Scope Reg 98-02 (COC)RX Hosp--Scope Reg LN Sur (COC)RX Hosp--Surg Oth 98-02 (COC)RX Hosp--Surg Oth Reg/Dis (COC)RX Hosp--Surg Prim Site (COC) RX Hosp--Surg Site 98-02 (COC)RX Summ--BRM (COC)RX Summ--Chemo (COC)RX Summ--DX/Stg Proc (COC)RX Summ--Hormone (COC)RX Summ--Other (SEER OTHERRX)RX Summ--Palliative Proc (COC)RX Summ--Reconstruct 1st (SEER RECONST)RX Summ--Reg LN Examined (COC)RX Summ--Scope Reg 98-02 (COC)RX Summ--Surg Oth 98-02 (COC)RX Summ--Surg Site 98-02 (COC) RX Summ--Surg/Rad Seq (SEER RADSEQ)RX Summ--Surgical Approch (COC)RX Summ--Surgical Margins (COC) RX Summ--Transplnt/Endocr (COC)Race Coding Sys--Current (NAACCR)Race Coding Sys--Original (NAACCR)Rad--Boost Dose cGy (COC)Rad--Boost RX Modality (COC)Rad--Location of RX (COC)Rad--No of Treatments Vol (COC)Rad--Regional Dose: cGy (COC)Rad--Regional RX Modality (COC)Rad--Treatment Volume (COC)Readm Same Hosp 30 Days (COC)Reason for No Radiation (COC)Reason for No Surgery (SEER NCDSURG)Recurrence Date--1st (COC)Recurrence Type--1st (COC)Regional Nodes Examined (COC)Regional Nodes Positive (COC)Reporting Hospital (COC)Site Coding Sys--Current (NAACCR)Site Coding Sys--Original (NAACCR) TNM Clin M (COC)TNM Clin N (COC)TNM Clin Stage Group (COC)TNM Clin Staged By (COC)TNM Clin T (COC)TNM Edition Number (COC)TNM Path Descriptor (COC)TNM Path M (COC)TNM Path N (COC)TNM Path Stage Group (COC)TNM Path Staged By (COC)TNM Path T (COC)Morphology--Type/Behavior ICDO3 (SEER MORPH) Morphology--Type/Behavior ICDO2 (SEER MORPH)Addr at DX--Postal Code, Addr at DX--State (COC)Age, Birth Date, Date of Diagnosis (NAACCR IF13)Age, Histologic Type, COD, ICDO3 (SEER IF43)Age, Primary Site, Morph ICDO3--Adult (SEER)Age, Primary Site, Morphology ICDO3 (SEER IF15)Autopsy Only, RX (NPCR)Behavior Code ICDO3, Seq Num--Central (SEER IF114)Behavior ICDO3, Summary Stage 2000 (NAACCR)Birth Date, Date of Diagnosis (NAACCR IF47)Census Tract 1970/80/90, Census Cod Sys (SEER IF45Cervix In Situ ICDO3 (SEER IF88)County at DX, Addr at DX--State (NAACCR)CS Extension, Bladder Schema (CS)CS Extension, CS Lymph Nodes, CS Mets at DX (CS)CS Extension, Hematopoietic (CS)CS Extension, Primary Site, Behavior ICDO3 (CS)CS Extension, Primary Site, Histol ICDO3 (NAACCR)CS Extension, Renal Pelvis/Ureter Schema (CS)CS Items, Date of DX (NPCR)CS Items, Death Certificate Only (CS)CS Items, DX Pre-2004 (CS)CS Items, Type Reporting Source (NPCR)CS Lymph Nodes, Primary Site, Histol ICDO3 (NAACCR)CS Mets at DX, Primary Site, Histol ICDO3 (NAACCR)CS SSF 1, Primary Site, Histol ICDO3 (NAACCR)CS SSF 3, Primary Site, Histol ICDO3 (NAACCR)CS SSF 3, RX Summ--Surg, Prostate Schema (CS)CS Version 1st, CS Version Latest (CS)Date of 1st Crs RX--COC, Date Init RX--SEER (NPCR)Date of Last Contact, Date of Diag. (NAACCR IF19) Death Certificate Only, RX (NPCR)Derived Items, Date of DX (NPCR)Derived Items, DX Pre-2004 (CS)Derived SS2000--Flag, Derived SS2000 (CS)Diagnostic Confirm, Seq Num--Central (SEER IF23)Diagnostic Confirmation, Behavior ICDO3(SEER IF31)Diagnostic Confirmation, Histology ICDO3(SEER IF48Edit Over-rides (SEER REVIEWFL)Follow-up Source Central, Date of DX (NPCR)ICD Revision Number, Cause of Death (SEER IF37)ICD-O-3 Conversion Flag, Histology ICDO3(SEER IF95) Laterality, Primary Site (NAACCR IF24)Laterality, Primary Site, Morph ICDO3 (SEER IF42)Primary Site, Behavior Code ICDO3 (SEER IF39)Primary Site, Laterality (SEER IF82)Primary Site, Morphology-Imposs ICDO3 (SEER IF38)Primary Site, Morphology-Type ICDO3 (SEER IF25) Race 1, Race 2, Race 3, Race 4, Race 5 (NAACCR)RX Summ--Scope Reg LN Sur, Site, ICDO3 (SEER IF109)RX Summ--Surg Prim Site, Primary Site, ICDO3 (COC) Seq Num--Central, Prim Site, Morph ICDO3(SEER IF22)Sex, Primary Site (SEER IF17)Summ Stg 2000, Site, Hist ICDO3, Rpt Srce (NAACCR)Summary Stage 1977, Date of Diagnosis (NAACCR)Summary Stage 2000, Date of Diagnosis (NAACCR)Type of Rep Srce(DC),Seq Num--Cent,ICDO3(SEER IF04)Type of Report Srce(DC/AO), COD (SEER IF09)Type of Report Srce(DC/AO), Date of Dx (SEER IF02)Type of Report Srce(DC/AO), Diag Conf (SEER IF05)Type of Report Srce(DC/AO), Vit Stat (COC) Vital Status, Cause of Death (COC)Age, Histologic Type, COD, ICDO2 (SEER IF43)Age, Primary Site, Morphology ICDO2 (SEER IF15)Behavior ICDO2, Behavior ICDO3 (SEER IF115)Behavior ICDO2, Date of Diagnosis (NAACCR)Behavior ICDO2, Histology ICDO2 (NAACCR)Behavior ICDO2, Summary Stage 1977 (NAACCR)Behavior ICDO3, Date of Diagnosis (NAACCR)CS Lymph Nodes, Regional Nodes Positive (CS) CS Reg Nodes Ex, Pos, Site, Hist ICDO3, Report(CS)Cervix In Situ ICDO2 (SEER IF88) Diagnostic Confirmation, Behavior ICDO2(SEER IF31)Diagnostic Confirmation, Histology ICDO2(SEER IF48)Hemato ICDO2, Summ Stg 1977, Type Rpt Srce (NAACCR) Histology ICDO2, Date of Diagnosis (NAACCR)Histology ICDO3, Date of Diagnosis (NAACCR)Laterality, Primary Site, Morph ICDO2 (SEER IF42)Lymphoma, Prim Site, Summ Stg 1977, ICDO2 (NAACCR)Primary Site, Behavior Code ICDO2 (SEER IF39)Primary Site, Morphology-Imposs ICDO2 (SEER IF38)Primary Site, Morphology-Type ICDO2 (SEER IF25)RX Summ--Scope Reg LN Sur, Site, ICDO2(COC) RX Summ--Surg Prim Site, Primary Site, ICDO2 (COC)Seq Num--Central, Prim Site, Morph ICDO2(SEER IF22)Summ Stg 1977, Site, Hist ICDO2, Rpt Srce (NAACCR)Type of Rep Srce(DC),Seq Num--Cent,ICDO2(SEER IF04)Unknown Site, Summary Stage 1977, ICDO2 (NAACCR)Addr Current--State, Date of Diagnosis (COC)Ambiguous Terminology DX, Date of DX (SEER IF157)COC Coding Sys--Curr, COC Coding Sys--Orig (COC)COC Coding Sys--Original, Date of Diagnosis (COC)CS Extension, CS Tumor Size, Site, Hist ICDO3 (CS) CS Extension, SSF 1, Thyroid Schema (CS)CS Items, Class of Case (COC)CS Items, Date of DX (COC) CS Lymph Nodes, Nodes Pos, SSF3, Breast Schema(CS)CS Lymph Nodes, SSF 1, Head/Neck Schemas (CS)CS Lymph Nodes, SSF 3,4,5, Breast Schema (CS)CS Mets Eval, Primary Site, Histol ICDO3 (NAACCR)CS Reg LN Eval, Primary Site, Histol ICDO3 (NAACCR)CS SSF 1, OthCNS/OthEndocrine Schemas (CS)CS SSF 1, RX Summ--Surg, Retinoblastoma Schema(CS)CS SSF 2, Primary Site, Histol ICDO3 (NAACCR)CS SSF 3, Breast Schema (CS)CS SSF 4, Primary Site, Histol ICDO3 (NAACCR)CS SSF 4, RX Summ--Surg, Testis Schema (CS)CS SSF 5, Primary Site, Histol ICDO3 (NAACCR)CS SSF 5, SSF 6, Grade, Prostate Schema (CS)CS SSF 6, Breast Schema (CS)CS SSF 6, Primary Site, Histol ICDO3 (NAACCR) CS TS/Ext Eval, Primary Site, Histol ICDO3 (NAACCR)CS TS/Ext Eval, Surgery (CS)CS TS/Ext Eval, Surgery, Prostate Schema (CS)CS Tumor Size, Primary Site, Histol ICDO3 (NAACCR) CS Tumor Size, SSF 1, Malign Melanoma Schemas (CS)CS Tumor Size, Site, Histol ICDO3 (CS)Class of Case, Date of 1st Cont, Date of DX (COC)Class of Case, RX (COC) Class, Date Diag, Date Last Cont, Vit Stat (COC)Comorbid/Complication 1 - 10 (COC) Comorbid/Complication 1, Date DX (COC)Date Case Completed, Date of Diagnosis (NAACCR)Date of 1st Crs RX--COC, Date Last Contact (COC)Date of 1st Crs RX--COC, Date of DX (COC)Date of 1st Crs RX--COC, Dates of RX (COC)Date of Multiple Tumors, Date of DX (SEER IF165)Derived AJCC--Flag, Derived AJCC (COC)Derived Items, Date of DX (COC)Derived SS1977--Flag, Derived SS1977 (CS)EOD--Tumor Size, Date of Diagnosis (COC)Edit Over-rides (NAACCR)Follow-Up Source, Date of Diagnosis (COC)Follow-Up Source, Vital Status (COC)Hemato ICDO2, Summ Stg 1977, Class of Case (NAACCR)Hematopoietic, TNM, ICDO2 (NAACCR)Hematopoietic, TNM, ICDO3 (NAACCR)Hist/Behav ICDO2, Hist/Behav ICDO3 (SEER IF126)Histology ICDO2, Date DX, Date 1st Contact (NAACCR)Histology ICDO3, Date DX, Date 1st Cont (NAACCR)Histology, Primary Site, Tumor Size, ICDO2 (COC)Histology, Primary Site, Tumor Size, ICDO3 (COC)Laterality, Primary Site (COC)Morph Coding Sys--Curr, Morph Coding Sys--Orig(COC)Morph Coding Sys--Originl, Date of Diagnosis (COC)Mult Tum Rpt As One Prim, Date of DX (SEER IF155)Multiplicity Cntr, Date of Mult Tum (SEER IF163)Multiplicity Counter, Date of DX (SEER IF156)Next Follow-Up Source, Date of Diagnosis (COC)Obsolete Codes - CS Extension (SEER IF146) Obsolete Codes - CS Lymph Nodes (SEER IF147)Obsolete Codes - CS Mets at DX (SEER IF148) Obsolete Codes - CS SSF 1 (SEER IF149)Obsolete Codes - CS SSF 3 (SEER IF150)Obsolete Codes - CS SSF 4 (SEER IF151)Over-ride Misuse (NAACCR)Primary Site, AJCC Stage Group - Ed 3/4, ICDO2(COCPrimary Site, AJCC Stage Group - Ed 5, ICDO2 (COC)Primary Site, AJCC Stage Group - Ed 5, ICDO3 (COC)Primary Site, AJCC Stage Group - Ed 6, ICDO3 (COC)Primary Site, Histology, Behav ICDO3 (NAACCR)Primary Site, Morphology-Type ICDO2 (COC)Primary Site, Morphology-Type ICDO3 (COC)Primary Site, No AJCC Scheme-Ed 5, ICDO2 (NAACCR)Primary Site, No AJCC Scheme-Ed 5, ICDO3 (NAACCR)RX Date--DX/Stg Proc, Date Last Contact (COC)RX Date--Most Defin Surg, Date Last Contact (COC)RX Date--Most Defin Surg, Date of DX (COC)RX Date--Most Defin Surg, RX Date--Surgery (COC)RX Date--Most Defin Surg, Surg Prim Site (COC)RX Date--Other, Date Last Contact (COC)RX Date--Other, Date of Diagnosis (COC)RX Date--Rad Ended, Date Last Contact (COC)RX Date--Rad Ended, RX Date--Radiation (COC)RX Date--Rad Ended, Rad--Location of RX (COC)RX Date--Rad Ended, Rad--No of Treatments Vol (COC)RX Date--Rad Ended, Rad--Regional Dose: cGy (COC)RX Date--Rad Ended, Rad--Regional RX Modality (COC) RX Date--Rad Ended, Rad--Treatment Volume (COC)RX Date--Radiation, Rad--Location of RX (COC)RX Date--Radiation, Rad--No of Treatments Vol (COC) RX Date--Radiation, Rad--Regional Dose: cGy (COC)RX Date--Radiation, Rad--Regional RX Modality (COC)RX Date--Radiation, Rad--Treatment Volume (COC)RX Date--Surgery, Date Last Contact (COC)RX Date--Surgical Disch, Date Last Contact (COC)RX Date--Surgical Disch, Date of DX (COC)RX Date--Surgical Disch, Date--Most Def Surg (COC)RX Date--Surgical Disch, Surg Prim Site (COC)RX Date--Systemic, Date Last Contact (COC)RX Date--Systemic, Systemic RX (COC)RX Hosp--BRM, RX Summ--BRM (COC) RX Hosp--Chemo, RX Summ--Chemo (COC)RX Hosp--DX/Stg Proc, RX Summ--DX/Stg Proc (COC)RX Hosp--Hormone, RX Summ--Hormone (COC)RX Hosp--Other, Date of Diagnosis (COC)RX Hosp--Other, RX Summ--Other (COC)RX Hosp--Palliative Proc, RX Summ--Pall Proc (COC)RX Hosp--Scope LN Sur, RX Summ--Scope LN Sur(COC)RX Hosp--Scope Reg 98-02, Primary Site, ICDO2(COC)RX Hosp--Scope Reg 98-02, Primary Site, ICDO3(COC)RX Hosp--Scope Reg 98-02, RX Hosp--Scope Reg (COC)RX Hosp--Scope Reg 98-02,RX Hosp--Reg LN Rem (COC)RX Hosp--Scope Reg LN Sur, Primary Site,ICDO2(COC) RX Hosp--Scope Reg LN Sur, Primary Site,ICDO3(COC)RX Hosp--Surg Oth 98-02, Primary Site (COC)RX Hosp--Surg Oth 98-02, RX Hosp--Surg Oth (COC)RX Hosp--Surg Oth Reg, RX Summ--Surg Oth Reg (COC)RX Hosp--Surg Pri Sit, RX Summ--Surg Pri Sit (COC)RX Hosp--Surg Prim Site, Primary Site, ICDO2 (COC)RX Hosp--Surg Prim Site, Primary Site, ICDO3 (COC)RX Hosp--Surg Site 98-02, Primary Site (COC)RX Hosp--Surg Site 98-02, RX Hosp--Surg Site (COC)RX Summ--BRM, Vital Status (COC)RX Summ--DX/Stg Proc, RX Date--DX/Stg Proc (COC)RX Summ--Hormone, Vital Status (COC)RX Summ--Other, RX Date--Other (COC)RX Summ--Reconstruct 1st, Date of DX (COC)RX Summ--Reconstruct 1st, Primary Site (COC)RX Summ--Reg LN Examined, Date of DX (COC)RX Summ--Scope Reg 98-02, Date of DX (COC)RX Summ--Scope Reg 98-02, Primary Site, ICDO2(COC)RX Summ--Scope Reg 98-02, Primary Site, ICDO3(COC)RX Summ--Surg Approch,RX Summ--Surg Site 98-02(COC)RX Summ--Surg Oth 98-02, Date of DX (COC)RX Summ--Surg Oth 98-02, Primary Site (COC)RX Summ--Surg Prim Site, Diag Conf (SEER IF76)RX Summ--Surg Site 98-02, Date of DX (COC)RX Summ--Surg Site 98-02, Primary Site (COC)RX Summ--Surg Site 98-02, RX Summ--Surg Site (COC)RX Summ--Surgical Approch, Date of DX (COC)RX Summ--Surgical Approch, Primary Site (COC) RX Summ--Surgical Margins, Primary Site,ICDO2 (COC)RX Summ--Surgical Margins, Primary Site,ICDO3 (COC)RX Summ--Systemic/Sur Seq, Date of DX (COC)RX Summ--Transplnt/Endocr, Primary Site (SEER IF28)RX Summ--Transplnt/Endocr, Vital Status (COC)Race Coding Sys--Curr, Race Coding Sys--Orig (COC)Race Coding Sys--Current, Race 2, 3, 4, 5 (NAACCR)Race Coding Sys--Original, Date of Diagnosis (COC) Rad--Regional RX Modality, Date of Diagnosis (COC)Rad--Regional RX Modality, Reason for No Rad (COC)Readm Same Hosp 30 Days, Date of Diagnosis (COC)Reason for No Radiation, RX Date--Radiation (COC)Reason for No Radiation, Vital Status (COC)Reason for No Surgery, Vital Status (COC)Recurrence Date--1st, Date Last Contact (COC)Recurrence Date--1st, Date of 1st RX--COC (COC)Recurrence Date--1st, Date of Diagnosis (COC)Recurrence Type--1st, Cancer Status (COC)Recurrence Type--1st, Recurrence Date--1st (COC)Regional Nodes Ex, Reg Nodes Pos (COC)Seq Num--Hosp, Primary Site, Morph ICDO2 (COC)Seq Num--Hosp, Primary Site, Morph ICDO3 (COC)Site Coding Sys--Curr, Site Coding Sys--Orig (COC)Site Coding Sys--Original, Date of Diagnosis (COC)Summ Stg 2000, Site, Hist ICDO3, Class (NAACCR)Summary Stage 1977, Class of Case (COC) Summary Stage 1977, Histology ICDO2 (COC)Summary Stage 1977, Primary Site-Ed 4, ICDO2 (COC) Summary Stage 1977, Primary Site-Ed 5, ICDO2 (COC)Summary Stage 1977, TNM Stage Group (COC)Summary Stage 2000, Primary Site-Ed 5, ICDO3 (COC)Summary Stage 2000, Primary Site-Ed 6, ICDO3 (COC)Surgery, RX Date--Surgery, ICDO2 (COC) Surgery, RX Date--Surgery, ICDO3 (COC)Surgery, Rad, Surg/Rad Seq (COC)Surgery, Reason No Surg (COC)Systemic RX, Surgery, Systemic/Sur Seq (COC)TNM Clin Stage Group, TNM Items, ICDO3 (COC)TNM Clin Stage Group, TNM Path Stage Group (COC)TNM Edition Number, Date of Diagnosis (COC)TNM Edition Number, No AJCC Ed 5 Scheme,ICDO3(COC)TNM Edition Number, No AJCC Ed 6 Scheme,ICDO3(COC)TNM Edition, TNM Clin Stage, TNM Path Stage (COC)TNM Path Stage Group, TNM Items, ICDO3 (COC)Tumor Marker 1, Primary Site, Morph ICDO2 (COC)Tumor Marker 1, Primary Site, Morph ICDO3 (COC) Tumor Marker 2, Primary Site (COC)Tumor Marker 3, Primary Site (COC) Glossary ACoSAmerican College of SurgeonsAJCCAmerican Joint Committee on CancerAPIApplication Program InterfaceCOCCommission on CancerCSCollaborative StagingDOBDate of BirthDODDate of DeathEODExtent of DiseaseEOVAEast Orange VA Medical CenterFORDSFacility Oncology Registry Data StandardsICD-OInternational Classification of Diseases for OncologyNAACCRNorth American Association of Central Cancer RegistriesNCDBNational Cancer Data Base NCINational Cancer InstituteNCRANational Cancer Registrars AssociationNPCRNational Program of Cancer RegistriesPID#Patient Identification Number First initial of the last name plus the last four digits of the SSN: W9999PTFPatient Treatment FileReport 80CReport contains 80 columns and requires a printer that prints 80 columnsReport 132CReport contains 132 columns and requires a printer that prints 132 columns; on screen the text wraps.SEERSurveillance, Epidemiology and End ResultsSNOMEDSystematized Nomenclature of MedicineSSNSocial Security NumberTNMPrimary Tumor, Regional Lymph Nodes, Distant MetastasisVACCRVA Central Cancer RegistryVISNVeterans Integrated Service Network This page intentionally left blank for double-sided printing. Appendix A: OncoTraX: Cancer Registry V.2.11 - Patch ONC*2.11*47 <<<<<>> Associated Patches: (v)ONC*2.11*46 <<= must be installed BEFORE `ONC*2.11*47' Subject: EDITS Application Program Interface (API) Category: INPUT TEMPLATE ROUTINE DATA DICTIONARY ENHANCEMENT PRINT TEMPLATE Description: This patch is available via FTP in a KIDS distribution file. The Host File is named ONC211P47.KID and is located in the [ANONYMOUS.SOFTWARE] directory of the following OI Field Offices. Preferred Address: First available ftp server download.vista.med.va.gov SPECIFIC FIELD OFFICE FTP ADDRESS Albany ftp.fo-albany.med.va.gov Hines ftp.fo-hines.med.va.gov SLC ftp.fo-slc.med.va.gov All Data Dictionary modifications and additions have been reviewed and approved by the Data Base Administrator. This patch will implement the EDITS API. When the registrar attempts to set the ABSTRACT STATUS (#165.5,91) to 3 (Complete), three things will occur: The program will first check to make sure that all of the "required" data items have been filled in. This is currently being done. Once all of the "required" data items have been filled in, the program will pass the abstract through a series of local inter-field edit checks. This is also currently being done. Once all of the local inter-field edit checks have been resolved (or overridden), the program will invoke the EDITS API and pass the abstract through the EDITS application. This feature is new with this patch. Example: ABSTRACT STATUS: Incomplete// Complete All required data fields have been entered. Beginning inter-field edit checks... No inter-field edit check warnings. Calling EDITS API... <--new with this patch If the EDITS API encounters errors the error messages will be displayed followed by the following message: EDITS errors were encountered. ABSTRACT STATUS is unchanged. Example: Calling EDITS API... Date of Last Contact, Date of Diag. (NAACCR IF19) E:Date of Diagnosis and Date of Last Contact conflict Date of Diagnosis (283) = 12092004 Date of Last Contact (1294) = 09052003 RETURN to continue, '^' to exit, or Edit# for help: Edit Set Errors Warnings -------------------------------------------------------------------- Veterans Administration 1 0 EDITS errors were encountered. ABSTRACT STATUS is unchanged. -------------------------------------------------------------------- Note: Each error will be numbered sequentially. If the registrar wishes to see additional information about a specific error, he/she may enter the sequential error number after the "RETURN to continue, '^' to exit, or Edit# for help:" prompt for additional error information. If EDITS errors are encountered, the registrar should then review the error messages and resolve any data conflicts. If the EDITS API does not encounter any errors the program will do the following: ABSTRACT STATUS will be set to 3 (Complete). A unique checksum value will be computed for the abstract. DATE CASE COMPLETED will be set to the current date. ABSTRACTED BY will be set to the registrar who 'completed' the abstract. The following messages will be displayed: No EDITS errors or warnings. ABSTRACT STATUS.......: Complete DATE CASE COMPLETED...: 03/21/2007 ABSTRACTED BY.........: REGISTAR,TEST DATE CASE LAST CHANGED: CASE LAST CHANGED BY..: Computing checksum value for this abstract... Once an abstract has successfully passed through the EDITS API and its ABSTRACT STATUS set to 3 (Complete), if the registrar makes a change which will affect the abstract's NAACCR record, he/she will see the following message: You have made a change to a 'Completed' abstract. This abstract needs to be re-run through the EDITS API. Calling EDITS API... If no EDITS errors are encountered the registrar will see the following message: No EDITS errors or warnings. ABSTRACT STATUS = 3 (Complete). If EDITS errors are encountered the registrar will see the following message: EDITS errors were encountered. The ABSTRACT STATUS has been changed to 0 (Incomplete). Each time a 'complete' abstract is changed the abstract will be date-stamped with the date of the most recent change and the name of registrar making the change. In addition to implementing the EDITS API this patch contains the following enhancements and problem resolutions: NAACCR Version 11.1 NAACCR Version 11.1 has been implemented with this patch. To support this implementation the following additions/modifications have been made: The following new data items have been added to the ONCOLOGY PRIMARY (#165.5) file: AMBIGUOUS TERMINOLOGY DX (#165.5,159) DATE OF CONCLUSIVE DX (#165.5,193) MULT TUM RPT AS ONE PRIM (#165.5,194) DATE OF MULTIPLE CANCERS (#165.5,195) MULTIPLICITY COUNTER (#165.5,196) These data items have been placed in the "Cancer Identification" section of the abstract and will only appear for 2007+ cases. STATE AT DX (#165.5,16) The description of code ZZ has been changed: Old description: US, NOS; Canada, NOS; Unknown New description: Residence unknown Two new codes have been added: CD (Resident of Canada, NOS) US (Resident of United States, NOS) MANAGING PHYSICIAN (#165.5,2.2) With the implementation of FORDS in patch ONC*2.11*36, data item MANAGING PHYSICIAN was discontinued. This data item is being reactivated to support NAACCR version 11.1 data item NPI--PHYSICIAN-MANAGING [2465] 2595-2604. MANAGING PHYSICIAN is required for cases diagnosed on or after January 1, 2007. STAGE GROUP PATHOLOGIC (#165.5,87) computation using CLINICAL M Following message was received from Jerri Linn Phillips, the Manager -- Information, Technology, and Data Standards Section, National Cancer Data Base, Commission on Cancer: "The experts on the AJCC Executive Committee agreed without exception that the intent is that staging for metastatic disease is 'clinical' unless there is pathologic information confirming he presence of distant metastases. There are no circumstances of 'pM0.' Further, the assumption should be 'cM0' unless there is clinical or pathological evidence of metastases. There are extremely few if any circumstances of 'Mx' disease. For computing pathologic stage, use pT and pN. Then, if pM is 1, 1A, 1B, 1C, or 1M use it; otherwise use the value of cM (whether it is blank, cMX, cM0, cM1, cM1a, cM1b, cM1c or 88) to calculate pathologic stage group." As per these instructions, the algorithm for computing STAGE GROUP PATHOLOGIC has been changed to use CLINICAL M in lieu of PATHOLOGIC M in the event that PATHOLOGIC M is not 1, 1A, 1B, 1C or 1M. If CLINICAL M is used the following message will be displayed: CLINICAL M will be used to calculate PATHOLOGIC STAGE GROUPING. Example: CLINICAL T: T1 2 cm or less in greatest dimension CLINICAL N: N0 No regional lymph node metastasis CLINICAL M: M0 No distant metastasis Computed CLINICAL STAGE GROUPING: I (T1 N0 M0) PATHOLOGIC T: T1 2 cm or less in greatest dimension PATHOLOGIC N: N0 No regional lymph node metastasis PATHOLOGIC M: MX Distant metastasis cannot be assessed CLINICAL M will be used to calculate PATHOLOGIC STAGE GROUPING. Computed PATHOLOGIC STAGE GROUPING: I (T1 N0 M0) Duplicate entries in COUNTY (#5.1) file There were two SAN DIEGO entries in the COUNTY file for the state of California. The duplicate entry has been deleted. Any abstracts with a COUNTY AT DX (#165.5,10) value which pointed to the deleted entry have had their COUNTY AT DX values converted to the remaining SAN DIEGO entry. OTHER STAGING SYSTEM (#165.5,39) In patch ONC*2.11*45 we retired the data item OTHER STAGE for all 2006+ cases. This was done as per the NAACCR 2006 Implementation Guidelines and Recommendations. It has been requested that this data item be reactivated for all cases for VACCR use. In order to be consistent with NAACCR terminology the data item OTHER STAGE has been renamed OTHER STAGING SYSTEM. For 2007+ cases the OTHER STAGING SYSTEM choices are restricted to the C-D-S, RAI, D-S, FAB, EXTENSIVE and LIMITED choices. OTHER STAGING SYSTEM has been added to VACCR EXTRACT V11 record layout in columns [1513-1527]. No AJCC TNM staging LENTIGO MALIGNA MELANOMA (8742/3) In patch ONC*2.11*44 "no staging" stuffing logic was added for LENTIGO MALIGNA (8742/2) and LENTIGO MALIGNA MELANOMA (8724/3). This stuffing was incorrect for 8742/3. LENTIGO MALIGNA MELANOMA (8742/3) is stageable. LENTIGO MALIGNA (8742/2) is not 8742/3 has been removed from the "no staging" stuffing logic. Carcinoid Cancers In patch ONC*2.11*43 we implemented "no staging" stuffing for carcinoid Cancers of the following sites: C16. STOMACH C17. SMALL INTESTINE C23.9 GALLBLADDER C24. EXTRAHEPATIC BILE DUCTS/AMPULLA OF VATER C25. EXOCRINE PANCREAS This list has been expanded in this patch to include: C18. COLON C19.9 RECTOSIGMOID JUNCTION C20.9 RECTUM NOS C21. ANAL CANAL This change will mimic the Collaborative Staging TNM coding/staging computation for carcinoid Cancers of these sites. GIST of PANCREAS, HEAD (C25.0) There is no TNM coding or staging schema for AJCC 6th Edition PANCREAS, HEAD (C25.0) cases with an HISTOLOGY (ICD-O-3) value of GIST (GASTROINTESTINAL STROMAL) (8936/0, 8936/1, 8936/2 or 8936/3). For these cases the TNM and staging fields will be stuffed with the "no staging" values. PANCREAS, ISLETS (C25.4) In patch ONC*2.11*44 we implemented "no staging" stuffing for PANCREAS, ISLETS (C25.4) cases combined with specific histology values. In this patch we are removing the histology test. All PANCREAS, ISLETS (C25.4) cases will now be stuffed with the "no staging" values. MYCOSIS FUNGOIDES (9700/3) AND SEZARY DISEASE (9701/3) OF SKIN, VULVA, PENIS, SCROTUM C44.0-C44.9, C51.0-C51.9, C60.0-C60.9, C63.2 Sixth Edition Mycosis Fungoides and Sezary Disease of Skin, Vulva, Penis and Scrotum cases have a TNM staging schema. These cases were being stuffed with "no staging" values. This was incorrect. These cases may be staged. Note: Pre-Sixth Edition Mycosis Fungoides and Sezary Disease cases and Mycosis Fungoides and Sezary Disease cases with primary sites other than Skin, Vulva, Penis or Scrotum do not have a TNM staging schema. Their TNM fields will be stuffed with the appropriate "no staging" values. Excluding sensitive patient data from the Complete Abstract (132c) When the registrar chooses to print the Complete Abstract (132c) the following prompt displays: Exclude sensitive patient data? No// If the registrar answers "YES", the following data item values will be masked from display: PATIENT NAME SSN HOME STREET ADDRESS HOME CITY ADDRESS AT DX ADDRESS AT DX - SUPP CITY/TOWN AT DX TELEPHONE NEXT OF KIN DATE DX (#165.5,3) According to FORDS (page 89), DATE DX should be coded 99999999 "when the date of initial diagnosis is unknown". The registrars were not allowed to enter a DATE DX value of 99/99/9999. This has been fixed. FOLLICULAR LYMPHOMA, GRADE 3 (9698/3) For FOLLICULAR LYMPHOMA, GRADE 3 (9698/3), if GRADE/DIFF/CELL TYPE was not 1 (Grade 1), the following inter-field edit warning was displayed when the registrar set the ABSTRACT STATUS (#165.5,91) to 3 (Complete). WARNING: HISTOLOGY = FOLLICULAR LYMPHOMA, GRADE 3 GRADE/DIFF/CELL TYPE must be 1 (Grade 1) This inter-field edit has been removed. FOL *..Follow-up Functions ... [ONCO FOLLOWUP MENU] FP Follow-up Procedures Menu ... [ONCO FOLL PROCEDURE MENU] PL Print Follow-up Letter [ONCO FOLL-PRINT LETTER] If the registrar selected a second patient within a single [PL Print Follow-up Letter] session, the LAST FOLLOW-UP CONTACT (#160,15.1) value from the first patient would be carried over to the second patient. This has been fixed. SEQUENCE NUMBER--CENTRAL [380] 281-282 The NAACCR data item SEQUENCE NUMBER--CENTRAL was being extracted with a value 88 or 99 (depending on BEHAVIOR CODE). This was incorrect. SEQUENCE NUMBER--CENTRAL should have a value of . This has been fixed. Note: This change backs out part of item 8 of patch ONC*2.11*46. [UTL *..Utility Options ...] [CC Create State/VACCR Data Download] The [CC Create State/VACCR Data Download] has been enhanced. The registrar may now use either DATE CASE COMPLETED or DATE CASE LAST CHANGED for the Start/End date range. Such as: Select *..Utility Options Option: CC Create State/VACCR Data Download DISPLAY/PRINT on-line instructions? No// NO Available record layouts: VACCR Record Layout v11.1 (VA Registry) NAACCR State Record Layout v11.1 Select record layout: 1 VACCR Record Layout v11.1 Facility Identification Number (FIN): 6211145// Select date field to be used for Start/End range: ? Select the date field you wish to use for this download's Start/End range prompts. Select one of the following: Date Case Completed Date Case Last Changed New inter-field edit checks New inter-field edit checks have been added which will check for the presence of codes 88 and 88/88/8888 in the following data items and, if found, prohibit the registrar from 'completing' the abstract. The following data items will be checked for code 88 (Recommended, unknown if admin): CHEMOTHERAPY CHEMOTHERAPY @FAC HORMONE THERAPY HORMONE THERAPY @FAC IMMUNOTHERAPY IMMUNOTHERAPY @FAC HEMA TRANS/ENDOCRINE PROC The following data items will be checked for date values of 88/88/8888: DATE RADIATION STARTED RADIATION @FACILITY DATE DATE RADIATION ENDED CHEMOTHERAPY DATE CHEMOTHERAPY @FAC DATE HORMONE THERAPY DATE HORMONE THERAPY @FAC DATE IMMUNOTHERAPY DATE IMMUNOTHERAPY @FAC DATE HEMA TRANS/ENDOCRINE PROC DAT TYPE OF REPORTING SOURCE (#165.5,1.2) DATE OF NO TREATMENT (#165.5,124) stuffing REASON NO SURGERY OF PRIMARY (#165.5,58) If TYPE OF REPORTING SOURCE = 6 (Autopsy only) or 7 (Death certificate only) and a DATE OF NO TREATMENT has been entered, the program will now stuff REASON NO SURGERY OF PRIMARY with 9 (Unknown). TIMELINESS REPORT A new option, [TIME Timeliness Report], has been added to the [UTL*..Utility Options...] menu. This option will compute the percentage of cases within the selected date range which have an ELAPSED DAYS TO COMPLETION value less than 180 days. Routine Summary: The following routines are included in this patch. The second line of these routines should look like: ;;2.11;ONCOLOGY;**[patch list]**;Mar 07, 1995 CHECK^XTSUMBLD results: RoutinesPre Patch 47Post Patch 47Patch ListONCACD0838272898809539,12,20,24,25,28,29,30,36,37,38,40,41, 44,45,47ONCACD18073960 90163499,12,14,18,20,22,24,25,26,28,29,31,36, 37,41,43,47ONCACDU2125381891273959712,18,20,21,22,24,26,27,29,30,31,32, 34,36,37,38,39,41,46,47ONCCS7684551774996540,43,44,47ONCEDIT120139271669999427,28,34,36,39,42,43,45,46,47ONCEDIT2116724261153071327,28,32,33,44,47ONCGENEDNA445659347ONCMPHNA77233347ONCNTX196340351993312413,15,16,19,22,25,26,27,32,33,34,36, 37,38,39,41,42,43,44,45,46,47 ONCOAI10896931107638456,15,17,18,19,25,26,27,28,29,32,33,34, 35,43,45,47ONCOAIF76029991064591311,15,16,24,25,26,27,28,37,45,47ONCOAIP15078512151844811,5,6,7,11,13,15,16,18,19,22,24,27,28, 32,33,34,35,36,37,38,39,40,42,43,44, 45,47ONCOCOM 1476191115372855 1,6,11,12,13,14,16,17,19,25,36,42,43, 44,46,47ONCOCOS 867046939868725,13,16,17,19,22,24,36,42,45,47ONCODEL 94246717815059 7,15,19,22,27,28,30,36,47ONCODIS 9467598823286,7,9,10,11,12,13,14,15,16,17,18,19, 20,21,22,23,24,25,26,27,28,29,30,31, 32,33,34,35,36,37,38,39,40,41,42,43, 44,45,46,47ONCODSR23965238247601891,5,6,7,11,13,15,16,18,27,36,37,42,46, 47ONCODXD6561673674082611,13,15,16,18,36,47ONCOEDC387597757774406,7,13,27,36,41,47ONCOEDC1152380761616255327,28,29,34,36,39,41,42,47ONCOFDP649593765082391,5,16,22,25,26,47ONCOFTS6012030671952024,25,47ONCOFUP441916120018362,22,25,47ONCOGEN16080209153396106,7,11,13,16,17,18,22,24,25,26,29,44, 46,47ONCOPA1209887691667241013,15,16,18,28,33,34,36,40,41,42,43, 44,45,46,47ONCOPA1A132603681907640415,19,27,33,34,36,40,44,45,46,47ONCOPA3149473501513965213,15,18,25,26,33,34,36,37,44,45,46,47ONCOPMA938925696257886,25,44,46,47ONCOPMB8865602911781511,23,25,44,46,47ONCOPMP2681596260918113,23,25,39,46,47ONCOTN19577694194377051,3,6,7,11,15,19,22,25,28,29,35,36,37, 41,42,43,44,46,47ONCOTNO450289346063421,6,7,11,15,27,32,35,47ONCOUTC649686266157905,24,25,47ONCPCI635171272236279,12,20,24,25,28,29,30,36,37,38,40,41, 44,45,47ONCPRE47NADELETE AFTER INSTALLONCPSD3087665343554415,19,22,28,34,36,40,45,47ONCPST47NADELETE AFTER INSTALLONCSAPI1305759675140,47ONCSAPI15176117538959640,41,47ONCSAPID5312683561428440,47ONCSAPIE6714259708686140,47ONCSAPIR4007167460683440,41,44,47ONCSAPIT7479426810998140,41,47ONCSAPIU1723015189929940,47ONCSAPIV2063954294274740,47ONCSAPIX2404582 243427640,47ONCSED01NA181902547ONCSED02NA352659647ONCSED03NA765729247ONCSED04NA399531247ONCSEDEMNA1310272 47ONCSNACRNA166002147ONCSYMP6699972649079743,47ONCTIMENA254016647Test Sites Upstate New York HCS Washington, DC Houston, TX Installation Instructions: This patch is being distributed as a KIDS Host File: ONC211P47.KID This patch should be installed when the ONCOLOGY users are off the system. The routines included in this patch should be installed in the production UCI. This patch will take approximately 5 minutes to install. Only Oncology users need to be off the system. The ONCOLOGY options do not need to be disabled during the installation of this patch. Your customer support representative will answer any questions regarding this patch. Recommended responses to the following installation questions: Want KIDS to INHIBIT LOGONs during the install? YES// NO Want to DISABLE Scheduled Options, Menu Options, and Protocols? YES// NO Routine Information: The checksums below are new checksums, and can be checked with CHECK1^XTSUMBLD. Routine Name: ONCACD0 Before: B41786309 After: B50497175 **9,12,20,24,25,28,29,30,36,37, 38,40,41,44,45,47** Routine Name: ONCACD1 Before: B35592372 After: B37943122 **9,12,14,18,20,22,24,25,26,28, 29,31,36,37,41,43,47** Routine Name: ONCACDU2 Before: B61697601 After: B62930508 **12,18,20,21,22,24,26,27,29, 30,31,32,34,36,37,38,39,41,46, 47** Routine Name: ONCCS Before: B25089621 After: B25211155 **40,43,44,47** Routine Name: ONCEDIT Before: B41142697 After: B75961355 **27,28,34,36,39,42,43,45,46,47** Routine Name: ONCEDIT2 Before: B39455814 After: B39277416 **27,28,32,33,44,47** Routine Name: ONCGENED Before: n/a After: B17687088 **47** Routine Name: ONCMPH Before: n/a After: B1505699 **47** Routine Name: ONCNTX Before: B81342152 After: B84335165 **13,15,16,19,22,25,26,27,32, 33,34,36,37,38,39,41,42,43,44, 45,46,47** Routine Name: ONCOAI Before: B27854044 After: B26893541 **6,15,17,18,19,25,26,27,28,29, 32,33,34,35,43,45,47** Routine Name: ONCOAIF Before: B23300069 After: B41938394 **11,15,16,24,25,26,27,28,37,45,47** Routine Name: ONCOAIP Before: B80340597 After: B83328289 **1,5,6,7,11,13,15,16,18,19,22, 24,27,28,32,33,34,35,36,37,38, 39,40,42,43,44,45,46,47** Routine Name: ONCOCOM Before: B34787186 After: B38430146 **1,6,11,12,13,14,16,17,19,25, 36,42,43,44,46,47** Routine Name: ONCOCOS Before: B16347858 After: B10396818 **5,13,16,17,19,22,24,36,42,45,47** Routine Name: ONCODEL Before: B20966808 After: B17087670 **7,15,19,22,27,28,30,36,47** Routine Name: ONCODIS Before: B1458506 After: B1400361 **6,7,9,10,11,12,13,14,15,16, 17,18,19,20,21,22,23,24,25,26, 27,28,29,30,31,32,33,34,35,36, 37,38,39,40,41,42,43,44,45,46, 47** Routine Name: ONCODSR Before: B76463285 After: B77463937 **1,5,6,7,11,13,15,16,18,27,36, 37,42,46,47** Routine Name: ONCODXD Before: B16132012 After: B17370508 **11,13,15,16,18,36,47** Routine Name: ONCOEDC Before: B9401955 After: B20416700 **6,7,13,27,36,41,47** Routine Name: ONCOEDC1 Before: B45858620 After: B50397068 **27,28,29,34,36,39,41,42,47** Routine Name: ONCOFDP Before: B14517564 After: B14858104 **1,5,16,22,25,26,47** Routine Name: ONCOFTS Before: B11936445 After: B13108300 **24,25,47** Routine Name: ONCOFUP Before: B6380858 After: B4130796 **2,22,25,47** Routine Name: ONCOGEN Before: B45716953 After: B47169178 **6,7,11,13,16,17,18,22,24,25, 26,29,44,46,47** Routine Name: ONCOPA1 Before: B64644517 After: B51172298 **13,15,16,18,28,33,34,36,40, 41,42,43,44,45,46,47** Routine Name: ONCOPA1A Before: B21375895 After: B35964884 **15,19,27,33,34,36,40,44,45,46,47** Routine Name: ONCOPA3 Before: B31483342 After: B32549593 **13,15,18,25,26,33,34,36,37, 44,45,46,47** Routine Name: ONCOPMA Before: B19369393 After: B20386342 **6,25,44,46,47** Routine Name: ONCOPMB Before: B21853476 After: B23097667 **11,23,25,44,46,47** Routine Name: ONCOPMP Before: B5147157 After: B5186790 **13,23,25,39,46,47** Routine Name: ONCOTN Before: B72159549 After: B74591340 **1,3,6,7,11,15,19,22,25,28,29, 35,36,37,41,42,43,44,46,47** Routine Name: ONCOTNO Before: B12536210 After: B13190026 **1,6,7,11,15,27,32,35,47** Routine Name: ONCOUTC Before: B15510360 After: B16162194 **5,24,25,47** Routine Name: ONCPCI Before: B14621628 After: B17696827 **15,19,24,26,27,28,33,35,36, 42,43,44,45,46,47** Routine Name: ONCPRE47 Before: n/a After: B1068749 **47** Routine Name: ONCPSD Before: B4903225 After: B5294026 **15,19,22,28,34,36,40,45,47** Routine Name: ONCPST47 Before: n/a After: B1743811 **47** Routine Name: ONCSAPI Before: B227298 After: B5208764 **40,47** Routine Name: ONCSAPI1 Before: B23736526 After: B25134181 **40,41,47** Routine Name: ONCSAPID Before: B20217307 After: B21856891 **40,47** Routine Name: ONCSAPIE Before: B48334363 After: B50726698 **40,47** Routine Name: ONCSAPIR Before: B20113305 After: B26610695 **40,41,44,47** Routine Name: ONCSAPIT Before: B63834837 After: B76432501 **40,41,47** Routine Name: ONCSAPIU Before: B5721954 After: B7316141 **40,47** Routine Name: ONCSAPIV Before: B7451329 After: B11259789 **40,47** Routine Name: ONCSAPIX Before: B9724342 After: B9859486 **40,47** Routine Name: ONCSED01 Before: n/a After: B13507255 **47** Routine Name: ONCSED02 Before: n/a After: B17490289 **47** Routine Name: ONCSED03 Before: n/a After: B44378907 **47** Routine Name: ONCSED04 Before: n/a After: B25577841 **47** Routine Name: ONCSEDEM Before: n/a After: B3657858 **47** Routine Name: ONCSNACR Before: n/a After: B6005907 **47** Routine Name: ONCSYMP Before: B12957496 After: B11984863 **43,47** Routine Name: ONCTIME Before: n/a After: B5620212 **47** Appendix B: OncoTraX: Cancer Registry V.2.11 Changes in 2006 XE "Changes in 2006"  Site/GP changes LUNG this site/gp is now obsolete use either LUNG NOS LUNG SMALL CELL (includes the following histologies) 8041/2 SMALL CELL CARCINOMA IN SITU 8041/3 SMALL CELL CARCINOMA, NOS 8042/2 OAT CELL CARCINOMA IN SITU 8042/3 OAT CELL CARCINOMA 8043/2 SMALL CELL CARCINOMA IN SITU, FUSIFORM CELL 8043/3 SMALL CELL CARCINOMA, FUSIFORM CELL 8044/2 SMALL CELL CARCINOMA IN SITU, INTERMED CELL 8044/3 SMALL CELL CARCINOMA, INTERMEDIATE CELL 8045/2 COMBINED SMALL CELL CARCINOMA IN SITU 8045/3 COMBINED SMALL CELL CARCINOMA RECTUM/ANUS The SITE/GP RECTUM/ANUS is renamed RECTUM. A new SITE/GP called ANUS was created. If the PRIMARY SITE CODE value is one of the following values, the SITE/GP will be changed from RECTUM to ANUS: C21.0 ANUS NOS C21.1 ANAL CANAL C21.2 CLOACOGENIC ZONE C21.8 RECTUM/ANUS/CANAL OVERLAP LYMPH NODE SITE/GP was changed to LYMPHOMA. SKIN - this site/gp now contains all skin cancers except melanoma. MELANOMA was added as a new site/gp. CLASS OF CASE was added to the PRIMARY ABSTRACT NOT-COMPLETE Report New field TNM (BEST) A new computed field, TNM (BEST), was created.This field displays the "best" TNM string as determined by the clinical/pathological hierarchy rules.Also, the existing computed field, AJCC STAGE, was renamed STAGE GROUP (BEST). LATERALITY MENINGES, CEREBRAL (C70.0) became a "Paired Organ Site" with the implementation of FORDS.2004+ cases for this site now are prompted for LATERALITY. Pre-2004 cases will continue to have their LATERALITY value stuffed with 0 (Not a paired site). Print Abstract The [EX Print Abstract-Extended (80c)] report was modified and redesigned. A new option, [QA Print Abstract QA], was added. This option replaces the [BA Print Abstract-Brief (80c)] option. Options Deleted TDPrint Suspense List by Month/Terminal Digit (132c) CSPrint Complete Suspense List by Term Digit (132c) BAPrint Abstract-Brief (80c) WSEdit/print worksheet FAPrint Due Follow-up/Admission List TDPrint Due Follow-up List by 'Terminal Digit' CICross Tabs (ICDO-Site) - Total Registry CR Cross Tabs (User Selectable) - Total Registry CTCross Tab Routines RADIATION SEQUENCE was removed from the [RF Recurrence/Sub Tx Follow-up] dialog In accordance with the FORDS "Instructions for Coding" (FORDS page 138), SCOPE OF LN SURGERY (F) are now stuffed with a code 9 (Unknown/NA) in the following circumstances For primaries of the meninges, brain, spinal cord, cranial nerves, and other parts of the central nervous system (C70.0-C70.9, C71.0-C71.9, C72.0-C72.9). For lymphomas (M-9590-9596, 9650-9719, 9727-9729) with a lymph node primary site (C77.0-C77.9). For an unknown or ill-defined primary site (C76.0-C76.8, C80.9) or for hematopoietic, reticuloendothelial, immunoproliferative, or myelo-proliferative disease (C42.0, C42.1, C42.3, C42.4 or M-9750, 9760-9764, 9800-9820, 9826, 9831-9920, 9931-9964, 9980-9989). SURGERY OF PRIMARY (F)DATE FIRST SURGICAL PROCEDURE DATE FIRST SURGICAL PROCEDURE is no longer be stuffed with 00/00/0000 if SURGERY OF PRIMARY (F) = 00 (None; no surgery; autopsy ONLY). DATE FIRST SURGICAL PROCEDURE is no longer be stuffed with 99/99/9999 if SURGERY OF PRIMARY (F) = 99 (Unknown; death certificate ONLY). DATE FIRST SURGICAL PROCEDURE was relocated within the abstract input dialog.It now appears after SURG PROC/OTHER SITE @FAC DATE. FOL *..Follow-up Functions PF Post/Edit Follow-up CANCER STATUS When posting or editing a follow-up the registrar is prompted to update the CANCER STATUS for each primary for this patient.This updating process is now DIVISION specific. For multidivisional facilities the registrar is only prompted to update the CANCER STATUS of primaries, which belong to their DIVISION. For single-division facilities this change is transparent. CODE DESCRIPTION CHANGES For the following fields the descriptions for codes 1 and 2 are changed. Code Old code description New code description ------- ---------------------------- ------------------------------ 1 Positive Abnormal 2 Negative Within normal limits CHEST XRAY BRONCHOSCOPYPET SCANSIGMOIDOSCOPYCT SCANMEDIASTINOSCOPYBARIUM ENEMACT ABDOMEN/PELVISCOLONOSCOPY This page intentionally left blank for double-sided printing. Index  INDEX \e " " \h "A" \c "2" \z "1033"  A AA 37 AAR 41 ABS 17 Abstract Add a second primary 23 Add new patient 18 Complete 17 Edit a primary 25 Edit an existing primary 22 Edit existing patient 19 Enter a new primary 22 Enter a primary 21 Enter first primary 21 Occupations not included 20 Patient summary 25 Print complete 26 Print extended 26 Print not complete list 25 Print QA 26 Print QA/multiple 26 Screens menu 26 Start 18 Status 24 AC 54 ACL 42 ACT 45 AE 38 AI 17 ANN 41 Annual reporting ACoS Accession Register 41 ACoS patient index 41 Cross tabs 45 Histology/site/topography 44 ICDO topography/stage/tx 43 Patient list by class of case 42 Primary site/GP listing 42 Primary site/stage/tx 42 Print custom reports 45 Status/site/dx-age 44 API 41 AR 53 Article VI (The Supremacy Clause) 61 AS 26, 38 ASL 42 C Capture program PC 59, 62 Case Finding Radiology search 13 Case Finding Lab search 11 Print lab report 12 Case Finding PTF search 14 CC 53 CDD1 54 CDD2 54 CF 11 Changes in 2006 113 Character ... 6 // 5 ? 4 ?? 4 @ 6 ^ 5 4 Space bar 7 CPR 45 CS 54 CT 53 D Dates 6 Define cancer registry parameters 9 Define parameters 8 Delete Oncology Patient 53 Device prompt 6 DF 29 Downloading Data from VistA for ACoS 62 Genedits 63 DP 53 DS 47, 53 E EA 53 Edit user characteristics 68 Edits Genedits 79 Interfield problems 75 OncoTraX 75 Warning messages 75 EE 25 EX 26 F FH 29 FOL 27 Follow-up Edit letter 33 Generate letter 30 History 29 Letter 30 Letter edit screen 33 Letter example 34 Post/edit 27 Print delinquent list 29 Print list by month due 29 Procedures menu 30 Recurrence/sub tx 28 Send letter 31 FP 30 G Genedits Downloading 63 Installing 63 Running 65 H Help screens 70 HIS 44 I IN 39 Installing Genedits 63 IR 25 IW 39 K KEA Term Illustrated directions 59 L LF 29 Line editor example 67 LIS 37 LR 12 M MA 26 Menu options 72 Module Abstract entry and printing 17 Annual reporting 41 Case finding and suspense 11 Follow-up 27 Registry lists 37 Statistical reporting 47 Utility options 51 N NC 25 NP 16 O Oncology menu 7 OncoTraX conventions 4 OncoTraX menu 7 P PA 26, 38 PC capture program 59, 62 PE 38 PF 27 PS 38 PSR 54 PT 14 Q QA 26 R RA 13 Recommended websites 3 Registry Accession Register-ACoS 37 Accession Register-EOVA 38 Accession Register-Site 38 Patient index-ACoS 38 Patient index-EOVA 38 Patient index-site 38 Primary ICDO listing 39 Primary site/GP listing 39 Related manuals 2 Report options 7 RF 28 RS 51 Running Genedits 65 S Screen editor example 69 SDX 44 SE 14 Search criteria SP 49 SS 49 Survival by site 49 Survival by stage 49 Survival by treatment 49 TX 49 Send file to ACoS 66 SG 39 SP 15, 54 SR 53 SST 42 STA 47 State reporting 60 [\]^_`abcdlmnt}~ʻ|xtpleaZ hVRhjIGhjIG hl"hl"hl"h@!hzhT`hhhVR hVRh> hVRh3 hVRhnm hVRh, hVRhNh{ha_h(=hd h-Nhh-Nhh-Nhhnmhh lh5\4jh%h%CJOJQJU^JaJmHnHuh%jh%U _`abcd$a$gdzgdl"hgd)|gdVRgd)|gd-Nh$a$ $ #a$gdd   p q r s t w κ{slhd`N#h$Dh$D5CJ OJQJ^JaJ hNhh  h?{hh,@h6 hy E6hT| h&$h&$ h&$h4h)Ih4h%h45h&$&hT'hV5CJ OJQJ\^JaJ &hT'hnm5CJ OJQJ\^JaJ h XP6 h6 hHXU6 ha_6 hAW6 hjIGh3 hjIGh>h hjIGhnm   $Ifgd&$gd&$$gd6$a$gd  ! ^ o \SSS $Ifgd&$kdw($$Ifl44Fz$$ t0$6    44 laf4pyt%o p q r t u v w `[[[SSSS$a$gdgd&$kd2)$$IflFz$$ t0$6    44 lapyt% L F <  q Gw@6gdx`gd   * + , F G H I J K L M k l } ~  yuhj*hvUhvja*hvUhvB*\phj)hvUjhvU hvhEhv0JhOJ5jhOJ5UhvmHnHuhuD5CJ OJQJ^JaJ &jhuD5CJ OJQJU^JaJ #h$Dhnm5CJ OJQJ^JaJ (   $ % & @ A B C D E F G e f z { |    6 7 8 9 : ; < = [ \ } ~  j,hvUjU,hvUj+hvUj[+hvUhEhv0JhOJ5hvjhOJ5UjhvU hv?        & ' N O P j k l n o p q r $%&@ABDܴjC/hvUj.hvUjI.hvUhvB*\phj-hvUhEhv0JhOJ5hvjhOJ5U hvjhvUjO-hvU7DEFGHfg45TUVpqrtuvwؾvkhv]mHnHujhOJ5UmHnHu#j0hvUmHnHujhvUmHnHuhvmHnHuhEhv0JmHnHuj=0hvUj/hvU hvhEhv0JhOJ5hvjhOJ5UjhvU*wx9:;=>?@A_`ڹ˫ڎ˫vivvehvj12hvUjhvU hvhEhv0J#j1hvUmHnHuhv]mHnHujhOJ5UmHnHu#j71hvUmHnHujhvUmHnHuhvmHnHuhEhv0JmHnHuhOJ5jhOJ5U' >?fgh/~jhvUmHnHuhvmHnHuhEhv0JmHnHuj3hvUhvB*\phj+3hvUhvj2hvUjhvU hvhEhv0JhOJ5jhOJ5U./0134567UVlmn  /01Kźӎźvivvevhvj5hvUjhvU hvhEhv0J#j4hvUmHnHuhEhv0JmHnHuhOJ5jhOJ5Uhv]mHnHujhOJ5UmHnHuhvmHnHujhvUmHnHu#j%4hvUmHnHu'Rj1Es5Ir1X#KLMOPQRSqr%&GHIcdeghijkj7hvUj7hvUj6hvUj6hvUhEhv0JhOJ5hvjhOJ5U hvjhvUj5hvU;*+,./012PQpqr  "#$>?@BCDEFdej9hvUhvB*\phj9hvUj8hvUhvj 8hvUjhvU hvhEhv0JjhOJ5UhOJ5:&'PQRlmnpqrst./023456j;hvUjx;hvUj:hvUj~:hvUhEhv0JhOJ5hvjhOJ5U hvjhvUj:hvU;6TUefg&'(BCDFGHIJhi j=hvUjl=hvUhvB*\phj<hvUhvjr<hvUjhvU hvhEhv0JjhOJ5UhOJ5:   12OPQklmopqrs*+,./012PQopqjZ@hvUj?hvUj`?hvUj>hvUhEhv0JhOJ5hvjhOJ5U hvjhvUjf>hvU;567QRSUVWXYwx !"#$BChijjNBhvUhvB*\phjAhvUjTAhvUhvj@hvUjhvU hvhEhv0JjhOJ5UhOJ5:GHIcdeghijk !"<=>@ABCDjDhvUjBDhvUjChvUjHChvUhEhv0JhOJ5hvjhOJ5U hvjhvUjBhvU;jC x 8!!!D""#d##!$$$O%%"&&&P''4(( )Dbc        8 9 U V W q r s u v w x y !!!1!2!j0GhvUjFhvUj6FhvUjEhvUhvj"?"A"B"C"D"E"c"d"}"~""""""""""""""""#######%#&#A#B#C#]#źӎźvivvevhvjIhvUjhvU hvhEhv0J#j$IhvUmHnHuhEhv0JmHnHuhOJ5jhOJ5Uhv]mHnHujhOJ5UmHnHuhvmHnHujhvUmHnHu#jHhvUmHnHu']#^#_#a#b#c#d#e##################$$$$$$ $!$"$@$A$b$c$d$~$$$$$$$$$$$$$$$$$ܴܴܴjLhvUjKhvUjKhvUhvjJhvUhEhv0JhOJ5hvB*\phjhOJ5U hvjhvUjJhvU7$$$$$%%,%-%.%H%I%J%L%M%N%O%P%n%o%%%%%%%%%%%%%%%&&&&&& &!&"&#&A&B&f&g&h&&&&&&&&&&&&&&&ؾرؤjNhvUjMhvUj MhvUjLhvU hvhEhv0JhOJ5hvjhOJ5UjhvU>&&&&&&&&''-'.'/'I'J'K'M'N'O'P'Q'o'p''''''''''''''(((-(.(/(1(2(3(4(5(S(T(o(p(q(((((((((jwPhvUjOhvUj}OhvUjOhvUhEhv0JhOJ5hvjhOJ5U hvjhvUjNhvU;(((((()))))) ) )()))=)>)?)Y)Z)[)])^)_)`)a))))))))))))))))* * *$*%*&*(*)***+*,*J*K*r*s*t***jRhvUjkRhvUjQhvUjqQhvUhvjPhvUjhvU hvhEhv0JjhOJ5UhOJ5; )`))+***:+++J,,-u--;...'/v//&0q0t0u0v0w0x00$a$gd$gdgdx`********************+++++3+4+5+7+8+9+:+;+Y+Z+{+|+}++++++++++++++++++++++,,jThvUj_ThvUhvjShvUjeShvUhEhv0JhOJ5hvB*\phjhOJ5U hvjhvU<,',(,),C,D,E,G,H,I,J,K,i,j,|,},~,,,,,,,,,,,,,,- - - - ----.-/-R-S-T-n-o-p-r-s-t-u-v----------jMWhvUjVhvUjSVhvUjUhvUhOJ5hvjhOJ5UjYUhvUjhvU hvhEhv0J;-------...4.5.6.8.9.:.;.<.Z.[.f.g.h......................../// /!/"/$/%/&/'/(/F/G/S/T/ؾاؚjAYhvUjXhvUhvB*\phjGXhvUjWhvU hvhEhv0JhOJ5hvjhOJ5UjhvU2@2D2E2F2G2H2L2T2\2`2r2t2u2v2}22222h0hAghm:\ hhI>rh|ht:h C<h+OhwAhq hhwAhBh\ hh'@mh^h}hnm h$Dh3 h|G6h,@h6 h^6 h6 hh hx`hnm400000H2v22=3N33.45`55667789:;gdw$\gd\ & F%gdgdTZ>gdDgdq\gdqgd3gdH4$a$gd22;3<3=3N3O3d333333333333(4)4-4.43454O4W4q4r4z4{4444444555N5S5^5_5`5a5j5s5t5y5z555555555556 6ǿָ˱˭ǥǡhwAhJ?hDhD5h$ h qhlN hAghAghAghAg5hD h qhDht: hfnhAghv%+hBhAghqh'@mh\ hh'@mh2> 6q66666666677 77777?7@7A7I7J7K7X7Y7]7^7x7y77777777'8(8x8{888888899 999+9ɾ·¾ hF hhm hh{=Lh2 hh'@mh2h'@m5 h5h|hv%+hq hh|h| hh'@mhm:\hwA hTZ>5h ohTZ>5 hTZ>hTZ>hTZ>hwAhTZ>5hAgh hfnh3+9-919D9X9n9u9~99999999999999:: : :::]:^:a:i:::::::;;; ;/;0;6;;;P;Z;`;b;z;;;;;;;;뿻h2 h5h\< hw$h2h8 hw$h\< hw$hb h h!\h{=L hh'@mh2hF hh/ hhq hhfnh2h'@m5 hh'@m hh{=L hhm8;;(<P<<<.=r==>>C????@b@@ABBCCC & F gd; & F gd & F gdJ# & F gd; & F gdgd8gd!\gd gdsgd3;;;;;<<<<<&<'<(<7<8<=<L<N<O<P<Q<V<\<m<}<<<<<<<<<<<<<<===#=wrwnh h86h_Yh86 h!\h8 h h8h_Yh85h!\h; h h!\h8 h h_Yh_YhlK@h$3 h$3jh$3Uh h5hfn hw$hqhs hw$hJ? hw$h hw$hfn hw$hehnm)#=-=.=T=\=_=q=r={========= >>>$>+>G>H>K>L>_>k>>>>>>>??????C?]?^?_?y??????????ǻǻǻö㶙h_Yh>w6hxh_Yhh!\6 hJ#hhhh6H* h6h?W*hJ#6hJ# h0+hJ# hJ#6 h86 h`h!\h` h h!\h_Yh!\6 h8h8 h`h85????????@@@@(@*@.@/@0@M@O@S@`@b@@@@@@@AAA*ACAEAFA|A}AAAAA1B2BlBmBBBBBBBBӿӷӷdzǿӇh8hqhh0JjhOJ50JUh h!\0JhOJ5jhOJ5UhlNhxVhhh6h;h`h!\6 h h!\h`h_Yh!\6 h>wh>wh`h>w6 h h>wh>w3BBBBB%C)C.CCCDCICKCRCTC]C_ChCiClCnCuCwCxCzC{C|CCCCCCCCCCCCCCCCCCCCCDDJDKDpDqDrDDDDʼʧʧʌh)pjhOJ50JUh h^0JhOJ5jhOJ5UhlK@h$3 h$3jh$3Uh|h h h^h$h_Yhh_Yh_Y6h8hqh_Yh!\6h` h h!\7CCDDEoGGsHIIKK~L0MMNOAPsPBQCQMQYQ s$Ifgd#=<gd/gd (gd.2RgdJRgd ':gd^DDDDEE+E,E-E.EFELEPEdEEEEEEEEEE!FDFFFGFFF2G7GP@P hJhJhJhJhJ0Jht:h26 h h ':jhOJ50JUh h ':0JhOJ5jhOJ5Uh ':F@PAPUPVP[PoPqPrPsP{P}PPPPPPPPPPPPPPPPAQBQCQYQZQ_Q`QeQtQvQwQxQ}QQQQQQQQÿڻ~wswwhX h]hBh%hBaJh%hB5aJhA;hB hBjhBU h>hBhBh%hB5hX%h (h}hJ?hRkha hzh/hho5h.2 h.2jh.2Uh.2 h hJ-YQZQxQQjRtkk^ u$Ifgd% s$Ifgd#=<kd[$$Ifl440$$f* t0$644 laf4pyt%QQ R!R&R5R>R?RiRjRkRlRmRrR}RRRRRRRRRRRRRRRRRRRRS SSSSSS'S(S)S.S0S1S?SGSvSwSzS{Sƿ֌ hihihnhBh%hNaJhw h]hN h0+hNh%hN5hNhX h]hBh%hB5h hB hBjhBU h>hBh%hBaJ hzhBhB4jRkRRRxoo s$Ifgd#=<kdU\$$Ifl0$$f* t0$644 lapyt%RRSwSxof s$Ifgdi s$Ifgd#=<kd\$$Ifl0$$f* t0$644 lapyt%wSxSSS"T[TTTUxooff]TK $Ifgd R$Ifgd R$Ifgdia R$IfgdX s$Ifgd#=<kd]$$Ifl0$$f* t0$644 lapyt%{SSSSSSSSSSSSSSSSSSSSSTTTYTZT[TaTfTjTlTTTTTTTTTTTTTT(U)U*Uչxh%hNaJh%hNCJh%hia5hNhiah%hN5 hhN hN0J{h%hN0J{5hhN0J{h%hX5hX h]hBhBh%hB5 h>hBjhBUh/hB hB-UUUU)U*UAUUU.VEVlccZZ R$Ifgd s$Ifgd#=<kd#^$$Ifl40$$f* t0$644 laf4pyt% $Ifgd *U,U-U2U=U?U@UAUCUJUKUNUOUVU[U^UUUUUUUUUUUUUUUUVV&V-V.V>WFW_WpWuW}W~WWWW֭֭{hgh<h%h<CJh%hB5CJh%hBCJ h<h< h<hBh%h<5h%V+hBhia hHhB hy!hB h9_Ah9_Ah%hB5 h>hBhrhB hBjhBUh9_A-EVoVVVVVWIW_W~WWWXqXyXXXX $Ifgd+H s $If^ gd% R$Ifgdg s$Ifgd< $IfgdWWWWWWWWXXX7X8XJXNXXXZX[XfXqXyXXXXXXY Y Y Y YYYY"Y$Y&Y*Y-Y7Y8Y>Y?YDYgYhYkYlYqY~YYYY˗hk[hBh%hBaJ hCghB hy!hBh%hB5 h>hBhDJhB hBjhBUhBh%hNaJh%hNCJh%hN5h%hg5hghN hp;hN4XX YhYxoo s$Ifgd#=<kd^$$Ifl0$$f* t0$644 lapyt%hYiYYYYYGZOZZsjj]TG]T sV$If^Vgd% $Ifgd+H sh$If^hgd% s$Ifgd#=<kd]_$$Ifl410$$f* t0$644 laf4pyt%YYYYYYYYYYYYYYYYYYYYZZZZZ"Z$Z)Z-Z.Z6Z8ZAZEZGZOZZZZZZZZZZĹ~uqqqhLh%hLCJh%hL5h%hB5aJh%hLCJOJQJ^Jh%hBCJOJQJ^Jh%h+O0JCJh%hB0JCJh%h+H5hBh%hB6 hCghBh%hg5hgh9_Ah%h9_A5h%hB5,ZZZ[-[.[Y[[[[\5\\\\\\ sh$If^hgd% s$Ifgd#=< $Ifgd+HZZ[[[[[ [[#[-[.[;[?[g[k[\\\\\\\\\\\\\\\]]]$]*],]2]4]>]@]{]]]]]]]]Ǿˤzː hRkhB h93rh93rh%h5 h>hBhlK@hB hBjhBU h9_Ah9_Ah%h4/CJh%hBCJhLhB hCghBh%hB0JyCJh%hL0JCJh%hB0JCJh%hB50\\\Q]]ulcc s$Ifgd!% s$Ifgd#=<kd`$$Ifl40$$f* t0$644 laf4pyt%]]]]q^^^_n_xofYYffP u$Ifgd!% s & F $Ifgd% s$Ifgd!% s$Ifgd#=<kd`$$Ifl0$$f* t0$644 lapyt%]]]]]^$^%^+^-^3^D^[^p^q^^^^^^^^^^^^^^^^^^_ ___-_6_>_m_n_o______________```"`$`2`?`i`k`o`p`ûȴҬҥҥҥҬҥҥҥ hzhh%h5 h>hhh hjhUh hRkhBhqh%hB6hih_ hCghBh%hB5hBAn_o__`$`j``*aulll__R u$Ifgd% s & F $Ifgd% s$Ifgdlkd;a$$Ifl40$$f* t0$644 laf4pyt%p`v````````aaa)a*a+a9a:a?aMaOaPaQaeagahaoapatauaaaaaaaaabb b bbb7b9b@bQbUbVbqbbbbbbbbbb»ठ hCghih_hih_h} hCgh}h%hB5h%hih_5 hCghB h>hBhlK@hB hBjhBUhBh%haJh%h5h hzh:*a+aQaabbulccZ u$Ifgd'+ s$Ifgd!% s$Ifgd#=<kda$$Ifl40$$f* t0$644 laf4pyt%bbbbbbbbbbbbbbbbcccccc#c$c%c)c/c5cBc[c\cjcmcpcxcyczcccccccccccccccԽ⥡ⓡ⌈h?hJ?h, h5h, hp%h, hp%hMh93r hp%h2h*h~lhR hRjhRUhlK@h$3 h$3jh$3Uh2hq hRkhBhBh%hB5 hCghB2bbcccdMdnddddxsnnid____gd+Hgdigd+Ogdp%gd2kd{b$$Ifl0$$f* t0$644 lapyt% ccccccddddd!d#d%d*d2d9d>dLdMdPdQdTd`dddeeee&e/e7e>eve~eeeeƿư}p}ieiahUhq h5h\ih+Hh# 0JCJaJh+Hh\i0JCJaJh\ih\iaJ h ;h>h ;h+H h ;h?5F h ;h2h2 h5hMh{ h5h2h, hMh\i h+Oh, h26 h+Oh{ h+Oh2 h+Ohq hp%5h?h?5&ddeeeee1f2fYf~ffffgAgkg|ggghhgd+Igd>gd>h^hgduy R  @@^@gdi & F h^`gd/ tgd+Heeeeeeeeeeeeeeeeef ffff'f0f1f2fXf[f\fffrfffffffffffffffggCgDgmgng{g|gggggggggվɾɾɾɾjh$3Uh$3h>hq hdXh>h2hm h\ih2h26h+Hhmhl hUh2huyhuy5 hM 5h$@QhUhU h5h2h\i0JOJQJaJh+H0JCJaJh+HhrK0JCJaJhih+Hh,0JCJaJh+Hh>0JCJaJ hih> hih+I hdXh+Ihlh+Ihq hdXh>h>jh$3UhlK@h$3 h$3(hh:i;iDieiiiiiijBjCjmjjjjjk:kXkkkkkgd+Hh^hgd, \ & F^gd26\gdi\ & F-gd+HCiDiGiHiKiWihiiiiiiiiiiiiiijjjj"j*j@jAjBjCjmjojpjqjxjjjjjjjjjjjjjjkkk.k2kkEküܠܠܠܠܠܠܠh4/ h(hmhqhp h(h> h:h> hh26 h>0Jy5 hOH0Jy5h+IhOH0Jy5h#  hh>hh ;h>hmh+Hhm h2h>h,h>57EkIkZk[k\kkkkkkkkkkkkkk ll%l&l:lBlSlTlmlnlolllllllllllmmmmmmm)m+m,m-m1m8m>mRmVm]mcmdṃ̣̾hk h+H5hWzhOH5hOH hQ hJ{hlK@h$3 h$3jh$3Uh+H hJh9 hdXhh>hhqh+Oh ; h(hm h(h>h4/9k!lPlkllll-mmmm n\nnnJooplpqjqqqgd gdL q @ (^@ `(gd__ @ (^@ `(gd^!gd^!gd9gdEgd+Hdmnmmmmmmmmmm n nnnnn nSn[n\njnknlnmnqnnnnnnnnnnnnnnnnnnnn~wp h8hDp hJ{hDph^!hDp0Jh^!h90JhPV1hWzCJOJQJaJhPV1h9CJOJQJaJhPV1h8CJOJQJaJh^!hDphJ{hDp0JaJhJ{h90JaJhuh90Jhuh5T0Jh26h7q hJh9hk ,nnnno o,o1o7o8o9o?oGoHoJoPoZo[o\o]ogoroxooooooooooooooοΰοrοοοk hUhDphPV1h7qCJOJQJaJ h8hDphJ{hDp0JaJhJ{h90JaJhJ{hL q0JaJ hJh9hPV1hL qCJOJQJaJhPV1hWzCJOJQJaJhPV1h9CJOJQJaJhPV1h96CJOJQJaJhPV1h8CJOJQJaJh^!#oppppp)p,p-p.p8pkplp|p}p~pppppppppppqqqqqq!qVqWqiqjq»ѻ|||m|g|chL q hDp0JyhPV1ht:CJOJQJaJhPV1hUCJOJQJaJhPV1h8CJOJQJaJh^! h8hDphJ{hDp0JaJhJ{h90JaJ hJh9hPV1hWzCJOJQJaJhPV1h9CJOJQJaJhPV1h7qCJOJQJaJ hPV1hWz0JyCJOJQJaJ$jqoqqqqqqqqqqqqqqqqqq r r!r"r#r]r^rrrǸᏉwswbP#jhOJ50JCJOJQJUaJ hPV1h-;0JCJOJQJaJhOJ5jhOJ5UhPV1 h 0Jy hDp0JyhJ{hu0JaJhPV1h9CJOJQJaJhPV1hUCJOJQJaJhPV1h8CJOJQJaJh ha hUhDphJ{hDp0JaJhJ{h90JaJ hJh9hL qhL qhL q5qrrDss;ttBu:vrvzvv&wHwIwJwKwLwX^Xgdv _ ^gd~X^Xgdqd[^gdvgdqd[ T 8hh^hgd^! x^x`gd gdL qgd-; @ (^@ `(gd rrrrrrrrrrrrrrrr s sCsDsIsJsssssss¼|x|qbSh h9CJOJQJaJh h"TCJOJQJaJ h"ThGnJhL q hL qhL qhL qhL q5h9hPV1h"TCJOJQJaJhPV1h9CJOJQJaJhPV1h #CJOJQJaJ h 0Jy hGnJ0JyhJ{hDp0JaJhJ{h90JaJ hJh9hUhUhU5hPV1h-;CJOJQJaJsst t&t*t0t9t:t;tgtptvtttttttttuu uu'u;u@uAuuuuuuv v vvvv9v:vBvĵ񬥡{phJ{h90JaJhJ{hJ5 hJhJ hJhJh~hJh95h+OhJ hJh9h h>aJh h~CJOJQJaJh hJCJOJQJaJh hCJOJQJaJh h9CJOJQJaJh h>CJOJQJaJ*BvEvIvKvUvYvpvqvrvyvzvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvžh8h!C\hL q hJh8 hqd[h~ hqd[h2- hqd[h8 hqd[hDp hqd[h9 h>hv hM 5h2- hJh9 h2-h9 h2-h2- h2-hGnJhJ{h90JaJhJ{hk 0JaJ5vvvvvvvww w wwwwww w$w&w0w4w6w@wFwGwHwLwMwPwRwrwswxw{w}w~wwwwwwwwwwwwwwxxxx x,x.xûִhhQ hQjhQUh26hhW#h,h h\lh,hhlK@h$3 h$3jh$3Uhiv; h\lh#Nhqd[hehJhLh#O&h~hL q hJh87Lwwx0x4z5zz*{|}~~~8cgd#Ngd} TgdD~gd"=TRgd_Rgd @RgdVbgd,hgdH4.x/x0xvx}xxxxxxxxxxy yyyyy!y&y:y{G{L{M{N{`{{{{{{{{{{{{{{{||||||| |#|$|-|<|L|k|||||||||}}}}}}-}/}7}T}U}t}ʶҪh'jch_Ujh_Uh_h_0Jh_h @hVbhvmHnHujchUjhUjhOJ50JUhh0JhOJ5jhOJ5U h\lh#NhhU-6t}u}}}}}}}}}}}}}$~%~D~E~h~i~p~q~~~~~~~~~~~~~~~~~  ,:;EQe丣ģ~z~zzh+HhD~h}0 hLThD~h @ h\lh#Njdh_Ujh_Uhh_0JhOJ5h_hVbhU-hvmHnHujdh'Ujh'Uh'jhOJ50JUh'h'0JjhOJ5U0efp|Lɀր׀܀ހ -1<HȁɁρҁ h'h#N hnhn h'hn h,"ht"hQ hQjhQUhnhlK@h$3 h$3jh$3Uhiv;hA hD~h#N hD~hD~hD~hD~5hD~hZh+H h\lh#Nh}02ҁ݁45<>B[\]nzق ,-.CEJOT^_ktu뼸ȸȸȸȸȴȭȴȴȩ٘hG$hG$5hG$ h'hG$ hG$0JyhM h <0hhdh)hZ*h <0h(h+H h <0h#NhEB hn0Jy h\lh#N h'hEBh' h'h#N h'hM h'hn65]قk$GƄ=Ew҅Fx  ^` gd"=Tgd} Tgd#N8^8gd'gd"=T 8^`8gd!C\gd'Ãă҃ԃ"#$NT'1<=DEVXjl҅Ӆ܅ޅ}thuh"=TCJ heCJ h@>CJhuh4CJ huCJhuhCJhuh}CJhuh#NCJh4h45 hM 5h#Nh"=Th'h4 h\lh#Nh+O hNIh#N h!C\hNI h!C\h#N h!C\hG$h!C\hG$5-!-./01:;@BDEFKVY͆نچۆ܆!lstغةةآؖؒjhQUh=:hgvh#N5h ` h\lhm-h6hlK@h7h h7hjh7hUh4hm-h+Hhiv;h h\lh#N huCJhuh"=TCJhuh#NCJhuh}CJ3ty}Ƈ̇чԇ!&*/2KPvwxԈՈو !f~ܻϳìììϐË܂Â~܂hzhR' hM 5 h}X5h"=Tha*0JCJaJ ha*ha*ha*h#N5 ha*h#Nha*0JyCJha*ha*5ha*h"=T0JyCJh"=Th#N0JCJaJ h\lh#NjhQU hx h,hQ hQ1x2TOЋ̎Qgd} T ^ 8^gd2gdbgdAgd}X h^h`gdR'gdR'gd#N‰ĉɉˉӉ։T`abgivwŊƊNJԊՊ*,17>?FH[\lms~ƋNjϋЋՋ֋׋݋ދƾh h]Z)h]Z)5 h}Xh}XhAhQh+Oh}XhrKh]Z)h@>hvi-hfCM h\lh#Nh26hRI MUnjҌ֌@ADE]bcjkż񟪖 h\lhbh+Hh:hvmHnHuj eh2Ujh2UjhOJ50JUh2hb0Jh2h20J h:0Jh2h#N0JhOJ5jhOJ5Uhbh8h2 h\lh#Nh}Z5čЍэҍӍmn̎ގߎ./38<ADOPQX[_xz %&'9:<h26h8hphp0JyCJh}Xh#N0JCJaJhqhgvhuo hx h~h7hhlK@h7h h7hjh7hUh&h+Hhiv; h\lh#N=Q{ÏGr+֒ݓT?eygdDFgd!gdUPgdUPgdM gdpgdA h^h`gdDF h^h`gd}Xgd}Xgd#N<SUV[]fhŐƐǐȐɐ͐ϐِڐېܐ*+01GHTj  56UVyz¾µjhAUjhOJ50JUhhA0JhOJ5jhOJ5Uhr !h$hOhphp5 hDFhDFhAh8hph@>hDF h\lh#N=ʒ˒ВҒԒՒ@H]a“Ɠȓٓۓܓݓ!',/BFصررر؍؀yryryrnhUP hUPh#N hUPhUPhDFh#N0JCJaJhUPh#N5 hx hxhQ hQjhQUha$hqhlK@h7h h7hjh7hUhgvhiv; h\lh#NhAhvmHnHujhAUjehAU+FRSTghlquz}?Aehy34:ZΖЖۖɾžݶɠ h~6hDFh26 h~6h,C h~6h+H h~6h#NhDF h\lha$h?h?h?5 hoh#Nh! h\lh#Nh!hUP5 hM 5h#N hUPhUPhDFh#N0JCJaJhUP hUPh#N3y4Z!m+F]Θ֙X5\gd-|\ & FgdigdM gd#Ngd} Tgdogd~6 hh^h`gd~6gd?gdDF myzŗƗۗܗ,1FKLM]bcИҘ(,569fܼܸܸܝܝܙܕܑh~|h~6h` _haWhlK@h7h h7hjh7hUhZhhoho5hohoh#N5h+HhDF h\lh#Nh/h@> h~6hDF h~6h#N h~6h89ҙԙՙٙޙ#+45OPQSTWcgjqؚ̚ݚ☑~wp hih#N hihO1hzGh#N5hq hzGh#N hzGhzGhzGhvmHnHujfh?nUjh?nUh?nh?n6h?n h?nhzG h\lhzGh,"hO1h%hff h\lh#Nhmph7h h7hjh7hU+ݚ45:;DIPhipq}˛͛Λϛ '/89STUWXYaopwxûַެ}v h {hO1hvmHnHujfh?nUjh?nUh?nh?n6h?n h?nhO1h { hO*NhO*NhO*Nhzh7h h7hjh7hUh~|h2'Yhp& h\lhO1hO1hO1hO15h6[ h\lh#Nhi-5ϛZҜUߝWoԞ0gd} TgdHzIgdB43\ & FgdB43\gd-|\ & FgdigdO*NgdM gdO1xΜМќҜ"*34NOPRSTU[\dfyumhNhN5hYhthN5hNh?nh?n5hvmHnHujfh?nUjh?nUh?nh?n6h?n h?nh~|h { h\lh~| hO*NhO*NhO*NhBonh7h h7hjh7hUh~|h2'YhO1 h\lh#NhlM?'ߝ4578JLWZ|ϞҞ0FfßşǟȟɟΟ?跲hNhQ hQjhQUhlK@h# h#jh#UhhN h\lhNht-h#N5heh.}hthq h\lh#NhB43ht5hB43hM 5:?@Nw ,-56=>?M͡ΡӡԡءjkƢǢϢТԢܢޢ$%)DGLTUVɺ񤝫 hVsh.} hVsh#Nh.}h:v hVshu hVshghu h#N5hu h {h#N0JCJaJ h\lhthth;7ht5h#N h\lh#NhXNhg<ΡkV^ӣX{֥W{;Rgdugd_ gdH4 h^h`gdHzIgdHzIgdiv;gd} Tgd P^`PgdHzIgdtgd#NV^ȣɣ "$56OQXdfqrĤʤѤ ÿûû hZhMHhQ hQjhQUhlK@h# h#jh#UhJh h\lh#Nh\hPJheCJPJhCJPJhhCJPJhhCJhS`hS`558AOcdrsz{ʥ˥&(34;<@AKLWcdepqxy}~ֵֵ鱭֭饡jh#UhhchIh#ghehHzIhwF,hqhzHhiv;hzH5hiv;haS5 hM 5h- h\lhaShaShr| h\lh#NjhQU hQ:¦ŦǦȦɦΦ<ƧҧBCyz{ݨިߨ"89;˩թCDFG[\tuƾƾƾƷƾƾƾƧƣƟƟƟƟƟƟ hahah26haheh3ph_ 5h3ph_ hkhuhuhet hkh_ hchihQ hQjhQUjh#UhlK@h# h#:DYrĪ&Ie۬;̮YȯgdgdM gd:gdJ#gd?W*gd+_gd?W*gdJ#gdcv R & F ^ gd26RgdaƪǪ ()HIKM^_dfhijo1348d۬&欨捨hqh?W*hj~h U h0+h"Ah"Ah+_h+_h+_5h hQ hQjhQUhlK@h# h#jh#Uh h0+h?W*h_ hJ#ha hkh_ 7&'1CPRclstxy #-09:;@AEF]^frst|}Ż͑ͤ͜hvmHnHujzghaUjhaUh"jhOJ50JUhqh"0J h#0JhOJ5jhOJ5Uhah:h:h:5hVshQh%Jh |hJ# h0+h?W*h+_h?W*4ʮˮ̮ͮծ߮7ǯȯܯݯ"19BC]^_ÿ{sk`kjgh?nUjh?nUh?nh?n6 h?nhvh { h {hPmhPmh?n hh Meh4B[h@Y h@Yjh@YUh Mehh%|hhvhPihnhQ hQjhQUhu% h2hPih-h* h`h"h K$ȯdɰѰ#$klбRͲѲ0Mo(gd8Ih^hgd Me\ & FgdNhgdEk_abcdloɰѰҰԱձڱ۱߱ &-/89;<=KLVW\]abipr{| h8Ih-h8I h8Ih! h8Ih:h *h Meh Me5 hNhhNhhNhhNh5hNhh0oh?njh?nUhvmHnHuD|} _cdi}CGHMw{|ô +,JN !"jh@YUh Meh5-X h Meh Me h8IhH h8IhNhh26 h8Ih Me h8IhL h8Ih!h8I h8Ih: h8Ih-B()NOĴѴ ,.pq޵"DfҶ8Z|}gd8IзѷIܸŹ\yͺ ػgdcvgdvgdcvh^hgdiv;\ & F.gdkgdEkgd8I"'EGHIQScոָظ۸ܸikmo}~ŹʹҹԹ[ƿƴƴƭƭƭ}}y}u}hVshv hvhvhvhv5 h2hPih*hfhPi5 hM 5 hiv;5h{t6 h2hv hp%hvh`w hp%h`whv h:hNh hNhhNh hNh5hNh h Meh Mejh@YUhOh@Y h@Y-[\jkmyĺźʺͺۺܺߺ ~ѻһػڻ 09;lm|}~h&hZh- hPihPih=GIh5-X h2h26hu%hu%5hu%h8h8h85 h2hPihPi hvhPiGػ~мѼXȽ3_ھ0&Nk]gd_)8^8gdTj\gdkgdEkgdcvgdcvƼǼʼмѼX]^Ƚսֽܽݽ޽߽78>?DGcdjkps¾ ,./hAD9hQ hQjhQUhK~ hC h2hChYUh8ht:hfh[*h[*h[*5h&hPih-! h2hPi@/0w}ʿݿ޿߿>?MNOijklڵh@ hM 5 hiv;5 h {h'h_)h'5 h {h@ h_)h@ 5h_) hkh' hkh@ hNV5 h@ hNV hNVhNVhkhT h'h'h'h'5h'hNV h&[hNV3K CKL !?gd\gdvgdv \ & F hgd/ tgdNh^gdRs8^8gdRs^gdRs!"$&'-3AO!C)*IJKLƾ˷ufYhvhOJQJ^JhvhOJQJ^JaJh8A4OJQJ^JaJ hvhg@hvhQjhvhQU hvhv hhvhg@hv5hv hNhhNhhyPh@Y h@Yjh@YUh8A4hNhhNVh26 h@ h@ h@ hNVh@ h@ h@ 5"}*45AMO^_copzSιέέΥέέέιΥΥhp0JyCJh:8h:85h:8h:80JyCJhphg@0JCJaJh/h  hhg@h8A4h8A4OJQJ^JaJhvOJQJ^JaJhvhOJQJ^JaJ>?Ed{|` 8o9:kl3~ L^`LgdvgdO^Vw%?XgdFD h^h`gdFD \ hgdpgdp\ & F hh^h`gd/ tgd8A4 @ (^@ `(gdp^gdiPh^hgdiP\gd4kS[\]^kl 14@`pv*,TUV\hpqrsthphJ/ h8A4hh8A4hQjh8A4hQU h8A4hg@h/hg@5 hVH5h/hVH5 hhVHhVHhp0JyCJhphg@0JCJaJ hhg@h8A4h/9!"!$'(ABZ[{|23WXYǼ hi-5PJhhi-5PJhH3Ihi-PJ hhi-hi-h8A4hi-jh8A4hi-U h8A4hi-hw hkhg@hkhkhk5h@m hhkhkhg@5h a9hJ/hC hhg@3XyY /Qs6X Cgdi- \ & F hgdi-gdi-gdkgdFD /1QSsu68XZ CEqs.W`bc  )*-4BCNQacmnxzhi- hhi-hhi-5PJhH3Ihi-PJ hi-PJVCqbc5wx+,jkc\ & Fgdi-\gdi-gdi-gdi-)*+,ik.;<>BDK^_acǾᝓ݆|u hi-5PJhXhi-5PJhXhi-5 hi-\h]hi-5\h! hi-\h! hi-5PJ h2xPJh! hi-PJhhi-PJ h]hi-hs4hi-0JCJPJaJhi- h! hi-hH3Ihi-PJ hi-PJhO`hi-PJ+cdW&FUdubtgds4gd7gdV}gds4gd!gdi-gdi-\gdi- !#,-.7BCKLU]_`dlWXyhYh%|5 h!hf& h!hT h!hIoh) h!hC h!h7 h!hJ?h%|h%|5hCh75hT hC hH3Ih7h!hQ hQjhQUh%| hi-hi-5 $.CM\czFGUWXYdfghuwxybctuh3hKh3h35hv&h75 hV}5hV}hV}5 hZhV}hV}hv&h76hv&hlAh76h%| hH3Ih7hlA h!heeAtmO+go</gdD)gdKgd&gd6K=gd7gd$gd3gds4#56GJKLOUVWX\`chi8AOjklmoqh?hQ hQjhQU h7dh[h hjhUhiv;h7hk0hv&h. hv&h36h<hoh@YhDh3h3h35hK hH3Ih76 $%03Yijkv o|괯hx*h hjhUhiv; hKhKhKhK5hKh6K=h75 h6K=5h6K=h6K=5 hH3Ih7 h0+h6K=h6K=hHOB')*+PWbfgotwhD)h75CJhD)h&CJhD)hYCJhD)h61CJhD)h7CJhD)hi^CJhD)hHOCJhmHhmH5h7 hHOh7hHO hH3Ih7h9 hQ hQjhQUjhU0 /;<GHIJUVWdfqrtuw!"$/45ͽߴʹߴ߽ʹͬh;7hEwh;75hD)h&CJ hp_CJhD)h75CJhD)h7CJhD)hi^CJhD)hYCJhD)h61CJhD)hHOCJ hD)CJA5:<ACmnpr0178=NPQRWY[\]_rŽʳԞԞԞԞԞԳ{hxlh! h7d h7djh7dUhYh;hmHh$hNh; h;jh;Uhx*h hjhU hH3Ih7 hiv;0Jlh$h70Jl h;7h;7hEwh;75 hH3Ih;70/n]PRvNd<hgdL>gdIgd%*gdih_gd< gdxlgdp_gdtgd7gd$gd;7rz PRTrsxz|}~ RTVuvwxMNĿĭԚh U h$0Jrh{h; h;jh;Uhx*h hjhU hiv;0Jlh$h70Jlhth;7ht5h7hEwht:hxl hH3Ih79NSTX56;=?@AF`bcdžssgjh;0JlUjh0JlUh$h$0Jlhxlh7hh; h;jh;Uhx*h hjhU hH3Ih7 hiv;0Jlh$h70Jlh!hp_hx*hp_ hp_jhp_Uhp_h;7hp_5' =YZe!GKmsu #<hkϿ򞿒ߒߒߒߒߒߒߒߒߒߋ hKIhO` hKIh7h4hmh;jh;Uhx*h hjhUhdIhth;7ht5hehxlhChEw hH3Ih7jh;0JlU h;h h;4#$)*rs  #3BJMVoùÛ××ÊÃh?n h?nh7hL>h70JCJaJhh;7 h;h9hhx*h hjhU hH3Ih7hiv;hO`hO`0JyCJaJ hO`hO`hO`hO`hO`5h7 hKIh7 hKIhO`1$!oM}u<ggd H^gdux ^`gdux ^`gdgd7gd7gdO`gdL>$(JR^h{~MZ]bcqr}ÿпппппгЯпÿÿЧЧßЯßЯhh5 hH3Ihuxh0JyCJhuxh75huxhh75hp_hhL>h70JCJaJ hH3Ih7hvmHnHujthh?nUjh?nUh?nh?nh?n689:FJst *+>@[\acefghmijwxþþå hH3IheEheEh[ h;h8hhx*h hjhUhiv;h Hh75h Hh Hh H5hp_huxh P hc'hq hH3Ih7:_ (7K]t *;mgdL>  ^` gdeEgdeE P^`PgdL>,4=>XYZ\]^_xy#$36W_`dfuyϿϴϤ夏yqhL>0JyCJhL>0JCJaJheEh75heEheEheE5hL>h70JCJaJ hH3Ih7hvmHnHujhh?nUjh?nUh?nh?n6h?n h?nh[ hH3Ih[h[hL>hL>heE0JCJaJhp_0JCJaJ,;AFGHKLMQejklm}~047<=Ľh 7lh 7l6h 7lh 7l5h hH3IhL> hH3Ih h7 hL>h 7l hL>h7 hh 7lhvhv5 h 7lhvhvh hH3Ih 7lh!hL>h 7l hH3Ih7heE8m7 M hTrz1z 1]egdJgdjcgd7gd7gd 7lgd gdL>  ^ `gdL> '(-/138IKLMy 238:<>Cdfgj~ @NZھh+\hQ>hp_h 2hFBEhh\hwghhx*h hjhUhiv;h7hv hH3Ih7h 7lCZlmpqrz 0OPcdpq ,-9:CEKPZ[ $&degiнннбббнШбббббШШббШШббСhiv; hH3Ih"hjch6CJ hjcCJ h26CJhjchjcCJhjch"5CJhjch"CJh"h"5h7 hH3Ih7 h+\h7h+\h+\h75>i5<"$<PZf+;IWptҿ hQCJhQhQCJh"h"5 hH3IhGOhGOhGO5h7hGOh+\h ~hhx*h hjhU hH3Ih7B1I4<?\sgd$=gd7gdM gdQgd"gdGO$);<>AYZ_acejAB^_uv6789=LMȸͱh$=hU` hH3IhU`hZh5hGO hH3Ih7hQ hhx*h hjh0JlU hiv;0Jlh7h70JlhQh"CJ hQCJhQhQCJ;+N x   P |      D e        gd$=gdEkgd7gdJRgdU`R & FgdZ  )+-.ABCDVs    L M ^ _ d t v w { |                      ÷ð h-wjh7 h-wjh+ShA/#h+Sh75h+Sh:h hjhUh3ehO.h$=hU` hH3IhU`hZ hH3Ih7?          " 4 7 P ~            F G d e              + . J M               P Q ڿڭککککککڡککڝڝککh'>h-wjh75h-wjh+S h+Sh7 ho@+h+S ho@+h7h+Sh75h+OhJhp_ hH3Ih7 h-wjh7jhU hhrh> + J a      P o p       %&N`x>xgd*gdEkgd$=Q [ e j k n                    $&)459?@NSV[_`eijtx}4h$=hA/#0Jh$=h70Jh]&h hjhUhhA/#h#8 hH3Ih7h26h-wjh+SH45=>?eft,-7DEJKZd%CDEQļ޵̵̵̵̵̵̵汪 hOh7 hOhOhO hr[hhr[hr[5h7h#8h;) hr[h#8 hr[h7hr[hA/# hH3Ih7hA/#hA/#CJOJQJaJhj04@>e,EDPQpKL_`xgd*gdr[gdr[gd$=QSpt !+LPT^"&48?OPRST[\imux|˼hhh#85h;h;CJOJQJaJ hH3Ih;hh75h;h7h;hO^J h;^JhOhOCJOJQJaJhj04 hH3Ih7hO:"PZ[9Hj<xxgd*gdEkgd$=|89;HLU_jnw ?@DQYZ_tvwxݼõֱֱ֧֖֖֖hh[ah hjhUhA/# hh7 hh;h26 h;h;h;h;5 hH3Ih7h;h7hCJOJQJaJhh;CJOJQJaJ;Aayz*HdD[hz+`gd7xgd*gd$="?@AEaxyz}  *+,-6@HIJK  hj04h#8 hj04hj04hj04 hh7hY) hH3Ih#8 hH3Ihh7hhCJOJQJaJh$=h70Jh$=h0J hH3Ih7h?   CDhiz{*+,7:@GHKVW^_ij(*ɶɲɶɶɑ hM 5h\Jh75 h\J6h\Jh76h\Jh\J6hRhah\J hj04h7hj04h75 hH3Ih7h#8hj04hj04h#85hj04hj045 hj04hj04 hj04h#8hj04h#85\7)*de#,-n\gdEkgd$=gd7gdM *=K^bfkn~ &()*?@\_ļɴĐĘh7q hKh7h},whjhU hJh7 hJhJhb,h\Jh75h$7Wh hjh5U hM 5h\Jh\J5h\Jh\J6h\Jh76hah\J hH3Ih74 D_`#VWy  _   !U!!!"K""gdt:W X   !T!""""#### ###$#'#)#+#0#E#G#H#K#b#######$>$Q$m$$$$$$$$$$%% %% %!%$%»ht:hJ0Jh2h>\h;hph; h;jh;U h{hJhiv;hPhI h]h]h,@h]6 hk26h]h P hKhb,hhLs hKh75""""""#I##B%p%%%%%&0&O&q&&&i''gdT,gdtgdPgdt:gdJgdH4$a$gdVgd]\ & FP^`Pgd]$%%%:%;%N%T%r%t%%%%%%%%%%%%%%%&&2&4&Q&S&s&u&&&&&&&&&&&&&&&&&&&&''''(')'*'/'7'<'@'J'ק㜘ht h{hth'>h hJ{hTTh;hph; h;jh;Uhiv;hPh4/ho@+h+O h{hJhLsht:hJ0Jht:hLs0JCJhLhsCJ hJ5h{hJ5h{h{5h3-h;7h3-5h{ht:h8]hJ<{ h{hJ>..5///F0001m11t22e333A44'5Q5555>6f6gd& P^P`gd&gd&gdt:gdgd)gdLgdJ/////0000 0"0'0B0D0E0c0k0n000000000000000011111#1<1=1>1C1E1G1I1N1i1k1l1m1ͽҹ޲͉͉́hRh;jh;Uh0^ h{hT,hT,h;7hT,5hJhMT h{hJh]ah,h;hph; h;jh;0JlUhPhJ0Jl hiv;0Jl hP0JlhshLhCJ2m111111111111s2t2x2222222222222223"3e3j3k3n3333333333333 4 4424hx nh; hM hJ hM hPh=hT,h;7hT,5h]ah?.h;hph; h;jh;UhPhJ0Jl hP0Jl h{h3-h3-h;7h3-5hJ h{hMT h{hJhMT2244464;4=4?4@4A4C4o4444444444'5Q5t5w55555555566=6>6?6f6g6m6n6o6w6y6ڡڰژ|tlڰhQYhQY5hQYhJ5hQYh;5h;hJaJ h&h;h&h&hJ0Jh;hJ5 h&hJh; h&h& h&0Jht:hJ0JhT,h;7hT,5h8] h{hJ h)hJhph;jh;U h;*f6n666!7;7777'8A8888-9r99/:W:::::::8;$a$gdVgd;gdPgd&gdJy6~6666666666666666!7&7*7;7E7G7H7S7T7Y7Z7g7h7u7v777777777777777777777778 8888'8,808A8K8M8N8Y8Z8_8`8m8n8{8|88888888888888888h=h&h"`\hQYh;hEc h{hJY8888999999!9"9-97999:9E9F9K9L9Y9Z9f9g9r9v9999999999999::-:.:/:c:d:g:i:l:n:q:s:w:x:::::::::::񽴽h;h;5h=h;CJ h=CJh=hn(CJh=hJCJh;hnuBh;hph; h;jh;UhPh"`\ h{hJhEchQY>::::7;8;9;<;>;U;V;[;^;`;b;g;~;;;;;;;;;;;;;;;;;<<<<G<H<v<w<<<<<<<==I=J=e=f={=~====ûóүүҫүҫҧҫҧҫҫҫҫҫҫҫҫҠҫ h&ht: h&h3P h3Ph3Ph4/h3Ph3#hhh;hph; h;jh;U hePhfhiv;hPh hVhVh,@hV6hVhJh;98;;;;;<D<s<<<<=F=b={==k>>??@+@@@Axgd*h`hgd'MgdgdPRgdYkgd&gdfgdH4=============j>k>n>p>w>y>z>{>>>>>>>>>>>>>>>>>>>>>> ??????(?m?s?~??????μΞΞΖΖΒΒΎhfh'Mhhvhc hJ{h3)"h;hph; h;jh;Uh&hiv; hePhf hePh3P h3Ph3Pht:h3P h&h3P h&ht: h&h&8??????????@@@@@$@*@+@{@@@@@@@@@@@@@@@@@@@@@@@ A AAAAA'A(A4A5A6ALAMAWAXAYAžŞžhmh0^h&hfu hePhhhf5 h5hh5hY7 hePhfhh\ShCJh\Sh0JCJaJh\Shf0JCJaJ hePhT,hT,h;7hT,58YAZAiAjAvAxAAAAAAAAAAAAAAAAAAAAAAAAABBBBBBB(B9B;Bh;hph; h;jh;Uh\Sht:hPh0^hfu hePhfhm7A\AAAB#CGCgCCQD|DVEEEF"FFFqFFFGgdh|gdXgdLgdfh`hgd'Mgd3- h8gd'MgdPgd&#C/C0C7C8C@CECFCGCfCgCCCCCCDD DDDDDD!D&D'D.D1D2D3D6DCDDDPDQDVD{D|Døzzqzzjfbh3-hP hePh'MhLh6@CJhLh?CJ hLCJhLh CJhLh'MCJhLh 5CJhL0JyCJhLhL0JyCJhLh\S0JyCJhLh 0JyCJ hf5hzhz5 hePhfhY7h&hY70JCJaJh&hf0JCJaJ&|DDDDEE#E%ETEUEVEXExEEEE-F4FEFFFKFUF\FpFqFFFFFFFFFGGGGŹyuqqqhb hLCJhLhfCJhhqhzhq5 hh|hh|hhh|5hh|hh|hh|5hfhhf5 hh|hf *hM hf5hM hM 5hv hePhf h3-hfh3-h$!jh3-h$!Uh ]h3-5 h3-h3-h3-h3-5$GGGG&G(G0G2G9G:GAGBGFGGGQGRGbGgGGGGGGGGGGGGGH'H9HcHdHeHjHkHnHHHHHHHHHHHHIIII6I7IQSQbQcQQ Rgd ]gd ]gdX xP^P`gd1 R5RDRRRR=SRSaSvSSSSSTjTU6UfUUUUUV,VWVgd.gd.gdXgdgdfgdPgd ]gd ]SSSSSSSSSTTTTATiTjToTpTtTU6U7UfUgUUUUUUUUUUVUVVVW0W1WX?XIXKXMXNXXXXXXXX&Y'YFYGY`YgYhYYYYY"Z$Z,Z.ZZZM[Y[Z[f[s[t[⿻⥟ hY)CJ hvCJhiyhiyCJ hiy5h;7hT,5hT,h2h\h$!hph$! h$!jh$!U hePhfhPh.h.CJPJh.CJPJhT8/ hePhBIhBIhPuh4Ih$!hPhi?iEiFiMiSi^i`ifijikiuiwizi"j$j%jajbjcjgjljtjjjjjjjjjjjjjjjjjjjjjjjjkk%k/küüüôühchhf5 hlph%cehlp hlphlphlphlp5h0hf5h0h(5 h0hf h0h(h00Jy5CJaJh(0Jy5CJaJh0hf0Jh(h2hf5 hePhfh26/kRkSkkkkkkkkkl*l+l,l0lAlElWl[lslulllllllllllllllllllm+m1m:m>m@mQmRmWmxmzm|mmmmmmmmmmmmmmmϿ޻ϳϫ޻hwh$!h:Uh$!h hWh$!hBMh$! h$!jh$!Uh> h>hfhqh +hf5hch hePhfAWlqllgd0mnnnnn)n*n/nTnVnXn]nonqnrnsnnnnnnnnnnnnnno oooNoVoWoXoYo`okoloqoroooooooooooo p p pppp p!p0ph+@,h0h+h hf5 h@j5 h 5h h 5h@jh:bh$!hRnh$! h$!jh$!Uh> hePhfh hePh ?0p1p3p4pipjprpppppppppppppppqqqqqq"q$q'q)q,q.q0q1q2q4q8q:q=q?qAqDqFqGqHqJqNqPqRqUqWqZq\q]q^q`qdqfqhqkqmqpqrqsqtqvqzq|q~qqqqqqqqqqqqqqqqh"Uh0h[h@jhqh@jh@j5hf hePhfh+Tqqqqqqqqqqrrr r+r3r@rVrYrZrcrmrvrzrrrrrrrrrrrr sssss,s-s2sHsJsLsQsTsVsWslsrsssshThph$!h`Hvh$! h$!jh$!U hePhfhiv;hPhpxhpxhW&6 hpx6hW&h"UhDh"Uhph"U h"Ujh"UUhc' hePh"U5qrrrrsssXst7tStuttttu"uTuyuuuuv5vgd0gdfgdH4$a$gdpx$a$gdW&gd"Ugd"Usssssssst7t9t;tBtJtUtWtwtytttttttttttuuuuuu$u&uVuXu{u}uuuuuuuuuuuv vvv7v9vlvnvvvvvvvvvvvvvvÿjh$!UhP hePh+@,h+@,hJhfh+Oh0ht:h~ hePhf hePhThqhThfRF5vjvvvv2wkwswwww x%x;xRxxCyryyyy)zrzzzj{{{RgdfRgdfgdfgd0vvvvww.w0w1w5w6wOwYw^whwjwlwmwtwuw{wwwwwwwwwwwwwwwwwxx xx%x(x/x5x;x>xXxjxxxyxxxxxxxxxxxxyyrysyyyyy(zٽѶѶѶٲٲٲhu hePhfRh hc'hY)hfRhf6hfRhA) hePhfhh$!jh$!Uhph$! h$!F(z)z-z3z4z6z7z8z>zIzQzUz_zczj{{{{{{{{{{{{{||+|,|-|1|4|5|X|\|]|`|c|d||||||||||||||| } } } }}}1}3}R}U}X}Y}]}_}d}ż hA)PJ hvYPJhePhfPJhA)hf5PJhA)hA)5PJht:hA) hePhfhA)hu6hA)hf6huhfRE{{{2|a||||}0}1}d}}}}}}}~4~5~m~~~~~ igdXogd0d}f}}}}}}}}}}}}}}}}}~ ~~&~)~*~.~0~]~^~_~b~c~g~i~m~n~~~~~~~~~~~~~~~~   :<=>@CFhePhvYPJ hXoPJ hfPJhXohvY5PJ hPJ hvYPJhePhfPJ hA)PJNFJmf߂4'ʄ%ͅOdž҈=`Vgd5Pgd{%gdxgdQO gdfgdfgd0FIJNU]efÀˀӀۀ "+V^lmrtx́Ёԁځ$%*WY[`bde䨠hJ8h$!hQO hQO 5hQO h+h$!hph$! h$!jh$!UhePhfjhePhfUhq hePhfhPh" hf5h" hXo5EFLPT_ablŽŹ hYjhYUh24hh]SjhEzh{%6hEzhEz6hEzhEz5 j<h20~hEz hEzh{%hEzh{%5 h20~hEzhEz h20~h{%>ܞޞߞ78>AYZz}՟֟ #789HITXdlpŠɠʠպնᲡᙑ኶ h20~h[vh[vh{%5h[vh[v5 jnih7h%UmHnHuh{%h[vhK(h{%5hY)h24h{%5 h20~h24h24h24h245 h20~h{%jhYU hYhH59hY47Z|ן8:fdEyjL q ]^gd5{gdmgd* gd{%gd{%gdl\gd4k\ & FgdlgdEkgd24gd2LV`fp&:tܣ "#(FG\]buwxФ٤  %>?yzʾʾʾκκζάζζζζΛάh_KhLh$hY hYjhYUhRhxhW5hW55hY)hW5 h20~h{% h[vh{%h]3h[v5h[vh[v5h[v h20~h[vhEzh[v58ӥ(/c!"JK !)35>Bl#ɾzvh]LhM[h{%5 h20~h h h5{h{%CJh5{hxCJaJh5{h{%CJaJ jh5{h{%CJUaJh5{h{%CJaJh{%hO.h*h{%6h[,h* h20~h{%jhYU hYhhY,qm ;<iˬ̬34yDEgd]L\gd4k\ & Fgdlgd{% ]^gd5{EٮfgůL{ /01vA g\gd4k\ & Fgdlgd gdL:gdL:gd]L#/ذٰ @ASTYkmot߲  $%&1ABfgrs˻ᴭ᭥ពႭhEzh 5h yMhh 5h24h 5 hh h]Sjh 5 h20~h hTih hSUhYhhY hYjhYU h20~hL:h hhL:hL:hhL:5h]Lh 32HJX´δ "flzеҵ+,/03;<=>EFLPT_a̶׶ )*-.79:¾¾¾º¶®h]3ht:h4/hahseh& h20~h{%hN hNhNhEzh 6 j<h20~h hEzh hEzh 5 h20~h h CgL´$+iԷ cSܹݹdKgdD:gd]3\ & F gdlgd\wgd{%\gd4k:;<AcdeghirҷӷԷ !cdɸʸ̸ 29PQSX\~ܹݹ&:Bپٶٲ h20~hhhD:hD:5hD:h{%6 h20~hT.QhD:h]3hT.Q h20~h{% hyhhY hYjhYUht:BBDFHtĺƺҺԺ*0`bܻ KLOPS[\]^eflptƼɼ˼ټܼ .<>FJK\]콵hseht:h\wh\wh\w5 h20~h{%hh5 hNhhEzh6 j<h20~h hEzhh h20~hhEzh5B˼ۼ Lٽr-; TU~gd,\ & Fgd-gd{%\ & F!gdlgd{%gd\w\gd4k]oս׽ؽٽڽ߽!/789;P]es ,-1BN¾¶jhOJ50JUh20~h{%0JhOJ5jhOJ5Uh4/hO.hhhh5h2hhhgHhYh}g.hYhFshYh~ hY hYjhYUhY) h20~h{%5Nnrsx+,}~QR #$9:;<@EF˿ٱuhlh',0J5hl h',h',h4/h]h]5h',h{%aJh',h',aJh',h]aJhlh]0J5h',jhOJ50J5Uhlh{%0J5hOJ5jhOJ5Uhh hhh{%h] h20~h{%hhh{%5.",-3489AB!:<=BKLǿ˷毫ǎ߯˷h,hl5 hlhljhOJ50J5Uhlh{%0J5hOJ5jhOJ5Uh]h{%5hlhl5hlh]h]5hlh]5h] hlh{% h20~h{%#h',B*CJOJQJ^JaJph4 )5e}~&'*^}~'¾š h7h7h{% h*~h{%h7hv9Mh{%5 jh7h%UmHnHuh]hhYxh_rhYhOhY hYjhYUh:h]hv9Mhv9M5hv9M h20~h{%7+6,q<pAQ\ & FgdIgd{%gd{%gdS\gdgdUQPgdw\gd4kgd,h^hgdS'*+01_mt%&'5689:?@PYZ\ayz{ӹh,h{%0JCJaJh,hM 0JCJaJh,hYx0JCJaJ hYx5hM h{%5hM hM 5 hh{% hhYxh:hYx h20~h{%jh7h%U h20~hv9Mhwhw5hv9Mhw2{|*+,dopiklmžʩ֥ʝ֙֙ʎhOJ5jhOJ5U hShSh,ht:hShS5hIQh T h20~hShS0JyCJaJ h,hS hS5hShSh{%5 h20~h{%h,h{%0JCJaJ hYx5h%Yh{%5h%Yh%Y52:;DEIJQUV[jklnoz?@GHOPWX]uvw澺沮林林揇h Th{%5h Th T5 h Th{% h Th Th20~hd(0JhOJ5jhOJ5Uhd(h T hyhhY hYjhYUht:hIQ h20~h{%jhOJ50JUh20~hS0J556:;@DEHIŢ̗ųŀxpxp̞hd(h-5hd(hd(5hd(hA?hY h!h!h! h"h!h,h-hhY hYjhYUhYh h"h-hahVh{%h Th{%5h Th T5 h20~h{%h Th{%0JyCJaJh T,   > m  !=gd*sngdgdFmgdFmgd>\gd4k\ & F"gdlgd>gdd(gdEkgd-gd.gd!gdk2IWZ`cilw   !:<=>E[\{|} ļؒh>h>5h L}hYjhYUj6h7h%U hYh"h-jh"h-U h"h>h>h! h,h- h,hd( h,h>hd( h"h-8'./HIJOPjk    MNTUVWZf»°𬤬ɠɏwppppp hFmhFmjh7h%UhhY hYjhYU h"h>hYhFmhFm5hFmjh7h%U h,hFm h,h>h> h]\th"h-jh"h-Uh h5 h"h-h>h-5, !",0=>QRSclmn 67<=>ڽjh7h%Uhh-5 h5j Gh7h%Uhh5hh*sn5hhh"h-jh"h-U h"h-hhhFmhFm5 hFmhFmh*snhFm3=?bP|Tkdb$$Ifl0H$-- t644 layt- $Ifgd-gd[\gd4k\ & F#gdwcgdgd-gd-gd*sn>?LMR^`abcrv{ ,-/345NQ]^ghiqtxy򽶲򛓣򌧌 h[5 h[h[ h,h-h[hb5h[h-5h[ h,h[hMhy h,hbhbjGAh7h%Uha h"hhhhY hYjhYU h"h- h"h.  !"0;DEW^dg}~坖{wssssid hjhUh PhG*hhc hcjhcUhG\e hAhCbhBcg jMh7h%UmHnHu jh7h%UmHnHuh*~jh7h%Uhah[h`m h[h`m h"h-jh7h%Uh`mh[CJ'#FGIzm$IfgdBcgl s$Ifgd{l gdCbgdH4gd-TkdE$$Ifl0H$-- t644 layt- $Ifgd- &',BDEFGHIR{|} abcl QRS\ξ販h{)whBcg hCbh{h{hAh{PJh^hUhhlhG*hahFK hAhFK hAhCbh Ph Ph P5jhU hhRVh;z{}xeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%xeR$IfgdBcgl s$Ifgd{l kd!$$Ifl0($$h t0$644 lapyt% `xeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%`acxeR$IfgdBcgl s$Ifgd{l kdU$$Ifl0($$h t0$644 lapyt%PxeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%PQSxeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%@xeR$IfgdBcgl s$Ifgd{l kd#$$Ifl0($$h t0$644 lapyt%ACLn TUfir|NQZ$'0ru~JMVx{BEN lox36? @[h hBcgh{)w hCbh{h{\@ACxeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%xeR$IfgdBcgl s$Ifgd{l kdW$$Ifl0($$h t0$644 lapyt% xeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%xeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%exeR$IfgdBcgl s$Ifgd{l kd%$$Ifl0($$h t0$644 lapyt%efixeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%MxeR$IfgdBcgl s$Ifgd{l kdY$$Ifl0($$h t0$644 lapyt%MNQxeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%#xeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%#$'qxeR$IfgdBcgl s$Ifgd{l kd'$$Ifl0($$h t0$644 lapyt%qruxeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%xeR$IfgdBcgl s$Ifgd{l kd[$$Ifl0($$h t0$644 lapyt%IxeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%IJMxeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%xeR$IfgdBcgl s$Ifgd{l kd)$$Ifl0($$h t0$644 lapyt%wxeR$IfgdBcgl s$Ifgd{l kdî$$Ifl0($$h t0$644 lapyt%wx{xeR$IfgdBcgl s$Ifgd{l kd]$$Ifl0($$h t0$644 lapyt%AxeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%ABExeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt% xeR$IfgdBcgl s$Ifgd{l kd+$$Ifl0($$h t0$644 lapyt%  kxeR$IfgdBcgl s$Ifgd{l kdű$$Ifl0($$h t0$644 lapyt%kloxeR$IfgdBcgl s$Ifgd{l kd_$$Ifl0($$h t0$644 lapyt%2xeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%236xeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%xeR$IfgdBcgl s$Ifgd{l kd-$$Ifl0($$h t0$644 lapyt%xeR$IfgdBcgl s$Ifgd{l kdǴ$$Ifl0($$h t0$644 lapyt%AxeR$IfgdBcgl s$Ifgd{l kda$$Ifl0($$h t0$644 lapyt%BEN8;D qt}03<}[]%TVW`%' ŷhY5hc hcjhcUhch y hT,6 h"6h2h26h2 h`h" hh"h{)wh{ hCbh{hBcgCABExeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%7ubO$IfgdBcgl s$Ifgd{l kd$$Ifl40($$h t0$644 laf4pyt%78;xeR$IfgdBcgl s$Ifgd{l kd5$$Ifl0($$h t0$644 lapyt%xeR$IfgdBcgl s$Ifgd{l kdϷ$$Ifl0($$h t0$644 lapyt%pxeR$IfgdBcgl s$Ifgd{l kdi$$Ifl0($$h t0$644 lapyt%pqtxeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%/xeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%/03|xeR$IfgdBcgl s$Ifgd{l kd7$$Ifl0($$h t0$644 lapyt%|}xeR$IfgdBcgl s$Ifgd{l kdѺ$$Ifl0($$h t0$644 lapyt%xeR$IfgdBcgl s$Ifgd{l kdk$$Ifl0($$h t0$644 lapyt%ZxeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%Z[^xeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%SxeR$IfgdBcgl s$Ifgd{l kd9$$Ifl0($$h t0$644 lapyt%STWxeR$IfgdBcgl s$Ifgd{l kdӽ$$Ifl0($$h t0$644 lapyt%xeR$IfgdBcgl s$Ifgd{l kdm$$Ifl0($$h t0$644 lapyt%$xeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%$%(xeR$IfgdBcgl s$Ifgd{l kd$$Ifl0($$h t0$644 lapyt%xkfaaaaYY$a$gd2gd2gd" x^`gdakd;$$Ifl0($$h t0$644 lapyt% 7>CFUVWsuw!&'FKgl@EQdi -2PUhmžžžžžž hq/hq/hq/h%hq/5h%hH5h%h7O5 hHhHhHh yjhcU hcKw$IfgdHl gdHgdH4"#D1$IfgdHl $Ifgdq/l kd$$Ifl44\$$ 888 t0$644 laf4p(yt%#$%&GHI5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl IJKhijk5kdR$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl klH5555$IfgdHl kd $$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgdq/l kd$$Ifl\$$ 888 t0$644 lap(yt%5kd:$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl ABCDH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%DEefH5"$IfgdHl $Ifgdq/l kdh$$Ifl\$$ 888 t0$644 lap(yt%fghi5kd"$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5"$IfgdHl $Ifgdq/l kd$$Ifl\$$ 888 t0$644 lap(yt%5kdP$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5"$Ifgdq/l kd $$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl   5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl   ./05kd~$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 012QRST5kd8$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl TUijklH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%lmH5"$IfgdHl $Ifgdq/l kd$$Ifl\$$ 888 t0$644 lap(yt%5kdf$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd $$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%9=cgi *.CG\`vz*.>Babuvz $CDHhim{| h hhh u h uh u hq/hq/hq/X9:;<H5555$IfgdHl kdN$$Ifl\$$ 888 t0$644 lap(yt%<=cdefH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%fgH5"$IfgdHl $Ifgd ul kd$$Ifl\$$ 888 t0$644 lap(yt%5kd|$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd6$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5"$IfgdHl $Ifgd ul kd$$Ifl\$$ 888 t0$644 lap(yt%  5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl *+,-5kdd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl -.CDEFH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%FG\]H5"$IfgdHl $Ifgd ul kd$$Ifl\$$ 888 t0$644 lap(yt%]^_`vwx5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl xyz5kdL$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdz$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd4$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%*+,-H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%-.>?@AH5555$IfgdHl kdb$$Ifl\$$ 888 t0$644 lap(yt%ABvwH5"$IfgdHl $Ifgdl kd$$Ifl\$$ 888 t0$644 lap(yt%wxyz5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5555$IfgdHl kdJ$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt% !"#H5555$IfgdHl kdx$$Ifl\$$ 888 t0$644 lap(yt%#$DEFGH5555$IfgdHl kd2$$Ifl\$$ 888 t0$644 lap(yt%GHijklH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%lm|}~H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgdl kd`$$Ifl\$$ 888 t0$644 lap(yt%5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl   H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%  78<NOSrsw $%)EFJijn  ,-1CDHefj"#'EFJ\]a|} hh+ h uhh hhh u h uh uW89H5"$IfgdHl $Ifgdl kdH$$Ifl\$$ 888 t0$644 lap(yt%9:;<OPQ5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl QRSstuv5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl vwH5555$IfgdHl kdv$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgdl kd0$$Ifl\$$ 888 t0$644 lap(yt%5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5555$IfgdHl kd^$$Ifl\$$ 888 t0$644 lap(yt% %&'(H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%()FGHIH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%IJjklmH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%mnH5555$IfgdHl kdF$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdt$$Ifl\$$ 888 t0$644 lap(yt%  H5555$IfgdHl kd.$$Ifl\$$ 888 t0$644 lap(yt%-./0H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%01DEH5"$IfgdHl $Ifgdl kd$$Ifl\$$ 888 t0$644 lap(yt%EFGHfgh5kd\$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl hij5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdD$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%#$%&H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%&'FGHIH5555$IfgdHl kdr$$Ifl\$$ 888 t0$644 lap(yt%IJ]^_`H5555$IfgdHl kd,$$Ifl\$$ 888 t0$644 lap(yt%`a}~H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%56:WX\yz~BCG`aexy}459PQUhim   h uh+ h+h+h+h h uh hh+WH5555$IfgdHl kdZ$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd+l kd$$Ifl\$$ 888 t0$644 lap(yt%5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 67895kdB$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 9:XYZ[H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%[\z{|}H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%}~H5555$IfgdHl kdp$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd+l kd*$$Ifl\$$ 888 t0$644 lap(yt%5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5555$IfgdHl kdX$$Ifl\$$ 888 t0$644 lap(yt%CDEFH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%FGabcdH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%deyz{|H5555$IfgdHl kd $$Ifl\$$ 888 t0$644 lap(yt%|}H5555$IfgdHl kd@ $$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd $$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd+l kd $$Ifl\$$ 888 t0$644 lap(yt%5kdn $$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd( $$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5678H5555$IfgdHl kd $$Ifl\$$ 888 t0$644 lap(yt%89QRSTH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%TUijklH5555$IfgdHl kdV$$Ifl\$$ 888 t0$644 lap(yt%lmH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd>$$Ifl\$$ 888 t0$644 lap(yt%    H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt% ()*+H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%'(,LMQlmq  '(,JKOefj'(,JKOmnr"@AEWX\pquh. h+h. h.h.h+ h uh+ h+h+W+,MNOPH5555$IfgdHl kdl$$Ifl\$$ 888 t0$644 lap(yt%PQmnopH5555$IfgdHl kd&$$Ifl\$$ 888 t0$644 lap(yt%pqH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd+l kdT$$Ifl\$$ 888 t0$644 lap(yt%5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl    5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl ()*+H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%+,KLMNH5555$IfgdHl kd<$$Ifl\$$ 888 t0$644 lap(yt%NOfghiH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%ijH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdj$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd.l kd$$$Ifl\$$ 888 t0$644 lap(yt%5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5555$IfgdHl kdR$$Ifl\$$ 888 t0$644 lap(yt%()*+H5555$IfgdHl kd $$Ifl\$$ 888 t0$644 lap(yt%+,KLMNH5555$IfgdHl kd $$Ifl\$$ 888 t0$644 lap(yt%NOnopqH5555$IfgdHl kd!$$Ifl\$$ 888 t0$644 lap(yt%qrH5555$IfgdHl kd:"$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd"$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd#$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdh$$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd.l kd"%$$Ifl\$$ 888 t0$644 lap(yt% !"ABC5kd%$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl CDEXYZ[5kd&$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl [\qrstH5555$IfgdHl kdP'$$Ifl\$$ 888 t0$644 lap(yt%tuH5555$IfgdHl kd ($$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd($$Ifl\$$ 888 t0$644 lap(yt% >?Cabf=Acg -1QUqu >B`d}015EF h7)zh7)zh* h*h*h. h+h. h.h.WH5555$IfgdHl kd~)$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd8*$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd*$$Ifl\$$ 888 t0$644 lap(yt% ?@ABH5555$IfgdHl kd+$$Ifl\$$ 888 t0$644 lap(yt%BCbcdeH5555$IfgdHl kdf,$$Ifl\$$ 888 t0$644 lap(yt%efH5555$IfgdHl kd -$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd*l kd-$$Ifl\$$ 888 t0$644 lap(yt%5kd.$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kdN/$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5"$IfgdHl $Ifgd*l kd0$$Ifl\$$ 888 t0$644 lap(yt%=>?5kd0$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl ?@Acdef5kd|1$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl fgH5555$IfgdHl kd62$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd2$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd3$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdd4$$Ifl\$$ 888 t0$644 lap(yt%   H5555$IfgdHl kd5$$Ifl\$$ 888 t0$644 lap(yt%-./0H5555$IfgdHl kd5$$Ifl\$$ 888 t0$644 lap(yt%01QRSTH5555$IfgdHl kd6$$Ifl\$$ 888 t0$644 lap(yt%TUqrstH5555$IfgdHl kdL7$$Ifl\$$ 888 t0$644 lap(yt%tuH5555$IfgdHl kd8$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd8$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdz9$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd4:$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd:$$Ifl\$$ 888 t0$644 lap(yt% >?@AH5555$IfgdHl kd;$$Ifl\$$ 888 t0$644 lap(yt%AB`abcH5555$IfgdHl kdb<$$Ifl\$$ 888 t0$644 lap(yt%cd}~H5555$IfgdHl kd=$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd=$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd7)zl kd>$$Ifl\$$ 888 t0$644 lap(yt%5kdJ?$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd@$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5555$IfgdHl kd@$$Ifl\$$ 888 t0$644 lap(yt%1234H5555$IfgdHl kdxA$$Ifl\$$ 888 t0$644 lap(yt%45FGHIH5555$IfgdHl kd2B$$Ifl\$$ 888 t0$644 lap(yt%IJcdefH5555$IfgdHl kdB$$Ifl\$$ 888 t0$644 lap(yt%FJbcg-.2^_c*+/^_cz{HIMmnrNOS h,h`]h, h7)zh, h,h, h*h* h7)zh7)zh*RfgH5555$IfgdHl kdC$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd7)zl kd`D$$Ifl\$$ 888 t0$644 lap(yt%5kdE$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kdE$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5555$IfgdHl kdF$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdHG$$Ifl\$$ 888 t0$644 lap(yt%./H5"$IfgdHl $Ifgd,l kdH$$Ifl\$$ 888 t0$644 lap(yt%/012_`a5kdH$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl abc5kdvI$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5555$IfgdHl kd0J$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdJ$$Ifl\$$ 888 t0$644 lap(yt%+,-.H5555$IfgdHl kdK$$Ifl\$$ 888 t0$644 lap(yt%./_`abH5555$IfgdHl kd^L$$Ifl\$$ 888 t0$644 lap(yt%bc{|}~H5555$IfgdHl kdM$$Ifl\$$ 888 t0$644 lap(yt%~H5555$IfgdHl kdM$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdN$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdFO$$Ifl\$$ 888 t0$644 lap(yt%IJKLH5555$IfgdHl kdP$$Ifl\$$ 888 t0$644 lap(yt%LMnopqH5555$IfgdHl kdP$$Ifl\$$ 888 t0$644 lap(yt%qrH5555$IfgdHl kdtQ$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd.R$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdR$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdS$$Ifl\$$ 888 t0$644 lap(yt%OPQRH5555$IfgdHl kd\T$$Ifl\$$ 888 t0$644 lap(yt%RSH5555$IfgdHl kdU$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdU$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd`]l kdV$$Ifl\$$ 888 t0$644 lap(yt% $JKO"OPTz{48X\) - M Q }          L P ~         E F J | } ~       h3 h3h3 h`]h`]h, h7)zh,h`]X5kdDW$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl  !"#5kdW$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl #$KLMNH5555$IfgdHl kdX$$Ifl\$$ 888 t0$644 lap(yt%NOH5555$IfgdHl kdrY$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd,Z$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd`]l kdZ$$Ifl\$$ 888 t0$644 lap(yt% 5kd[$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl  !"PQRS5kdZ\$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl ST{|}~H5555$IfgdHl kd]$$Ifl\$$ 888 t0$644 lap(yt%~H5555$IfgdHl kd]$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd`]l kd^$$Ifl\$$ 888 t0$644 lap(yt%5kdB_$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 45675kd_$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 78XYZ[H5555$IfgdHl kd`$$Ifl\$$ 888 t0$644 lap(yt%[\H5555$IfgdHl kdpa$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd*b$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdb$$Ifl\$$ 888 t0$644 lap(yt%) * + , H5555$IfgdHl kdc$$Ifl\$$ 888 t0$644 lap(yt%, - M N O P H5555$IfgdHl kdXd$$Ifl\$$ 888 t0$644 lap(yt%P Q } ~   H5555$IfgdHl kde$$Ifl\$$ 888 t0$644 lap(yt%      H5555$IfgdHl kde$$Ifl\$$ 888 t0$644 lap(yt%      H5555$IfgdHl kdf$$Ifl\$$ 888 t0$644 lap(yt%      H5555$IfgdHl kd@g$$Ifl\$$ 888 t0$644 lap(yt%  L M N O H5555$IfgdHl kdg$$Ifl\$$ 888 t0$644 lap(yt%O P ~    H5555$IfgdHl kdh$$Ifl\$$ 888 t0$644 lap(yt%      H5555$IfgdHl kdni$$Ifl\$$ 888 t0$644 lap(yt%      H5555$IfgdHl kd(j$$Ifl\$$ 888 t0$644 lap(yt%    H5"$IfgdHl $Ifgd3l kdj$$Ifl\$$ 888 t0$644 lap(yt%    F G H 5kdk$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H I J ~    5kdVl$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl     H5"$IfgdHl $Ifgd3l kdm$$Ifl\$$ 888 t0$644 lap(yt%       5kdm$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl       F G K y z ~           K L P            =>Bmnr()-Z[_%&'+]^`aeh heIh hh heIheIh3 h3h3h`] h`]h`]R       5kdn$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl   G H I J H5555$IfgdHl kd>o$$Ifl\$$ 888 t0$644 lap(yt%J K z { | } H5555$IfgdHl kdo$$Ifl\$$ 888 t0$644 lap(yt%} ~     H5555$IfgdHl kdp$$Ifl\$$ 888 t0$644 lap(yt%      H5555$IfgdHl kdlq$$Ifl\$$ 888 t0$644 lap(yt%      H5555$IfgdHl kd&r$$Ifl\$$ 888 t0$644 lap(yt%  L M N O H5555$IfgdHl kdr$$Ifl\$$ 888 t0$644 lap(yt%O P     H5555$IfgdHl kds$$Ifl\$$ 888 t0$644 lap(yt%    H5"$IfgdHl $IfgdeIl kdTt$$Ifl\$$ 888 t0$644 lap(yt%       5kdu$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl        5kdu$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl  >?@AH5555$IfgdHl kdv$$Ifl\$$ 888 t0$644 lap(yt%ABnopqH5555$IfgdHl kd?CtuyDEIfgk!"&WX\h heIh h h h=h=hA h2hA h2h2 hhh heIhM./01H5555$IfgdHl kdh$$Ifl\$$ 888 t0$644 lap(yt%12`abcH5555$IfgdHl kd"$$Ifl\$$ 888 t0$644 lap(yt%cdH5555$IfgdHl kd܂$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd2l kdP$$Ifl\$$ 888 t0$644 lap(yt%2345kd $$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 456jklm5kdą$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl mnH5555$IfgdHl kd~$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd8$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%?@ABH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%BCuvwxH5555$IfgdHl kdf$$Ifl\$$ 888 t0$644 lap(yt%xyH5555$IfgdHl kd $$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdڊ$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgd=l kd$$Ifl\$$ 888 t0$644 lap(yt%EFG5kdN$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl GHIghij5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl jkH5"$IfgdHl $Ifgd l kd$$Ifl\$$ 888 t0$644 lap(yt%5kd|$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd6$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl "#$%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%%&XYZ[H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%[\H5555$IfgdHl kdd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdؒ$$Ifl\$$ 888 t0$644 lap(yt%'(,HIMz{ ./3abf%)\`67;abf'(,\]a h:h.Ah: hh'h: h:h: hh'hh'hh'h heIh h h P()*+H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%+,IJKLH5555$IfgdHl kdL$$Ifl\$$ 888 t0$644 lap(yt%LM{|}~H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%~H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdz$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd4$$Ifl\$$ 888 t0$644 lap(yt%/012H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%23bcH5"$IfgdHl $Ifgd l kd$$Ifl\$$ 888 t0$644 lap(yt%cdef5kdb$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5"$Ifgdh'l kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd֚$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl %&'($IfgdHl $Ifgdh'l ()\]^_H5555$IfgdHl kdJ$$Ifl\$$ 888 t0$644 lap(yt%_`H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5"$IfgdHl $Ifgdh'l kdx$$Ifl\$$ 888 t0$644 lap(yt%5kd2$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 75"$Ifgd:l kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 789:;bc5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl cdef5kd`$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5555$IfgdHl kdԢ$$Ifl\$$ 888 t0$644 lap(yt%()*+H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%+,]^_`H5555$IfgdHl kdH$$Ifl\$$ 888 t0$644 lap(yt%`aH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdv$$Ifl\$$ 888 t0$644 lap(yt%  H5555$IfgdHl kd0$$Ifl\$$ 888 t0$644 lap(yt% #$(QRVz{459klmq  ./3Ffgk  :;?mnr*+/UVZh h{2h hhh{2 h{2h{2h.A h:h.Ah: hh'h:Q  $%&'H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%'(RSTUH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%UV{|}~H5555$IfgdHl kd^$$Ifl\$$ 888 t0$644 lap(yt%~H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdҪ$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%5678H5555$IfgdHl kdF$$Ifl\$$ 888 t0$644 lap(yt%89mnopH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%pqH5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kdt$$Ifl\$$ 888 t0$644 lap(yt%  H5555$IfgdHl kd.$$Ifl\$$ 888 t0$644 lap(yt%/012H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%23ghH5"$IfgdHl $Ifgd{2l kd$$Ifl\$$ 888 t0$644 lap(yt%hijk5kd\$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl     H5555$IfgdHl kdв$$Ifl\$$ 888 t0$644 lap(yt%  ;<=>H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%>?nopqH5555$IfgdHl kdD$$Ifl\$$ 888 t0$644 lap(yt%qrH5"$IfgdHl $Ifgd{2l kd$$Ifl\$$ 888 t0$644 lap(yt%5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 5"$Ifgdl kdr$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl +,5kd,$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl ,-./VWX5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl XYZ5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl H5555$IfgdHl kdZ$$Ifl\$$ 888 t0$644 lap(yt%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%   C D H z {        ! ! !>!?!C!t!u!y!!!!!!! " ""@"A"E"s"t"x"""""""""#,#-#1#^#_#c########$$$$ $9$:$>$k$l$p$$$$$$$$$hK( hK(hK( hhh hh hhh h{2hR    H5555$IfgdHl kdκ$$Ifl\$$ 888 t0$644 lap(yt%  D E F G H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%G H { | } ~ H5555$IfgdHl kdB$$Ifl\$$ 888 t0$644 lap(yt%~      H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%      H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%   ! ! ! !H5555$IfgdHl kdp$$Ifl\$$ 888 t0$644 lap(yt% ! !?!@!A!B!H5555$IfgdHl kd*$$Ifl\$$ 888 t0$644 lap(yt%B!C!u!v!w!x!H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%x!y!!!!!H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%!!!!!!H5555$IfgdHl kdX$$Ifl\$$ 888 t0$644 lap(yt%!! " """H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%""A"B"C"D"H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%D"E"t"u"v"w"H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%w"x"""""H5555$IfgdHl kd@$$Ifl\$$ 888 t0$644 lap(yt%""""""H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%""""""H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%"#-#.#/#0#H5555$IfgdHl kdn$$Ifl\$$ 888 t0$644 lap(yt%0#1#_#`#a#b#H5555$IfgdHl kd($$Ifl\$$ 888 t0$644 lap(yt%b#c#####H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%######H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%##$$H5"$IfgdHl $Ifgdl kdV$$Ifl\$$ 888 t0$644 lap(yt%$$ $ $:$;$<$5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl <$=$>$l$m$n$o$5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl o$p$$$H5"$IfgdHl $IfgdK(l kd$$Ifl\$$ 888 t0$644 lap(yt%$$$$$$$5kd>$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl $$$%%%%5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl $%%%%F%G%K%t%u%y%%%%%%%%&&A&E&p&t&&&&&&&'!'J'N'v'z''''' ((#(B(C(G(z(~(((((() )$)V)W)[)))))))))))***.*`*a*e********++$+%+)+Y+Z+^+ hK(h h h h{2hhK( hK(hK(X%%G%H%I%J%H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%J%K%u%v%w%x%H5555$IfgdHl kdl$$Ifl\$$ 888 t0$644 lap(yt%x%y%%%%%H5555$IfgdHl kd&$$Ifl\$$ 888 t0$644 lap(yt%%%%%H5"$IfgdHl $IfgdK(l kd$$Ifl\$$ 888 t0$644 lap(yt%%%%%&&&5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl &&&A&B&C&D&5kdT$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl D&E&p&q&r&s&H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%s&t&&&&&H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%&&&&H5"$IfgdHl $IfgdK(l kd$$Ifl\$$ 888 t0$644 lap(yt%&&&&&&&5kd<$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl &&&''' '5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl  '!'J'K'L'M'H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%M'N'v'w'x'y'H5555$IfgdHl kdj$$Ifl\$$ 888 t0$644 lap(yt%y'z'''''H5555$IfgdHl kd$$$Ifl\$$ 888 t0$644 lap(yt%''''''H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%'' ( (((H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%((C(D(H5"$IfgdHl $IfgdK(l kdR$$Ifl\$$ 888 t0$644 lap(yt%D(E(F(G(z({(|(5kd $$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl |(}(~(((((5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl ((((((H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%(( )!)H5"$IfgdHl $IfgdK(l kd:$$Ifl\$$ 888 t0$644 lap(yt%!)")#)$)W)X)Y)5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl Y)Z)[)))))5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl ))))))H5555$IfgdHl kdh$$Ifl\$$ 888 t0$644 lap(yt%))))))H5555$IfgdHl kd"$$Ifl\$$ 888 t0$644 lap(yt%))**+*,*-*H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%-*.*a*b*c*d*H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%d*e*****H5555$IfgdHl kdP$$Ifl\$$ 888 t0$644 lap(yt%******H5555$IfgdHl kd $$Ifl\$$ 888 t0$644 lap(yt%**++++H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%++%+&+'+(+H5555$IfgdHl kd~$$Ifl\$$ 888 t0$644 lap(yt%(+)+Z+[+\+]+H5555$IfgdHl kd8$$Ifl\$$ 888 t0$644 lap(yt%]+^+++++H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%^++++++++++ , ,,:,;,?,i,j,n,,,,,,,----=->-B-m-n-r-------...7.8.<.h.l........ / / //:/;/?/q/r/s/w///////000/0I0J0K0O00000000 h!2ch!2ch!2c hK(h!2chK( hK(hK( hK(h W++++++H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%++++++H5555$IfgdHl kdf$$Ifl\$$ 888 t0$644 lap(yt%++ , ,,,H5555$IfgdHl kd $$Ifl\$$ 888 t0$644 lap(yt%,,;,<,=,>,H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%>,?,j,k,l,m,H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%m,n,,,,,H5555$IfgdHl kdN$$Ifl\$$ 888 t0$644 lap(yt%,,,,,,H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%,,----H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%-->-?-@-A-H5555$IfgdHl kd|$$Ifl\$$ 888 t0$644 lap(yt%A-B-n-o-p-q-H5555$IfgdHl kd6$$Ifl\$$ 888 t0$644 lap(yt%q-r-----H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%------H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%--....H5555$IfgdHl kdd$$Ifl\$$ 888 t0$644 lap(yt%..8.9.:.;.H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%;.<.h.i.j.k.H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%k.l...H5"$IfgdHl $Ifgd!2cl kd$$Ifl\$$ 888 t0$644 lap(yt%.......5kdL$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl ... / / //5kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl //;//H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%>/?/s/t/u/v/H5555$IfgdHl kdz$$Ifl\$$ 888 t0$644 lap(yt%v/w/////H5555$IfgdHl kd4$$Ifl\$$ 888 t0$644 lap(yt%//////H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%//0000H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%00K0L0H5"$IfgdHl $Ifgd!2cl kdb$$Ifl\$$ 888 t0$644 lap(yt%L0M0N0O00005kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 00000005kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 000000H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%000#1$1(1S1T1X1111111111222G2H2L2|2}22222222 333D3E3I3{3|3333333333 4 44B4C4G4y4z4~4444444555A5B5F5l5m5q5555555555666J6K6hdn h!2chdn hdnhdn h!2ch!2ch!2c hK(h!2cW00$1%1&1'1H5555$IfgdHl kdJ$$Ifl\$$ 888 t0$644 lap(yt%'1(1T1U1V1W1H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%W1X11111H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%111111H5555$IfgdHl kdx$$Ifl\$$ 888 t0$644 lap(yt%111111H5555$IfgdHl kd2$$Ifl\$$ 888 t0$644 lap(yt%112222H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%22H2I2J2K2H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%K2L2}2~222H5555$IfgdHl kd`$$Ifl\$$ 888 t0$644 lap(yt%222222H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%222222H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%223333H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%33E3F3G3H3H5555$IfgdHl kdH$$Ifl\$$ 888 t0$644 lap(yt%H3I3|3}3~33H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%333333H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%3333H5"$IfgdHl $Ifgd!2cl kdv$$Ifl\$$ 888 t0$644 lap(yt%3333 4 4 45kd0$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl  444C45"$Ifgd!2cl kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl C4D4E4F4G4z4{45kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl {4|4}4~44445kd^$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 44444445kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 445555H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%55B5C5H5"$IfgdHl $Ifgddnl kd$$Ifl\$$ 888 t0$644 lap(yt%C5D5E5F5m5n5o55kdF $$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl o5p5q555555kd $$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 555555H5555$IfgdHl kd $$Ifl\$$ 888 t0$644 lap(yt%555555H5555$IfgdHl kdt $$Ifl\$$ 888 t0$644 lap(yt%556666H5555$IfgdHl kd. $$Ifl\$$ 888 t0$644 lap(yt%66K6L6M6N6H5555$IfgdHl kd $$Ifl\$$ 888 t0$644 lap(yt%N6O6{6|6H5"$IfgdHl $Ifgddnl kd $$Ifl\$$ 888 t0$644 lap(yt%K6O6[6z6{6666666677#7O7P7T777777777788 8 88888;8@8b8d888888899"9+939K9S999999 : :::d:h:i::::ÿַⷳhx hKhFh|=h hoemhVshK`r h h;Wh;Wht:h;9hW hz{hH h!2chdn hdnhdnhdnB|6}6~666665kd\$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 66666665kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 667 7!7"7H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%"7#7P7Q7R7S7H5555$IfgdHl kd$$Ifl\$$ 888 t0$644 lap(yt%S7T77777H5555$IfgdHl kdD$$Ifl\$$ 888 t0$644 lap(yt%7777H5"$IfgdHl $Ifgddnl kd$$Ifl\$$ 888 t0$644 lap(yt%77777775kd$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl 77788 8 85kdr$$Ifl\$$ 888 t0$644 lap(yt%$IfgdHl  8 8 8 888HCCC>gdz{gdh'kd,$$Ifl\$$ 888 t0$644 lap(yt%88:8;8@8c8ekd$$Ifl0 $$ t t0$644 lapyt%s$Ifgd4G>l c8d8h88xees$Ifgd4G>l kd$$Ifl0 $$ t t0$644 lapyt%8888xees$Ifgd4G>l kd$$Ifl0 $$ t t0$644 lapyt%8888xees$Ifgd4G>l kd$$Ifl0 $$ t t0$644 lapyt%8888xees$Ifgd4G>l kdN$$Ifl0 $$ t t0$644 lapyt%8888xees$Ifgd4G>l kd$$Ifl0 $$ t t0$644 lapyt%8888xees$Ifgd4G>l kd$$Ifl0 $$ t t0$644 lapyt%8889xees$Ifgd4G>l kd$$Ifl0 $$ t t0$644 lapyt%99"9L9xees$Ifgd4G>l kd$$Ifl0 $$ t t0$644 lapyt%L9M9S99xees$Ifgd4G>l kdP$$Ifl0 $$ t t0$644 lapyt%9999xees$Ifgd4G>l kd$$Ifl0 $$ t t0$644 lapyt%9999xees$Ifgd4G>l kd$$Ifl0 $$ t t0$644 lapyt%999 :xees$Ifgd4G>l kd$$Ifl0 $$ t t0$644 lapyt% : ::7:xees$Ifgd4G>l kd$$Ifl0 $$ t t0$644 lapyt%7:8:=:c:xees$Ifgd4G>l kdR$$Ifl0 $$ t t0$644 lapyt%c:d:i::xees$Ifgd4G>l kd$$Ifl0 $$ t t0$644 lapyt%:::::::::::::::B;D;J;K;O;P;;;;;;;;;<<2<><?<T<U<c<d<o<t<<<<<<<<<<濻z hV6 h;96 hc+6 hW hW h%h}aJ h h}h} h h;Wh%h;W>*h;WhVsh|=hhKh =hoemh-H1h#hhjVhih_ h\lhz{hz{hW hzGhx hx hAL h\lhx 0::::xees$Ifgdz{l kd$$Ifl0 $$ t t0$644 lapyt%:::C;xees$Ifgd4G>l kd $$Ifl0 $$ t t0$644 lapyt%C;D;P;;xees$Ifgd4G>l kd$$Ifl0 $$ t t0$644 lapyt%;;;;xees$Ifgd4G>l kdT $$Ifl0 $$ t t0$644 lapyt%;;;<xees$Ifgd4G>l kd $$Ifl0 $$ t t0$644 lapyt%<<<1<xees$Ifgd4G>l kd!$$Ifl0 $$ t t0$644 lapyt%1<2<6<n<xees$Ifgd4G>l kd""$$Ifl0 $$ t t0$644 lapyt%n<o<u<<xees$Ifgd4G>l kd"$$Ifl0 $$ t t0$644 lapyt%<<<<xees$Ifgd4G>l kdV#$$Ifl0 $$ t t0$644 lapyt%<<<<<<<<b====xskkkkkfaaagdR gdH4$a$gd;9gdW kd#$$Ifl0 $$ t t0$644 lapyt% <<<<<==$=&='=+=?=a=b=u=====??BCCCCCCCC(DeDnDEEEEEEEEF F FFFFFFFFIʿʵʖʖʖʖʖƖʖʖƖʎ h25hUh25 hUh2h^Wh25 h/h2h/h2^Jh2OJQJ^J h^Wh2h lh2h lh20Jh;9hY)hw hj/hW hW hh,@h;96 h;963=== >>)>8>E>??H?l?????A@j@@[ABBBB\ & FgdR \gdR \ & F&gdw$a$gdR gdEk ^`gdR gdR BBBBBCCChCCCC(DeDnDDDDDENEPEEEEEFFgdR gd lgdEk\gdR \ & FgdR FPFFFGG"HtHHHIZI\IIIIIIJ)JBJDJrJtJXKKKRgdR gdR gdR gd lIqJXKK,LjLLMOOYZ[[[m\`]^^^__``xd}d/f8f;f{S{5kde0$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%$IfgdR l S{T{\{d{l{{H5555$IfgdR l kd1$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%{{{{{{H5555$IfgdR l kd1$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%{{{{{{H5555$IfgdR l kd{2$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%{{{{{|H5555$IfgdR l kd-3$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%|| |||(|H5555$IfgdR l kd3$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%(|)|1|:|C|o|H5555$IfgdR l kd4$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%o|p|x||||H5555$IfgdR l kdC5$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%||||||H5555$IfgdR l kd5$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%||} }}:}H5555$IfgdR l kd6$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%:};}C}K}S}a}H5555$IfgdR l kdY7$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%a}b}j}r}z}}H5555$IfgdR l kd 8$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%}}}}}}H5555$IfgdR l kd8$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%}}}}} ~H5555$IfgdR l kdo9$$Ifl\ L$$Z Z Z Z t0$644 lap(yt% ~ ~~~#~;~H5555$IfgdR l kd!:$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%;~<~D~L~T~_~H5555$IfgdR l kd:$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%_~`~g~o~w~~H5555$IfgdR l kd;$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%~~~~~~H5555$IfgdR l kd7<$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%~~~~~~H5555$IfgdR l kd<$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%~~  H5555$IfgdR l kd=$$Ifl\ L$$Z Z Z Z t0$644 lap(yt% !)/6<H5555$IfgdR l kdM>$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%<=FNV_H5555$IfgdR l kd>$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%_`iqyH5555$IfgdR l kd?$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%H5555$IfgdR l kdc@$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%H5555$IfgdR l kdA$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%H5555$IfgdR l kdA$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%H5555$IfgdR l kdyB$$Ifl\ L$$Z Z Z Z t0$644 lap(yt% "(H5555$IfgdR l kd+C$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%()2<DJH5555$IfgdR l kdC$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%JKTW_bH5555$IfgdR l kdD$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%bclowzH5555$IfgdR l kdAE$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%z{H5555$IfgdR l kdE$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%H5555$IfgdR l kdF$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%ĀH5555$IfgdR l kdWG$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%Āŀ΀рـ܀H5555$IfgdR l kd H$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%܀݀H5555$IfgdR l kdH$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%H5555$IfgdR l kdmI$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%3BNiHC>>>CgdR gdkdJ$$Ifl\ L$$Z Z Z Z t0$644 lap(yt%iQei+@'=)?ԇ`gdR p`^p``gdR gdgd lgdR \gdR gd l\ & F)gdwԇ-Xm"7zщ0Uk+rɌߌ~9O @ ^@ `gdR `gdR gdR ۏ4Jʐ(ϑ DZ\rǕgdR `gdR ǕΖPg՗3ax6MzՙgdR `gdR E\ɚ "NeӛoT  gd2] & F,gdwgdEkgdH4  gd2gdR `gdR 6=?@DVW\kmnڞݞW`@ABKOefhvy 8W *-(+ ;YZ\^lüh-|hy0Jh-|h$0Jh-| h-|hx0 h-|h$hx0hyhh(hW&hn hnjhnUhW hj/h$h@3Vqѝ5cWoҟBh gdEk]gd(h^hgd lTgd(]gdkYB^gd lT  gd2 u3\ Z>]gdy] & Fgdygdlgd lSgdy ^ gdygdEkgd$ ^ gdx0>ƨNҩөcƬϬݬ $Ifgd3kGgdJ{ ^ gd@ ^ gdXFgdlgdEkSgdyloѩҩөx-.z}߫ "&';CDX`bdfgotwݬެ*/03pq̽hW hW 6hW h$6 h$6h3kGhXFCJOJQJ^Jh3kGh$CJOJQJ^J hj/hJ{ hj/h3kGhJ{h3kGhOG hlhlh$hu hj/h$h@:ݬެ^UUUU $Ifgd3kGkdJ$$Ifl\$$t A t0$644 laytw*^UUUU $Ifgd3kGkdpK$$Ifl\$$t A t0$644 laytw*+,.0123^YYTLLL$a$gd$sgdgd$kdL$$Ifl\$$t A t0$644 laytw3qxح %>UhҮD  C  L$  gdJ|pgdDq$a$gdW qrwxycdݲ޲ӳԳ JKopUVcd                   ŹŹŹŹŹŹŹŹŹŹŹŹŹŹŹŹŹŷŹŹŹҰjh260JUhOJ5jhOJ5U hJ|hJ|Uhv5\mHnHuhvmHnHuh|=jh|=UhDqhnmCJ aJ mH sH hDqhJ|CJ aJ mH sH hmH sH <'17>EKQXiů6NdkqðL$  C  D  ðа .4<DJ^hnsw|ٱL$  D  C  ٱ*FRXbdjвֲܲ޲",L$  D  C  ,BTaz̳ҳԳݳ &1=CIKTnpL$  C  D  pvش (ATV\bdtǵ͵D  L$  C  ͵ӵڵ+Fawֶ 4;AD  L$  C  AQW]qʷз׷޷ 0 Q X a u        L$  D  C  Statistical reporting Define search criteria 47 Treatment by stage-cross tabs 49 SUS 11 Suspense Add a VA patient 14 Delete a VA patient 15 Edit a VA patient 15 Patients with no primaries 16 Print list by suspense date 15 Suspense date 11 T TIME 55 TNM 54 TR 54 TS 49 TST 43 U Utility options Compute percentage of TNM forms completed 54 Create a report to preview ACoS output 53 Create a report to preview state/VACCR output 53 Create ACoS data download 53 Create state VACCR data download 53 Define cancer registry parameters 54 Delete patient 53 Delete primary site/Gp record 53 Edit site/AccSeq# data 53 Enter/edit facility file 54 Print condensed DD-patient file 54 Print condensed DD-primary file 54 Purge patient records with no suspense/primaries 54 Purge suspense records 54 Registry summary reports 51 Restage CS cases using latest version 54 Timeliness report 55 Utility tools 59 UTL 51 V VACCR Reporting to 57 VACCR file Emailing 60 VistA conventions 4 VistA setup 67 Line editor 67 Screen editor 68      PAGE 20  TITLE \* MERGEFORMAT OncoTraX: Cancer Registry June 2012  SUBJECT \* MERGEFORMAT User Manual PAGE 19 June 2012  TITLE \* MERGEFORMAT OncoTraX: Cancer Registry  SUBJECT \* MERGEFORMAT User Manual       % R |     % F ` |     , U j {    D  L$  C                     z {    $&`#$gd@ $ !$gdU=V $&`#$gdU=VgdJ|C  D          ) * C D E N P Q k l w x y z { |                           ɸ hJ|hJ|jhOJ50JUhOJ5jhOJ5Uh|.jh|.Uh26hY0JmHnHujh260JU h260J1         gdJ|#gdVgdRn5 0&P:pFK/ =!"#$% 5 0&P:pFK/ =!"#$% 50&P:pFK/ =!"#$% ?0P&P:pW/ =!"#$% Dp2&P:pFK/ =!"#$% 5 0&P:pv/ =!"#$% 9 0&P:pv/ =!"#$% P 5 0&P:pv/ =!"#$% w(Dd <  C Ab'_W q2͝Z'D=n'_W q2͝ZPNG  IHDRBQPLTEѽӽǼӺһκҹҹѸжȲ˱Ȱˮɰëêäãâ¡£}|{y|yyuxwwuwuvtuzsstruqrosmqpoknsjjkijfinfcgffefcfeeceacbbi`_aaa]_]_\^]^[]Z[YZYYaYVXXXWWWWUUTURTRSPQQRQRYPROOPNOMMLLIJGIGHJGFGOExDECDFDBCE@zAA@?F<<9:=8u;8x77~<4p53|9/j4/p0.y/*v3)f-$i,!_*`)[%XR2bKGDHgIFg>U cmPPJCmp0712Hs$0IDATx^][Yf(0D; R݉Xry+1(K &Pӈ`k"鲍]\mv ̟{9|7LB̤篜nkJ"/^WGb˙,slvkk+^peufzt[]N__UɩUnm>\%凙-?ە '3H++ O☞4h`,Sur fy.8l5S7r`A7WoݼIx?pfe!*W}Z.jbh"f7V-|ܜWb Ŭ%[!/qo1T=;?h6yxo# \f1LWiؿaI^qV>3廫7V @-Z{ _Dhw5JhoǟaU[i 2B w| Po9*K\8_E/j.~MsY)K81-D ;"\%I4Jc43fEC6ՠ rNԒݭ[Hg8ȰJRHݡq *_a)!33a?쳵pae(Q!Ȍs.3rM J&9b= ȧJ"Z|p܈!X-p!FbjXgv Niή}Cflg7zpbGQ[.dɱj 'ak+Oo d苴EܺX_ 2dF'_Fc휔l?W ,ڻ +-Q`˯#Ί^ް3ZnMkcűFl/o-$H#4@C/ώuV"* HHP {u>_ GuAMJ/[.`+ɮ Vޘ6S9b7j vs`3pAKjVo˵k9"ѢB]~5nֈ ĔvXå}S040[x=?\q,ub82,%0G&~Y5\ɭgͱR(іMXןfAĕ+B7$^U j8ׯ#8`QQÂrr̖ڧ$ӳ%$2JB#@Ab k@UMVV ޮ.[N ̈B 5?xE|Ϳ.|(HqP7KF%ZbҋVTbDmmm#T?(ӊ>6 wFCD*|xN?^B$;"LG[N_Vu. 5|_ON ,%6[dDl̔m& %k Eܷ<€/]z:uvMe5[|Wëz*1戺E NXaOͺ1u Ua5xL V`hDh_%J{eDqGk_o\51ex+Ox U8,fxba;pF{ X,=4dC1HlQ<}KAgV@|_7~+%!~ȴㄳbQ S5+E[~ ^x8V{AO'T$(0kq-1n+n; i, 01PO$Y!Cjcje@!0gj]b#PB{gvzb֙7`Ja*:,.}{}”9RN8^, ⎎#5`i>NMJ Pd%O2,jW#rn%mVIߛAo2i:(5``Ee-z!L_{}D\9sW8`Sr̕E < %رt0^BP=ݤ056Z g^`!6n8088{=蕆{" ên X:ИL$)@pGDXt]Ukт8ruR7 y8֢ݵo#CG1P _=x .]rikdf/I&eNFZ%did(h]E?>]c/~ {H﯌FnHke\^nbpo$*T0Z-^$)R' t0T#fT&{&:V%@I*L8v!R#͌|݋ ,1(_0"6-2]#]ϮH7|:Jk`$89th/jj#GV5)Xw$e[Ȼo疀ܒlF_vc>cm^0J>5p =^ p’@c=uq֧ãU^;5SLTyyib+i.C^qaT$IKpo}xCGHHz5(؇+rxqfr xd;x?HOvUG4ZUqeXyJ3/wHk$UC|ߦ] TmwݥnHP]U`,*JOyMlҍ-Ot텷Z'~VTkkkK- uj^]%gK܊EVMn WDH x 1KL6z1D8mKoxQӾHtb”.V,j<sHx%fKA6열 C-0L#R".!l~ޓK }f_L.K_mN]rŽUq8>z2 FD ļ$͕L͕ͅ ILYQ`euNWi@ȝwAN8wqM=r }$ C^.iӠ^^^ăXpj%L;Z:i|?u(^3B/q;H&4.Zi[ꌋX]ZOJxO-]N=o=1y M,؁V25Vh_S^Ukc 6֛b=Tmj<?4MW1\PHDEv$d%t,{1Vz uLAO z!r3-faAK 3]qV6?W.8]*xLayOtz)M)e[Z IOAf_0 NB&  4|J )t~7izkQzm4\]Ш,j:n.-vf%5ZD_O_WWLzI(%w0;l7xaK0ϗFiZaHͼn2~-uLk:uϽAl&N$tuBHVj-jvˍ>Iy_K^uѐRb1`VG$هq5UEw\$X񪞞F gqOp5-LbZл ,yp.d:K+ ,LyϾ&uw>M[b- EO:R]ADa{j^A\3bڿ0}]PDeTǕ^go&&,Woo?J^PE2`?ѳy JXDYb8`#/dJH]Wֵ (,b4> j+% 0e}p*Sњ^Fς(`#}{ -a_:h `-؝}ׂˇ%HNN8[T9^Sռ>({5hyZ_KB;47k'OL&+Wa&no-8teeiż zhtcho,^8j'L޶&Ly/@*9&i{pmۛn] NatN4%aur "؅ݕ&(Vgۘ^\Ġ;q.ViwVU6U*KNK;5uJiMQ!˅W% Ӌu^Ҭd,Z3 ay6E#j<тx2khlnI5'bU#:/T_촦Sz.iDՅ3[v "o$>DJd +]p`IКgD8}ZGJn/E%yhAd54kْ^k-=U]!xuLՇ6L/EB3\Fn fjI)pb i:\8Aʲ~Ao:qԑN>TT%C]SLmnNPn^M9_*VI!RutVmYE ,h.ymC^.iy.;omT74TRjX'OB+:߁Xk7K kk8ޖ5rV!aD!!sj\i-ӱ6/;Vht.R}%^*KV{ ܴV-ͰD18'nZնB+L>_Ki[J ĶK7Bo03J<[XE<*`qaJȳHVm?qM`7r5|-;B%:@[p {>Qu/gy>Dz?C$̼dޣC8H͙B;psB{v!pAv/!G>== LʽU00=;~?@3Ǥ!ƴWQ8$&#aP{Jl[ƕ(8`9"6'Qie;Z-;DLIˌp3;@/ߊBr?Bݓ:D ~Mcu{Wʋeٌ͓uƒs!;8Y8:xH&Z#t%Ip—z?C\nJysq+^7eJsIq?Uq)#DK_ >O"jL4'|ңC0K1kq绹pNS}PeSZՕ)Zm9TK>"IcQNS/j4ϛ,.~M2^7k_ķg0S r\-a>IF ({xA@ gp?h<^84 ȤroO$qr_B.t[6F۲))e7hՁ˷ҫjKxtږ /U HKɧ y4bU"1ysF>;w_N +t>:4ׅmGW3[||9 sa){iuѓpt:|dzģ%Q;x2">>PsO>BEY,x;v+d8|1 {G~W_VtG⩓Wr7y2pf-5*J[nT'Ro\Yʀ^n??/RbxJ|:v<&숄k_k X?ޔչ#?}Rze" }.; Փdwށ;{vؽw`ށ;{vؽ/nHZsIENDB`$$If!vh#v#v#v:V l44 t0$6555f4pyt%$$If!vh#v#v#v:V l t0$6555pyt%}DyK _Toc173658689}DyK _Toc173658690}DyK _Toc173658691}DyK _Toc173658692}DyK _Toc173658693}DyK _Toc173658694}DyK _Toc173658695}DyK _Toc173658696}DyK _Toc173658697}DyK _Toc173658698}DyK _Toc173658699}DyK _Toc173658700}DyK _Toc173658701}DyK _Toc173658702}DyK _Toc173658703}DyK _Toc173658704}DyK _Toc173658705}DyK _Toc173658706}DyK _Toc173658707}DyK _Toc173658708}DyK _Toc173658709}DyK _Toc173658710}DyK _Toc173658711}DyK _Toc173658712}DyK _Toc173658713}DyK _Toc173658714}DyK _Toc173658715}DyK _Toc173658716}DyK _Toc173658717}DyK _Toc173658718}DyK _Toc173658719}DyK _Toc173658720}DyK _Toc173658721}DyK _Toc173658722}DyK _Toc173658723}DyK _Toc173658724}DyK _Toc173658725}DyK _Toc173658726}DyK _Toc173658727}DyK _Toc173658728}DyK _Toc173658729}DyK _Toc173658730}DyK _Toc173658731}DyK _Toc173658732}DyK _Toc173658733}DyK _Toc173658734}DyK _Toc173658735}DyK _Toc173658736}DyK _Toc173658737}DyK _Toc173658738}DyK _Toc173658739}DyK _Toc173658740}DyK _Toc173658741}DyK _Toc173658742}DyK _Toc173658743}DyK _Toc173658744}DyK _Toc173658745}DyK _Toc173658746}DyK _Toc173658747}DyK _Toc173658748}DyK _Toc173658749}DyK _Toc173658750}DyK _Toc173658751}DyK _Toc173658752}DyK _Toc173658753}DyK _Toc173658754}DyK _Toc173658755}DyK _Toc173658756}DyK _Toc173658757}DyK _Toc173658758}DyK _Toc173658759}DyK _Toc173658760}DyK _Toc173658761}DyK _Toc173658762}DyK _Toc173658763}DyK _Toc173658764}DyK _Toc173658765}DyK _Toc173658766}DyK _Toc173658767}DyK _Toc173658768}DyK _Toc173658769}DyK _Toc173658770}DyK _Toc173658771}DyK _Toc173658772}DyK _Toc173658773}DyK _Toc173658774}DyK _Toc173658775}DyK _Toc173658776}DyK _Toc173658777}DyK _Toc173658778}DyK _Toc173658779}DyK _Toc173658780}DyK _Toc173658781}DyK _Toc173658782}DyK _Toc173658783}DyK _Toc173658784}DyK _Toc173658785}DyK _Toc173658786}DyK _Toc173658787}DyK _Toc173658788}DyK _Toc173658789}DyK _Toc173658790$$If!vh#vf#v*:V l44 t0$65f5*f4pyt%$$If!vh#vf#v*:V l t0$65f5*pyt%$$If!vh#vf#v*:V l t0$65f5*pyt%$$If!vh#vf#v*:V l t0$65f5*pyt%$$If!vh#vf#v*:V l4 t0$65f5*f4pyt%$$If!vh#vf#v*:V l t0$65f5*pyt%$$If!vh#vf#v*:V l41 t0$65f5*f4pyt%$$If!vh#vf#v*:V l4 t0$65f5*f4pyt%$$If!vh#vf#v*:V l t0$65f5*pyt%$$If!vh#vf#v*:V l4 t0$65f5*f4pyt%$$If!vh#vf#v*:V l4 t0$65f5*f4pyt%$$If!vh#vf#v*:V l t0$65f5*pyt%}DyK _Ref164474433}DyK _Ref164475161}DyK _Ref164475280}DyK _Ref164474433}DyK _Ref164476214}DyK _Ref164474433}DyK _Ref165274786}DyK _Ref165274852}DyK _Ref165274885}DyK _Ref162679760}DyK _Ref165275024}DyK _Ref165275074}DyK _Ref165275118SRDd-   A ?Screen capture of the VISN 2 Mirror  KEA 420 window with the Capture Incoming Data pop-upPicture 2Description: Screen capture of the VISN 2 Mirror  KEA 420 window with the Capture Incoming Data pop-up"bOo[$fF噔Oi=nOo[$fF噔PNG  IHDRtW,BsRGB pHYs+OeIDATx^}}%UhM*hWIɎ>֒mH+$-Y;k"q!4L(]M #Y}PT lvmv.l$ͬ$"SBŢ{7s̽ݷ~Vos=wo>}>|xmZYY?/ZW~)%pi; 9DB (y&M8+I U/tC:xnK{GЙEfۇ={{{W|yyy8쳠9'|0O< z\whӷ9x|v_* 'q~S= x #_ė6o nX+|s zrhܵ ! ftl0;wx]߇{&N-A!ZDeoMO0< ^T oa+rsB`YG'tl'&Ь˧px{n~:4⌭c?7x 1>-M$|_dl4[YθQCY#>K ! b`]FZhAEc ac65ijkbWNP^HOAg1͘sFw0iQMp .9Þռuڦl:'"PQhNal .<'8qo7:)1РuCޝRfJ Uz#sfw1Mt$RC|vWVn*ʜ+#i&*ٛl<F*!y ݭʄ %IJ^3өQ#s $}xc^8Jo=C(ǕU&1G1Ƭ.yJ\iiPB@tpz7B@!P@ʬ98Iq۪DIV &! @0Έ2-护QEu'- _I\dN4 S^C! @mBoaʗQJD64 edjʺƖK:X)-g{Qc%b]J%_{3C 魛j2e[ W:nƽҬ{n^@lrNKbO*`RuB@C[7vt{ד En{#=s9+dc5_w0n4BoD[ "9(A|ᄃQ~ :B5p5"Msv`7.Yn 6g'Ď64^@E<uV+4 K* 1۲%2H#P?ˌ;0|9Bhd]5 קw;k$J((by:P kgƀPXL4eQ;xvJK@VŞ Hu@ծt8VM4K1H` 7պ,8cr }ĺ̥spk\IQ>u>r9GZG{.07wJkë @3OA7sƗq|oί8CoȦxO =YRTUˑAGv\dZwxT>worMO*'?i@j+R .|Q63I"#!<]oW&Lr>F.1y rH2MMpRb˕s,2 YHo $%4DzdJ2!bmơg$Ϝ5!Zla )-P? ,zP(v gٻ zD?CVk%.$C?115h?QlsbFSlkֲy3S9ZlQ5?\Qr}ceRX]}F#c7> cB7 /Î NA@+VAWշb|(@hl9RlB@ArH ! :@HRR ! unkO:&nς =U@qǁO% NF/T.! f@:WUphprUT!mq5stjMm9Ul)GU-! @udyõA '㛃T|gH E*Wpt+j1/ፊbU6"'aU~_N uwn2=PHik!5 u2$Z[!"a7ԩl̷o?Pf? O[6Z|z(c᳑PqCPHS/x5IM!P3/`4)0f'4݃q6"sP5*B7DZmM, T.2Hƨ!իL&;9@B܍/y57_-?z57_#`o~-q~-f׾ʷ; ̓{k_|h寿?F^G(|7^?o}HZv_b߾}O8!:2#"L5#uQU\Oa??񯇳eO≟Ȭ n0^^c_[~VoY[~ȻqO/ O~{D/{GB/mp%ΛC~W> oiQtNد~۶,wE9ؿ}d+AYՆ.4 fѣU?+SU R^nzfx5epX._}|z?ɟA_z"(_q?wʠONpNI?ֿBfn4|x2S=i;q5Xބ^{([Ǿ<:bg|vx.im׶FՉc[[X%bC%dZZ*ѬsXh+*?GU˖֫Ւ/Mp&d Y d\BJILg3Ox(?O)G7 -(价 D`p< =Mu:ڻ3!d})ų?Գ~gpa~wb-1”#8 &D /S8>P;lР_4s凟z5ϣ9GѼNnVu[mSU)[Vi1Յ*Z:,ǿ%׾_}!oll?wS$z: upܳga><ܶT궞>X_<jXON"2d[dLl+a/DCrpN~! H\_N-n=$mTs@Li姖Os\,lrk__? #>Z(c!^dӽiΨ_i5,I.rmF0HoX_fy;c#мry44T_#k HSqQ dAORp) g Gy< r1)3JFƛUTuOa&HK2S6r/moM J~kox}g%MeC-!#W&!=P&J,R} 96ᦓkУb,[ot|5 o= hq_ /Fao~gOdmtq~Gk1у:,2|Э0Mp`nhk+XwJаpKnv֣N6W|԰*wNحmT~*5UO;tLZ<#ǎ>veUh~iotnVo“T_=Y/;x;&ؑ-<QiҕFn;__gzͭ"Dޥ+XWJFHze2 dp|>ʜ$7Fi6<˘7Q6qdbLtlWe.sbQ%AY :x~ ? ]v!h5 ѠDžAI[@JZCf{d bCgϮ9}:h( ٳΝ7J2[A~_}}a,/?ϔM'v%^3yh 0#vSoZNZ/lYi.lA~3%j77ЌS2}]`pر{o߳Ї-Ӕ#>?O| Hi1ZP Wߋ%8[ ~4qθ ʁgp%l#'q{y! |aH,Z!x9ҸmH9{y([LVˋ]j)X b(XX9]\Ŷ$VQYĊ*2dB;z22i:;.qǿux0 ,`+<αyrmKEzn{iq'4X:vB*b'0Ɛ|W-n3 YLtZ>,`=SGmǷ\16pߧ s+$|^^‡k4a xYpD 3B[g-~MNzۥ i, 7^.o,w\ ~Gf6Mv"3j_2.K|'/3&F|A={fq駗u dB5u*RvK.֭:W'SƶOguz,ncbcLjϐ=+l _⦃Lgoxzc%(U0XW6Jw,}K;$ uii|"00CG/Ñn[p>XkovߓUzwy}Stȴgבb"dV֛s+~H=Xr䄼[ϧi}z/`+&yPQp?c{~==#YG,0ljZFbI{ɤ%?p`o17}!fP*[Ql=w5ce2G`l-&.629 6x x;f3(7ϓX5ɵx96sc^o>Lo;2y^<1ˉb1bcjBVVŜt| %ϟ4f|ga-2o.{`;%kmJ-m}#*8{Wj"B`A+Szt3-N=#7>"ļ8gsβ-?wst%p@)ǐyzj L򔐣h/5S}e â s82=KNt^6ln\g٘\8Z zPsKZ0T% I>d8m`q!_^BfL`*6A|27ܭfo2hբh!ӍLaƩse?G85#GLM2>ZOGϾ_Ԣ13Ǻ XZt1 l"vl͡z!?D^*bnРba/BNLZʽR&ڧ&Mx9! f#T)6;hɼf&aH]sqk `V|ntc|&@_uN|o@sa, k!0CSF0V?F 2kM@`O(X9kb']&$BGҫ^z Dѥz?,]Dfuc:uʄ .tQ,Bp{2 :aa =uDs|Lu2gB@L]>ȑǎqRG#}lE! @4r Wt6ڜgyP<q{nяT9F!*&,/_ #xGS?|| k gBLȼ" B(4CB@"P3N + WV.E [}⧓'7M(f2qOg Ʉn@uKʪ _4B@ P V2 g›XTB@x2%Xpx M B8ӏF38/ 2>M$'H#~I^X+h+P\\PJMZB@I_R 8Ȱ'N܄HiAkw UX |/6"+\` ~v ĵrLZ|ݒ!(1h+ӋGnksՆ hU;vԩS& Z%E  NWBwܹFeMօg&hl_֐VU LlQD! &G`HK B@! #5(X ! @SԌscIWsu<< ^>Z(@Zqs) buj$. z|Xj`8VϊX6 &842[I݅`r=#|f]ҬY"YB EcܼeB}My !nm@!NN>݆' ;7O '|d& ?^XPB03ybWDIKdı%Mۦi)fǗBAxKeGLqӥ NQAˑFSS Рb5 ~XOSN0񁎘s`\-*Mh&ֳZ~tެ83iH\I1yFcY %d[>>Ts$+.3哼b|ܢ {5 '͎ b S]n୓^&Կ}b]s޷I_GAK2Hk [\&e̼eewy>%U vf)&8mKHL-Vқ^IN}W5 ! [j¬4" nb+h5S}A s08"cEdF:}aAEgx(̙ R}?՗Q[qe|z#6d F+yƲB{4{zKb! @Oh,Z ,D7wGJXj+VFf}ccZQdGzGf+ޗvݬH--jf}npP(c"xر{->&:R5F HLXڌVu9sjT_GjW={bh2FF*힚’ ~"eMՒf=y >4lF>1ax.x[_{[ `R}--Tߔ֔xu0E"yR~@n]_ Q!r:?f_hS:ye;[BB|w^?x*DfT;OcYYa{ t;~jk("Oiqry# Ei"9RJ7NR7|[zev)n9;As?̷LoLaꩡoíU2xĉVR}j Ij:a֫9 t.-6kp:?=,/_}rpj(  =I+h uk1mc\)^$2AI خ]_CflO<{aq7ß?%&$g-Cʴ+Ytxo }'>Ojx/~>{+ӹgw|Y%h;AuV])7WS^셀7wWz _/)%@yw_2wQ"@Y߳g>5QB@L@G&m[okH.! " b)B@Dl]-lY֧x}cWZ|e֧6pXf}NYYļE@f}'@W/Dޝb犭wu! @4oj#"ֻkYEG@ˑ}H! z#CR}-B@ 2YJ! }H! zb=P##/@Plg*uXt[_ CB%B@t2^MI⍢矟Rs`[ wE+.Td vwfY %ͶXT),x r5U!ze=armǏ_bnB,ӧM[gzB5Q" aJ>!&mF@L;6&Gl4"%<}IpNe|̢ YYNlɍ[ܴdbf=|܎G(ey!s8$,>WB ԛ rpqyy}6a 'mր7(ᣵ"پ}%!7hV̪(~:z(hߨ0`&%+lm%HRĪ k Z!ye(מɓ'wڅ'޻m@Fs K/5_&r47Զl˾F_)!YL@L*APl=ذ#F wo95ceaZzIFU4+*$6V$+bn*[s;Y4L q{񸙛hm5<,ĮS$bn.-)$l;vԩS:;ry!G޾hAWx 9;R"V۸M=;aaן_ls@M`pQ E5:=0&qmZkkQ<9yIm . o…~:JЅ&;мu!  o}QzZz !'ˑ[_^teRx08D9JN k"@Wb,Tܹs1밳|ȑ,;/w!Y'k'*4%9bNJ@0]R~'<ɬO~#xe:a4 @Wz[WlO2 !.2}==vԂ!_xߺzTB@-G!jJ!0}i!  g4fB@L}Fc!  hg46gB@"s!379U,0XOϝ%K}I$2!!W9c>9D9\MJfU͆:/pvHte,K$3F01ƭrVyڲ92lN30Ӡǐ cYc>u,ğ*v4bo\qbrl^FY!7zHK4Me04~m&xe:Oob94fy1_0/;MB6 XHb>G/w ?MN\A=|)MޓH>@]6?\nFr̾ Gw CTh 2O?YdGLr ^W\&tikAS%M7eq4S~PRyJtb%e#d3W8rDGZ80*6-djIevq;^4$bm C6n0{ώK&"\ceP$=JB=gZƇ'pA :2}N,'24F6f RD+q˸oق!P ob*e=!DDi͙jV }5޶ NO*}>"W~6rlв i:lOoB-itW%%y\hJz r5x+Xeڹ'KBWt9{g0%W=)e0GH-]׋O&e3'l6T_ `/WZ KZTn5"Dx4YQf6\)WYL5ԝ5Y*=Y4^wR>ggcҴYN \jT lx-+׭/lKJbl9_? % fIǞښ+8SLxq)zi`4/[!X}SlaHPR0&f-CyAxg VOa)tǼߋ<'1,M9q#fE@8LIfkpLӲZDiؒ.edUV+Rɩem}Uł{ /\#w@ yz&R~8U*ž M EF"~ZoXxt\hˑ:o}.k|Sf4=Sҡ34ɺM4-`Su!7LJc=a\D?j 4ϡ-EN Ix,EH8 ͪ֬`D N:Y"YE$pb 5=[؄Ya ϘA:1nxM\38#bt8VmgbEͺU,oV䅯1chp@6[d>DwР+HPoYo eK筷210nļVX6t"-X!KHF椌 42>ΗY=٧B5B}QM|P@}P-  `a̼f¶4SQ=O-6=cX_ߕ|;He\(KW^X\2S15l'+DNepxC,e:q2LTG.פ-:С+瞛ޭB@ 8:ߣjc{I! r+\D'JՉnB@\)) ! :#u$B sBn9& EX Dh g(t!Y'5ZqW'),;VDžBs!jJ ԏ{$S!shbZ8 ArWDkdzWDhϡ=irÇ/-}r_[ n /(6Grw`?ǟZԉ- )؁@[r$! @м$B@$мu !  ̢BOh9RzS! I@!+ʴW)eze1 ;BԩS!0GL ! @WwMdֻڝ[!P̺BWȬ;B@f]c@!+d{՝RF! 1 2N)#YB@ ^uB@Ȭk ! zzS! d5B@fW)e2B@^! ޫ2B@u! @YUwJ! ̺ƀBWȬ;B@f]c@!+d{՝RF! 1 2N)#YB@ ^uB@Ȭk ! zzS! d5B@fW)eXN>s;wԿp{tiB ! *SAf+XD߿?ɓw08 =@̙3vn(^2=\ F@f]A!a: B@GɬkT! `0 Ȭw;%B @@5$Cֱ){޽Cp{tB@!PEBF! zEA7I! b"6`sQIENDB`%Dd   A ?6Genedits iconPicture 3Description: Genedits iconS"b!Q ӵcmUR=n!Q ӵcmURPNG  IHDRRA@sRGB pHYs+'PLTEW~ IDATHՕ?n@?N"HbwH@r4Ӥ26Tv%'I6s}o zxl/(MY w]r31+eaYHTdko$aXoiN%bEI2I>l($>IA1xRSY'i$-m|ΈR]ؿ'k2UP=Yi9j}x-1zdWrQHwj?-AZ@tT g%HXnA#W=HN8r_CDt# -Vud-oFl:֢h71͖O&z;7INk# :AIdԥ ОCwܗP)&!R-Isrg\lZY5Iv@83+xA*q]K*|VmF{uWUn{]=KlmZcIENDB`7vDdU   fA P?Screen capture of the Select GenEDITSv2Picture 4Description: Screen capture of the Select GenEDITSv2.0 window with the Open Configuration File pop-up"bKt/#PN{tt6't*=nt/#PN{tt6PNG  IHDRJ:@sRGB pHYs+sIDATx^ ]U,ʬHdN *!8&:NO44 0X;2^vk:|m ؒaZ$rmhIpJ406إ4@(rzɽ3]WW瞻>ϹE/b/@ MEgO7yB@ Ex@ kS{7?ӕ_좋.^u#,p!x]bZ {*/rXYV׉VYW Jo\XW,KZBurȪKJoY֊k2m]mYEҵ *krk Xjor],j]fvp-5N kB9 ۡ>jpOMZ^-GFMyZAC2$en̺XKU Ӂ5rه݉dNc]Fu[X~ђ$~_x6wM*)^Cs͝9?%21D߿\;vfޝ<87w+aή&|C[^w]?TRA @ _||o9e_g2 ԽQZS\8qb޽^{\}G8Kizg}78?|&Ο]?GW9?/g~?~CX$釿֣{RQvovJG!v#? W|?=5 @ :G`6ӂqrZ^^>|WڤO=é_{7[΋|;{;W`T̏׽ ;__?V'}?o)7?ѷ2|'% >s\2'U%} ?sN0|kv>~?)>w?x.kw`s~%ۯܳ#Xͳy+~߻3R8t.oY5#?{ֿ՗M`9}'f8V3zٮnFy|'|F< ~|7I>@ 9shS Kq׿_?}kQBh/|s?G8Ezw?lg y;旣ʡwoޓbs|?MQ{^fMs4 կ{Z9''O[W+o~'Cӌ>Q# Ty?~ǯ/E _~΄=+O-}΍Lq@ 0~C$7ǵ1-^oxsr~`+~ۮ|/~Sx*wz򃏾!;.r ovF{͕|W|>u3 {:9=\Z?/.ߜ Z{?8+_ӧ(I'H\Wk:-3o]NKxZ재͓RS};bb}FA@ Ċ~d@g?|:c@ Ǝ6gs @ Aocǎ7 Mߴ{n>C?fan-w b^|ʈ_;|ii daȑ {btSw}a^8䥪_QR+~ AL;wAeʊ,>7d^xWeeNB s_"K=$hIrUcR#m.=ڼ n;EjBO{ބv%N.ɑD@Z-c+>% PBJހ(FT`L9Qͅ"j8昺ZR|3j%lXiQ?zc@,w\Jw{巅Gv]i5,0`٦e#D]] BA L&e\' ݤsRrGFP$ BChXW X6no2f+B"ZMC6m4x[ZLf#@by4@ k|v6BF@`:X拋}Aս2Y͝ԑE4V\͞'#dY1vVo Hk&Dk2Ifo*4[QA`XJՔEO #US|!l5+|T5r{AQ#X羽zLBiI?Yqin)GIJOeboFHE<1zu~xVB!_f-E.C. .ywv|\lgJkq0$V-$mnGk7ã_ %4NewbS"y`UpMCܸ&jV*1Y";hԔz\*F7d;z=\BT}Cx NcrA.B'{lPi%!YvE=D^"IŃ[ {r\.DFq6  Y{bsʍl!< `EIO!cS&{˝T2l1<ʐPcT1L s lR`b#5A$7wLLD#/|(Xb|+&BUu@cm_N 1JoVZc.-2;ĉ{ch 7i9*/<`J @WR=>JdR~s؁v]Z-dm3wd> 5wbs+ I4iVͰhZ;K g 7'dLQYbDL ays>0=F5&_bP~L$52>@5+8 H'`b|!&ˎdכ WcdS$HedGT\.Oq{M!a*,n:~$o?'n{HVΟ'd !kDg/"H>&0s||2vDC,TJ>;.s[&IG -kɗ/JvD~ԺiR O֮8G-[pb+{Ao;/9CLh0D]15͢2m~C:g(C&J D`Xm ufY$@.rvg9x{V^\۶>ÚB&d-\]L-DLu.1 .us{}1Cr֑VV9I:#GQM~Kr\C%Bꋧ$BqKKϳN2A fbuy=(J 6$6i-yZ|^4R&64%]&⽷:^dcmƵBv9׾[nQ bϞﻯbNd#8;u17,w\^{41 M-OdL40+/sKM*lIBM/PF>db=Q^7t|D>?Bt}"0m%1>Z|7Yl"qC@ Xr)adФ5@ ~.+fA`1-!g [[~t@ 0-6rF ֮(] L ͧ@ m7Jӂ@hi(g lmBo @A0m(;ᖶdOϿfUBI*3-' ~;ׁ$4,emֵdC@`hsm7|"n:fv*ͥ"Jӂ,~iibmnu__)_kd;0<%HKmiρEʹ8m'tֆT]$M{C+.Fq A6Og,+DH;ԑU4fzە"CIx7L>,}GTIyдaIY.dJ/> ]ŷtӳ-O7a/mmjd@ P@Km>eV"Y2eCo2c75 d@ 0<-23s8QGrMvᆭ]k6@%Xٞ=;˨JVVeEk^[gZ E9;;.) ,RϹWSK ( p@.I.Y )?/x~co]ti録#IF0تСG !Xs O傜 O2fِTHbNU٦%IfR$}*Ӯ϶R \bh@ lJ{h{>)BG`qӗ {vu97ee~￞l|.\gZmB_}@ h伲&-0pcB.M5syMf%kjvA :! @E=88 K,Lw4(c lIZ&<;3Cά|)"YOL F$G\yyE@ ƃ@m Q Ι@ك/KgCB/n.H@`tM=:S:kMFA W8(!yQ$@ 0:hs<E.Q(啕2/~f;myo=o>v@`Ȥ>Fu_;r_ iܲ+ g@ݧup y&&vx]gQqi@_iL^{qy!9~pnΓɬ6nXtH; Ǩp++dVRH}uoޛPh @h7"@ \:=@ L-{A'!O S@h)oQ@ "6")G 7(~ lBob#|@?ͷHEF1@`hفws85=$ˢE@  iv$m]c@qv{Crpnw!8@ 0$=-)N吩n'1(!# 9cw `-e|mWd6A*ي0b:"‡׆u(-FdLK$L"H@ki4t(>~{V)DӼh[JÄtכu$=vk[ۛ PVZX%Zbobx4-N"M  Ǐz3o&K oTǎw!}l]č @ l6vq ֨f-:W6>7+)SyYu//IG DFwπ}IXy-M(1l'g;~pcw |[!c<`BxVGۭ{ELqb9;3啕ۮ}?};'n0C"_b&\E`qJ>Q'Orz˜mƴs &ZKI) " CMǏ^/~92JIC^?Ls1v]uCY8nQ]p @6Ň}Yr)(ʉŘM>FtVQ%Ļnh^1焏a(91܂̿3$?|BT?Z>yi/{K+tw&F@Km0Φ7 \~}Hyct@qbE GaI(f@N,n[*HT2@ "FgXNnץ3g|ѥ%΢D+S82.7Qʑkk6@ h@7ow|CXaspnQFxOg{ݺ(1!n C-Gya/¸h&mʈT@ FKϙ)ͬ6L"S=d Qǟ~Ox# b11ty8w8ֹ袋$*8^9޳Y%;u E@ XE`1X@2~\7;1{hRr@ 0 BE@`t@ m7Jӂ@hi(g lmBo |Zj:[[~t@ 0-6rF\ЭDn̲Z8cfG`عcޫĉx\[\.-Gב)iS*"#/1o Kh 2~$ݣUj/l׽Wb-B}D;ɋ/U +lIݹ+Ux`$-h>l3iU_]ـW7QlWLbd@h@o|'kiWij+˨U.PB5kkFbUQvncq(OKK8: @¤~8txdluf ?zt91'eE<"rIm }I2OJ+Y.079 HJyDV.+X($X޽n:{de U=VU UG"f߈6)ߩJX-yKΊ:⋾[\o)=ztGw^9xp³gE ,ĭHJ%-b.2KDJM)B6l/=RٜW~{Vb,>i0"kTxK@ MRvid2YK/e s#6],TYcbHӕBL^:Y2T*,U=z|HUn5ӭ>gE*b-d"泚S*1MH.{"FFPxP}J.G5V$>ܽfb#lА扑RYVrx(#0QWĀRّ_[2r&|C*9DVGB{QG1\AȀO 2/?}}+#s *I>ٶVlq>6z'?q2)=Y.v.\z\/\_|wg9>PBN!K0cK|6)ڪsl#W%}yfM3&iE|o}7y o++~}=]=m~# y:!kQJ";w۶sde8.p _~mMqc~|ܰBN`N2?HdO_O\(@F7FzM:+&\-?Kt߁fD[Жᦛ6o.n_EJ [HZӰ)oeGp52HΩL0BL?&'n+a-OgLUMhYIrk/P͟=͟T_ʄ>j4C0hMJ|Rpr pKn-/ϠpƘ'Kȩ]Ow8xM*gW0CIrD* _x$W(GOp+%,C6In +HƬ$&+oG֠ `H.!0gw<ȑrF:XO-4[ bubK~:a+JIx /roP+5Xi;pŐP/|,]q#vRd*.(!P7)bu Cs_i‹!CXky!lYuM΂İQ;iA1=mo?"~_%[l4e⭬lgFq;Y>wn;f#j%$4Չe 8^7PUBDj#pb</7 $|U 8Ax.%1ZҜad] xffSRbKTRKC"s/U"6$h\"Asz '!@^n="N<^2 %#o5-Py1 ckɬ^GrMч=ԍ%@`8=쳷k?R~XY9sfg?#24DFv,II3)Rd KƷ%OjuK#_?Tބ&֠?NƽYm.<~dbiEl&-Vfd,G6U'b*YFdN6 !JxQ X%iL1?\Y[֠u+F'܆^FA(~|۳gVKZ79yהFX^Yb8;ѥn2X$p¹~e$^N!@4O.pQO`+A 5(IVj{dr4 kl74ۤ oB&MWMˊYRk'P [S`EƷlSu&OلUn Õ<>y& >:l a9&3)fF;gߎ}J[F2Dj<ƜXJbKE]f5BC;屸E-HAB[,E"j pBJȚZ4BI8Hb2(Dվ4<V%"HQYSjlI k{y$>*`z:fQ[R%vUDSRT} _o{%URӲ"pTv~k \8kyOCA`Lm^MgK%-"oH2rժrTVcj5ቷ^UT7SF^?uڨ^Q!5ѡ+Fe-WAR6WLͧbhd+VdhJR7mףYvقIeT 7y7$J*_EͺUgl1ZuM#](S%[^>*!JV}BRyNP[-̈́[.8WpCWr1ʗne{˲-JH";MCKl U=ŕJTb[o}mQސjI&`>EUH8O>Hndz|ZzsٹY4ݤJbr&hɲ2 IpPkb^r;0U$X@Y%8T |vFr3Q- lѹhG̪̘5$wuMݑ7jQ?/2&!ERߧ%o\@rtfr,,EًSԓ@M-Ʌ@ 2t<{\4`QF>8Ķ6t @LKdG_"K+!xHȸԐI%Ɖa},XB4WbLUCZK.aWs5$)_՗g3R J}ecцv,ֽCK9$R0o12h6q&;NEd}&zHCW!3[W=n[XCV(oMEd؎kopv'\}hE-ȨguÁuCSҖW=#-wڇFXy/r`6Ǥ#IUgsfdJ{Gl|+|u_@--i#G3VjUKI^j-o~Ƞ(Mժ֕mԩlx >Le%q1*2E)$ *wǓJ-\)|R ۜi\kJ5Fh5lE l hۛs2Xk.>˝bQ(Y=TgsCڇ?0WD,Qil+IPHJt!2Df[Z8:sպ*s*DsDF&UQ1M]Y+P$\A_&OKR6iUޖ? qx6Q0N =""_YVUqI[H(Q_.Ǚ&QM$XnːQ>ߌ?\l,=@AXB&HUIۣWNio2/ m.bTRjE֟2JTNoq{ %@2`N'-D*DtY-%$}]L+ɊAB5{@& @itJ[U8-w{m.4 w Hvk1jv%i.5y~(DZWv)",3UYu&Ȕ3A!+! ^sGUP닧re+QHYU#֢j'qt\z>[\Q_P3>J*=մm^LzW Mle:H,Y~I):5Af]26@և4&D5^RfoQm]\&LQ.И1r%ːFU.Uxe5 R?ܕY'!ʤѠ͍dۿiE- _D+KBsJzEu[`.Md6f 9 QipUen]i4!_j]*;.m(,D04-0_*^Eu9Aurg^ @`"DU\c`jh^]Q'ߏ*e<,w[.>6Q')ȣ~˫>wgbt:)XmsF53! ҭV’)nD<ʒ{EvoaIF sEs4)9ђ1je{kSA%Y|o;tXu'd̷V4N$l-%찌C SFt&3;˿+C'qH B/`X(ڮn )BS -ƞ'|(eg)-R_VRm!CEeM$b16Wx~)b⟭ U艃[dIƗ1vk3ʘ .[<ė17a:IE59-R-]jN?Ə#@la:RmYv5Hb( 'Shm^BrtCQvb?a_dhnH2?|4K&eBzG/?cEEC,HUq[Tv3rYЄ7#[ .U V2U$פqPT3 ʢԆfH5ڃ&hA-چUyI[ny.zJZ[$&%/yVˡY$dׂ1min*I¹i*UR\j6$F*G_FW$kX Yy9V CtʄE.aztF0KPqi_ 0p8 'LT:0v&}-<<jꇟ=Tiek2NI2(#c)wk[co Vb"R”[s$l8IUׅRS&3Q0_}@l(Ҥւ +- 07lzUrXтti?|O˖ωoWrSz=<4Yi :\:o潬KJX=ܭ5EeKv?J(~.yObN97=AބO̾_]R?TܦP%F!La閬&Aޖʰ"#3V2(RUVh5|>1hfpaĝZxZrSl5 ڿ[oQkjoMNȨU.Ԗf!Oة&T*Јs\Q!֗5\J{L#SrkZnѪtّv ՚W; hw\t#@TF㣬s&UVVs*>Lq@KNW U^b%ڔgQj@+ּ4سgw/Yh*+Y!b@H2zg6QHlFN%~%yP%܄id֒}Bo35%y[FFjM4!BBEߤqfTs礼Op@o1{Z$O8bv<-]Tk/!߼E2ӄ*潱!jr 3a$o/̛u&@OêH:#oFcj_AO4b^fG:j4DŮ,Mk{AšE e ۅ[Eu+kuzJ`so˗@m XJl tHu_sthI]y/rܺ&if]+ɺA/hᆭF&/R: fe Uz;"SE^\ٹŴ#ۄHw[!(şzDḙq>az&QW4]JIIC|c*LHϭ)/"g[8"{T4b#L#w(N ˎ>Z[_ZKUjw=-L%&[VѺemOP-:)!_בXH:%7;!O[$J1ϝ{ꔧ;sDI/Ȓ>Afl/hr^YGRG;|u'4m@k/B42-=-1-R b|;FԸriI _U IMQ^:mh(-ZukK91PWC$+:x(T}}MUѧk5_mYn|!Yh@q;޷X+r|($I͐,oAJbk4T束STp\hDi K"q#X:+ G6J 1x2MæJ$<2%E*,kWMeC섀bye6fm}axUU='(!FU϶P %2CSݺX5 Vlv$ފL5O@H+5ok7{+Q0I1/hV\YiyJTLVK$X ɕVR:LXӒ Fʡ6aKdVf(>IAUCHųEv-ȖJk\vJz c0lQբd䪵rEF%IʲTx[*|*jߺo"n)86vQO2L/wR 52ڠ2閫:=Mf{(}5oʒ-RyczO\VNi:CBX1FuЃd.IلOiDTɖh=bRǍ| ?B&ef/o.մlm Ӫɷ7Ob}Q2Yd(k9m h:~s[(?V/Y%O8)|J }s.-W< ,X謱݊HBm1r,MxsH/lb}L sly|isA&pPoM7#:CV!O`:w䈍#:]m ɗWLߦ&# &>JǙw ;tV˲-H#G`zsAG^ A @[iiE @ 9t䨬π;^*,Cd\L Oͣ~&Hjw"A E@VWh..΃!~6Wk6*ڇwj^ G@ṠB6ڬ6;}Ÿozmf% @h\Q@ bLKu]/o5!hEc.X2u5&f5Q:U/4Zt\l/ѭ6ӆT é~ZsQkwxlR~Dэ瑄IȎaz&>?%Sv⯺&;|/omm,n]lI~Qrg]:N4Иh%'SUbR ygR#U3+`. #[J义p`WV @-Z2  旕Xr_ ]KJ K6<7%-B0'k-5l./ K q+6;vKh Q^RAȐ01")z%JEV;0 i1·<{ɐO1F׉@Jk9"MDr(V(ƼD/, 6jAl-ɊC(JCl9tmk0FtKzv˅@ M@@ 55J6]L`nKJ Rqnٮ$N7P*度{_18AVT,beq9E&<G]%#f$6liA^Z,9Od+RYE]bTZ^d ȡ5rF_Jn8! JdyaMcDY{(S%[M"o$d!矼W Q?yPG6ӽr/>xkB =khb! \nCUNy伇䖩)OM2y8K2TidyMạR^IRd˛7MɊ-c{Ma#@U(Dtִ|ָ)k.y}9Лȫ 6EeV(bNڛn:[ԋx 1!f;oH0H]9|.œuZtA>!#ZZu<6bA#Ȩxg#R k(B|)M}#G'Q]y_s_wuS2p7_ŵڈǀk;=L =1aKXQW2cacY6"&3'8 #)؊h,!Ck%xQvޱc ј5'4$q*uA(RlN z[K$C9GwqcǤ!ˎ@sJjj@ ^ss%fYvYwħRةtbz~\eT,q:܂&DA/yZa5KJ(=hKKQO[(eP'@i^F*,w$Rrhob)aI(yi1&<++0Ey#O>q@`rT$A`k߇Ç2pYyռLˑ/zȬ67*zmx;I*{]>w|&ߥjO@ ĉ6_G+bjd.IHk7*l:b*i󖞖ђQw.Uk/zVZ_%<1ùMaH{]qBw>knOolT+|@ @7[Y:LJKim",,' 4Rxlfgfq{BobOKc: M @OK%9p-@xZƃxxZ:9<-S;B6{@Oٱpxs7_0QGSK!ustCtqmZ-8xBG~1㨏|hhR6Zmލ߼68,Wc5q+LmVb4IӠ[nQiIX)kayX>ӤaXBFqSJC䙇 aB밭6J{tLi{ }SlZRd? R6߀Z*0%5b[i}U?0ܭ&3OVw`ۮJmhOd0'FRIiK*Zdž_3\m56 _sBwi5CY rS V(SYA$Iv6PĹ=kg%#wKRaH8o5OuN.M  Ri'?m!hf9 =2-G MFM#qC ^ɼٚi\IQ-6da3e%;74V'u!Rh Q@ޗ"֗DTӐ%T +VjY%U.;:m2e?w m>~fredU*n-UTWg%ѢfkKdv^lN} ECJcˇpa+{H3rKJI uӦ5%'Y8q,8 Ƣ\{-1,W BZ1 ~MFp 62#kL$⸡2i;>r&»v$U_GTi ,2P"\o>rxN`1޼L@ 6wWl{ !` / S{ˤC\ĉw9Er*ߚZu8{H3wMF7? e,lF@sXF\D{JMhs4[.)F:8[4$zm(|Oo_A2+LW#vյl|I$LR 9u$ASu$ުd*xQ1׽Ӣ!fْ|Fcnxر9"$Y:VH-˜Yߊ4rdeXpiRփ]-kZW;VnF"j"`Nko=2n\+8[T:0ԃkM EэH* cD6O;{wa"c[ #P|%# Im &(27$RMXXU7%ព[ܜaluL6zV"R#X4D6D_(*҂Ӫ^뮲,hB@ @h hK0F1]ܳsLuuQH#1ΞWG٭$Tb 62U/{YdT#r4J\UH|{72BOB` ;AKrJEޟBV.zJ/ɐ Y!*@#1-qz-/fK-,68o;-,,`^Nr) ָDzF@oyL8qHKኛr+;]S \|4Q#[{i)rJ?d?>J-||RljsԮisnteVD!iR[* &Y~R"9fmDK#moLW5ڼ+$$P<SYˁNGjC\; z!6ZxZifa獩5m^]{ՙM1ES\ƶ2woj2&[K33Kq{ ]ͧ f ۼ^A=@mొ7hF1X-t?BL/1'6(HOfCMlXǭ30 /(kc^TL11>Abk6j-[􂎵RmVOe6nU-40Q+rI]NrK")nbh)E5)\z<X&WiOThF۹6ג,6mn"mg57?FxQjs/S|"T9-m:kN&ZĵqRhh&lyE\!)PX+ͨim Cbˏ(VfP\Rš֯-+$4{>&x[9MzIb3aEC p5L͐,FbJK3y -"2R"CےJ:eCCN2V2D$K?ˆK<І !m=%$̥ I1l7l"1zy$",X܆ck\e0'T.01~egKSDcxn=|GfFQ/Fp ݭ! OL<ӔJ0;(++xއl JJgHcHUT"+IB/L.>B C,p콠}p 1,6'}k:qCRR Sw!#-KJL)"I2{6B>NJlGI@ge\M呴swy"Ж+F(C>Dp$hT # ȞRvG6$| <)LtiɕW5+pFebl -9#/H^}.I7 ڼ^Pge/'*$d5&W@nZf B4 Np&ACJ^׸~3cE)^qnVWd'dIBdξ6n&Elw 'oFz|TaXErBo@ avO2:PB`8CAkΒU8H_*LxeQx[̑ʌzYM>~q US0-_pې,YnufiXHFίN 癥uͩG.;|-։cD6elsj,YC?@^ ]> |s%GGS $r쩳rˊT^5E7)/G ƴK$o<"hhg3ر=ARUߨqs`{YsN`M\\s54 >6<|uDG=E-賔*5 p4D+_}ӟyryyvo/[@ٕNI94r+3OsOeq!%!6"Hb.'2ht/ƷnЉ9/ TxW~rQר y ̬kHvWC '!1>~EqEs +Yʻ1lFo>ZۨCKNg߼ECcm Y 5ͻF?f؀?Ҷ({=^-W^2湃!ɐ.Hi5 a`PҚkS>M`;=$-=_扩x -PtlMHC~@ė/"7d<ڨUMjP߼ Zzwz~OP!%ʸ6g #OH/ZH͵vctx}mKZCsKﻯ&͛Umi' DC{h j𴌹k=U&y$!".YӁ@ܹm.' &&Li.LRہbNf(mlvP7 \dը5ۼ9f9)l=Nm+y ͫ(&Ņ"0ĵ5Mzsg۠Fy{DB:C˓c9TzTmnp6~6:ՙM1Eh)Emn؅߼}3@ LZw_scUs[XJDJtnYMbJV2J0>G/mFf@ P@h6 V%QcTͨH<}۹E@k]qJ%: < _?w$jZZ &PP $O@ 0!6߀@3ڮZPkfgk4՟iCUB嘻.r/b\ W,þFt#|_nvʝPJ&-INFl^^ʝlqt"@:dqTXFaIksSNE}Mnur @ ، ڐq]);hRMoBr>u [RSKm-üQq 0B, u*c}:p9/2.+Ak(ޖ]ڜDhs7^0p֛'"@ C fUPdkqF`0Nrޥ.%4YTrvqIdL_e&>h/eg[Ucׄ"f5A+hWCBW?j̦"W~6mޠLøÃ|2??D=Ķw!%L"uɭcN㶸tܹs`㹃]M$FEiɂ:g>G9qT/wՈC7]3ጞ5MTPF2HNIʼna> +K+gKxV>o6 /V mc.(m֖ULK"f9aTzS$mt%KH8,0,Sf4&#Ik1-DMJ/M8 !0L 5u.Hk2ѧ@6(ufaR)B ܌%/<%цhX`Cbe4`ەhUXqMʫTyss#J8 M73 vPnNR_{ؓ)T>ETE/[D¡C'JT7wDL*Cr6soEm^X y ІM¨o~HTgC ϕLJ$BbViXmVTȌ2\/Σ%܎4҆ c&rȨ/IlT0"aQ$x_>'"0?zh33s,ngS'bSΚnEݡO,\F':0I}jt` h1)'8PЇ= _ҭH" &≙e7iBቄ aNUZlg'νP6=_~լ~o:.*d]'"a$6|ȱ*9/1>vΧLks\jAƛ#F+nTinX7Don6njAa, m>)A]gO mn|mu/u;n|; /uW'aOHl! τp˳ڽggeHlJpeUFw1Q@KVNI$96Cn5]ݣ'-d\K%[hC|e$[{^mjO}Y!Cop[79'˷>ڳ"%=I/b +Jl!dpq!F@`Jm>֊Wd09wSڇH"J9s`xyH{a"I`mzUD%μPCɧcwvwreLgnb"NHI.Wn㣝䤬m9—9b \RIof{i8;u{߂N9';y%q"$doshShyW\"=4 S6ƛ[E6nyfncu^Lm>fC6TdyU߂T!+`ܮu;ɑmS %G B-rɘ(~ՇqӐAL &9zDie[FF іrGn<5 y&ى,UФ]P@wܰ ۼf@ 8BoX:KVuRRe ߳vRouĤJF8 2Z6ߘ Y"$@Y32F)MUAP28!Aďuc \@曵zݪ180Äm xR+|a@ PuPPh:hT ++LH JBWB4L~,FetF@BxbFYq 7qc` 0nwXs7A%cҡ*6ߘVQg%A>NpfT]SmU Y[%X65غ]C E 1lLˋ\@ i6"|pGf@ W|jԂ" t[#^` Dڼ\ G U ͫ[ijҠC lg~C]\߸Z蜥û2ѕi m^(͂B#;1e4ѐ32o^>yVzj^A#F`X#-h6QH{(6-Ӳ*$@`xBap@`mu@ 0<͇08@ 6: @ c@ xBo|@  @h1 @ l<?AIENDB`zsDd   |A ?æExample of the Line Editor screen of the <site name> - KEA 420 windowPicture 5Description: Example of the Line Editor screen of the <site name> - KEA 420 window"bxqzC+2>wWTqa6=nLqzC+2>wWPNG  IHDRuwqDsRGB pHYs+pIDATx^ dWufA9$qlPZ=n@0̲3Z0db0GTsOgA%Qbiy,bЩ ^pX&̒y7"Dzwn%ߦab#sܦ:(!IQD(}lΌadžR3$F&daX2ӱ8ش̸:dLs_88sܥG`cz>I1=ugcO=w'AOvggOybno;?s w| o:٫}Ν>w y?~:s|@ o`LOΞ= (䧃~y[o%V9 7dLqȑ_7ox|8_;dokO/ogK˞#_/󞂒^zS^zߧ~~?_'{3/~_OOA+?o|<-?Y?{x!쥇?{?0>c+ ?xSy~?ǽ5pE@ c˞rh<9!sǯxg2rzСG<gLe >W7M~UWW6>pd翸q:K~k_PC~0?W?#|?a||CzE!W~;xA73xg 9rd@?6]G~=}qյBS ݏxG? ٹ*JEl:"Ϝw|7"O?l=!-'}_/Ǔ٥y~ -]/~/iⱏ| }~ivKK3 :Fp+2t ?tf@ C:^ (17˜?[W<Fנ<}23[Lgcv$tu;1\?zÿ;7EϚ fq03QιNk@  C@ttI%H¯ 21{m7<[=z=yfϿPZ??tZBiS.RoCΧ;t|@wLc>$ú-jEs& p.Ͻ{3O2bAW-o Yθk9G1KVx.KeA(֧w08b- M\OOlXxI^tEyws{Û| >=fi,n١nYL]x_syOgW5͇>v>Svh$ bcp}UL#Շibx=bygoNRi]5QJ47 OefΔ\̛2KԏɒYeiXww*'f: [ѻ•g t#2w)1.RS}# d:Qs(It.b0ı|_ , qϾL:H+\򱴨7q@-FN%ɷϼGK{twBL:X5 Bz IPߥGGp^m@  `קh%@`r5ύ2xW]4:01]K)-"aԔ$U _~6xjch,4uE:[ @ W<xi*Z8q*>71~Ov^uOSnZ;pk5ZeUcHo(檵B 2vL[rR8Mvi .9XWڳ+edo 4[N'Z-WWDO(7jMseQNU@ <]Qd|"\C_͔/ǐQnk.j@ {!2Sܙj^1FY #0$guKT}@ ?iԳہCz YW\2]e]9POOJjUgoDhgNqY<."rt_ܑ%Nu B XIzU,@ "cz@` PO3@ {{'(@`[8ݶ-oow'!@;1ގUV(yڏO]Uwÿ?j@Vͧ#_ƈ./&mo慨 &Utpݩ^Phݪa~WD{#o%8[Os/6R_ C j}~g}R> x =,XWiOP/xf &U(wj>B^3h母C7N{zg~7A- j}Ãp]M[dZ`<0<8Rwɳg3PD@R~NAZRWVѢ_x*\+ g>[tWG#1NUsؓ/~Ǐ~.cO5冐sX|ׯW| %:ǧq_lNW8pw>yZye`G?hw 4Mh(gsr!칭jg?xo0g32t ;gv? 9qxيZ/Qw"cuf֕4(g+[od@xTk˘-ջ yײOyO|=)Ow6k~*qN,<rCᡷAe)G.ݡ݄K$B_4 S?{Λyj+yCm@~+wf܉#`z+CuLgʞ3sǟϼݿw~R48ɸ<;qDcf$I^ZξO_0P 3CSѢDZ#8~Vٛw*1?a|`J_ыty근腏뮻1LvR殯U2y!+IF|{T磩b#&dn %dȮ5ʅtow0W)>v}?zDyY78s䑝;?w> X6~ V@b2O?sGm"/'RԮ$$!0明G<-o7%6 a/r\@?V |ǿ1)O>Tִ`ӯ3r/~+,؁'ߵ*Z =c:rv5PrW5ފ103 ǁ}iys6yyTOIv$1]p/;c?f̘.3涬-Tg?|4;w'O6چќ7;o +^D!,G>Yp]j:p輓>wEOŁK @`u6?Y'q^.jIq]/%~;&3.뇀,$2)Ϥ;R:gRuN<˜ЖOǼ@oLDȗ)OFO^黾(f񷐰:V)L6.Ήʩ]^?;qħr#ԑ'oyU: .6dG?z?'ru쒧[(O7Eq%K.C/Oˁ'N&r1ltr!eC_L˭O ̃/8J0 ܔ\^ 2'?P7P,>]e$C%BΎ\~u1z C|ÞsOM:p>>a+3Gh Ww@옞[R2 7%sIc%1F iiỵgԓ9BI>!zw`,7S7e?I~})L,96MF#s.FjrW)O,X2/]=#X8o]U2l՘ K2^ˠu@@@ lVlI ۈ@ثS WbL߯=~6"c6jkχ߁@ Ę>~E w l#1ocO@ _1}|ۈy` L>g @ fM-@.̑1N~B}3/>-;?~ uru,ӄ(QE/v-*@ 9d^Νbɓ< o3uP|܄hb8aG@ Bs/ɧD/ѩ΅%y1J̙Sq%2Z- dڰSXݰrʹt\f-̬g$O%%4@dd2Zce.2Jkg 6.-Óz6%i;GnȞΫ@؈4$ݦ ~z^c.xP6S(%qq:<ݣ|Ṹ\8DNPΞޤP9rΩ}ųg0ӌZSgwG'Jݣf@ Ȁ)#eĨ0>|#*Lz]\Us4Q>D@ M,; ]1_wK :Fj&)5)Ͻt/,L=K4mok行dQ%V~˯=/̧9ryE$z?]![XI1"M6uE[~kM2DCLZ3S)cQzrj#wv F 1Do]N-z|=I 8:jC $8t^x}ݿ|ߵ7Y}@ RΝ{b:ϥ<2n@ B~3/׽ջl>Ryz/SB8@`In w}K#]Ҿ@ ЎYH?#~/;ۃ&$@`cȍ,/X͢^d:o0b ciBSVe8@ l13[5K҇6#oF\٬h1"P{߲^p4 ommek Wr#SR^58^k9"0|>-qOsx`_4C>E`o\ޘa1@*@ |7Ëaݮ68ڱ @ Tקo9b<WpxšU0d<+>})nv@@ 0"5"*]F 8v@ FD 8F3T@ TfA!9١ O汉pU@z@~8c@ n()Wm(L-bU#nZي̯B_]D%ntl"7%YZ}`M2"1,sn'͞>iI4I="C5 +P(H{pxqDC"?Hxq_}'RUɯ\`֓!7e2MS%CYvg,Gxˆ }2dD1:Uc--%BZ i0>l}`U{P{pb};9Ɏ+{|dtS9]Ϛ,kb#9 iGLICbU7~M[a/յ=й2Qx3nqCL r؜UV@՞j!TΧB{H(dOY"C2zX˹$h9 3@$  eWUɮT9viPa ZF dewPO£gjy{46bënL&fñW(ɯ#?H7 O[q4K!鑙H%s򫁈3zzGεdJdC9=4R7 Xb4[)N=usx7w,7BL9\8}s 4Sσm* Q2רBW^4N+=-T @n@F^ΌCh_2k~Aa+:U#ӊ-ɷ%\qdpgTأ^Iv^7 M>L:§N=y1E6ĮZn @ČGPs+\b)Xrx-o5pu >1*-zƲ9@ ~Ky:͝AD>t!;=+ @`DkD0CU @`|  =8']24Uz$^QuJ@SF}EZD\rE{qxiV/1Mhk9Q-^uz|4h޵ js$@M $]I*4ZՑp--Wɱ.M^--Te\z#g;}ͻ[Kr7ZїP,}rk1jZYRɺ>[Fgh7J<r5Ӻ& u_K[d/ШWybHPt-mN6W[&R3myUOc6iOLKMs$`_g!~%TyI=]'t_W9#XOV#F 1}`юHId0Ba:*10C 0"R1&EnpFsS 7}ApfiԄ!KN\B%=d~ȶb,Y8%+sx~.lSv0jS1i\Xx@|.zȩ@IZޢg萫dZ,{iYG%-'0 qx嬪67O^.+564-{ 06zh6٘Fϖ!Ӯ:9D,N+wNcr}UlKh/9ˌN$xN+/Hbl1RT *G-+v́EFWh 2}~Mj#0tS%[]_e9a_|Rc(RLJ:%k[h|F#9zKqxfw{*lpIUxd7vqνTđF#uG-"՚SVˋsi`3kA2 [Ke%D߶DjER's#I`I׸\:ZҲv>v1i٫0`8T0}^D{o$%-`(1S7-:˚Ѻdk_f$B=[ wVzi0'ՔP2ۂjsZO!8c vߘ4/{Q*kUKi<|:UF1g1(НdžJ lX4iF ՙzyLk4MyaJCI3d 3Dݳ(a<N >~eN2ב3^s!ifߖC?#sGaPF\%"&sbmvnS;pt0#IH$Ц#Mqm2}u> ๮>[Z%0Qsfif4LSb/S *˛^کK,M霦OO>uIP{%ClYLs!v=$Ia!UAuĴ S MtF4%՚1g_ )XMbózYGPE1|-I!  䰢GT MjZOjPѧ}baj!Yb8(1 Px˛nGZ19xz#}3p.XG,nH iڤ2~E#jOe8T&ADwD U^P]wǽ5݀@ *7@cZ@  PGcz8C6]E`=GH4@ p`@ +B`=G+2@  -(L {V{m| PGjiU= G: 9n rH ^AOH['- с-}#@ bgIeiT=\o%sz[@ТőscaGr0$~UO#$~a5<{ؖh?Vli-H.>W1ܷYup&c޸ +@ hA.D&2!֧2@ l=70"@ @u>=@  >}tUD?Gxy$cVXBZԢ6m!H󐭥Dmbϰ<%rf'D{Bc=H> zn(DFbD= Vl5br|Ҥd rThs^^,StgC~< Z|*v3͓x7Yi[EzXKtb=;K aO9`=)ON)=Guc+[`. f3)-E0f*oQG]ࡦXk'B3C#d e'p(di:aI1L!'7bR=rマm$!u @^Һ NKSQдDn\(&R@FHV/$S&m5j3ܦM_ ;2,7 |p>x1|gܕs]s0&7s?u|V,NAXE\r5e,4'Ŝ ifϕx}/ 59򝝃39k9 905M[bZۖ1\{}-'{NH+t{nrN#rHOJ@pvde]֦ =aϊ8~ջ uo|i>}gq+ @ @c5z@ V@j@ փ@pxh%#]|:~U<+R䆛)&Mi I6 Ym$zD;Ȫd9'Mjlɧt .4őFPEZ9Vz{eΰ.ӫdU)dC?u+,XuC#rnp\B7Pbk'cjDLHְ~Z@ Txz6QpwfBzuu'W64%yyӨUs~wBz@=`2u@@#H5IŪp1,%;bS8ЍV*Z8J@`"Hy1h_qx1C)Y~NBkay <p-RAÖqxCW Z(=@u>}MHU8ՓL@2t#^9jGvpxuFv!lʪ[:{kpx^h(d@`O#. eU/>vзK8b=B2Ti}pxyά~K@`O#^{@ !@ c!cyz@ i}zՎ@ "PG^ eɠfpm%녆iKyƮ*ػkSM^+P!^_Ja!&)\E:{h3DcJjF$,Xquk K T^]@ X548hc;GaKIyKJ`fȑ:B "48<w3 kzS@:@`WΧ)Qf뫀`9^nn/3B8VFpx!Ds9y2˂YET@ -vër9vsxmYh;@ 0|2^*f1LsզEA: ,7O%u/1b!p "U ;^3]9tyV}qUw"5 ë @`o Tae @u>}k700A $ꞣu{1 Y@W^HQ- +j6%JxYKKqFa@`I6ët}k"5aLM2@ !=Rrx[/>fNxfa~T}{6@ݿG nL`qxKт ٞ%2#VAW@u>}H#%P2Vrxab wOhtQ˝.sx$H-Wn+cJ.=#h49Wwm3@` `*[АJ2{7AsĿQsΧ|-Z bEZ1]"f%ǯIYSn xyL/>[ocȗx|!sV ,@px-^ @`9ZǺ͂$ @`"H,tax @igaP 9{9zߏu|-4E{^>Khpx QHk!G~Ⱦ9yYK.{:ܠСuItFE0|؜%5ŵdZr˵k{%BS)$r^4Uw'TM*fKnr4ge$8¥b4(fFU-~1~-$Zh kR%bpl=8H$NWHxZ_t5hKfAik-Ha ӻrZvB7}ӍPOa+h1SwhX1,y쫇[=X㲠DyЉM Fz{t܊%]bqfSvꃅɸίky"PO9Bfۋϔ[J (q4͒v-F<=s+n'31R $/wBh]iV]hUI%M⡐'k5`w` 6г4 !5 #zPPR1ŀAfe`Uק@3h^ 9{ ,Uu'w*gj '0y6x$|QwO ЃK:tv?2^x(1,r@5Y $(`kw+l+e` @9MKZ|N.lӕ?91(,Ѥ&*d1&NNiX%x"ЮSu2@CTً>]m'%%:' /`y涽dx=xz撽:U# /jFJaUKtKWB&FNyE"q5t^ 9sǖ*sW46xlRT%ya;[A8(Ԗ ~\SI._T:3zS'&Y\ZvtZf WZ3kt\qo:A'4:U&D\uS}hq^'wiJeY H%d%yjN5Ղ#ɧP]z)1U2!3S{$wlE\5"x@!3:*`J0iHOzrK/,/#1< ,Wrg|戌=:L#4MBIS{xYBÞ@u}?aQra}:ViŀVZ/{1m$@ >#P@ yHϮR9ܟ ag.B|֗~ç,㣘VS̤W%ԯQ\,ZH#Z8g#-Jz@ "1]T]2j}ճ'.'(4rPULGO*P Эp_؟-%̯V4 W0&B1GP@ ЍOB&e7gFFK$F6k%g()l/Zk1'p[n^ԃ*RIZz%)}\ %$wTx`YR8G|:qcl0Pe&g)ZA:^ʊv+Op, gI-2#PO/#@"[ej\˅V2P8Ita:hf~`!wU9i̴K^m=@`zO'/.Lm{"!SаRL[6[ :eߨP),ĝ.YrG:;A[N3K>%9{@ ~#{~vWo%qnӦ*[B ^4>k݋Q+ i;{19h1<gbL1}ZIT$lD$NDBIj!UbH*m, 4TdT/#,Xi1[."Յˠf'Y,y⟚%I<8]G] Z'V E稕?}f@ z#m"@ @i=v 9{9vlGz*e2*Z9*͢U<@`ΧO[ny (_dnA_'k 4lNĂj8\ AKVNYU^!.U=UêUݘ~-VAY:s>}I)wȻ(`h+ POsxcve{j/!(wh ʪQz.@ s}z#TaDp.Bz%,yy'vkik8Us/2ZSD2eôJHduUh]@  F 8C@ 8{`, @ H@ E`{kz@ `#=i; Xݨ@kcc٠u&G*uXb(X PUN;r:6G-^ DUTj0 ͱk@s FXuy-mpyyfK4>h*V}hSJNe#,7m$'S~,kH`Rcӹ^$-jEQ!n,>lBsB[8saZ9Z^!-QOir2L}h0b}4zVI۰I$[Rek_m%+d2WT ˛,b %N|_wU&; |r$LΦG/ <61B`dsb6CG2VH3zDħiSpZXh:GƤz 2'N8tumu8F pޢI%(A])]|-]kZ˛dL >*lܴvڼB$i^ȕKTP܎|\/Q{=rA<ہ-yl27 7h,_~ Ν;w=sryF8r>L '@kN}d$WC%lƯrC)3JaUd[>R@z|grWw2%/Ibɦ%  E5q Bguj >5Ĕ*i)׈:Њ4Bt6F;UA$P@K:HGZNOA{!'k7[Qk6]Xgr{=:Kf,;=H+WlGxa({e&(yasU Ӥ\# ǛSK8sވ[^5l; ֖y%'!`Sd0( fߠr!wtYhe[u>llQ-0=CX`, -QO(s)J$+lϽ+TLoFiT.tVO6ӌ4bY sEdسsܠ/h5N\ ,x}GεkPvgӠdyɈp, !lqCʥaX:>MЖύEcusx&dS*@ eSwˤusxUon }@.6a@+G@ X#]Ҳ@ =^r|7-6ZA~cqKC̆}N.0~ vvXEm9ZJ/DeiZIZ7h't7 M S/à 1a}pS\aCyU5`۷a, }--a*^\f0L|wH9چ&ӡcΧsKY 4uw\lJfa>kldlJD Jo]'^?S9cTY.Ӑg!)X&K#_vĸ_ͥ>cvUDkAH2֚8Or?5vGKzX(ixAl.s]rn<@SCQq士eĪ=8 Y!PG-%釪8e.01@5U?j24Ӑjqd#GT_9Z;!9≖r(4ڞBKZ(14X SQm!#ke: =(dX#Q2>kSTl@4^< ϭR(晞S \GͲ԰JAmvOW֛,'dT4ʍcdHx vJ-,v1'OujlbeXrsdf^hUb yXߴ۬J[gb96y^{C ɍfXIinKd*WpW~4fS>-)9|:Ldz˲l.홞pfhn q TLN}K,wW[!,ժ MI3&kyn\$=IvFF#6` a>bgPOw~ħJlkYؤz~Ԫp/j<׍qahbΧO\e0m5'kz.I$4Kق@Us ^3Yµ$Kl3w\k)iId-OŬgU}Asèd2UĒqg[`Rh F-Lwd2m=_.rZa͍=2ʢfFɅ:zl^a~MNs ca ʥ,O"K;y׹sf|@chʘ=%5Ų) BZ]}&4$ &4B>%{r1HZS \"UrOp1>zZ&S]ޏKO{Ks x+<-E#x ^% tvMSVIEMKB$POYI&$#鎤{+Ǭ r.˻^!9 m9 ǗDh N`͐ e-ifr5lz*#ĐgښQ"nkO sImV ˵ in,*@@.ԍ*@ X7צin=nû@`ytvG[@ 1@ @iu/=-=-ey]~I7$ ZF74l/>ۖ-ʉRdYF+˶^VUqU Sjst Ȫo1-Z6.Yf_*\<7\KZtAph{h'r*_ C=c.Lnp){1,H5uIG!j{u`1Ӂrf($8d|_*#j0S,ިG]DNq_*o+v&g~ZB =Ԓh[LFPk:pzY)XE{$Dsc2MK Tg+ Ǖӧ_\cbV#1X drׂBmsPC*V;qW}gq6u]2k`N!h3fNU-P' VUm H=1E JoRH3+IF|dq?1X{ !%7p!Ru0e>OC0ʐq{/GWٳϴHĀ:+ |Z1iaRWZ63~| i/Ie&r+;$A[]H/DLCu>,Ć'* i9x8h BUr5a/R9`e ,^frЀ%f4jns2kn{#<|6rޞͽpNXU[6^˰҅Q3+{!NҊW_d#y&^읾$k]ϋ\؛&d? !KМWtC*hf^g]}LsY M@ιzV0,V?5砖r#-vd")Z{ fL2TO[Q:Y"XĆ!k6mDzN*z]CO f@[Gd:܈X}Ū{pxiQ"$J2A&rO;;Şj!ٞ#I|j_=%ZG3"1;;uI8ҪdԚ *ErH%vPrfZhԝ0U~b_AH*'j!G'"0sx:UyTwgbd:z:xNXbH!+YkGTP=_x^6ʗz{[o-7ߋU[W欺Qs(BI @^1G@ g8wIU|; @`6B>@ g#흧W fQ@Uv{Zkfv3XU릧jÔW5{GjIu ހ-ԨJOG|Dir#9Bq TW r\Cbnjٌ#3lI"8Ly[UKږF-DAC2R=اڣϬnam%5ZF$r C^|M=խ7vErLs9h=ɬKgW,šJMݎ4;"jL# M0bd%݈֍f @a9v}Ѓ^" 0%-fh Ń443{L3v0NV"wtb_O)ΐal$푘i2$tCFX}%cj&-V&S/рt #$5'#Y lz]n= )"K[<5 ':tqФka|e9 /ʴP#6GR,U0IK¯}Gz~!3@5Ky>͙D'!Fn!}8ozֽ>1R8dIFnHikdԚ4^-*o\?s;w3 {̧k,}&}d5Ӗ.dɭI&#7띄\k=牄Mws'ƥW(u=lT;b Dw;_&[1E %{Kۜ$I> rfW7j'i]\ͅyUMBKsXÆuLXmX$5KF4!p;o뵎T. MFn:P>Bd2b͘ش.ʍ`Fɞc6Xs07d(n0n*SB62" jab`zNT;’~]v!Pk I{F}aIԬE9*V[x7%;-l9`M4'XZ6=a,H'7ă쿕 2yP0abrdʳU-@h'm=bɀݍQ~MtEJFGH_ 3+d4'EHβFV:{eFVS a,HH5.c ߏ#oTlCerb89w`˗kOe lS䪚KӜa?dlbpĪʽZuC; ^T;R lo@d_ltjJ*v(M@"卉vcшj8Z[2^7c9e ^{@ B$=hHaf ی@i\W3(ȈQ2"tRۀwDV^ sabF ネwP ? (_Pó=[=G=NN^#zD%c JA~~aEK莖  bDu@,ned }kf̶`5H +16AftrȮeVvY^_M/ Qa9ox)ݤ*lNtBfB_P;ˋU+7 9MǕjkMυ:wjLic@K5Z,' 3mmDŽzY?["D[4[P1=J3 8$M2CLzb:ރːsZU !r W P gP#NSQQ_XHǔ_Aӓ jajt$|*ז0 4@EגIa!ҼIg_-ZK=˖D[[^KCWCzL#Vc?joË'jCW%?gc*.D @ϘX˼O|fCX%/8t~͓pԬĉh7I$d jq\?.=Er)aH|;Z *SM- jBĀ締@ zXưĘ\2k)Ϲ^,]>J{}%] >*""L s루W}1QX!ڛΧGʁRS2^8-+TS,;qagƭ޽J6 /THHrsY{2,206&W,ߢ}-5U @4#~߃o,yfi>Rh-c:X{&|u HX](sp&˔jsKO"f$=մjЉ\3ʙ0*PA-Kè Y xԓnr-> wh/'֫^mɭ5ɋ}IRH3qeq `XowGyZJBN$k^c8jn1Ob f89ZZLNΔt_|G)u~UR20"lPb.YQ+6'Y $Wʲi epUw2wWN7*=!j県r4"0U|IҤF@t]dqrMP-~i+q?7j^N>ɲ,юơJ(V 9T !2鈀'iT>B\{rT>.$QH(Gr mL*h[Lr$ypЌHI`TSP$*|a~x\O)x4 |xҷYoi,yxv_;[:g*x/qSmOfj1 Jv6ĕv-ݏ-%b^OQq_" (4 P1p @XÀK Z~F`g@ 61n?aC =~s/f7pY=}tUuSf~C`=G7$ѤϽmBqIK ?maC l7cΧs^;1$i0̅ʥ@I bL$9Ŷ;\»@ p=vskX!7Fh) IndOхl]_"$WQ-z IgQĆVG.Dwx&6; iQO yFv$Ȝ'aKDB8ٖ_]d "0|z52Q׈@-L s>TUt$%uVG4٨ |zE%P'+Q+ %5kN17kx-^o ^fBؔt6f鉒s -&ZFjTj?J%oeDp@ nT弬^ @  d<5@ X=}c8& 0=M'l@`?#PG:Gz؎{2Y{cs/IbEX."zr1`nP>mo{}m@  POr]+evzc }(*`y!5 pܓ0_.u#K)s F_]MFB*^q gRNV[K[{\j?@ A`t,^,[elV,!ļ݉VQi\ޗ7@ fUzR{Z33S?1.s/2h3Af*{]fEr</BR-'t^|'Z MC:.^ =53,XuE0;vM9D9ג{eI{M˰'M ⭈@ !Psԃ?}V㺔 =@ l ##,‘@ :=uW@ ^O^ ˞5t2hJ:L[j3%T mCF"Yҫ^e Uًnw0$WEzf`kkgqpx=tGx@zZϒz3Jµf1iܒi*0bvկX7p!|7;;;+=W2YXpxI6P.I:\ȋ'ۯp49._%gGXe Ms&aڐ V֓BӞm+ 4w1o4FcR Q2"j6#t0vWr%q_3!Ӓ&6Jشȕ<rn'm@Gk7zGWTruGf31#:,w.k\aB19|W\Uml+ր_$_~?_ǘ.YO{'̸0vify9U0Iëso;}k9h Z V1[Iڬ3bz3a+5(_+"4Gw0*tYi3%878(Hў[3z+VgBC<@5X֔aꚖ fԩ'ݙ=h/;* ;;LГ-M-UyD[Y&>LЊ4d qU,,( _ `q%Z983=E:$4T" q;1~秙bOF`qޕ]݁We uewy׽«Nծd}+jeF>Mbm"/5Bvўhz[u/OG[8ok__@ 1]nȬiQA \mZ@ l7֫=7.  Җ7I z5.29ņQG4.:\uB]}LoR9VVp҄(UwU#ymY:2Uȕ.}ر:4 32hY=Z9S~ Lg|q;Z_ح*_DL\LcV4V>{}}Vs$JLh bjlv$ :t0ȯI{m_lD۩k)tB¤C޵qMxWQeLNu8wI^ڹ&AK sQ΍v~5 H~#1c oAYm5VXKH:fw&5 ܽ/ O9n\{3I 6IF?|:4V<f%8`{ wiKiD:NQ-5/V)HaLHNm%l0E@`D1fUvN6xa^)j./P; VgsqV_R`,`4#djtì.w63. L|cI+94&(*LB,XC@\+^^$saO}Ջ"YdIrJZB\H8~W%ɈTfkJ_/<<:HҨ-ړ6"55]֢ ӟŝe6"#fRKd1XJrTSU^02[zGsדkxlO+4Wب$8~ eD%.|A c:>1/\ޚ% @ l7X2A71oI.. @ #8g]%O8w流FI@  C`{ZЍ ́@ ^ʜ{~7Mcv7 Dw>/IErXQ}=( V} @ ?-ۧ1[^f%wQ'ooz O%wIaI EH=RT"!YLQX7RH͝8x# ^ iG4ihKgCZz Y@ w#%2ζO6wb#lT3R@*z=yk;^e|@ :~6|LPr*cp?I,\`I^]G< @`S.s/+cI.eF@ 4w1=Hjm3&pp\`{@ '>|s/2yj礰/'ԋ y펄d 3]:(ʪ)KKHEOVU(QgMR)3b'ɞDyY2Ɔ>dzڜ~ K@ ( @/x=я]]XL ]>3ʗ`FxX/ye>]wu`_@ l)t[ZCtA@ g1}v]C @ ӷ/Ó@ bL@`{1}{2< @ @ =ބ'@ o)W]MIENDB`SDd<:   A ?Screen capture of the Edit User Characteristics Screen Editor screen of the <site name> - KEA 420 windowPicture 6Description: Screen capture of the Edit User Characteristics Screen Editor screen of the <site name> - KEA 420 window"bPNsCxk.K̭(cbP۩=nZPNsCxk.K̭(cPNG  IHDRtG|sRGB pHYs+OIDATx^} eWUeUEBMRhIbZ Cj7; , գ0FТT>MږO_@§I!j`@B^z;[oݽgs[w:o^k}YgSmso~V!>ӟ흟sS=B_rR_> ߪkD-E5Ju7d uPC~I<J뭞̛}_(u`j4E#H0BI<} [rkmS-QFɽN`_&1B+ GHhʍIeoLR#A_g."a%ɖamϧ{vzͶm<~oe jΤ˲*E9?G{݅/}֏~2;/x~Cw2_g=_vw\76V76^ao~ދo"~B@B{? ~}Yx"@e,..n{_s_s5KK|mo?|o. ~_5}KW{C|귿KMo>_|?q3~!|%85?I>;ŧ gᎵYK[ۃ2\x3E;%uk}k>-Wܐ[! 8)O޷|8}q8:} }=j׮]gqZ|>p~ :iO(l郷{Oڛq@/3VGrUo˫(ySNf?}?|Y[~?,#_WW^ w~a|AC9_ğ߸nǬ1{ wn䑗̧~"JׇWZO/~/4;o9x泗 ;[)?٩G]5E/(C: }|? "plwl==+~۝p1U?ز1Ϋh?q#78h ~?AdןrFc9-z! @3̲#&7>\:8˃cw=pC/vn G-xVW/|(-^;2{`|Y_fp/8{ԧY! @(NGcPFV=bm̚E];(|5ﴅe,!8}?eK75 zM zL MtccbV=~-?{|'@]Wƪ_d ѯgOvkb=:24 : ˲ڮv*کC$ܠԷ-29X_bG>_je^kϬMe4-;I[`{Zh[k-&.YvYQKY{P bَAZ/-xz4o|28#lz}7Q[6={k{Rk˛ۦ-7ǀM?*ʙ xn*G%>%>& x/BAݲ=?E0ЪͶ@3z %9vR'aky%uAB FWxlHP{/@zS $tُrw}0Gf^65 u$Ӄq;O׳OT! HY"4m&J@ʅM!B@<}WIMFc8%քza) I5nQJ4B@!ώ;>MefhhǙ.3v[ ǯէV7Oc݋$d)lr$m\e-! r-yFfP_+}Aguo1;pL n*3! ZYŸ&ݥLBc4o()[%ȕ@!@J}v\2`Jg&2};\C]ΤO(y55ZB@20M !tT}2qY_V&NcDN+7ZO 'nq_x++-|>֨UTV2cċHwiJ+oq{ƖZ:n2z7 |Pi-@]GhR1hۊ/U d"B@ J9@F!05htB@#%J! #kŜx2?_F~=wӋR!P"V@Ÿݻݩ=*uE D`a7+n~X=_Y_=!K_ɗ1>pdʖ/U3] ٠{FL㞍>-ޏ~7ޑ<%!P?kd*k)O}) x~{ľJ[ 6Q &c&1pSA_w\vL zrAӹ~ٚ Z| G$eK}}Bz_X'gKwUh+6?8F qu}c8җiwf/@'S]ܐp΁hq/:W #r6^L!]@z&9臀- 5^WS7jg>ȻWY e-810B:۾aq""3þb_d"P7{>u_Ͻ~;x;M[V~JXX~ٿf6Kģ+7?9V3 Q [?S>ny[Ac⠉ʩ}x==.yHpAԀL7|3M& {ny⨣+]w)0jK zKY9! υ Hszƿxx묲]v>{"A ײHen,.TɡmݻwtIn =m{N4pͲ7W'B< fv>o{~񥴸.KNnZ_iL믿<̲h@r ]w[q>q* pv0刱?߁*`̇ra{-;.iT!0!iqu--m[ZZYZڱ‹oY|><8qӊub 5`/մ0ܸgDC~B~u]SZsك|{:vn sL賿?4OpO1) |A#\띝 tU1OPdz9Q<ʯJXyb?ݐxWqs0\_Ū h m~N/p&>QqC_ڱtpymaN-E,@j={ '@luԽpcpIO_bi׳mU$ b0V="2x?۹%s~2\ K>-s!P@j={ٲVVŠY(h[90ީčmMo c_$ֳ| kUg/4>sKnG|( *Zv@t 5 ʑ ;,qŊ›Yvna*/E읅% ۈl!cX危J 7F+ 3; b"ZA`,{+4`R7Y25YUD@=( ! zF- *o-oB`:e~B@|dB`:e~B@|dB`:e~B@|dB`:؎7LR! @($ގLei8B@LH1 :o>|dI'iB B`އ./\ qů-;B@)CfΎOY(';ge./wn/Y[;m}t_%b1 *Z-kZ%^!ea,myΞON_bmŅlXVLp"@0W9_+hvnsaYw66ca_|-J>Vd zOfy3q]iL8UehĠKbR i`MXD͇jN]јҖ$iݻkV4%†ШU` Յwla~VCثI*†O,> A3@Sl4X0`(gx_P5Y&J1c5MDuh.ă *`$LV޸1f4U)ϔ*Mfꗅ C$h3> &:x_cke'׆(L̄T 1zhku2k%%];gdD0 ujyjiOUkb}e^` VyӶp2A9phQn7 ;Eyٺl]y}2d, n&~yA4o :醄\#D'9}sMW'څM٩LjO`/ݨ<ݱ9݃ϐO?|MXhx}8YK!pH,5G<F?J|ݵw׮{|srL6h=^[Y9|x'E]Xat-!1T{{`"Y-131"ƓO~Ҏرo=g>iO8$HJۅL! p%+aQ4"! &c{PyBX|vC7xRFDʱj"œPB`g'j[!0 q$uzfP/3HXkg{9cc,GY2XVAgfi7:ٴodNZb簙ǷW4 3}gd&>FaoMݾɩ_q~%O{h u*3)v*i0! f T>B@5֣G!8ƀB`P}zT! gB@)Z>/F4:&)4!52gPq:>?Th'FcQA93Im9mٖŷkD! dw 0>Jt}OO48e!qL$#P>{Byp2]k%|v?nF˲ߌNv948|#%[Y9RL d$?@dه;ݏE6mi]8|8t4EV؟'1i@I]T:ă4௢|6{}VZ^XRUh b,9cСCѦ9QhP&U8|u`іdy+xl~{8}&gC,384,SEZ.bӵ 'NU70CZ>B7Z-IwUg}RL"E;>ADPx|!)I#t͵!I5l3׳gOb#juV"8>宾je-XDWqvn"O+[P)[@_7ژmۖ6}Ս w0g/b2pyɋpM8*|F?e 0 Na|b"'6Ə"ѣژ̝JM٪Sꑖ}cͱC>tyvp=w㋃ +3 0to>YH)fP5@ 1Ƨ֢RLq\eրgW4A'B`<dT: {yڸ#4E\&cG<XN ƒ={KOc#H1_|UWla>w[=吰^FHa4Byb>eE+R4*om.,84+e vYa' lmY>f/MƧ֞mwFM#>Z-THCkYhbq&!#SzᓙoMxHZ6^g2^Vqs{n\Wn>T2~x_ڃ, 27 p'Qb)쀧A =j8NI42(Ox3YJ/0nxTuܩ8ca;N--]՟'F'>_9yrp7v[ w$|e/Gܼ nuXϺC֮F2*)!Ap[ρ, {3&r˩5ތ`AJ/dlD15 N?4Z>ώesi}n_|~MJ{psFAͺ,3q8×uF[ٙ{p9p }>#<_>IWKqӝPٚɬO4֘[PqH,c3>W᩶I>[y!𯃷v< yl89x8ctzR'hXy[eC s x8 2sf|GQ!x<=3}vY:I4ooq^2WKcgm[yAxҤ`Co&ws=,${`;WmFafĦyQꫝJD[m  b^dc9 6Q2dLjjn"gWv !0:/յ,@4,#XY݀O/ϰ85b Ou(ֳk0C2usZbAF0ygq,|pƘ053-|^)7attB>'7t24\OL%NN%Yv`B.ZKUewB@AB@>~KC!  8fPm`H_! ̝JA>蓃6s=qeN.+V"u9|2M@D*!h 8iX'r{qfl'8Wn}]ekm2f5"6jqqEҶݲtu2g3yedRFL&LqI6` ~:UV[eꂨ`u@8fP'$Ҍ#o UU&ů[آ2 #Zd-)VBejMgJHf"'ek'| 6 s͠LB>9")#؄ FTC>e',' >,#S9"U 6/_Tg!Jl*MB ! hUC!0k(>k=*}qvPB@L ک45]%A(Ξ ȄSSUT!@L!05(>5]%A(Ξ ȄV=ZJ! f͠pJ5! ͠iKm! f͠pJ5! ͠iKm! fgsssR[F@q\&"8vB`P};W !0(>/.1 4:5]%Ah5( ! ͠NMWIP! @&AJdB@A@q* *D@qLD&2>kj4s&T>n!%(EKs٥W@!0)dُZ\\}hmjb{cdKV?/cDojgt?B㶆_st^L4 3}gd&>Fa؂WV^Y\E};v܌X ӐUFV," [|x7TPR8FAB&VLXBe3{766]{䟛)DJQfoDјV`!|Ҿy8;`.,Oݻ嫫ueq[ ikvNºh|q$V0֪'_)CAo;wpZ, eމ!VX+=湰µ5 r_⑛4 :+gC}[yܴ2|73JQhUha{hXJ`} UnOP7CA+p M0Vvg"AWݱ-T!Z7F]1WVǰæ$9 FLكieFqHt FaX@-VYTM7$cnZM8W^cY-DojJA;q s)ȜAmٲà0~bíu #91Ykog-n&SCTJ[Ӆ0 G<%~e'ΙRQTm.9<xt(&Ih24[1r(" ,`m}ܛlIT p 'QS9PF3;iӊ΂p Jhx=Fo|%q;Byb||ƧRw 9lb:vf ,brՐp@ $ey Vܷ^(kVZ>Q*3>3pƴo­0Zv06\Ano|d3,da+,pN|2|<,hw>$U˄Hd3v*MS7H) ?eI ](g.sbشgkY ' rg '8P:W1 ި* Q LGAX73W-)xχ QR'XPo+ 6q qr;(~$`?o!XPt &eu3ӋjtWo|$ ( m^}N77V2Ͷp6?(FF8O,r'C sU=țr2lzOY&f}|>iZی%;l:Toܩ$>ΦcMFH,WA1ʌ`вs%sEˮd90fVȜAefOL^L`2xo#@[T'yRL/ک4}+y`Yqr8XN>5AԄ Ad,@@q>2y`Ex澓POaJn#X׌nf!}aF0G\IHy+܃Z ^]bC~_B`ԂkٻrZ.-%e-Œ`7$c=Ln#'V/-]6]C_ iD sUF9hjp$eҮ e.Kl`[֡ S:d TS! ZD s,{ Ҫl8|48S)@L@yek*BM2gPekbHNt]w8nҲSpkYzJ#F@;8f[jx3SsY9#)]|(D@q "po3_eW&RxbmT۽J\8 dٵ&"B@ejY!0g*qvEcElg^$}n$aUe֞B@22׳ghk}-"[ L^xa\ Y r,gfF0$ZX^wg;׻P/xaaaqqF k[9{O{ve HUXBv~X& `ï[[>{ m&` WN_F0mpA$my>UPH)H5`ޒ2(})JCJ?_GRuV4gc>駁fzŵuACM A s,YN+aJ8#X+.a-J/VPֽi 7#w-4ȴ쭇z\w^ABG݆*ǡF@ ,{S6o3] #jƙB>P(V9\by*vcÇ ARݬT9!|a~*y_coQ1k=*}k ! f gGB@qv! !8B@d"٩ėYbx%[ec%q `e/Ziyer. kܬ%bh ^# ˀn ؊ӭv !P͠&o+F˿[FQί $ix^ZM}!x3߃z~`ڛQ!CB7 q`b܏ sB` :Zҭ MU48 AT/7BgŞB!YO4(Y_?noBmlJ_(D뱐7j$6 ؐ {WH PcV3%tr!X -vQ}-d b4ϾhLx/5Z;lŻ,cn1\"WFRINmu_ nB&b'=%JE ԘAwF_MuN{Nnw<\e['@@Cnӧ{y'[Nt,y;6_{  K(gŒEKrLG) DžB^FdB@ @8;=ur4]L+BS|jZPRTܐUɼ lE @ԎY?ۮdpsUigsC΄m6m6ɪWTP#x€x We@`U]qX̍gd#MiܺvFm"ݻ$[͕4s_PY٦Fr:;йuAY2z6f:THb`T|^MG 3ξ}|f9QC3'KM!0}<{1$;Fk/^Ug=CBv}HrjVCӋFB gB@!0dHB@e>UB@;F)B@hh"h4:#ᄀ  jTE!0(>#ᄀ Ph"hgpB@(4UB@L4qN;]\䢪|/O j*6kY-4ݬbZ$fhU^̀m6՚Ko0y[/1]z|e*o%D"B@L ',.0)&9(^ @gװz#ǯˉWn}a@#I}s۠J<'Is_0 *ȜAYv;;7 栮<`uc0HZ3x|vt07ᷱl(@J]_e{rz~*cږ 4.B<`F;~O Rqڅ੢3 GH%U&6SXOV[@}bqC cF2Yi{fg!7 0NObsǟIzW٫[4z Ielq?C5-dnz OlZ~bCƧ3BQv]yl=ДiJ67VwKSR."TFa4n},GViSOu/Ǟxr`7SykJ4B]2gPV=Muӻޙ]`,Z>ߗL;D y^6 Sbʦ<i=?3lZYvOqط'ci#8}\͸[-<޺;Klt0.[ǭݻC[ 9Qb`cm2kk\@|4Ȋ.uk_S.?1am ̀O39UK@8{a% 6VL-\f(T~*I1g47J9zdfEmTj u XT DɬY+ }g0L5cZB` g7 ˖#D߇2i Na@3j}462g0A@zmǟTsN@eC0$<>+`^p#~"$PmQM֌ Q~Tx33┫GggP-"B}fŖ)ĺqd9s3L "0ژD* ! &fP'U)%k2gP3K*3oVk" o R%pmuVHM* @J2/aC'S(2q{`3KX祂ƛYtRVUA9ҲJ]BCz͠.7c:`mgm 9͠6ƍ;c.d4'%#XRN:\> cؗ/]Bc|d6JQKV/ " :Xa!g_#{@|wPL0~`Y2,#*!7UUÉalˇWӂ@qUX0WF0[@3`rr`eIӌC#,ֵOb.>H,wY7C@9X@C>(rsHф$? ivֽ@u2Q/. P4znK nmNjT,C@8{487tp: K|V@'cŃ`"p4؟GM^Mkxd)|*27q<6ܼ"M|hT gM_4!CR8ʧC2V qc&1YA"KCJST fԋ7kD;9ar1r`b#MʓӺ#[&ae:O٨E׋m9ghyᣆ\Fsg/SM4޵̀ l 3U6OUˈ )=4&PAXw^ϝ|L'WrAudOй+ зMdc 6} p@y%7'O1L i|"-^˄Br0ѐ'^m̜m:)sa +Gv  %-W&pfe4PC2Xul"Wi}qkϼ* #gzƀXt@j@[;k7mon 8{5QdJ9 Ҏأ&>insXֻ4GsF]Ak93ޚ>z բB`\vZ+#X%D"B@L ͠NC! 35jSv*M $T!0dΠg~B@SoKW! 磟U@@qgi)P}>YZ !0O(>O-]g~B@TҠB@L AB@LnL~- gSdB@@`?ˎSO{?>/^wuIB!P /ʍ|ZX!0ȲOA'ID! @-ZpX!0N}]+`mm>NRB@Z|?aQ5Vk*b! 8kY(ʊ|qvB@4C@kcZB@F@q?I/|"g<ݾ׾9*Ӎ[|-ط|e٧;%B'͡uϮA"VboȲOkJn! @B@iB֏~WL TB@9v}`׮&@N%Y9'R_iB`y}{V(1| _zNSwJV! A8FB`*P{,,TB`Y? Y9R_Cܯ>}]( ?sːϮ1#2`~{KUS֣W!F\9A!V=OP$8Hc/5- |ctǎeLjB`@?c}gևNRix}G/Xܺ/2pSedF9պ 2$YB&5۷E8?*͠C*J!P\nwv}-3vZǯNyXhVXTŮKIjF4m^J9oDz@f$LyAIe{#f,aiByZ82KNPצOPJ< Շ"+vj= ( ,k_Vbޔ4ith@C,e c xL[_6/\Q6baᶮ˹#J+Բb>DuXؽU"?Tܺ;pZ kQ]Ux{q:[wKp:nrPw7~V=(!oipy%Eb;f-o@sZdy,ϲza]wYg7TF Vz-D&=`|o6n#lm ,ƆUp/J~գ|&WL*'̉6?N, J W<Ѩ8~+d|bkpn KdڔFyv޽c5 eAO4B`Xt]N=s˻4FBp 6B`AԦEk,5 *C>; 6anAP ꮯ=ײ-B*VB`Pc|6cӝ KsgX mL,= i B111"lq[yé ǜ5mfP 3^G|{A߷Z)J! &soQ`P3Y +ΞȄ}_ ! ƊB+!G=Mryvtfq! h%u;U[$B@!0zB@eoKqB@LB!a)NB@@@}2AR! C@=,I!0uUA!*jTqo]IENDB`^JDd-  A?øScreen capture of the Screen Editor screen of the <site name> - KEA 420 windowPicture 7Description: Screen capture of the Screen Editor screen of the <site name> - KEA 420 window"b8HZtԝqBH=n HZtԝqBPNG  IHDRtW,BsRGB pHYs+GIDATx^ dU]9ˆLg?VD<{fUvnCw38-ߨR]~3++hS%𩴭jZl̨ȸWM'q#~{7rnS~m>RE-+ޜPש)z%]a}Gu6k 2#6mlw*=(Y8}{=qvRWOnf8`.APѤKߥѣ XQTҵ!}ć&f#/7(GR7BwDXmJFMN{DGtb 7B-a2Tm<~a0 Cu <8IӜ1+8'2?OXIg"a:ý4hbb ۿC_LRC=tf[2S}S_=Eqmw}w܋9k[#G<:y?G~mzϥmu/?CΟHsncܲef>~4u1}M1ӿS~_]qíS9+EW@# h./WhXJ-7bE`f;gl[~U<[olm}}_x;qys_wI8oq~?ӿ}7]^ߤ[N[ӎ5~eRn4O;y5A@ DhS= 7y(wacssNv#l(_zCwY/iNwW>ߔ4{\97q|g8s]w]/u+>v*E^Y+˪  P/䢐^ݟN'?yiߪUjZq_?si=[!=g^t[wGGk/N.x:}OKxxE%ֿXqZXbzN1CtO^6r>[.ӘNhN/:߶v-@,/ y&zR}t%~¯3|%gu6գxno/[/Uou>gܽyJzex.?+o. D$P-.[Z;ȥ֏n?iڰӋ)߹;0cXGݰHܗ3TC;~_th>77711!2b;w<%paEд]d :u 롉vzzGw#tJ{Lo-_t&iwݙ=Ҫަܑ{ݤdmyւ: &=~+BtHtt(.}.鸱+]n "68|.v-B׋};*+/0AAu5QB}=DR}7(~52}L6`q :QUBDׂ{%LĨ.CT &P]zQsgEM>  a=| uh2F&V3ʃ4@߰.Qs6&@DW./)i ]Ra.B<ˆ:]Is[qzkP@ R;d* ezyw&늮VFZgmiv\νd/PdP^1{ [= KyG&Lթx(d 3rxE䰮hU,94O'`hфӆ֐I.%=sf"CT#8e^M w+>U u#./)#>o@@F'a8LMjQ?OjK_^)T&¼V.R'~}V\1x2EV|bCHYٗu0rn%g?"  I`#yI5(`A&3^Q @ Iz b"^[_L@WX]?K> @Eٽ-2gטB|ʡ4BP@B^Cl|k^gů;m5$ʀ@Z[Y3 (Tr{}V<#bREW(@F([[>SjkyEtqqI~QEVt&]|PBIٺ\=TzKic>@z(* *p<DÈ>4$gtFz.>R=<{ɫ7l(0D9¬ #2AƆO?]ua:ĺpN_|tvzv);Ă 'ÿyh)9<[݈BKzD&_#~^f+W,~: E,My^_g='4SiܽW"Z)绎:{n|nlz.2{?bΐuRG;>>N,Bÿŏwb);S1}O_{z#9؄GdXb'7Eӓ4@b:ӃP!Pb?EJ_'B?@`ACg|.I|$'r(rN}#4 ėwhLMƩ9sϤ)]ȸV tKg#FY +;y>/^X{ڢ'%op@%c+^ sǓXr]ys>%1}%acKD;W-7NNRИN&.l{YN{i^Cl>l5qrl? 2It(0ԔͨSo<,*SW |:Mh7nL c=xa){mo9/ZN-zrn^[wKg|ᪿwSavy]y+Oz5:1^f F>$F= md]!чSO=mw6T?wNB2dJdO .9-2.nG5v۝*9fh>15A/T~ɱ9ύmۘ4@`z^SSdz' Z8c8ztȼ=HŚsO3h8Ӕ87V$2Ո#2SIL:-pH4$b ]j#;ϊy۶3!!TN"[3W[/.JʰNyGCbNM!l5qm*:I?ug/*At%hXuN|U!Qak~G-Si21}lruk}EM P>nUZNg pO^SϤ'-7YK1dSs4k4 wǧf<MTvI6~hXΝ.qhM+&C9x0L=;[(g:B+0Z2$xN[>HS]I$l1fHe@=vc]4;ҙqR6&]vx l3qc>bO ±%Ga}Myރ?! *< +V_׼h5Tv^=9q&!4[X\d͛NrC'x}Y[WVMR3yCSpHFH[v tHn!axnWζQzvcÿ9\ؤ>.d*nd^Z%k|B%jGȡ437yB13xh4k3VEwiLgt=|UcSkz֚'gb 0l8˗/ξ'2Oys`7Mϭk|.QIt+>kwPSZw挶5_']>s릭\&uƨ =HToyy*U*_"8)"ѥp؝A N 8n7r0>jz] =llTwױSP ]Z\~_xu:ᑝȵy5ML䖠sWúAMVWh#tӒG~WrX4gHC-=#%H1xVl*'Ls\ y xT@,{9az](1L([C HU,*WyY GʨQ@ Iz b"Pۓ0h  %ae K%v  ^[X $ `X_n %ae K%v  ^[X $ ,ߔYhh!Jp MB0 @ZAs/wssG" m&a?km >wίbXoa&a}Iƃ, \nŰ$#AG`(~0װ@觌'e~z AG@tz\ @@Kۑ  hv;Rwnn0ƝP@~tݔ)8z7xau ,xSl}ѸOC@( u ,Ѐ1/_BQ <^nm}j &;=}1![|51]:nbTev!!IbVX"\aXT}CT.4/X-:"hJ{@U뵤ƶ/]ύmA$VC݄GpźE .=T^欭_,_~* _SS}&:.%Oq겘XHEMc}Xp1}D |DHzHBw.\|#9`]:tFkQ@JdF3q[!z<83]OI]?q%4>!멩^_҄]Ϥki,3&vFUw CYW3Y=lL#%&\@\+>y+kA9@e\޶4iQc?ݜ;w&iSSKOa974!}\9ފnJCFEl l1}^ L81tP_(bx).]!P`LÍE0Ev1S>{EmTz9kŰNa}lβKMC LAc:}Wtv;<:LWP,{.gJ&\MЌr\ǞOz,!L2G2DhFLO.[/w EU>ٖae-.:iCuNzѶXtPd`H.ѕlNu\T4eܺc5ϲJZČ\m}zv]IWrB.3ukeX.V(/#:!|(Y!TRoЩų{yE1NwPgl5jQ+5˅z+#\]4C%PU{\2w;Ҁ8P@@`9ۑT_SS7ϟ_SS4Hè   0 9Lq!@B '.yR_3FL[VN+3zxUAtu2J&Q' dژԳ#^H䵽T @D ɩ% xy- P |,if*T'@q떡{2t]S@K*`lqu[|Y>98XiJ/To> 1[fuÁ!G:17{e9<^Z2m%\#;7r"0knKӸzgfN! R/20Zmg];Zrҳ!} ^(xjJeMwFFGdxn-F&-rݪ}f4 YDV9{0oL!%s DL+>G\ձfȠ?kI^}vmNpQA^^4w2\Vlnذj\)#I땣C(lRCmYwUb?KzB_z| ͜r-q=sS,gm}akBP y4\F kGcT'_Q9ygy>HD#[< z#*0:JeJu a:8?j=^+Uߔ=@.nhHKl&#GNp* 6 5 ?opаhV:lw7};?dmZh 1I pwH>$ZwA"'ʕ7[wF0=闎y4  K|"ddpeۑF`?Xe!Ņ-S~fqmA@ DR 5>ˁ2-w@@`)I̋E!@`!W<<fI> [^] +?U^ +{չB`tQL kq1I$*Hr T30P}vi%ֽm󶑲j5}eņjI\9I CXQW?D^ yd5hIJdJ uqGC0ۏw,``1-i( 䬭n$8ue)A zrVS$֤#pg1|Uaɿuђݘ ^2kX~/j< ^99PBJfΠS\r-L_ϐe^$6̙&Q AtFa!dFr"eiRӟeegEP& q:X򨕉\?6tig/ (3$,iH!@,*K xZ4ȲP @[h~DR.VԥZAaJ2-+A@FO-A@J4՗TWSۖ9R+7V2J'D@!jZȐ8a?G_wеu3Kvr{Օ2i8Wsœc$|kHP Q_LuavȐR2lX[糮9+ CtSt$($IQI҆z[ DsS}ykqs:'`0;BDcI <IDPB(SuLYM |Gڊj'r2Qn294cP7dln |Enf8k}\J Ş1diCZY[矨l͚9Q$[l0+v.߭g;AӝdIs,6 p-r 2jo7\}rG41蕜ĘWD=%\DI˸qs$3О MLxE7;BH."#OCF]FsXVFrF$u&A'd-nISH11])c&\w3Gi.Љn|zQw%,6g>9@cYZH%oB(%r<+Dg2͇8 BKJ9fܸ ^.r"RGFk>kTM>3jRQu>&r!]Og`y-rNd1PQf=s3~q+Nx*sWIEXLԖ$u I 4ǵ9uEغ,8LОeZ~eLT3Xo)B&,|R#na$3ϫ[c,֟8k9rֹp7gDNE:Vs2Ʌ^tsBl}T`HLV]'"e|RJE66z@UM<𼪔^((+)Cn]>gmHU-0F2 uf2[ݣ%i IҙGtoG⭓i&>!ԝ$J g()Hw6nL>,wY, '¥2dd"L+6$VbCF|XqΒvG"VÈan=Fy=%cZ@Rtj^'@CS}5I2ַp.0rpo4CȽez0Pͯsaeřrnb> dT:൯>+AwG/TY酖@@*ȽeZI8**뛳7~91Yrdr\&2^ru.lϷ.YRzxO.&Ր17/5N>M`W5݆rTԫC@*^[%gm}(0Rio56FRhr#RqjqʡҜTrJjd.RIKZrDD4/]@Z7ӟI9F85 !xuQ;(Ӑ-WkH*{Lae92j1IV!CY5 qsBig3;iKjrġ:*g(l+ԿZjT᜵[\ߥLIGdv!j'Tg+73@H\Mu ě!/ MS $)-)GeX J(Bj 1쌦-w/q59P9co*CYn)h~ipJB3'ȴ>^D-7l/'SWIj9b2&$וΞOܜY9qs_j[-[ͪ tx-ʔ)SN H&9O*lr:o9gk;+c:Z9n ss1G«sɟ2dI&+rF,t%WzǑ, PhTĿ#dTHj>9#_hmX)HэRW*)fK=J`?""T_YP@ro%@Hչ}4w˯4^*dc3A2A -EeKr! RCWZV*+ /\bm? Ƅ{TL zT Q0PgMKr2!o'ʚwMҒa X[M4>F]Lq_Q2N湿e L"QG-rpw%,KR-8]!9iC?e*ZP~Ce\!Ҍdf>V/bi@qtӧU^\jKФOB>ssVG^e?i#cӋ?|!;! k}g^UY U½V\dEˇ<^֗H*%H $6qF}Oz9͙<^9&za]M]qQn7.sC0٩F3x}i tvdrx)ӐL'X-S$|5rE3"rI#9M*kd>CC  !PCB^Y2!Y  eTD  e߶ Qiަ4}Hw4<`x!4 2}צM MNNn2sJ z> "d "޺;R!iŻt4r_I(j>鸞U~[sK ,Ƹ~ܪ7=6v<Ͷ}Z-s[@ qk~2^}9eWaqM3S&[L\F_g6U~$h7sv$Qv=sYD`p#6s aEɀ1oGcQ$sƢ g翿fkڵ;~v:+׬MBeN1 ̑@1E_ZmʘIZnk(x=bTCm4ㆄ{P#r;H˸4P`W@=3Q,Cݼv 11/6']y@|yf+W^fU 2#M[9#1$AաMhM"lۈ }gBn;C_X+0 9arcVxv:ar"6g]Xy!L41zc]@\9|N?aennhsn& iSzԸQ4ީh!+:]P ?u1!v=ۑF|M1d.Ŗm[og^;iLJ;Zچxޡ//r ;$sGq8Iwa}X!@FFK.Ȱ!"3O疰3D  'a}"T'0;;wy_,8V  0b7is@@:6P.dӱS/j D~Fc;-@ A^a70"@@`foFa}@  0PSJ>\Ta5vˎ°>zh@' /z!@FLfGs  0:؎4:h @$^{}%$dΝObX2.өg۴iI''aF ),`$!@DzU@@ &/QS] zCfRf֛*h /_~R2^$4sl $#8 I/͘Nu  ,4(#5[@"h;Ҳe*077w_ ع@@+5k7   O`ܜ_%A@NL  `X/ A@07AP@^J@ `Xo#a/pA=(Gȳ\IENDB`|UDd-  A?ìScreen capture of Help Screen 3 of 4 of the <site name> - KEA 420 windowPicture 8Description: Screen capture of Help Screen 3 of 4 of the <site name> - KEA 420 window"bnS1BUaJSMG=nBS1BUaPNG  IHDRtW,BsRGB pHYs+RIDATx^} GUfwEQt,% 0$v5 5ӡ;54Ay 2#(y ȌK4Y0$qp߹֭_>}SkoW׮}vv8םyw|/w/ T+jfɐض;Qy$9l8ضKd$32&SúP uě(T*iHyK'j&){S/G2hc=z=CMV|lQ?Dc-2 =An¿Z^;ͬMmovXtZ=owz8`L̺:=4̺ѻ>֨=.zsۿ-p?b]/]q66V66^b便\ ! [n)ۿow};ǎ#@e/.?񪫮z߸oKO=;;̋__IW7l捿' o+.g?g>z =no}sG_{م{K/|ܥՏzi=})(x7= ~΁=q.޸sk{y\<^th9'EV!]xg(pϿ`B>g>Vl`7^Ǟ={r|+W>y'>uob}2>ú~``zWc>܇q \~G)\_ !適y[.3( }-6 Ouo#b]ו5o{%9녯]Kޟxاo}&S}{^7O7o1nq[ǥuTy! @tQuý4f=o| >_g h?e:VW^aa?/t>/m+Ј[?4i0E_~y\g>0䚺lBY[//#b~:{{ ({g:}=A}]]o&/z"޸k;kCuD]S:O]Bx|i/G>4pyQAsWΛOo .0>aqozG>ݮB@!Cl ‚md?~/"Me:Im7Z 4Sf]f]f)S}Q飣aͳ΀]m&Uk=\$wg۟yS(l:k[͇w&[[l9yl!md!1[h9<{:S/Gm*)Ըy*ݱ2+ `)WPa_zwۉm:R{[6LuqF6$1 @ qoCףLdpo伛#*gUB6}޵^F^qX qFP@B.y6<8Z! T #慀B e+kSxŌ$VgB`fm%xI0Vi .QϺ$~䐥 !&W8iwp@f=G5*#@>P;vn1>m}XazEϓuW괡l7:e.!iN{,q^\xg *kT%s|N׵20X2sQ 4 d:n Tu˪6)%,F' C7+(;{wM/@3Ju#Gnz3&B7I^#iRؾ#>K!!;at&]RtQ]߀0,Ќ0mGYܩ@3TK!Eτa \G׮TP0tZY 锽їqŊ i}U%[ƉUȾ_qvoLJ_}q(RCd2 !Pz%D* &c$xB@=;?s 3Λg< }~ȧ\&?J ! Pl|??֜׃N G)2B@Tl^3fUw>o*nlnhLޚ_+z.-ޖKQNS/z-+@d˪` #A?F np ~`_N:CoODWqkp59 NL!ӟСA^N_B9oYR5tQ.^]uaU4Ȇl=莵U4ch 4)ao7r]<"x] GRO9/}uϴY=e)Pk<5/O[#ǜ'iO Ou!+"w]󲇿x}o.|aɬ={ euyn{DE:seu /]}{{#aׯ+!",.?0<:3TFAF5D.*71t2.aV'`,`:6pݷϠ+Ќlp;l:p|ӟ5;nw'a'^4RO:|3p𪃃ˑ(`ğu"VهXw3BMМDyVpʺX"(a?>ok(Yf!ma j{hslË;S@:f}iiu=066P`~ Q`˿* <8}:|pe2y2puϋ_<,:kk/|w>ѣ0Y gtw)']X> 8pԣFah2 F.g Y'ՍMG{_ͨf ] r$2E5LX>=>WOO7|s6?}ai_=wq83U) 66bGscݻNç\ļxà yl،Hd.fQ0ӝO{(6@^Ĵc}m$!—I{^_|G00dtiwZ>l|!`Hؽ@)QkfI?Y8Zbr@gc{ee5h = Wغ_{륞Y?on, #4e>6ʈfı$hprž<aQ ӝ̮׿7|nwQ2&5bVˬv)K\9X.? @&*&C3?m|bׁijm^'^]DQ9NG!u|8 @#@Aش{ Χc딅B&"잰lp )Tq-&{*sVP( :qpßQԂ)oNQ:Q]v{/,G[?=U}#|ڵ+}GOOOOm| Do݅/  6|r]@`7KQ}= e).G78ŝ9t ]Gu#D, UGQln .ATVm%68H.z=hE_(5eM<`Yo·e=fcۆ1f/PwY -;ܼrzلM#h!X Ք<$Ҭ{PCt EKG^|YYgh 4؟c HU4f*'`O=rݕ/gmHk?͜0V+~:#&rVD:_@KfʬĢq.qj * !Pz%D* &: 3MBW! " >dB@%2sv -" >dB@%2sv -" >dB@%2sv -" >dB@%;2s)B@ Hpy&AA$$B`&x;+93!B@2.$|k뒋,&!`'`.~Wf}.kdZ^C@f}t* \MP|zʬυ%Pt_2볧kI$#2O_ !0{M煼S$B@ q$u!  H>yW7uQ! t#O Y{ ~".^^r4֧FbT!pB5nʬ! ۿ22SK1*߹[f^l}ij"|^bpzQ+i_-,\ޟ,*kkgO(:ٮlyFܽCH* e2Tg7Ez۵T6Nh GU2Z^za6lÄ\bEPXEGun՚[g76Ov`Tpiiۯ/[VBDM.F~X$r˰{ V&T Xvפx-5lHxn_zC]֯LfO L6]rysy zfCA3!bQ6NӖ^Z:iOvK];]=/CU ZDʦY^T){IpPa}E+ZTA9T )GrAD^1Q,F+wdEԇ=ݲ>C:++҉V {u!31 Q:hw_ƫ5B9rb@lOrGg<6=6dD]Rz,bRʊCQ ::?zv^QO,JH*)T[)׵aps ~Y5䰗#ZZ9eB;Ũt23<ڴa;,MiZWϤ f8frzHN[G{Hh PfIg^hzSa3_D\oQvIHޝL%|4`;܉ jo߫3 9lsEwH@n!ϮxZWڂJRY&T}3TC@[T&=`sS:oS+uW4K\gl)5'3+CH9LzHh L#e PkT\M#ewLJP{,U)v}oG~ĖRK ARE9{wg5)*njC쉲MQU'eBѶ*p6`Gk˴@ \~ILefpEI^? gGs2>/#}BOх(d ߦY1Ej9;a >A=YU8[Ǣ7}ND\&y߆VBp=0y%N]ɰWjl>)\6[. cQ-k#Cbz}otfAB4m NUƆQnlmԥ=0sR:R}sӱnSrHcH`^0\_}ɠvnSwy}22frr3-`![Kl X|5EY[rє z6`ᤛΎd {#d*Kqq>4va޲u'aMl7!D6V۩Q`aSYZ>;Jt:‰gR+5֣Dפ VO7-YjH@1+W-Gs!Ms껵Gj ! @r#pB@ ̊P˼ᐧo]GK(h@NzK Q5! f [Z[[Lcb%%3_ D2tD fsA {i wd)UB`y]s}\,P:|ś,Zu+fү,f UF!G^t6)7 k] !0˦2`=sob!b%e5\,kYkMps8Y]]>!f]HP-! f uriJx,h-knjJB\uE-HgkI!0*`P*]C4eKbp")f(`Uh==4HeFK>R?Z6B@! X*kdz##WM"$5[?r䈫0ӌ'_ dkGBa<.dQCLW(Aux<?%6iˉˬҋ !A-V:HYVaDaq4ۺF%Wr[P&?\\5||zY})72MyH~^L篟Hb! f-δz%6jMd #bj&^B@G@&_GP!PT_[;aen;<[_Llr222Љ""un+m_gex7A+X׬&>+w}v@cUQ!99-o[yrʻuuw2e4Ꮇ ޺7?nR#\B '>X60}y !2+F7ݵtK-+G0?{Y! fQ2e.&W-NĂX2͠M{}! | Pot4 byeGZB`fY2UQB`Pױ$B`kB@iD`cӈxB@L9uD(Kl! qJ! Pl}PB@NPlS8EL!0n[ԾBS[NB@L 3 ZB@-#! f -Δ:%B@KB@B@K3N #ȉ~Oըrɬ?ΨK+lIm4?xCue ţF#r߭7%M=WY<:ʓ5g mYcv6Y\BB< 4>ǒ+$Yv dC"w6 )x*|š@Nloy랫pՊB`qQ ! &Q,ND!0jq $6@UB&x=%M]/{`:@*wY7-GhJf1h%~ꋀYx;8ST_ T}7ydk,)0g}=+xCo}(utdgMLP6:HT0A(2Kϰzگ;(N1+/ E=j~s7+ш"H&)XN[ƀ7=] 4[ɉ2#dxNewH-Za,/8˾%ժ(QF suaLOj6$*Ek2\ִoz3sfc^gl8{e<:QnMʴZq%hM!~<.eldgߺSh#'-9:ns5ܸ`qd+&uЦ20Q6:/ UES ِr:A06%>t LAR.b,uYcNe}HfZM%@v? (fY~QwNKl {~/H3et8MycJ,b6ݡj這\LjX- (ZH%9+l/ յq)sͪdٞx`(ź Xpž ^zhO˒Av(p蹃=ap4X_Ur_:;Qsx7r&LԢhljV#xQ۪xdiVS˶rme &рL+Ѹ'fT!b|n?IxF 7No1`'Gp{̥> X !AqjZNQ,129Af7gePO5!@cƳdژ]Ul ]0eX&T]"dvx%TB@BHsB@z;aƎB@ r0׋L?u9%fU"$䚙^@wkM43GKkե@@UI[ǖ[*~e=k}ǡ$[kc{>R4\[4|糤m5bo=z.a.ϧ6%uoLoqOoK}췥"e0gx 3ѼE&e0C)x <)B\=`Zh 60GOq1'!lmwfH1-E 'j' 5\NطԵ?Zj )[X?gR}i6OW>֞sT;c̰CȌ)=sD6> @{Bcz߷4:td6[v- g>ʩJ^,&H ӘyؑcPe2@0&t;Kiq#8n?q]沵?=LMY]L#9[֙K‘9P˛a4Rf TkNʣIZ&di X/KI([2 }[?{NOp2e.*Ќߚv`]] *SH$M^/Ii,Ui,՗QN,fS?2WޗL-E-LDz2]}4MOMTFw[&KM{ )34ݫS}yWzeD/i͡և)"i]T2B@E%Ӻ B@A%6m]hV\Gz{EA! ȉ ϊJ ! @{zOnL^ZR0*Ftb dcn;WY1P+\N1]+:ӈ@Nĉjnwr {R=+_ &GxHNv'Ƃ)R;Z"0ѰKU1+T_^]^"0g ,ly+]'ъ%~;~;iR. xG\y D E<0lq}/R BxH!U O{ۡVwIYR9 rbmuϋq}T_a,ʖGckyGX#J2az귊d;$*Zm:xhR}}r8 =^@Xx,:Cu< ,L1ҝQ[uVwz%OO"Eė.wsɤ7kKfNLi?-K52D]p^ֲm"s`M#3sa+bD3RiB=LjJN,ط^/xF2Efά3,*?ɡ*(8Sw('$$%4:`%;}Lm&#<[/+/Oc{;TD68!z?~d!`pxJþ3uScTJjl=/嵕Ŭ=Ԥ0T_9"DS}@}/TAs+X*"0HIX7՗+Me)]/68mOhVveX\l^|jOm,]&o4FWr̦@B4W$b TTt\&PU@K<.3]L>X2|ġB`fŒ̀5ς4}3h]Q"B@'9턙OHj! @zO7ȑ9gYkk@ Pm7u]Uݦ[H% 0Ml3o"Λ>h>Eϔyh{rs':ޚH%!0T_yV ŗqYӭ+d]UX}o`,[[ ۱߶7[vkE!+7 #O _bȄ-§WXXN `;.6:jt1(}Z@s vVHd"jɔ 60p4iBq<]]p;"tHia(L[@AgCw*SdjbwL {Z١|X7#<.٧%Vf܋[|eRxYLrR!NʧgK,~M(ϣw4Q;'Lz?dS=M_@̽O܉@MI^ fM[b.g:I&Drb68NI!0[?aqq6?\)WL"qR}yT9ݣ9zK5%@N*Ev){0D I6c,82-cP8vFB`T_nj߱;ě#C$_䮕k ы@zObI!0[mpa$B`ٷjg/Pպ8R?:xn_Acm7+TX'GtZB@ϑ%be(!)[ !0(>ZB@ϑ%B(՗zB`jВԨJ ! rВiJ*#d:5B@d! ֧FUbT!b9(B`jPl}jT%F9(! Ç_qS#BŲB9\|K/wN6W5#FFl}isFAޣ uΉ ! uv%9.5}B@C`+,2q߲ط^-R2֭o9bm[y\:ҢB`Y22͌6tuuvn7.ڣ>yMO>@pAJ$a.yӥB@zǑ1 ɾ}<m7$v nX5ɁkY}YCfZ! "PcɔFFvkeenxK"[WE! l#Pc4 Ua[:%p|WdEG!0-ԋ{aQ]/%Mm͓wlQ4M^)2B@D '>LnjNdPB@"p»so&O}klIks@@x=saL! F@NlAﮯ3JԖB@4@@*B@E޾ɕC ! @֥P! D`:vd bB@F gTf}B`9$>S*0B@6Z2mJ:! -Ν%b볭_I'!ܩ\ !0(>tB@ϝ%b볭_I'!ܩ\ ! 9hVME"w:aNZ!ʶPºflb.ƏWBys@45!Z"0AKWWOo)Os yެꈍ5iPͺ5-X[.2`o{8 >b]t@>Y2 ]ýfq(Y[iF=:&ymȺ>4 :פZ^>/^]RfC Zo0X #v',j9r',3:Q?v vm ϕmhn29̔"0%ӕKgcl (S (("(C q㎵htp|F=Q@ĩKm"'&I}Y\2֝?E˻ ,,\oJ>gI0fQ1w>I2۵H}iMe"0%SpMv;CqW;/lW!{l}*fu$ޠXh F+nK)tPU迃?yÅ'Tļ *B`2=]y\-'ԅ;p۳TsYppB[=d',n뵼uw gx6 ^aT`=-]$Z.C!c qsHFFb %֍mB.₁ ;^|K V,rN1t#k![qF@qb "WUcA 'W\s¢B@|]x7]~-7߄Iw RGI%B1sB@!c xR! h@Nl]AB`he{D >ow٦'TH6WH<0sªi!P ޏ#b+K¶N DڴU/)2d^ՅŒwQ!-1eo8̡sydi+X>'yM>iZy쮦I<3Ul@!!Q,,V":y3UqNd)LEwS x1-ypfjyx,e; ,m9}^(BYaRtR;0$΅!0%Ssxb;lem7ϔ#'9vSt[t*N)4r )AwbpjBYV9FnNbʰ"Zf3^F[O{|ƇM`S /c@mP罦\Ő=sxV !R\”UawM/m5ZOR}6GtZElX0jsef"&AMDI-7|Fnn,{P%Qf)ʛ#<;C2ҙ̟g%T [T_Ŵ`kEct`b6^B@: 6]03"$F '>z6V*(N{SMTU)@, ! fغ )\! 䭫! QG"8ĪB`Y2Ufڵ,#FtiB@"%ӱ¯ƅ]#z׈B`(>VոBk[QB@ B@tb]#*zB@"XWB@q H@]m ! !%FB`RВjF| ! !%FB`RВjF| ! !z#TI!0(>_B@F(6UB@L*OfėB7Mb듪%hb`S%! "jF| ! zC@zV]#%Ӯ=! XВXWB@Вi׈B`htq! @(5'+~5.ֻFTcE@¯ƅ]#z׈B`(>VոBk[QB@ B@jS!-6M/.-]x'^gBX4~Ici@܁Ik g ’-7T+nSX\vr&wɓ0֬M?D++S}֝z8҈uQB@tmrkox띣 B@! aӣ^7ǽN! >mH9a]}!}gPP'eZt#ComSf}d!! @x~:[RGEZ!0zdGZB@4G`mm/|)&Qmplj ! F=ٳ磉FeG5'hi..@AB`$~FرcGf}JQB@ahɬwH! FG}uB- ! Z!?{3JEf,=0O',<2_- ! G{{ ~;vH:#2\]Y36꘍6ai鯼N"68>)(#ļ7P5Wܔ^Aih;?̢꘍6ac㵞w! "d'ȬO:"g֟ox{?~[~K@{bl! >SӉ_P_'+]ө W l Fkө*[o,{[ [OW<3Vz򓟌[;aVWO/? ^9PMI㧙 PʊU_]]]^^Tb)hEj<^(ocfxiNnW} q+YC,`$9^'۹;=(Oc/×=vT>δ8\ g!!| u*O {TNXӈWLVNǂ"9k r'^ű2kzZXn׆C!5e=j^ 1 M PvNf-cg[vJ mEmQk^̑#)*Hzdb[QOkى*_?͝ǟ垃|Е=99*e?H<*g,x3ּ㕕K0xB.H R*  +Wh *]ϊH(GMx\颀Tj*ۻw/U-O_Be(?7D,zzlPwpc4PS̀mtX*,pY*'6 sf߳Mx{)`<9rA(ۅh.Ў P|:Q]s 9=!GeƏn#u={^ gKKf+ :tA:?k-XT] D3ܒZR󦇏n-S&#iRLAʢM4TЌ-j޷o+*޳찛,Uj3\ (MvlQ\ydžI2Jvm v*I ey9|gh˳5C8=F+mZaBHH7+[2\M= ѥ;=*5@)s=st=tglb\Q:eG ءGI%R$7^YݞeIlryu}{kXU,'g[l!uNt=F07B07#׈@q(܇evas@1ݜ ,Ds( Y[evj'2D[*adIB -$3)lEb|TXVguyv{Q&hmU6XwoNt=FOu`!턆w`Ewte7txFp M/ %0|Ҧ:7!HJ$e΍\x+a4Hҝ7Id3`0@P$]qC-,gJТL%zq1#k&V;>cJtgV)ZaMtŰz`n+-6鬊D%M449N+>WM8:l+5zѡ_ݳ9LT5XD<2:>_Ȳ MtwwO2z0? s )fT0+p x)GݸMguʴݜS{QZPLjL7q!zscdufp1̴M:$mLJܽPn/ /?7@n*:Q@jUB3QupE1c,/?r{= RYEDD! FNluqjN! C@e! YjR!2a+B@1 >դB?dVc@@f} I! @Ȭ( ! ƀ$IRIENDB`¤Dd-  A?ìScreen capture of Help Screen 2 of 4 of the <site name> - KEA 420 windowPicture 9Description: Screen capture of Help Screen 2 of 4 of the <site name> - KEA 420 window"b;kW1x"\uɜ=n;kW1x"\uPNG  IHDRvҍIsRGB pHYs+IDATx^}TMA{LObL1A@ 5 hL{o*ufggX4_/d3ws)ë! HIǮOEE1ͨ$~Ī_sq k (+8UMw8N5EoI~E'̋8X/kxx[˲dr8s|>͟GJcs9qmQ290 E]sWU6yGs8/$/2ݶ8EŇȢHa82geT-]=Jܶ$D%,~k{e>gEg?GCu|fw -GL':Ǡ?d"$24RPdēcyAtLzLӄ¢ V<ua_9;)qDYRX]JptE٥ʇDd!M4G7cZpAvuxu3Z@,=V,R Ɉ$E!ZS]򔺊}ErrQX ^= dP86#Q_isXH޻kb-'c抾e,S崾ݛ+j4](A.ekl8F*-Uz|?/b+:|Н[#p[ogzR[i sqoޜsҝhO_M*ok7xg~ci;rΚqn[Rd_X_l aׯO8h`ƺOY2Xzb >l93:xz<|&vě-Kl޵qP/ 9O3|^>_)gpC͕r8)z/~߿pl0=U̧[.g&Mt#6Ws@9 `AXuQk$`P,ٝUSGD;eW\y92o\L@gxAwL35jXG}&rҲ2RF+՝m{^9Io5208@lqˮ5vdJ0ɹw.z7ap;=~O7eM~QNE됾ωa߯I +.>膉Y%.z T47^wO 024 cӦo-b21 ݸ֒%}w{ eEtK˪,$!;3݂ !vя}]Ԑ7pX́ſu9 (pT  <$b_+, XR5]3ŗKFG 0s7^se腧D3.Z IP دeQq.rM+%vBQ GODu\\\%Lx#ƍ?lHMq:i#Qe~捯 *,ºhƉh8=ܼ!r)֭v]l$BK}.(6F'%JӤ5_ܨɈg5j;G ʺQVgD%B V4CYZg8Tē1ESYp-[P2Q6\Diw}RF0_PuTJA`Aqē$>;jY&տ1~+fM#`p#0~Nح洓q$0T-37wDÄ%JG# \*5B|P"U}<j{.n=~8"rqn8ty`w}qau8ly)ڱ}#/>MHlY$I{v}ͷeYQ޴SnҒB$;'-sкyv=75#DY=zhZ908JGbx^`gN^%#","'mQJP%Jlfo616Ѡho@t'8HSLDï {<|Ax:7ÁK_P?Z,5qA_JJ#?EC|$; E& P -ìfuyU6şT*??~ siA֛q-!\,ʴ5ޡ>3cnKZUޱpğq<"eS]56Jt}ޥfqZn ecpvk3CMK#4&o>ׂ9,d֭`Zw]f5f[+#D&J@BZHfzH?3`e]ڂKIKIn w2'2w,M&h oY}2}gJc,c}"2Y[ XZ҈fl8"8?8h0W%81]I;L%]$- f#+ɰ7ы,6`/-DdaBHb1eqe87kz^۟ldxF9oйpjCab'=%lZм#^b9]E\T[EYUDP* %Q7 V W3lel5%`Zɕ@b+?GkGHv蚦eK;܂Gd#dmSlHfj=b3ŪM3Է ۽aD^iuɬL9ok}&@: nϞvt0Njwuikweg7~d9Wa\G6u<]:?G^ z@H BRx_m=VFdƋmx)BX)M{JUTԴI04`2!G0u*DɗMCkU'qEQqQLeS+fg C*睃6%w0)~y=iozt2RY dl3A{:ܞN?l[шMՒ7t_1ŭgouGfݞnuCֲ<8g:JqJjY_˝;\ϖk۫dksz p7r]?\H|vH/!6 6>JL=:D<^r0T<1#+뽗 μibֽuf=8:[o{P-#0Tj}| 3 |'@#jfqŲ|4)H.ڎmGl3 3D5ofFr;27)cklᨭu@-\ߺSYkdl=;]2ḳ%naLkz:-?;6G֧9qqwzMQ!e~bϤ@buDlOl4- 2N [ 95ůֆ Ge -o%v⦍[FFWqҌ3i0iChB[ai)J,6KVӺV1ڭvX18AdK/[g^ٝ.L&շ][Қ'mۤq ޡu2PdOӵ=ul؁f8)Ae˶,&PںMK2tmplnվ5>cOS]آh[m̔9H$}ek-{!V-=Rva1n/-7kGC٧ԥn]~/sr`agl qAPt +Bbب񃆍=~cO?:f [ e)>_mpDzo#No.ˍu9~…W XjHH/T)'܋\Dސ%2=TLJuew{kܤxcyy[qS Vo\/9XyM"nҎK:f/^xiBL[0 N9n#0'/~-/EPWwKeܻ,,4+j@6 RVd޸`a+ 0ٶd#7߶no+dMud_;4vWmZf}ZGw޷㑥ݸ:4?-S>tV{#=;޲ߝ^OaywC^b:"GK`|?*F 3e?Wf[졮h[b7tkp=!͛&Fz8}7q峅݂`f>w3uuYkoɺ40:?ݹ&J"[a&oٲ `0Lm[6_~1Od M|7數SeUO'4hQ*cFp`,SW\q+6cիW6ln:i>53flٲei6o2lpI&ly;E NƆ2@ ön۾iC=rESyF5t 'o*Y;s/XcF_A˗-m+ 3s.t֭C YhmYӦxiBOƍw'~k׭5rȑL@Ns ^ZxO~ v՚yK4cg7c~v+.d&3sFl;c92y jm^y|QѨ~yF6[36L=LڼT2! 7󋋀Uk(ܳƎJ>6P̥1ǎ4B嗞}i%.~^}gvN>!$̰'浿%-Rn.uμ|-oz|]Vwi\!!/'|9u+lm\.ۺvB7z4nX>KX+u!$' CǬhk _yްE]dZVe #'κrU?E~GqkBv6GSN6^6ŀ/ ϟ4nacEo̺j6hhrv̓B\6cq ī%IXHƋ?w2Jɦj'f/#:_-C-_t5ß?.C(ڢlxުͩ_ &#ˈ4@N$mټ/BNJqmzMdMb.8O);];ٜQ$܄f1گ_]ailN$Ugq[L}K7oYjG8n$ {fc3 3j"0O4$P+?cY/su/8)g6{ 64 UŅhaC> fʔ1ȑa 0D5K}A~>;Xr5ӯE zɪ*{^Xqƙ3]kyy ϿqF72)ާw/;}U/<}YG=BMU#0??c'ϹM:[`8#;CQuWvMxe:>{1|[E:JzSԡe1SK/̂ZƏȀE^ M [+(`z(s):E13c=_}H#h[Ho Yg̑`_oߴ>k5̬#2[sefxۣΣ<Ń?\}v rd^^~,?眳.]䱩PW]}X$ w˳񗣿-tx/ pi ,/ ɰ4,! NX] g!%ʎ V9X,FBΏ`8 >{( B[_׎wu'#¶gV;:/66d7@P)"& iHvÐߏy9D\dH!0zש@p0f(EG~0<2E>`X~BkSWgHϳuO'ea@ <AtW0A8ЁgA_O3t>05GcP ̄L[/#q,IujUYq ؈7 2!36? < 444@Bd=S T^>@$k_@u!a aAl ϳIDQI4)Ed VPUQfNiOw!K@5H^^7_k*ٿԴ#m[kfԾKgW;}z|N[|D0 H=#ere){ ˀgT~Fqغ``]eg,J[gFf.٩wl}흱u82bD#$j:&sD/R4;PL Q*BIa1AQ>a2:&"wSi @OMFmXHcRg3LǗ;٭vnyz4 ܁:;G;?ΦRzbgySOd f3.fEdW5~\w?/1t4ei#=*BQDgS2p}64yF-h04Ð/=E4z2Aɤy`ldhLǰ9x{6 Q_zQ3p! ǾB ܂_q kвPUUɴfG-c y{X^k>AÄ:$]`w}O>gu:xs#p^1Հnim$ЂGCG#ű;zYSҢJ)yfFK@ǘ30фjH{Fu lfbAq,9t,ӔhO0:6skDZrgJ . PrKN؊` [ϸ[umB~rr)G ڳuZ83Vd0s,Ndžfd 1V?JbhlR3khۨ`l A @ #ni1F@ &T*1;\{o^pm<)x=9.fͤ3\ A4z^$Ty%cs4^ڥ [ouWct`X,$IY0]7X"GpŽQ,ᕸأ%=Q{#N=T\ ن˘ dH* |k|؈q>tXMdaAe%O@@( jT!~صk"RY:TK]tABp}1N;W2f%P^k+*ˊ f A} f-^ݫU}fF^ ': $_1SڿKdbF*oX*f$*,m! "[ollS05t C'BozS6eӧzRnA~_࡛?Znҳ9o!֮+ DBLoABL?묳==aOr5UUt/uǬ"|7/*eśZG/ s|~_BlQS6L?}bK4L xX+/g6mC͜=_K7^|ymܰ׀Y$!L{I@rP_}+lgڴf A ` )8`{8'YV^p˞={|s'9o߾_\}*oN=aaf Y6[j~ ή*H$t)Jp͠>ݠdI'UVVz瘛n޽d.T@x_Y/\SS}p:'-Hwx"կN<_j=/]RֵMyYI"<ʙ2=4m袅 XnkwI߳2z:IVƟ>ឹp-'OJz8ݷ)=H w'P3$"5/+~'kV-))`vx?wQ0{^czNPNgܛo; ꮻf8.R>3a`l`z'mnC{7V>P.?݃kVe@λӯof:hv/hX6ZF"O~/z+WE9Xm`Q7M޽{cm}++)9u Azt<`^{WsՔ+1rk+\; _ 藗_>mʕw?4g7N=kOO+y[T^;q}ߜ &Bү^A`CHL3L#8) xssx'׮g-TB{^]^Vlz>aԳCΌ=!G% 3%S5KP0_h'7|ξ9sM9L89 7oʋ߱ck-+tcEă?ݵWᄀ< E/\Eݾm;:H +O6ھc 自;3|pWMͧ6kaiCY.hˮ io }> LՀܧ(%K/[t%U[M50e_yL_^0͆Owܼn~zݶOv͆GњJ D߿3+:b lڵMMXΗ\~EeahYܷQcr:'$x% zC?n^Sr3/=nA+0ɕ|>g;蠭glFdEu5PP`v5U'v_?6|DNhV5D -EwIE^V:DdX")#Gxwyo~s-^=H&QhWmP< ŕpC |'߰a?L&&-,`^0-2=n% V jՇjxkThzإeFʻu⡇8q"EUUu(/k[?;ꝷn >%F)wS "pV5Whŷ&?QZ%Tw@,2 JʶcN8E+ A* /_8ǟغK8lZs`MM7,]C[nO`I#23UWPi z7zkyY޽w>}׿ 1+\zяK0/][޿ 4"/': A B_\6% 9fٌ;5WoGo|2I.ybhv9GW8254+ͺiN)ۍd*/T~_g}mv÷vѠAc'qb`B]{?w/_؝3 {ښؾ0L{v޿gŋ?x}|'NPmmݲޫ*+-=`8Ƀ>S eBIM4ތ?ۻ/tw`57ƋphUz믿>eՕeyK,iZqQ믽vۭ$&X,0J ΈzQ10|ë@4*:Mha5$jDoU&PA( ps`@>[4N1q;m6LXKSsI =]~K~“)W^^vg@jܶPkp{`ʀW4i~`bd?G hG+KK}t $k; cG??qБ#qb܇KXCF.wuQWW?{+m݆ (*j,"{ &lp"I=OPwtYa <;O:{ºua<^D@=h4j5oڴ媽pFfjL`0?ȓD5OV=3{Kt^^KKst2ę7ZcEAF %Tvvu 9o޼5kV_bXWǏ.BA!ՄOL ,|3soE^߳g%K?e"(ڡb0/T_[o N$g߻db0M{ i[,x[ӎ`A fmۆv9|=Ѱv0 IO&|vK)`m4=kxgf&|!:P***`[3<̝(R0\F&DA c' I=_1(#GL<0„ A)؞-[6!X_x x <ݳ?i@,oI4;wg~G~'` %&(QE%G0p`U]{J^[( ^ nRd˗ǩ 8ۛ>af ś\3_栋s?t /F[gg'z8VǻYMr`ȳLl>mьkpE"H\ iSo_!2mqLXEaގF$TT1C,݀|7l؀0(@aA! Ћ?\ҧOoAO?REW pߺcFK]GK>`I_Q;쏰ҜD _VVvqhlSRXX eXdN0n,RVVxߞ=u)0g}gL,654"PzD&"Vv'CӷLĿ=wsoB6:"Jid$*2|-0P0fPF*xdp{vF!A~~f Or ovfCӇ8q{~9ټa=>WzS@H"H6l(!gCM-~8 ?ݵs'n!T<|\@0t0gܥK@h,@պ2[AU,}w>䓗/~WQU[3g^7h8m..9׿|B_6˂o_P߾j k=G=eƝ߸f}w| !nU^9 S߹iM:&E_ WF4MnQa#pl܈Y\9u9gLx~5.qW%"SE};N2 %Bb2~c-ptI5B2t-kiR`|)sOs`):MG,\:v;A҇rJp[]q%mlt[hP-!#m"̄$jZ0jA:aPHv  U&LO~ <GaMUQM@^r7RcWa0CA«"‹nJIoC7A ZےK%9M.Ŀ%rʨ8ANP*bz7)B'Ս$bR4~q"K x".am j~gBAN3vt^Zb+̏D&3D<5,T7z C( B[VԿ?% e#d}=ڭ juUUzxS޵uXW$ p$HC1j;•8 cWԄ8q租ٳK |,] ~  Ƌf< A COI4Z<(tɜNJ dI|HۙqF:=f#CI3 iQ t8:k(ϸq}-RQ&7a%`,Fub8"dEo LYb&`I V't)C$ijo( ϲw Pu6y"G k8~cc  :A6 HýUBz+Gϊ:rbX) DIH7L onX̔98-l" 1,B:BS%7ڈXIvĝd7?l8 0 :GFY)]xvzZ*),!!QH7Jj-hz.kr 8b-GڮikeF.̢L-ڷJ4A5;%VGqv/~wl4tU&2v4D GaW}3:Ҵ$9l2;?z2CFPs@דYqF@#GqO;(;˶!0H F^oft󦉝/{ZmtdB枣'[HFa_M}G[$yLSSs i2!V9&S;-^Mˏc޿jO{쨟re(#HE&HFwsdb wYxT0KbE B5Ql1s~[vԦo9 (@GgqpEl+c Wѹ:oټnzr8CQ?9##\k'G$GF[*F)I$)[Ž(/~ۖL쟙 Lqu%9YW>d+9&6b0,m<>{:l}ǖef7:B7֊ֽZ9~dFN?zQ:xF^byU!El.] SNl]¬ex!׫ӎSi+[Ox~/T$QS:0G/A:]ˎZE:pΣa.^R:j$-"%HTݖ'A{#"x+P)a/pij[$MAr@Ar`"2DKE%CBeAہZn+48U "d7՚2GrQ_EB,tPVEyd|:q-f"-ѝ @>s&'dyK@SQV+P}Ekh:G,!DEE9P〤%|h5-N SN_<8TNQKCqP XAVzZE>Hy-B6Ǘ4To$48(S ar}!1 a!Bٳx!ruA8BEHl"BnԤ(N9 ((0m9"TBM꫃/0fۦ5E$F]O? nr7B6ͱ/库@9 P%Xह2N:iu($jAT4Q GrSONE _vTy:uWꙕh&2rQ@88GYLv%\zgp8;> I܂Q G3(`!\`aW]yٴiWO:?]w݁0*ggLg9 (_N ;,'[\TaXoii#˹~9 |1)1Q.b%-LRZZʱXꡇMOpzE8<l4@FGx($ߤ3J$ՙd08IwyɲׇL2h YN?%Vt#^2-gƘSu!{}y ٽm[.T#;P9qy ZvrXvy>dZ4`ۺzW-=j{}l!0T ze3~0e7Lf*3evd 4f>{}a`ddz!<2&i޸2'ehg {h61en{vDΦיSa^2S5g&w';'ӥ9MͅG;3eO׷V%gVB3m>BT mBL(#oR!{`C9ǔyQVێq~`%.fB (>F^T\4Q.pEq.aq~"A[ 8~k*#}Ŏ be i.!*mhţ)+]<'xlω'ͮA\&q3"?HW0.Q=D&ZC0C5]L),6=ZxRl5zjaMlbL&QKgyf : E[MkԈFy.@¬yj.@ :lj]0LO"gb01D=|炭ljJJrbuATS@aUԀ>[gFob" .w2NhscWValp/Ȉ(@uմjͶ MfAlz))O'adr]lQl鋊n+^`E6x&pWjR3'[#%fYjBqc=O:3v℉'rJ02t,KgLܱ./pQZ:KS"_,繎l' );Vjź $:Rr4V5KIdDAU *p 5N5]]uMYШ` ɡKWRqLu`.TBBTҰ9l/ !BI&8() \ P PDتcf*R)nRh k9hhtf ;إs½#ޘn?I5NM"1l\X$4E)(l@X6ID4! 'x(\ r69- $$BDeI[Pd9<:x\>}HGl4o<Շq:a0IA%b[I7Cpu ^UYIٶn*?-[Rp8)TDF,j&~ٖpDR!dPF I#ᦄ.>aF,| o'vR6W+İ g6ۭs|h25&Z_6/c2A;W;f p`* sFpXZBozؕn @q}NMs~p .|$6NDSyt$e7ʌ8j\., xDʬa ¼ ێ I} o8ɼ@YxfO8X6$4:v90.v;iyYCÔ@Qd@&u ' 76cH2gdߓPq!h9Һ -%|Ǡ`'Cͧo#DhM.=: AH mHE:aD*ě9>,`x_`"$#Gmq3Y|ĂXV-]0bģ`́ Dj8b@NR"F&1EAp%71呼#͗aRa l!Z)DytǮ9 whvVƆ&v1c tH6.+3^*v kͥU`DhF5,Tа[ XW\[Mf&S\MXߒt 끶 DG^o+1ҚU J-m!%d4%6AW>HȊfW] ˠ$2b4לAQb Z8ׅ-n(Z8@%4EgwEQ$D}>hRx&,;A*m,jª0֍f{k#" [VGyp갸Cych$,$a_3m:\LpJs\e`,囐"72jg]b;qLtPpD[fpj, ,fB+ݓ8sGU6țq3W5k\7'&nwV~Ѯrt^tAfX>xD*Us 3L.SYD886fA[u-FsqU1ln!Xwh&p=blUL'+Y3'm];\ߛu[w>=uKk~Kh̘'{mɺUw2~Ϩ;޸qKL8y3K B,m j&졍\GpYcC !CpLiީT"\dHihf Yeyѕ$%8LslSG8N1c/c)Aǁ T0#vG1p;& C=qxQ < zNFYC1Ni$"/@, eP~kW˷ZkY~ &j 8HP- Dwbg"8l]lW֪ 4@&> &`\+03mi0! ;aV:Mc?;}/3on-6 g nֵ&wkWKVw'z ;zpk)`ܐ'q0M."4q2T,"I \9眴tFNG2&,ESUkrF AmrH DaC̘SzqKdG9WZC [\WN5B8$%>Vᚰom}ᖫO=Y.8 elrOYƲ/8|a\(z2'zO LG5wwMvg9w޳;44a>x؂Z 0OVP+6'߻Pɪ jEF1.&tFEcaccO xQlL2|"F$%._u5[.yc7mnsxsÚGzI2MuuKIjK>)s ϾYYl 穦`>OYw&:cHMv"LY˗X4{h}=j'E@Ŋ$v F')DŽt,+~C*8 \sP(%AJ4SiF")!˧.ˎ VEc7)k9U"_`ZRS3x>2RIB>,vba"b,Q2dgJPz[nBN@1pb* L(,_ t(pdRI(Nrհ:(eJ E}%7&?-Hұ&,ib Y.1Z1ュ3Fn9͊` Jj#8 =hеqL$SO. !,T5!^a:h'Ĉ=?gЀS'ߥqPғl! ii7Jv7p`(- T,9]Lr`S 7%s~ /N CVf"(Pp598Тz@ -سgv2n>D'&=gM+4I]n[ !|r -xꮽDI~w~uTv{%,8 ^4oܾ[Mkz^+(+nְsT_Uqʠn] Rzp6uWǪn;rˋt55C̉`1⌓А Â48Z4oCܐI;z}ᖖ~o86ekV<ӁȉJ6Ln 5\9 QqܻgNzF"ݺ5HV>TTR*}LX瞵[y nPcO/jEUv~Kd̋/TfS}n+o'Fmx'‡U;*jjv}"Mz?o_wH-l8lUK}- 㦰qVno |A t$q)K7LU4=nniO+TV;1;uڂޞzG_8:f=ۣE 5US-7A< UQ-neĩSvsKn ->/R#RcIME `o]7U5qJ{j5mLIpy;IS]v7~l@*%MALlX΍6Fo:֓;qį,K8!dEo䯃G~nK|U nt,G{fYpaaGL#ӂ'9{hP>KWԯ[ꙓxaWRF;NVGUIm 2{rO>ctqx2LUVWu)qJ~ΖΒ|kH+M'DlI2Ƙ_tEz|/ӈ |Ǘj* Ţ>xޣK7lze˖6És=ɔ}şNFSz]:[N!r cuq^N`ST[I}1k%vSЋX;ڻXs+nܬ1M0z=ЉcZ ÎWNP.!#*rץFnȂ)Z%p|pϺ'vgѦpm:%qT .ӲdiAąj~Y!lQF "pԨ9n?SdvLm p]#ewͻ=TiuK҆: $!5Atzu1KŠ/&4lMАNVwӎBű<0 ɖ55L(-Rbf@؀OqÍc9{4±DUa+)4? SBRJBw?(TL:(5M ^N3~<V|N*螈}5$Ɇ'#]J$]d"ip()QaM<ͯO4UMl 8BH5M+;;vTin1|4A˰΄q;7, v,-o_xͥػ!aWhyN/˞c#fIE#ϺO@mz{lӬ8#T"=~|7m[)fmccl>)BD+@C맟h EOwąQRW.J} Q<=EZȼ )4ǍFqTc“@~]:Yyo1 -1#~u_pRR5Ũ ~Fںoڃwr(jnW&Nemu|^uUwjM 2r4[$_ oiBᣏT֩J+"նg7\vmIaHt—߰ΒL7o/JX ;#̨i 辛o$8dAL9} 7J7x:D3K7d 1Rn;Xm{UWVeZޭ+X|CmUNG8|!tFo8Ɏ'_x`OK'ܧ$ex ؒŤ&4^7˿u#~i+WNUkER~ZΚ(zz7^{WO?w=vXk_l6r}eI1ᰁ̰ME胕 z㏼X:~mPJ"KUlPegN:{:m9n) |rf OtϿ ,cЃ|J酂?}cpFcWR| $9^ߵy}p¸)ʃDOO>P߄{뮗 zH, ˂@2{h[]5x +d2/{hvIdadž„ _vzٍ,bcЍ8엎 V)AS5$h}\&|-o5#>L&4#.X]EͩUwF떻"O D8ʵ%]p&Y;dR޺(!7\H !+> =b-*4$"PL{;6rpP=䚶&Z_aݏ.~jϢ9]9N4<,Js]{oOԒon'~moQlMp_Ze˟{fptɶ'SrQ&M(|ŘI>_Ǘ?TWd㋛dc+_2UQ2.Ih:D~Gl:s Í#\+yS;d%zzGى> uvzq\F`ZbqN/B'mŮY$aY-qT>x+)I<IZwX)RD*A1 S!8"$E7=(Qn`'BU g,SՃJ/j1-5򗿶}0w6k7N+7옷u܃tOD#iUoʲoOH}v;iMr;_{~6PYݕ[q,=O=\{AajOaa18V_lޝ~*,؀=[^y|jطqϬ#Ӯ4Ӓ5B P[nݫПFVPf#n˪͵t+fS?d+B[7'!U݄oѠ!]@ MT)R'1nMf֟ rF%1G89BzyС ޵%'w{ӡʞu]y7imp% 28uDo:va<63a@ȫş’p"ziih k\:^zqO_w*)-Wve\#+@br|U&@p_Z?PUowFjVVU+ 򅜁d8RE,1%_ڶ05 qfISȂp@4hSZ O}lqvjGxOyLJy=:gދ9Ɉin( ۀРĢɼ@~-e r;PAfnV>aCCս~zv.Udʼn{*ܽ=X n;XUPUsqE +h mξͬwZ5Vc;.hn);~]:&=}VqpÝ}UZS۝m>肪\[p#n.hrx_aÁڃC;\eϞsv{]EVn:u凚 vT}_?)kX=U ?)&' s'㢧n\gͫh ~r[uwo.W4$ 8!.ƿgM`3{USCO(w;`uٷUb_E6>a8PulamS {*uo{W9wpUiuC.|Љ5Mŵ{mVTv8T_Q^s[uUWAj*6^ufd.ٽW=P鯬8RypJ_u]qUuUT8T̓;Tj׈+*qvW5z7*:M= KK$~Hn(8BaU.ftę^Wa.F?SS|“w珊r&\ž>0a7"#P+] _pŽzn{!D( OltU]"ƶT7V;wݾá{4߷yÈNѴy_c+~r2ĴzJRiҤ8S8fX»>$R]." 0?+b3Q*nm87TP_>|­]EqFÎ[UC7jv957v?XWpn즊-QVR(օ N,s*0~%y21fW y -r9O>_L! QI]ȇ-~0T b]<|Ma#EWF8_|{NW | &"En^kF| I2[K|HAIiJ,x/f;-cz,0eEyw{%ނ"#TыG\:LmV*_^ n Hv~G/a"|fl[5s8}TBڢp'x=Qk*Yk?qo3g"o:'*+%Z DASɩX94PnY=* r zr+'E|f <cqN H7⛧9dIQh"yw-@$Ek^^ABg*ʖ,3lEjٰeGY1g\㆕eі r^8Lj[&$BPdEmV' RЉ l )?s?o! ":HI5\%`V YVдMK [R:ICSv3/NZ A;%ȾCIMZ*'fIbrRnH=DYw( ;P6,@Й$7=\}6 iN|ZSҘۗ'yxӍMq3/L xkhaaND$ɭ 7B)r /{هT^z_*';~  F“f.)G7b<| jNH$rMsW!:q)Π]|Ū0>f9eoxؐ@D5(J]p}ő+f g?VsQTşze0tE'woEIyh*KĈ e­ۇyw8ntǜ57u)+ï, 0O<.(?0~w~ Q$#rq m*;żSn_zWǍ=cU/XLn{0ˮ).-pRIqXAYD~DUvoksx_=`o?D8 >h<'U36# wxaռ>Q"wko~|]`\k3B{+mr{UװQ7*ܙpG#o# ]~]t߫{꯸>4-#aE_ {hn>e\II%Y+ν>'/S<xLmy) UqM 墊x\]n>g?u!,gvࠪ7 cǿodMSf%gQi5/lXh4 N_" %m,CZ]_^v'>PFXDT?1aRir a-YǑ/,}l9 =< .P4 r˧׽_Y=s|*IAi5PuuHYR~Z^:P-֫?_Hb}Ɣ{ ?c%O<7:- 3oe!| [65-_"/XWqY: , -."WhKUH6cnRFxxJ=S0[G2+?M?]P%R+Wp wE/*#iЦ8 "=lPv}J{>DHG,< M+[YWrI?CP]իGgQrZAlY2ӱ O IUQp:SU:uQ8P/9kX^"ab )Q 8TJ!.)k뮺W^;ĉFS pGFe!qBLh ~&p ؊ETܴ蠙/V3w"$}y!]؀ƃB4"B| RlD)yDDEsR}5{$/$j`\_kb$W"LBTbc#S[w˰45`8rirDl:ŕ|B/9ds%їo#;ק6w=HBʋo|Or.WIVJ,Hu$pꛣͮ6}#vk4`h ؈a9:ݺueA .T{w)RJ)Ҷ[`NrPuuOå@ /@U#l\\@Ao{~cL] 㻋B"G\!ĉ6Et9M4ڮPcv7S}r]\7@}eU0"ۆCt# ~m mRߺ/HCz{} V94 X,˳%8 M S|l8fJrIfaq 2T I6 ;&RK0 (xrZ'W[ǪT=t@*-qaB2o$a¢êZe]r͚Xcp"xP ",-"mآu)Ei%H b5췸C h|h,rH]bQ B5z\DkFR]n # FDT >0^p$ V 0EY#K<$k͖"+ɔLTYjq:fe #0keKPce~<&FIvXfSሕ5 ҾڃMoW,qV8'Ԉ| .,s A&ޱl޺o#sz" n<@Fpj>5? |̄SؔPea^Q];̗ Ps1I Ff]4IJĈG )/L MU`#yބ$0lZ՚v דC1_+pfU 8v)d:%n|TߏTlD rn8N*ԭNQe5s&lf"BlSlmCo)3 ׇ,0s)@,DpJ%gơh' HmhLvRH}QV$^HE>E ;Q҆N|mALJ4;)Xpk CJ)gb= #H.RI!d wf"q4Р3G r󥵭cu:kY W_xc80 3*3Dj`"2A=. ̤-H5#N'ڇ}FsރƗdǫQ99pM9؃@@tx. Kjd09#gnwZYKbou\[LP}RD6,n |ƃ0Xsܱ][6+ ,mp%uGZ먒Tֽ $f3e e>a'EA<#%31&o\wz2 #*gi(Ez줆,An:RgueO85zF6^"Ъb9f0I(uBwiDH='L]xp $XE4jmr9C?.,>3DoZ")ƟxZvᠡz=k䝄%~^>9<&\Dlyvab`^0Hg,6q PydѬ>gEg.UlRh-84͗tF\Ngfۯr>p^2HnlUt9EAK0mK*8<Ha lD[ 3Y x.M1ĶcPEz0| )16 &%X[߀ .´Rbr08d.'c\&-ig Fx:! (CEC:?}v.ˈ[41 ukJM y&Wn+ ;,.($NTod`$@hlBˈ9A\luԠblC6chJa\h0 YInF ,0n63p0)3 yYY@0} i500&TBiG kͼ& q;L18`ր+ ں{}n x<60o1Bj=6ň*ba60BVW?!΂Hp zJLqg  bݓJ@"F~X5[p*Y RFDؤY]2We$dըRW5є(e [5ED|*O؀P/8"]%XwKV [ ^0@eXQFp!8A@nPnxۺRP(!ցGu3D2D 9[`ʼnr^#ܤjanR`ն)j p𶒧2]~~^C42$Pfȥ]ln:8{mM5"ɟ)&X#!@1vWK| _= ߣ tj'H iat G3|:xkviNfVM4*x!pQD̄%UVWF|b!%-aOq_b_8*}u7^L]Bx@cS++%.L+X b攴օ3u Pd/:("E$mN04Ja%LG$7kg 6H@I<6۱҂,d3t)dҀ@?D؅!"ak62;%UN@ |[36q8L5ӆWpޑPI4-%=wk:dNi{⟌3'.]p{@8: 6v_f+r27CI+M2>#|P֋*Yx hM8/`2zev['`bI@;,aX@D ~wB;@5L,L1"B<`z>\8`kG mq3n;D;Pm9t{;fYw3f# 'd$YaŋL'1q8>ʲUK 1Yw}];qIz馻n|$ y,q0q7~]o><8Lu|=P-{'LǽN8TrÆgR-pW75 !I.Ug1@i6D4]whλsג|g8,=2嵪t?U|TEs-W0lRONuC Ik[?BQ )-G:5K" 58IeEjCv\UVc(Ҵ %c(t%VwzY0d33vRs15`yM8.8`;0qb  lҽ8,t^'s;11m]j;VT2.La8i֟@H>fytݙotTox[~ki,cAsҚLMSh+b3(* xH\@}yǼcx0xє{o)-*S@.3秏=\cS Uw>O{W -$8T*NhaŤ|{$%jZ&j "jbM;fBPХBI`d=g9s7yðwߝwAUd8nܻ@8w~mʱ`8o/?}sqBw=}mChA4PAaNFт_V !Xǃ?tmw=ӇgϞ+ ?w8~vqu_`B"Y1t fExiP$3oZWg`Elգ$<#T޸*1S: %,tbS6:l)?6HYϐHrM`c򋒴&C9mlI\a(!QwͻCu`&i:o-YaB& G :~hBw؏#>PVN՘5jj BAoJ"[JPtJ$H =k?q?7/]ŒeA{C)i苵WX}sø'ȋtl Xq={AyJW<~D坷m71{@;ܯJ|uuoY,ūpW.@mކ.uIP3;@B9w#T`+ Y>?9RKtf~4Qf*l!N>c<CTiw3 ʓ>>H1CkPA0Ș3>"O_M/2O?ew{YO›۬T6;5v ^2<ݻ Na:{Vf,K׾׬gf<Ի=qGM^o{2k7SЌ]k ՘Y4YsN^O ]En@y?AeO;v$>gϾBzp. O@%Y)`x `8 hH\4waKe?}(,K>8=tq.\B[owq+x3Z{]?Oðht$?YȆݚXo._w-^!x-E*tT* 8HABJ8Z(傲b{˗/Eh8;qK]9/r_OI Ze"A V\j3gi:+j`z+ KPS5䉢aΞ=M8J0I'C0aҽ܋ہj@FxAA _Ͼw·.F7ЃH_]+ tdMk'5X׿u K}v̎h܄'" sҤLhօ2 dT4 eqg ՠATJGso*9?_2O]@_F @3 ,B0 (@\^(3ϊ}LL& >+2lT@ַdK 8JDcVyY9qڽ;>eZֵg:>x@Ɠe\1(q)0=-XY( ⥋Gؿdɒ!P_|e~*|qs`ҥK>胹eNH2@]`ـ]tɃ=4tqV #]wيe?<"]bٹ .~zAm|ŲC1/Q"R]wT裏V]~?]p`-zY LXlCp0zxVYه{ص>Zў}y4)ہT4G/B\<7??Xru>Wkq>wA9 |))ٛP}v=:n00s\s/ر)!GH:$s{b>%%h%sl=rQs pGlzYy{2it@u&XH.Y8(_qݯ|vl-y yz"l=0=EPʕfszn}(q()r /(֊\(W%= b`|6/6P|.#&9}FsϞ^sG7D5lJT0_EW" P1t, a`Y&!DbSC$h_Fl̽(GsuDn,xdDDu[_9 (9(qSz6RhF2i#T2y[} Ljrk hOFN^hPv%_ԫkג.MÀ)*(h+*-+G8錳m1bP(")+3K9 ^^j_y QB tDXP)*.ALɕU?1{]8P· :;x@]O g7 ! ?8<りXLIn_)}ƿޟq#g&y,tRx3=G/ ɣT Ktgًb0Ql,Tq S+p1+`^ J&j/8Q%CC;uac0:r"dx{aA]S}F &S/ߛH?V @_P9 P@)=z &؈b/ad`L&vA`j0%SJ>p6ٿ*~|;c}p2BQuP+q//9Q G(0taV[W <+i(/|'54T%[vQE VP]f%_F]rB[:TNh9 (_Nh"/"\w) :|,kW֐y7JA6`mrF#Fҗ0!Ԁ |k:|-j_/|冟@N 2E.7Rt }EnBduT/۷jfYz;&$Vg&P$;hg?2*򂊀7zPJ*FsZ=;GoTT4C{GK"@ YF0 Өu| y!^T,N ]LJX  "I@OП%,BDij"[4)uSIjҭU;?5OL\, YAkF-Dw@~5 2^}+GrwQ[e01 CM/C#. f+$|Qu =n5UWrQ㢈bQ׍ .a4\'k,0J2p]ܫi‰ƽ$ %chP|K?9xO`C޳7t-CZ0 no?}f߇4rMsrQ J22גUݪzFB@a/iӦG`x#ӵq%X6Z=}z:Zč?ϡ;CqĕϪ .OZpm|v |~AxOhnA8sxb5j}' p~aO51,*ު'`ɒ] .+8Q G-']dՕ5*Wuu49﮳ D& Dؘ ʚQQarN+j.ֈ`Uw9A@_|qe$@<=5xpЉ""c% ptG{Sx=jqʔ)H q<3yd.9[zV=`=x>wl#1#pJ)hșӑ)$OFL/"#"5Uz8; Ps9'l* O>[kq h~A>i8>(]qx^g=;}'=qo6m>yS8ȎQm׊ܜ\DZDSKzHh;^Ekz)HQbb@=3V:Fc:FTA܉ŭ|d-MMzp]GcdǰB,ggś>uF,riӦ7[lA8Ư%%%鸉`4ܼy3U^^E]v-~Mxȑ#x0oEOAzir Ŝ):hLG?~ /]<[o}DiI-f4I~uKO 8;F9p M[)L,>M AzIx$F`ϱx Xm^z o*Z ۊ&ylf`P!7|Meh&K2fo#AvS{]XV!Ax7x-AI1 Q ٷA#1| tK洳ݺegdGbB,'TMuUfv$ 7.yMGkP~l<2adY[b\i@ a]6VG'⺗XHcAƴ-HqD |処_G (Z>G R|Rʊ+-yaasU^F,WCt낷Pgc:Fc/#kj9RMU* !' }L! DD4Z0t$Mx!C?x/N `eI_W+:Fc:F{33OaТ9HAA 6QзCq/E6#S. "Ӌ.ۑ;c_~ dEL)px x0 ,XqC `2ê]M(m*xX>pi(};0kB>@%़xIl{# 0 /za` cO,I{Ы$ƶYLƆV]t?Gx…aTr 8Q?&Gt\@?Q8 6=';zKs3l@eq .qX` hGc(SpS'?bO$ /eyѸQC(Yx+u-@Ki*V/@`+Bbx/xB t:+Y Pѩ'noKc>AcW:}w8 7QF$zGcqV'6b''[p^^遾 c4d`r:μPw/x|.u,U^zeDr[rb]&ۈ=鰎Nx=YWӉbz:84G{D:FT#QsQg^rqYG"2b/:Ig̉FشHQ@@Of84[GHBsg&Mq0a`(^2ܐ[CTJj^׊+Z4-^nK9xD="ʘhbKeKqx 76-`f [LV' hGKބ1 ;BpFNjS#bjrm vXǜDL_ett1iaJ'8r ".sMk&Y9I轊 \~DOuH-{"'P$'>˰P]B Ct5^ho!(!"+p$2MàGHOɌCq`-8Df.H(dxJ &1^@ ("LSuR'p1 2o.ʴ{+!dL'fLȮqy_pIp :'oX?8R6@4Ǘ%5ӑ9Ѭ6 !x:JP2~M'ֽ"^B퇺)19+iqyjE/!%MC$=ASLV<(&hL0:%O )cf`с ,@ "f c! &1 ndРֺg3 4,N4|+#Cc8L YZ81CgXN BJx=H49Qc\!B% v.2ytD(hxqQ &YD&^=<ڬ^5]'4ph-! pB pRıW#J;-NdR>#~6FtE-X/rm+$5dwbT8&+ꇋp8ۏ,9[hX&>$x%Ri a}=Me `ɪ,HǼ-}-3QhEqJ›~e"WIS^6 s+t,Y \ E]8dХ.t2ulkډЉZ-3v 2sx?],صjZ e'6.]ͲDP%(G,$ϳk-,>4; ʸ$q18puD0Py@VB>#\tMV97MEa 3*B>UAQst NT'h4N 2mVUB2&` %M[XLXȧnsy]4}RO4kcDv6)Yqz'e= i&X:F/Lg ydFhCC}(IA-R,YW2}}u_wu@d"t> -oql*Ot|Ѣ>N鑤}XYrh o'vJh_@ .EiΜ d, # [`ć'8#/nah3ϴ dkb@!B\61 ͬOc,1N~!"xzJҎkXpUwi7wk@dEf2ʻt 9$6=}#V|XR f2 jvC9Uqvc .(;7Hf9a]vmόnɭLydC5mo !9ӯW]MkG^y]E7`$.ݿHmܽЊKfMP'/-|'ց~RbZ ԝ,Ew?76𾇖ǥ[#<^>/gK7?UiCt}CK˓K~{muu"u>mS|M,ಪdcmU-&- 7l(m-͐,]Pӣ$ p7k.S.}SƟ>xnӁfa&1#+? SG:dh3BΞqckrc^񇷗LI]sۚM 6a`7{\'omfuގ--({u 0v.X4z]˿>js Xwd?ȋzR_aX> Y] <}N26){!MH@xz]H}v)qɟ\Qy􉗺/[y /E3cƺ9\EM&)r.zyVv>r_@x4S |DhdT0~ O^ֵͻ*)H[ϼXr͵7jHb^9,Wn4a41@i@Ak0ްBLLceͽfܫY]]:a0Ԥ#Íe B@BarIioo7Z$k 3{詗m{:]g-VF Tݿ-+KiriNnxQOKYS}.}*S/vxoGLOQ.hĻPBRpQI/-W:W.ȃWݻeLߑaϭXci6ցՈ咺e1z6,3N]oBE~#})l#^]7/ AlQ}2:>uHI;MtL"jM`/2e+$EWǖYM}`ec*YǸ֛Y_0R?`,m#x1f;FZz8d\aYSQw|Yl9~zK څ/yN zʫ,+xIQ-Ľ|j*X`mȿbJ~ݎj5ۯcG]k1x@Sӕ5Hg5\^Z뤧~I+nU8\5oIQ,Ws9)&B\,=J4YdM8t<a:^`yQ(LGi6if>-x%wC~,M$䫪aI9՗pr7P"SDN؂Akwnj\rܪo>P\$T2If|O 3W-"pm"mGM1"U~Om /h!+Y{ϝy mQтA٘aؽ2rBy?lXёzhm690$F?s_}O`F`Q^!,nXXZY[' JrY>? RZj5}ԏf/}ˢyJx2{wp҃XO.J3jJ: |wo yk{kNq'l,wHߜOR^+n5zzM^\hk hN/|Oű}r<` s_$xD"v!XFP5kL, Imm0 .(@X_[ z c}̿,;ىbΧ\!a57Ȑ,!dp*J//-PZX([SI8 ^NgYP4.{HY5 vBk)JJs bQ\&6a(8n\抧.ycm-w~Vm6&D,W~Ewz/S >UjK`#1ԲwX);RZ9OM}N;t_}l۶= A3| [M?C3)[α D \da(fЬ퇺a Av,g zݥKc8>b%H_g:sjQL,T?b.+$Glm>Uq=н,j{UQNKMK ]RzbTQFV^[Z]TΆ1i焩^I}&e]"'hO1:jŧK' J@J#::<|+ה]8sV?<}G/BRgH#1L o?,7LEvJ3"#cg:!DeYna4DdfH5t?_veL8"2a;C%*äg1]e%R:n7HëMxsI& 2̾I䘑17Mw՛>M rGxJb3pl{}篘1xkY?sєnw3ӯ7?2 E,"N@Ym枊Dˊz _,O<jüd';z㷝w^@]$-SmamMM[C %X.J %ʥ[7M-v1M̈́k\0wV=ATolh1'NL|߅#πPIPw /<5ma].SA| H(V~^>y-MM Yu8<{V_l@ C54kMמ.;"qlփJwUS9ZײgĘQi2l+i8{늏ħ$YF:Rs+m^fɞ=[SG YR[)Nrt8(t_H@6셕ƵMekL In_]@H .5bUeem[>/ZA}zb冪kdNijoGasPϋFlPLv :Y8F>@He.wqo㦽%LJl\^]ٱ(9}^Oas_ܱ`=wW c&{njܰ8tݐW4i_CM#`y+KFlF3|y Ll #mSi0- tIӅjIaxfY &0۷ToxȥG9 @}@1 7j ):^Z5_F^ChT S0 @.~Nit^/NKLM!PL,>Mt3$A= AǨ2|ˋꊉC$I-Jjtt򨉣K ϸMqV@ I^^p!2$ίk h9 XF+R ]Uw y!2B4&k xljtf/);Hm5Cw3% 7..$"Na\LajAK\MAWVQ5J@J(F:Ll@cda$wm1C{c5Er$r"'A ]ފ>>{AY޷ xO2rIw/2)^"Ch9 q*7Fsw9=QS 1hAK}(k'I2}EeUb6(<0xKB jc0YU0k j&qUɊk8r[+a4gvD^J4Ԫke agȞ.E5pPP,Y휐A%l!&DO6-!"HXԹ<ع4>ҩ0ب.Lqۉe%:X#qjWܸh3 `k b;AlKb1Ps]Ff0DxHmEgn番rl @E11j`ǂ3">@bxA8rIpB{ =ax~I}m^ MegqUΛp̰``2A0*Ϛh>̠I݌;ExsJiJU HɆjO V:f2.&ںPS AB}pc%ez4ux :`+8xV?`;_ <2oa{3fDLyD#?ykFz^-YiiO0IW3I\rY.ȳg-KoX2*4xf)X5Xr-ӣnBK#}'mb-u{wmYˆL:84@ N' ׆GWJ`tl8H֬K C,#,'E*ǰy1HcP]\ XP, W9u" xai5#jI$ފFKQ :D~fjy&0 8Bn+Zƪ:P~Éh61tI95Kw}*B@O6Z9!pDZOƹ 1=}^ES#jgPoeL65H2pӻH#rT1 la# KNz'߱odvb"ψ2ip"Xl*b"D'L!IJQQ24\71 c!1m!Fa4GJλ)t%aV N1ٸ ,Y3 jI`)IR棖# ʠ^cPM:"W=ڥ^ C0vp 3EXDrui46'@3#K'4ܖ8)i8uXCv6*ƲIՇAsM`yRa8xȕI(߸ɻ~ MЀQ4wX+,,@ hxNݱ>Tadnq s/Vcm6pM.O6B.cbK+xhҍvF 6fqSYaEW_S^hvL ɮ]%F#|͐x}*iq]䒶 ;{djNw|| [Gw|&)A |X4:6l`la #-FeIFmUyI <qI[9.b1LUM(+^u{v+ ^O)m{@oA!ti4S6%0@~gzI>@'35s=EäMBDJr;o̫QIkhNFKzY68љ\rXC 0\E df &'P @$?*q;!c(FM"ihˊJ7~'d`WA_qc8`l?԰v CP6䐦ײ=*iӬ<8aUٮ>Ш%2LsR\hM%}x“j!Cq=\c"yw!Հ=N9oq$25n60ztx~py "11/UiD2y@Df`Ňw^MYڽiQ~Jt;_|?Ls? srPijWfF![:9Cam5]$/)8&tw}ͺ$maX3dB+`x4rvndsS1G^X`EhA!$@BQoem:/ژ!"tb.R|/>"XaMm6t6w15mWdYJ%n,lA`v ;ux%ao~ŞaxI'em/2Ssr+|\pCFXI8zPa@}ÁE1XdӢhyw=rޕw:,0@i fu8N pQ+y(x}L$a2L11H`-kCbL%cƜPw{^HUQiWm=;;}A⫿rqc;xB-uO;}zvB;8tQ5"Pv2x.xeh/'~o0lH3_e#Ji*cK*|MTPz8r<ȑ6JF8]h:71@dC=9`_D6ݾ(jGS$Pv6';Jo=\~EL;ÆG0H]ޯ vuث?n1"=KvI m¾g`pBJEx-OTo.L_ t<*xk回~of=P쎟XգnUvW+qts;KZj jwXۥ˦M` R4˙1|k+<"*,v6~:s=;ﮯ)^<ڝKn +:UVDY1qX#5XtVP#"im70)͘sg鼾x)^dĭ&(?!ϊ,SjKKk+%~F.;~l3+Yc'-*n|mNp%%V50,K_\)pFׁ "suSJFNhUOtI6#'qEK]C3~;2QbGN[ vԼ(l,M==i9gVwx8it}=ٱ%~¢Κ> 8j9f[ž-mo۹\:ߺv GLDRY=䪬=MpLAF6ITǏȹ$U\ZcӚ.*j /)S`ykG7v څ 0춆0!`>镲(iFM}/eH'O$բSE{60`Y:4[!k⬣ݪy`'j*+jm¨6l nJ/7wM-WW2F_0 EydvHoi ;ok N?#SLcmya.WrCϟ?1l |6ETӴ3o?>'*Ukv(#̻X?r^ Cj|gwwuΤ30E^]+Oo~߁=ц-~͟-ۏ>n?la`y,ZR6N̝j If/]}yTxkY)C*[-;3XAqZ-F=-a0@فKK'm=s/"1v\@bٽW[3#0Ϋ}6vˆy7r~zs|{I"oYCws#gy(Yӆ=K {U쬚Q1C3fS\ 1Pq C 2Cb" 0yꁀn kb_'vչ\a<ewҮ\ #7RY q̪#[xR1%zzsbpܛ/Uk?X=' #roXf4*m2<. lrSs#ۇ>x\we4+HttOnnKs7>s."3cD{; @N3} 6mKRH܎ժ9grW[gn=4ОQleFܹdL|#hm60w8cQ} E54ЗPWS)`6%d( (+UG^Rxpy)%xr &T&ornQ7 =t"F*:젔ѕ2h_(! gLuϖ#UI-;sR$;;E:#Yp2498 x^/=%T~*JF}l׆]V65ʪB)>ztàW' Xհb!QRܼN\m}_GO\csW5jz ԙACϹR"皜2k4NX˟7I˾'n4⵹޶JujȾ\~mmINx:wy۟z7އ3:o=+W|0@ۿ3!K`u KH*AZ5yŋ&5U歂己}28I4ҹ|jYeVa1c %ֆ^%哯=,[uQx8 @G5廊o<ڈݹ-PHgzB(icPhFBNvK3}>bSSJV(6#IiPϘкXep|.ۨzɸƸfYX6i#R4s8a3f̟t(X?8yrTǵmZƁGx=,"2U(?yhM|x!9#(π(\۶UQxpDW5[H́45FnjA*1!HQ8lJwMm|^UuCsBcˋV$Wp>&CʚNȢQl;lmկc ZBFY `N8,raC\$17[k[ ꮵu.Y2 秒f]M ?'ȢʑcϾ:ˮgϮ9֓uszk4I!˟{oAuҲX=;O1|O=d&s +*xݢ:%g$& *pf7^ {dOu=4cŦIˎOd2<"!i+~T w2SRmCzڤ^~fHMj>C* ]4i<4d,8|:x(ӗy~5/[N;{zE]ki/l6}p@q'1pLP^M$IZ~?(xdCS+b-Z13RZp @Zn8ҡ y׭G_93ݗl>gGcQBVhUǫv}P:7ZTd@z܌9yyAEjSWn@]]ia.%WrcȤ7۫οx)QQ2\ a_6M׸HD$Dq}+@>>|ܫ0CI"*نVĦȃ"ٱ,l=d6d?h0@B=q#t_^wG.}hปn' !}-ˏ" V؎ jB]\AŲ,jɋ?FbP;吷O:eN4҅7"ED;G{,5ʑJ4D-X[PG o޲鲙~M3g\' вSWLnxܶ2ܴ>P dkCK&.$gmC \t=#j58LPuQᒝ1ɬ:ڼMY[D U:) vrL 4œz&ZogfVQgc;p= [ZlnٲhɖV֦LjXeWxKlE:gG풠m3+ɹGk8ڰ-j"-dߦmIӰy~2+|Q%Jˊz e5>ᆤQZvFx|d %8>Q(8im{e 9>B .fp*rRl,(\5HɌ'D]-mZYՂB599CҦR*UC%QyĪf-ׇ&hxx=v󎲅oz= ÿpoZo]fV%°cdq@B?@ #@ 1Br<5GkGbggI@?|Ȱv]AuOKM7d3Z7CS\-lgXwd?93:XEŶ-%Ň+Td]x;?=HDņ 7{G[TBL 6~$$+ȃ:hcп ?W39h o3u'HG, Iyl6:r7w3ȸ!.cH2F!F́;F" j ;?u׮B#%42ah0\pnWdqu!ԤV5 Ose`YvfkCN*WlIZ;{nHQvBt /f'MF񅓉$]1r o^`v4 9mP쳘ZjAO" *.tvpxֱ}FK0_J*olԹ3rƦNE0O.(,(\F Ԟsf"ZX/I VY"ZUJh%E2Y:G0 Dz.2/" |Gò~1\j+^|]lC<8b0eDD{>+$H@&qsGu-vqh&ICQ~" !MaciY j9/r]l=b!DK-'9-H,bt7|eXCvM6l0m@R`+t')' 6+ivWHa)& iJ" pdԠ.B)OPΎG558qSJȺ!䮮9ecf11<'^;80פ8.@ω8 W,dXW{><&`McB>% M11-}34JXAd\vWWlϗ[T#l8Ҵ𝵓8ZTS/(/ NˇgIHu5-A̶ Lc)'f j,+AbzB!N"`$ܙ(Xi x޿OxӒ8&|ot:Xv\f2*Mp=e%$|bAX0Iol}eߴtÄ$[%[plIDAT>=ѻJO$F:tnRD,8̳ dYPT$AԲ5#zؽ\OKX~ m-03/8ʁm(e䨅w8  Vu?,3."$gL3`/fP9QOPk!^ `ӮHxxޜGZh4Lx<ʗ[FPq<L!/))=E}$/|Nw*{ʑ6Bp$v,T>dy`؁cPAٛ, (̋.8duUTՏӽNWFXߧ@[TTe ܓ.ԨL2t9f⦀3Х[Kѝ9 ALC.|!v8x'kIWdfvDAN׹, "pR Jŋ,X:BɋaGgNQwk|A]Z9K5LEK Dְ(aI0SaԪ,@M9~dvm `7 ýbn& j~0bjB!(kH^ jOsm=B0Ȓ ;1(L5A6`IH]1 ^?m=ӂ↦Ϙ@i,r@Db?&VRhc!0# 4aGըP Ylp.lRk98~qO?n$,0qbH$XcpX@ޞ3 Jaʢny8&4襂@}=1R]D$6jMe V)Dd9njA"UlΤe7E\6WK:bX#{kyЦ h:{n8BKp;\@3_C:o"R!tnLZR܋R$^S=;Ro-zó(z*P4cCX8{ Ѱi,GORN;-ZVID/i}iݨc?g'0"]Yqv'p%z.3,\ۥeN}Gc!*{ᦚN@rEx¸qFo( rٰweԴ x⸪xҩQz H|c.~Nd5ލ`R2#elϨӎ ݂Ij[Iu6L c&ʀdft+}z49eˍ/6ݐQ ͟i墌 q:@~cA8̇(tMddfЗJ!T8tYf!,]2AAD^W2RFB|ϲOD,V 8muYKOsmݐi<' 'a|׍S3?Ђ.Cwchz]'Phd;f\QHe:Ϡ SObRA9Jݓ&|X}]K%((,hƜp8!t5#jP9 !Q <0Z,+5J5hʚ kxL|tHGsI?K|H>%W/{rIx9nݭp WH&kaOĢ p؆X#]\KU?1jJfQŗkƭ%5CG( ]~-/{GۦL^ 3 #5[0 CC0 -HlHHӗk ^DR2"ĬuK#Ǒy)GT[=)*2)^Q=a`\6VE^6& nf[6yQq0mݱ86T5#" <'QEӵ2 1$8ǶZT(n "Us̫mҭgdV3 Q'Nr?✀ZQ^|G\7Qm[G9Qp_1f[ГM V?yn+K',3'_K&0x-Azxrʛj舚, }c[*+Td|\WyMQtEb~ߧm`eI(UxwL#*"Dz@3mK?Yզm9)cKLOܽ7;\ Nu^uO>vg\Pduߞ g3|n\zפ3wՃ;#aˢER`,u۔tԷce%I1-O㦤t^23bPQfMl((O>xص9+B8%esv=oDzٞ.ѷzVFE_j>-eӬqMՎz߮fwo(tInG=6ξ`o%ᝐ =hܨ g> 月L8)ۄpm4;#ijkϽ:Ԙ? hrM/rbDZ2,+.̗^jsr)㷔 ?Hw/yKnkʞ}7>Vpo+s sMJ@r]^3 *G:d|dM{zh9{˜nK.F7 ΢&{6%XL0I7]m>p詇nu\W)>Wf;~ʱ 0莭cNL,m9OX.a#LLR %p]|E~դ,Ȣs߿쫽E~#"lXlB O*X5t@w;wPv+IXe @0xjl$>BYJlj1{*Sc';O^}쾍Z@9+rZY9Ͻ7yfhKT=¥D8̸ PuDBqH=v|SweP}dZ{pƀSh$;O }0qA~ hel8*:grWIX -.Y6Qiϲ%YjѴ>w`J&>kvݝtJ*;_yC\u_Ca.wRY޶[IǏ 6O5"N+|kFYzo'WuޯY??`w^4 1>}uwPoew|kz>XV=bhZß:Ds Ufm̨'fbw*ެA*~VV0}M#Nfݩg5[Zk$Quk$j \+% T[psd;澻wVu36 3=V.+ /#UPA[-;'9}J#CQ=RBVtC7MV?4 7/ ')@UD% m]XЛF­U|PKpX`C=G$tCsaoͱH/[wouFw{c`U,FNO='frGqRdEV,)kid&uo'KoH5db1/TOz P} xu?rOi) TTd#@Y4 5o\kiۋu0d-wEq$vm|ǟ|znM1TJLjqQḾm9Q.!RC˛wR@,nOO=Yh[Xz}@tK6X(%骅+˦G[  -@?{Í𠵸Se"HlPs \)\#ZЗYd'x/Wtj%:?1r@KlD;f԰nhJ -p΂J6 ƉrݕgPhRGoCw?;f NѦڵ.S[0k}'z /f |ᙥ)-Rǟ/l?DBg܎cN0MC! &@kkߩPҤ噧\<;J1J#5Hge8~>qcg>EmފV<'ᆘb"#5`~n2lˉ3C!u،_可>of_Yx*ٳ7k]%ڞW*稑 οhxfa=l'湿{d!'>3pBmбPwJAL<@ד =gХz7X28QE紙Ƭ1V$ʘs"x,WH:QV6 <~K%H (oZ@4Ur,Ƞ$T>Ջ`|&Keg fQ )Mţ5͊|@6I$G(MJ ?y<37e|b-r<)T:0QUlXnb|k̼9E]1iv 1NVU\[Fy}ߌU%miv(քF&5&B[з몧} G͔kK s:&7x_O#sI%*!*3.]7c_!uWi-u39 Nb{G,"Vs<<,E*8݅ (]W\1M> f7*mʪ27a@/?t>xyClR&ufv ʂQ;f xwumHFEQJ m9Y3 am}xo\9y{8v-!4j!RQsy<'%8BP3"j*vf%މ0 D GgD"r l}o1gf%c54:kɿ0]c*<n _Y?5ۊ;̶W=t,$1 ' aAIE"ǣ ޹G%ZNG{l/494i2۵S"3m*i3U鍛JHȥ+^ݴ^Vؓ 3=i|CLO%W1݀erM˶(y`gY{Te\ ^8h2dCŃ>hUo75EťZJ &ducx_CY!H@d 8 0 (x*u6oL֝&{uGcԱu)1ܢɓf&G$rB!@x 4ij/? J@*8mSȤ5aIdwtM6ԃ ٙn*?"8diskuQ7̧n Hg3GiZ.tQ9•T35 6i;Dz\菪5B'b,M:ęa B *?^<:b+ SE zv5[f-?+ FdlPhmHHdSf]@ȏ<-\̣5&'dO!AH$ '۞.Y! A* 3 !hVJ; L.&Yr[ +d NZR `S+Xl;낹*YhG,D 7˂cSh^w8Jn[]Y-&L#b!FVڠQS`Qo >c/1=p(;Zx >V 8VRS#Ą%F#c͔L|:Il+ȸno0@ϑI75WsC2ߎ'm9!?%ꎃx^GiguȎ"55>Y]S]-A} |ZYeRPߍΎCVKV&wԿVVh^w 2ءW$kDVg׊ \<"-j@qG200[ |m 6I$FїLt8I8[T &\ @KBϋW]^9Wڅ`<1DjU+#$L0pfA@YD" Ww!=T8lqf *0M >hC(Ac>f65&%|\>k#P1 ^,O d%joӰ !U0Ax5)jX*B 2nP ODoR|A @ gM׌DŽEiZ,K$+~!#wȼN`izVmc@"'ߐdQd/ۂg< ]b*3<&I|#ma?us9!SDE`҂OiÄ+tLva c RJ20K98< ݂@sMXb Vghty@.6L ;w7VO*:XXǖr68(ĴhNG%Nmh.z;:idQ?kSM<*EJМyd9 8M%6&80}fj>/Yl8˂RR虯b=5~}an&X@j#nP -t[3ŀ(E̕hL wQSfØ.E.L1z)JTt_FTߨnQ}Rlэ1`UcI\q2ˑh8.YyэB.QX8i|6p4 \fL zH %M Fi%_'dbGel}`;¢4RFsQL![KQhuaK i,A0>Qgo hz>2\q`Mܙj_.Nn 0_zizn{&vpp0}9:y DQ발' !~tumu'_uQ3Y O48#%S/H4aQW[T'k `ڽ9U[%/*5O{ؾ}j,rH8bG(w[SG  b,)~]K^nQJO1#B*(ZҫW/6eRYyѣݶm'K8^8xSBKx\yiI8}@#*CvKK<x Ym'o7#ip1|c-M*E6FLmƉn>1#~avSR>,ckWLBU;[ }?Wu@.yZಕ*,Vh[ʇ4r{Uӆ~rE'r\pRX*ϼyS ) (|î缪 Rӭ0mUodYvk)FP՜i|pP2xQ{]r 'G m m٬j544YRߞ:}eɓN.oYϒ'[sw]o] _ɧ+\ST_t8Ljщr |Oy(Uܴe Մ~ӷ {.p|Ctrpxa|ȑWZͿ[6oĵE3ԋg]=G꧖!:ڛV.*v_puuyܶ\USޔ&uŮ{tĄʧ_ '1m/4fj]$cbuW寏]4׹l;g.Ν{U*Z5淉h(o^cױ! p'h-5p muW>V{c#,Eu>6ԢTt*Leڄoxowec\w,Gת|@$Re[ $SvSbw~c;2QھU=\;V} Fӌ7|:[ ΒԈcSshWgdd C,7L`Xa#50pB+kk;?ɪ~}άr|_;agul597لμڹhoyx¾]Z 'Rtv8;7 uw=^6j/h-g kV\.ȅ#ߌ79Y~a#wM?}Ͽ:ޔQApEA6UN̾v#~Df>r:+56 qVi@Ӵg](so> ʾ# l=gkyQ{ =^!@O,x:$Ʊ\MD{I| -w\؎;}{g2b%#3]v/]5|څD})nd6_!Fd?a=lFXǫӞv wFSgM&%,viֆƼ,}x /ܹK2UĈ;Ql5c|gfz|pWJ86@x(Sr2~fJcEξ~Vk\S㘽Eegꦈf`.kQPbpTɼtYmsmrO&HLdGbbr #H=un| RWw?S}hgV'Fe۲7.Y9َp\H*\4cBK'\ʹuؠ9hp!JLK@EM*䊌Yt.W/QB xk%iP3A&}Jn 퐬GI]ǚPU~~*+^^S߯(ޢtXo𾇞i -(9T{W'Zme̓w }F];UW9q71Ȃ0_[W cfDPCBe I:4<|Ƽ" *>b]=eQ~HK?+0mCO߰ Co?sֈݟ~vEX` ^~dp}z }9nE /u${Kq># 0̯!j1瓍Y3C.YNfPӐv_A-֦I=[^J630å L5{+3K2cEuw"M-hCLj @L)Fm,3J =a e'fZs40|fv4E+/ÖCA2I[xj΄0:zN4N8 jv*,exEoqp,Ň[΀-&W>)ty@>?3 k9E8wk\/1Ӗn-`zr>ʕJF=PEn,yx&TY,P֬dzE= et6Ơ;H۲S"='ڠ}Qǰ'1DGAEosܾбSr)UpD\a@F̌?pkcGg*"w嶙 2nJAwczθ+gV\sW̸ R7ګWQgZgV?G#߿_\. 9`9Iwւ9m8de3Ѯ:)8㡇epg[QCu`t #wtDb﫪sa"u|Ro.A#z(r~R"Ks/_}YW[LRopL/(RԮTsu";>t5{kwpؼPN5.{҄̂f/Xzo3~  ?~eIrQWpm!RɓzP3cţKoLng@mXS~}YҶ}͞zAy'Tu0PE5iEZvc(b_Pہ+8q㠿%ӓiɻdӺ$O6h>Ԟsdt?dؕWM4BFlJY-5"3| kK/8#7=1-hW=XH44~`=ou>d1#^Rft$DO\Л#%m_uy[$fv]W"7ݼ䅑ݝOG;/?DaDSndkRձ\cf?L']wi~)xrz`KD\mU27ʓK8o{&*0oA,3@t/oN4qAhᄌc& ;i:(}s\U[Չ=fl(0$mA=vWQ5Àݠ 5| hWlHJ,{ቄɂ[aq' I?x8(]IV́:YqUmCqP@KzX K(dTx ڷ7nh٩1_nQ%SOBUAtʲ,V_]@%tQD9d?LLMQk -la\[̰õJL=XRtV?l-=lcX-ݞc%Z) 'p#U7jmsVFjԭfFwqA6Ul'uE. p%Š)ǍH lˉX(Bߌ*ڋTC[Mk$N0I#&9nQ @M:ۍ fH  #+=x&1SmQbm $zPJW 뒽t}ډi6נ m-@[$ 硋*X}a|лʓ"\R=5,wjbOB?uZ,z< ^񻩘ֳ N Shxz i,Ƹl{Fm'fTBd)`ӝ!>*ňrY2L&PEпp0,p;*.1K5X8Ԡ>=t^ dpԓd0QՈJQ+}_Xax >A!:7xEt0mNxy!!D=З@udyHl u|ۆ'2*τq<1I Ć>!]4ϫyX!v`W[ɈnBeK$ǂ%AM+ 旎# @@'Vm vXC`S$c#uO>Cfl5 nѣ|HM!^|&K ;a"ѥ9;7)¨0APT֮{g>LBg .A . 4#TѠ ̸wd~GC/3=8,F|ꫣC/yf] ~mp1֍w(&C< dxBtkD&p b&ooܾ/cRձGM-•m6Q^v60_'#FS5"vd $ *\3":1öÒ"V{QBϝq9:?0leFB+%޴ D|8:Z-FXui%&xgzFY̶M`H^-VZ65d7P-C6| AajD ifW{:X6=MC B8..$a˅b;¶!9 Q}& dbƾ{N#gcyF}aT]8 )L)WILjZ5kݐ*I6Љ ESLݲ FCKDEnZae&0`DË% 'x1! Mc2(nC:6u:;yEct u]U~avtr2OZ#.JFqG!у ,OW?| hBO-Q.H/ce>E1 h [S]ܜ 7)!4Ý12 x#o`[ h`#!/O \)>LHBZLlLR^' 2O܂*u` L l :|k̇8JȱxC:o@6By8813 0V("pRҮ_Ʊi1팈µN!iW̢+>*tFYDIPQ%V':{G\;a>dFHU`394s@3cq &`蛈4SX4!p[+@02,$m@'r~[$…L.6o1D] q dE,b#AS1§ [׀#%K-T`"N5$vt]Dɵ,e+LmQ`ʩk)pѤ[(GugA >$4ΎQu84/XWDk#x5#f!G8kipLEG\t" f5AVvX^Lɑ:~)/gmYjcD`#@i#aVuu0`WM dIH2-;lYpgBDXp3NJAanԖRY&u `zZtz( f s[S`&9ڰ؅7G̃AMox }RIhgCTBW,n0 6cE١ 34IP>2oꛦM}Lw6F@D2t:f#s&>+=/e`4f Cj/' 0Mck'b1 VT`gkm'0 1'%j!)cr0%FSh0V(wݠa*T;a~f>cAuuSM@gZg ;y&2pd*YfNX'@}TԽl})@vE,w_q9Kt]XBb”f %1>ojmBNo(p,,~ѧ㤿rIx9nݭp WH&kk`EC0n֑Mi\E_cZD6n?Wv̳|/`I"CHrәmԧtxY4҂mVhr7q(jKRʆ :S1i7 md[X> AB"eB+Zt=sἎ!dkvȝ9 882k@G*(#(CTs~Y;76i`m9ѷF**"9-0B a,Y^tmڮEFEL=}@h>}fGA<"0hLtfKw}~H}>L0hcFd`0уȃY)x+ȻEO--=ڀr#0ARL5 ׷;~so?4kܔ ϚQt/<5~%R ެ7%Kzr|ў|23XG)`qi”F+_`ԁه߾}MM=Y w ;_$P A?ILj6Kj}b?̒ K9>gBn hky i2srfF"*r0JӒ[!:w #.AfysjW&)O~m1)byM/sߝE۞yޱ.jǰ:f%7v"6-=}rYH=ę3صۯ,sw]gW(pt_'@}B&Aj@sGz͎Ъ3;R'caGc'gF|OAD}={IvыW.gc}PIS8?bĉ:{Uӱg V~^>G-MMXtj#+@OG$JWn)UiasT'IbTT:N b̹7E}wׁ!O@aowp7elU-;Hc,"viڒV$VoN(+qՑϛ?/oxǚs^ЬfMd×fIir6ɿj MV:{\WEW5n1:6e9ݳ+&p^=;|›,^|Mv;ۏN:{k `tyx96y<7]/!n;֐$-U=zґ7>^do%Y\HMIщ EWO%;f]tK^"x۠KP]ȭi%+?/'u^kw6w7Iꙗ9 Nzv5v4*nc&>:gKIo V}*>^מ3cq%Omu.,V41usݲy𣫯(%a˗QZ" gJ}֑JwZ$ -fЊ;pތY]gW}y/xߒ2껋$2}|cw'kw NOr}\?-^eڰaD  bvAq;JҪےO`{;;b`f;C~?]6yxM'zWxcF2SL]=s5֣00.*UTcJpX6c?WFn RQϥSƢҿ`=' ],=X -{KZ.Wr/f(h,xDu+߽vfѓ%.[8MwNG :Ɯ1 {ϴk^e#EV>,7 `M.Fw_{F͑Z{k^}W_ݴpQr8~;P뮴tRT׵kvmw:$in8Nzߺ-k{'-̹m pk߀U<('J)I/_pyVա.ϯb;<}`ζuCf^ѓ]AD'j(30t2}AFV=`ȁ=mkwlbȂܹso[h$1Z펽k)άmK* ;+eSpmMҿ˗z(3;ҫJqO{W^>_| [:kĔ$ç'&վGL=5ka}ފ Qd1p /MJԣ}qҰĖ]5锗T\b-u}BA1k =0jv`쥧 &Ӷ6Ǯ|'6ZǕK}*cw+N 3ٱBYIt62phiooncf)=o}w >{̲=܌9 ].PJhbb FKDܞ :D$R]&Zg ќeZ񮣏s7?.1DzYϾzO0+0Jʲ!AhNj) N/K/2:%K(2|,%%^[gd#NJ;Y]ɇ6c}tbNiDeYY}eOwϞ[y]^xez= ˆl'ns^>eXBsbw ]K>0َ^#s˱ӈeoN}-ҥvּcķrБ.{Hd" ҔCzH|;s CsM=MZ~f\epS&N2I`..i2=+e1ݟ0qb|[̷7t{Q , Imm|J-y,d>].B-);4='XPXQ/trBSǩ5հ]Igل;>-|S6 1ꨟcό^9[8MglZ(d'ke0s0O b(ݞY)g7vK۴ۼ{u-,ΧK?Td#bGSddv:(L~#MEC0"@L|p͡_nMmk͠~+W>$垒g^)**ZWN~2x>P52ֵN)x~u-l]i}0$ΠfК6L,ɆCCF6c#&V^ރ뮜yd-gV.H`$m zB:SYWg- sˑ[~?u^{[ȉ9Vı=lɣ Y VNõϙk+6eGF ~pp.wZꩾ9l;Z&2F ΣgL,hP9cxF(U+/|G{'n(}z\&rT)jĝ$$! qº,.!F mD'6qoSsrcn7;]]u=yG D]ބǎiР,|rݻ\tٚJd=zy@2r'~3up#wI|@LB)z\, @kkLĂ'^.Zht71/cd_ܳ_܌["D@~Q+bc;ؿnXiRFd}vßL⏪)813xgĊ=7~vU\ɍ2=,n)0cq.0ݞ Nz($eYqu[ܻzMj7~ȳ8(**d5bU |x%v]92p`(je@QۃS~>DNݽ\SٺsjYAu*Hf*\ !V]-"I+W&jjK/9 ;czbgEK& ySsڰiXl% be[d+W+XG MJ5%ӨieYEzt5R%+=;6/tzC,.KVnJ5n4i)JڰLtyq twV#\3Sad)xwN[sw$9\G\<ߒEFߙO^]ښ|35:lXgQaǺ@]$;!wqج>yY|Q:> X8n4h {= z$(k]3T&"UG'{ҶI/O@[C6aTpk17g[dN9 fxMH3 8&qȩQ(HOLMGڣe@acuf?#y- , u)]*Ɣ+8q64v  i-J(he_^ވ5f ]!_i vAC @̓t &*nI*8b0qМḏ8_$:m\!1BslJ` 6pJv ±8X/n٭`ZFXOh $yqۉ{g" MǞUs|x]6^pg!fpsjAc Y* C W2fwxӸCI)BEs`=$XR$1O'ae.9 ,ȃkPn`W8=$6 :p:($pP9w#x66^JKP$tjk!~FpR_&dFLdp#x&3Feoe_)p 7'2 ,`6/ d-@Z̀ gyHvAF!1i&+a{wy/=Es[vpϣLkW29h>Lыɸc ܁nG,n{Y%l'F7z,މÑb̍lzs,W;13, oAƅD$$fl~22w gl DarDlBMƓE9CDg6R&F-lSLЩ<wSv)~7Sf4IJi\]"X6A5xFC{-$;4\Q,cr70X,$ElD ޹ZL G%{ܝa!BAEg(;֬01 ib46n`ݟf$݈# 4 ?}woGfMs`@'o a aJ`:Q&bQ#N"lH e*؍BA`$+k35X`c,xOǡB ebɛe!B$BhB)Y9Qgk#3{x(c31XZu L.\1/,3Yv#p:0(yl 3'<с)֋Pgc0E:Cc!.YbFtP迷 e*2 RCXʰ+183uD Go:ezeH(TTg R_au0HKXJYhbLMo@,ݳPFC5}9Q`(o7Q˝ lmjv ${A˩wCfBOyE{_ͭ]VVzI^XN0޺ .ںּ0; VV"2^AiF7ޖ LU{eIia/| ?cP@7 |{J.1(@L#0u|uzЕ<.C6 ^ZxϦiM C5a37@L=K8pL(y ?xf7f[^4gz qo/`W&W`ȋf_&#:t}Am67PehQTX֖9/"uauģ=MW6_ܬf6~ᙍzGMe؝c"jd){˖%yvW_Y}s@6yQOL0xd z^Y'>{ș 7 ;odUp,bj.#HȞ)ʄ9vz[{ȫ:G ;Ҭ7Mo϶ ד-{Ͱ8;dOW, < a؛l×zv(>5PcK@|)dN^=R=#fot~3NǢmQht1Ɋz:zBr'LJƦFRˍ@nr#1s̪:HΡ-6 #QfR՜F?`QX_՝+&Z%"?2EO}P} dh.'rp}"?qD2D#:,S mm8qwy7t-7{GHcvmϚNʊw-Nlym/ɤx5uAp>ȍ@nr#mQ-$ *#SC%Ђ^Ͻ .R%Ex%(:۴ .Xtw+[00XY3=NEMV1/{Ko"pN`#)wFs#(G:0Б18)4pŮd"0HwԬַj |U@Ħ ʩ/(I.d2er5#ug_aρqŔM%IudX&m2ު+˲iBBeu`' Vf\ӱla?g2'Erуt:7ȍX NXRRPTX_[}S҆`;o~mK!υH AI/COsWs%,obb(~`d H(u +kd/Z'3=N#H}#.F9C "aqA9&D|WI9runr#?4aD sPW&`IyZDTEKkֹt;<޺ *iAu9sQ9"`GP@${%vOa Gnr#|+[Ge _}uWu!тJ:2lA~9 u*7:A!+`|(Abs9xb[e.-nu.!\L]ɹ#΍@nFfڊefXbMmS3;гf,('τyYZ:QF 7ȍ @v2#+oCY655oYRLKE*J("f 4<-z/2~B+~0 gz^ߕ{#7ȍ~j528SnOp8"+ې~+S`O&ሿ_O$RzBm 3Kճ1>+ @Lo3=k7yf?}~coN7FZN̹ٙ6,)Q<8z(Iw+.阂LOP(hHp޷Z@@Yix Xvx ywVxXVg%C_գ),(g7{3GA߯Nw#u\x:7g9N%N.!gj<m[L;& J ,b" 5v8nz/9"\%Is(fQؗ~?=D6$|/;T}w3`lX 䁢=QsC5g X#9`B@Zښ~YKwxgpbbMDZ5_vM3$v."As"s&`Ԉ_mXPq͆@{|"4j)mG6/>4Ȗ\yzg3%` 3IYAn{98( XA [f31+aq#pv7dm<7#L!:D^Eބ{/[x p,&@bl}|qd3l})[~EcNPٿ{V`g ޡ`xh?lO{3(1o.*4h^iaY[oWO9Ub ʹGnZ?l@b j@ >w^4= ,G .L)BprIY7%lz-ߎ"+ۅ۞U`61bh*QK~#Zd8("iOB Qi6t\(5Pɕ;n Y'kt`r)(ω>khlEYy9rzlp@}=Aa4S}jE0,/ )(xJDjvRBچъNP>E5-A3,uF;> muSNY;5P \0 =OO4?.+x_)[,xѰqLK%pNZ ;wLCFf\.ʋ !҂%m^8@P_/S (V0( !j>u‚hMwM \tA)獸jS%I .F%0ge^*!w CUy[TOZBZI{l(V+8n]=9~ OZd^RY6SK&! TZyGÀ֔F0u"'ݎ$W%t$%ID|O %]t0u>C`{1nje”Y1d3LOYN +[lC$9FADMW<\d1|ebIj|۰jfrϿ]rX1n^D& M4yɶ߸~_l}7RMhi3oRwu N"`^\!mxX+1}ʠnbOZ_J"[1p@ 2.N:Fpq@6N)'V~%qKG{ǹ(AFQaCikK eF!UZցh'O\|Y>9OhI?ۮ -\Ѳp'Ul}[6 Z%;-FRUjQV>'کJ8-*k]%O[v_>5v3/i/ !+5Ŷl-ܵv(Eۢ,tGx,&F,JWaOS8g N4XJq#~-?3}WvۈoN[TMtݬfqQj|#߼Z#ojNյuW''noa{]lw 4.Mrmj)ԯFN>i:fdW߾.>W ieBw> F?]J& )N}MZk{1^Zy#Es޽ct*(ڛoYJ^P T׺q>2׎;bGW߫o'߲uP4B ;R͵wr_}kHYpnO^yU|_Kg }F+ч<7 ؉:hV^Y0ww772M 9wZ;|ÄɘT:'HLl9Op͝)~te/?Ч->cfKa>#eՉ9/=q6oĽQg _Ě:2yX*AwKVy ikC^w}{coYwԶ3-ON#[>a)Yb"nϩm:@{n_3fڶ.\oP!ϑܶ#LJ96652^^ڤe Jψߧ,/F&"IJ&U\X҄Sd'Lִju<ֶ3߀Od<',SNI#><~?2^=jLɎʒ5 :;rȻyCn}}ܠ.ް^'U2Î'Qڱ]Kv܎wV0Wrds}YXARhJ:-`wzIsPbSNc7߲'_usǫ vܑ] vy2v1o'b=:{oVkV_ **֞>|x]=pۅtJF7 AL*ɉ\YλW.Kq+URM۝-2:g^ךNB!fx7".Otoyg媴"oYF/B>gtx^;!]`=Y{t]fY:" HhXk'OܭߥERa]p{}QJ8N}> ߷j]>l#0j[0v?5i\lWӦJ33{1}#qyv'ge1=_V>{=f.0D"T˿l _~a=>zk.o:~¿;'_y9Tu0ȹGn"p'e t|S]M B|qYcۍ e Rb, y#i LuŪ350,  U%z><s5봐x\~]q$q46 O1^|:>Q6s߮s*@!>C^uK5Fjd]5 {="AQHFöꐡw< LEY..-,Æu؏ESMr -;cvROzc3ft+5*}y 0Nrrf/;ѕk_so3ٵ` Lmf!qjbc =+O2dysѬ+YO-SO y^;ppDަƌ Nwnڜjtu2>4 >cc,vA)Oo3t%m\]Sդ|Ar#yמl`P-!Ҫ7,=%\^ױ"n JX0uԅ]vU;G7c\k? *+CIsa8,S59_wcs˓ԧŮ3@pe005gvz̍t^ ֭!A \L ;q3?wn7&yA>_ 1qe;+ī#gu/\efn']ѹzÖknj)~Ŏ}L$!ud>ry`[XP+Wf6Q x"C` 4zo7n|;w>GKנ=n̠ز(Ƕ{/yI3_Ȱqq0b?z/:e`\~y~7qqX\s:nr}kޯm(~XWb~0Ț2啫؉3ei!{rݶ;']G՞I+)R5k>^mD+h;w\ѿܲ58ɍԑ/}bzjq<y6x?_xˁ;~يԇW,붣jКK~dÌ'6}}򄊥W-o>O9ߥa-aEMb)mk\VG~ CBȉBɌfjJ& #?;?gkVGq$@A\""$.Se>Ai|>\UKr > gal7(H&ljUN 5bt]AB:;(pE ј,Wh}]@eLapr ^к]ŏx"@P7O8UD;JmI( Z<3H&H*ðvL 4 Ly<*HbyA5N.z"ȺDZvM bD IPi),lt*C9'- GUVS8lGen#($CR&e`h|ϳ,m`L(iq$332Kp<;fCB2<@QCf Dy=@@cm~ _&9r;RwyFAL(WŮng fPi"w\Jqr)Ab|=oe("4#`Dx@qQ4?Rfm{L5rmS.&H*%j!J>BL(sA!Q( TNC@Rˑ#4J)$Y3(Κ1$TlwAhrlGXBq"<kW&"|>AoC, U@THWMc<tn ,>>#4Q(;!lT_O@uzl]Ɓ;(%FnMy)$v !Կ ̮ԂsjCu_Ԩ_t*ftxx9frhTiFòM >Ŵ"R prgQOPd!ap<: S̈"V,BXøp!Kp3cn<G\ # ]wpkH4)c6«F)H>pD֌)&7ƅdz$(ۺl#$L_N<< 5H #5ʇt#- x7 Ĭg) YJ3@X'n&5\lS`0@y E9!eɚgxi{g9|eM\1l$Gl L gŞ#zV:l7>Kʮ/MR3shSÇތK-g{afƎxc 5 !=gok7APTR7N;qG٥~!ߑ=`aDPOGQy:pa,l,S50"H,D:NARH-@ ")m,$@<1I.1Ku"q:,+^ vPXuqK2.Tx%S( [9u sD.aEA+U@ Ph#ZwPK~ J'A.m;&$,pAB1hAwx5SWU8˲FHDmDѥ v)H(EjYCw[qc[%.#dvW |F]i!aLzQf9.[!y" *DZCv{@X"d+P4@_٦pBZw)buγdE-fegLg$.jJi0T`"IP óqbG9N?8bWEɅu$~ kq_tuͨDl) /IPZI|qaUT'9;(Ҭ+Q@p\BL`5VNW!\ִS I5UI}|맸 Jt`0p>0 An…{J e j}8\~7[ |tӠaV<>ϵ|mw,vU3"~A5ѯӤ G|3-e+F*:q M"mVqHԂqh63FA m烘)θ_H̩A^m+hHOZ2cR}a`D5vb8+]ZT$Nu(9VuA9! ә"bӬa{LddNM; ˜4` %6$PGQTHk1ɇcZ!(?&h?%HS*"r*M]j唪mP`vBjʖ4Ejw.HA²[bJ-L0Blŕ8PfrEL4 zǰ8 "yX5kI:{7o7^_ C>h03< HQaQ+ |l+_XV 5)hJ5*4G=/L9#:BTFM&Ӥ7Z)(0h`յsPv풪@?hA= J5ُ+TPDba1dס2WIǵk AUGx/ }ll[pD<XwԼm vLB&Aŕ|aUJ.tU[e> ʥFF`R9Q@W錬< H3T˄00)XG/BHQA]qe(ݯy:d"_̛v 9z;RɲBK_v-XZ]VEVyCN4jnㅗ!u SkX0jvKiN!"xQE-vmL UTy:^O%PLq̈;p{%&J%H\|;2>U)F5TtSAD$hBYIWrc)ݭL5%R0mNOT圄O2ɸ+_>#Q? dGL -x Z tvl)SURe3]E؎Z I>3E ڤ)@j2u[ki-~u9;P}qH{wf|c˺U):r[~a/MRisƃH~&!Z1f1PaXH)M& P+< U@=sҮч~wVe$R;"B (iTe_FzzиKJ[[.>qC'T;$9l!Վk0. i0\I)/)9M,nm:O1ʛ?)-X<@I35aq]Kk༊J z{,j; O@_.tNVXR͌6QPDd$4R#0ycM:Of>ek(ڰ]5Ad)V1޵\e&oM?&^iGPCUiO[Wy_'`)2EXF/1zMf +_w21AA7F0Y&0:dx &ƕ!aqX?\:N٢԰u4r}O8sY_{]0&]$]5W|߱Lo5mb/lָR}.qʳ}pK\f〚eD?;wWE!4rʛ>wnD0sgaG>ZؗXeXnxx (i4ȁ篺aO{? .CQ&HZ!7[}(Q4R!%a }F]i M{6Sjj_WئɫpB/igm[O9W"H R`nF*4 & 9E2 uOq% &U6^J|.J|ys8k%]sy/.?E V~C2ŦѓL76Eh2@M>}~ Uqd=r \ :_ UXy%奯dgf^ k⢠xEݴ~˝HO/G+5?Ѣ:ۈ@ SuwuCLsʀkQ]WI6ʷW;S|Hl<>}-S2n̐FoQkLhhդm'\95{Ecgȫ&k[09klsY3?W+]Y=fg9j(Ӗb%QV7])ŷ;kځꦪ|&\41@n]!nVx۷oi/}ŕw4TJnEmI0 o]uۣc& V wh|;wOvvmm^</}?vEuaӆQr%zR`Ia)ncG<1 f=;]8LђI6Y\;_Zaiw`';c}_1'˲'!Ű~Tᠼ=:$)P[E6חj_ʚ>ݐ2<CK J$1*œ~2~{/l8K1~#?2Ra%)=Ow4K\@{CSڝoe}~D)w{Z~3o }گ,궭^$E_ߘ7N=UlQ'Tok]#D(Q@atb}5n㭗Njܤ]SN;󯟴!ᔈN :>}i`s+no_dwҶ0Tt֛Ne+?+[56 Ư$nXmeKJKaWi`7>Ms>OM|Sϝ_Ɲ2C Qs+-P,h$2y'2RkzѺo;~O3mcv~qB+L7-]^ ]4,~D+{}o-]fty+6{(9QCv֝Dms;: ]kT<0-8#duBk:K)O?hc yھ$cB'ꊃe[W_{kds;G39}Ӄ׈ ;\Aи̞M]Au}\|BxkW6`M2a=.S;51 4947h>CH+ꮙhE%OwkF7 |'1;4Qdƒ*._: w=2G+WK.q]?/jv)߭ ;\7hnK-k!c/tʤJ!r܇|W\7Z4]UVt[W]wx|^{˯6^# ˼[Գ4ѝ#uK&=]Aw_<2 4v:`GOhQ5HAg;@d }s$pa?Ȍvg~iew R7c%'ǒ΅W׳λ'R*jR iw^+Oo rg8lwh{"$&q\gN`Ȧ{.H'4A.ȣS{C^ =0XwȪ\~Pp&w+|! uD+=@v' fr}jTNdK(ʾe˰c׊VAND nHq;"nw8&0%m9< 9&pn)˗޼)eK?zqw(Dtb6Cs%E5nA Ge2H%&)SS$)c/EZiF\so+ʦ;CG'G4-vp_3/=53L qeR2|ݝ .`@XWEVu| y2w=>)ous ptAٖ[n/SwU!3,0hzfW~U4L80ڹ]!?֎yCqugKU7܃rZ3KQuF9T(_v>}}^3#'9O^"層E]t3/ bqA ]RQ'tϸͻ+JL$_-==@2({waӲf>矵zãj.+7cXuqȓRb !puzwCO8I v]] Bf!?<rp-!{e&4UN/OIRZ bI]s# ={M{i;ۖ5ZICٱMkO[['tIׅ}Bi"uʬgm|sw%ᄚ{ϜK8N+2Sn>'Sh oHk<1b\ &/z#uX؎ry0Z\؁}'-٤}(ǿl|̀ݝq8)ZhˋZ|I'"7\rsO4WZ lXD3zgϑL'[xCT " 9#l|_*/}V'Sq;g-[ָu[6tG;yW BIQW P;Hu :=%@FBPtӓmvw'+[zـP3f{Q}xnzvXb"(?5H Q_䱍[_Jֺօy[~Vhg7[ȳCͩ΂gݎTVtЁ-{y|a>a.&/x'OZOh ʓpQO3kw+!ڡ1w{Q D^xm`eग_7T^xů E tj r$-i#($)ͻӮsEfN_~G۷; YmYF;)KųSLi 9]V`@z"$(%L8v%EWvixpwLH^n:B"c`Zς;c澸+wܬevdQ(̞N aB{ HPE8mD}Μ؟?A;X7-NQ5t/xso\1`1+D>̧$əleܹcV8``!#f&S!jun-' o}o6{a͚%_q;y-z꺯LN!PjM|%3!E> ? f 8GL+Dd#{ ^)/IdtG p~i#S_h) de+7pѪgZN\KѾ뀈*L!bfbJlxş/;ayߧHl6.V-\ZZak*xtHAY5Ӻ|m3,x5K>SD\qpOE L` ^xKϭXm2H@<ݩe5~3O"ޛ׵x@ݞc]{[k鏴]|9 V֬PԶasMʵ\i4{{i}V$k]3rE"?oܲ3IItY6a}-_kׅvPnV<< fLGdZA0Ʃ%_Q2Tǒ gkkUGX$gVT3` /SNGuXj# /ZV<+_h#Xw~aNI Je;7,=3.2DJ?$lq/x&TְY?RT1_&gU$,E}׌\4yFO,M;*_Q[궪q[-{|P|no=.[-_Ι*׶GW/;>tZ^F HFÐP8dO4J-߆%_]z ߴyg 4u-ll?g 1hSP5A|۪ijbyMoG= [Xۧ+Nͤ̂M;J۱Jjo/^Y;ntgtKkep**v|6׽r[vNj 9|g8 -\,XeGRoё n؁[Bc8ća@dLtN A:zv0?FVj`tT iy FqNfQ8HԐCQ<)Hcu")bll)ȣwwX0BuJXW26*UH-J+'or7bꀅ ZFͮ'8/R(J#tQڏ{Z]lY!)&y\J0$B@S(5lzNltiЦX2oÜ݉[_lFt4PT` y[V@&AAe;sF#.cXxy.ϷCa RY#`ZGS\fGeD0"ʠP4w,?-/|'յka^a,)/,TdaP %nT1Yځ{)R Q?٘b Jp%XԀ @QC+f Ls{{3[=%z* y3%@ҚL hU( R!l$Q<J2bwb:&"'[1 ({1&D ?Xpl1{F2),<0`UF-{Q=S?EiX b!K#DDZ,` iM`nDA>6@ _:\ׂg ,vA (=>DPOl ox#|ÔAъdt8,Yfh"X0"bLu`S8Nbi y:(t= r18WEpS&m< bn)U{RuOs=r#p$\yMh^94A,I$7:Rb( "SLrL ZU/8BiChE0]2tl&I:a$!Юq| Q1+( HH?}!ne@&~CTflCpR$]πK5<4xQj~$o< 4 X:,a=jY#6&[1/ѬMvV E C wP0'1$H߀ H_ifQvNa}[7L=&;Z `^m΁<$VǨ6UdΛMN=m`Wء!b.;4`ȑcCX|@`ovl*@>wa¹UvAD,p}ʠ؃.qa&hP%T!m evbɾIC" Kє)ۘ? 1DpB6r,e.o0c)`DK``[D[Ěwio1-fd»aMR|da@=(fAoϽ f俘XTj+0MA$!ƋYT1A`(z]#hv +z0(N 1Gr~u)Zc F~n!i)ю3pa"Hh…Lc/t>8 1P;(kg"BB'm*4 .v)qbt--;&-S$٧,PZBEEe676@+?1,V y"WS "H oڼ[f{h+ ;gw 8sT&Q & LZ:1p(hacp -8 ҝ*ȋ_7ypAEdF_]WF@g"o!,>bCyI000 ͪsLE,<)#O!ДyoiXDhOa&d2]pJQudMQ;|5d#9VaSn_f]u+ٔYtЦQ%ڑo4hٹc6m9 dmqPb ;^%>EGcY0_h) [e$s$(!p$Vq06T늶l}D.d qTj5ym|ma%+o#p Ͽegڇ im`PvŠ #7QKAzF!$uH!;oc;O ԤN .v܉C} _T>SyF=Xߧ ޔEٞ/oθ/}_GUAP0FH$a"~?pe w5qH:El$l?YQ_ J[ ?U\텕焗#/ by~~WN( #P'-yB7;)K>5?rwM1s`~dӦX _a<!,,l!J %Ţe(,_hP_C! |@wT*"3L9 \Ųr %Iyy `5/P++ vg!‘-&>W9~_y&\HOB7U-dG=e!hࢶW Yzg]u}gmSI'9/Ԇz[}dLAڈ%*KI*(Yc;~e-mxe낲v j)(L'jx|7kmG@ vIQuבfcᨕ`;B;|Æu'^F-QOq!3]X)vmfrNyǞXs/K]zx7Kï]vX)Uv>n~`6 $$q?ۺ^ls8$?m5㮺ܔ/*2Go~\}o|z~nBu c5$ ۺM&ZT2 W=Ok %OrvS)D J6L )VTsH]wm+Vѝ>GNL:ys>LV%V WEPY_ uaaI6K]zpJvB(ģr0p>Qiw:ȊW2y#N 4_muknVB Lͺ \FAKYtK/&wo3xs`Uğ~樳5aaS6uZz/)vYbe} 38RVnõ| IvҘotc[E5ߘȧOO0.+[rMnFA=1b+ڹnn'{v+k\@)2`Px׮92h'HTNXw.p`V/w\;OngKzds z7 *E! -n ,~sTdx{A2S[Fx֍_ڿ!eNa33M6,bp ?xh7X_+(9x?ǝ xB=܋Ν{TV~ L@H yF<(A̶8@:Nf?Hc6su#̰`*.JpNKhf 7=zw `_O}VZũ fVCkI+[a[N;,VȩWc^}_?qȵ^:6P[RP`RRQG0"av)cRWS_\V\cC=Xx~vYz/`ȷZ@g?@93U]ଗt-MedӴ,Z ?>~ 5>3]5%sؐl)bH EKsEz&uat~&!+mn9x?ɺxauŚ3};K37-lA[>3noEN?VN3"&!-|@>C_krJ<%9Wlꅋ?_d A8 /剶c0l hhvs]2N@ke?hx y#~AcOC"SHC}s<h#;}'{Ǐ*f'݄&sF=?* 4rٔB7gܨĕDI DyO]㧢ub) c':x~O楓 .t<( ^veOI(BȢ.̶`U I H+F57q@%2li0E0L)NDKx^!Sm`3#,1Թ.: k=?}{k6ߐX;ٖՑ(_W `v: y:ųe7^p~W4H= Z:`g;_ٓ^z: |k̛q'q\LCڛCmq`< -RTn_/z'.,|€?b%YvM=+_Lu$F+ B#*{C`;MqD)c1ֺ>ڛ&n? |j+݅*v8(ψN LqȳnZI79ڒS/lS/fZzlQ g]vḭ8tL! ]D``uKz%3}`ҽw39ifz (,6>e+eѶY45BeI&A7;;'͸e80t>zF=pJ1V;_})7\ ʜز1U*HtI~O{"5b Z̥N% >衧dC_}*x͎%+s( pEbOM~& Kwliғ(ɎÑxO+CK$SX@ B;"ɫLD`H|K*v7VڱnmNv+HAτfC$kEӉه3ri`evrVys0#2&jA_giY<+t!"GpF<'#n߸4O8,Q4䒉(gR?ԗ'@jz QXڐ0t6;2_iFtI [qLi^F+Ys}E̠N5V~̶Dp4!!ۆ)fIC*0PLR AM8hp-;E!-bӛaLd]^CyD4ubNT& Z͜ԓp#>Ev/tDZ{=ICځ:PB F""Mœ #Zު' e4G!pbҁR$2Z|@3!`^f6mp;VSd)(eMFHl4`"DQNw+e2.Ti1](D,`؆ HzL M9tHݙ -x 3!$@0`z? 의Qv'E 'U]R!*tP0C q||UK"Vc^Ǫ486J=  i 4y X~$V;3(xx1 w6N:-6{4a(tmұ 먪7T757waudʨ*X &D`,$Dn*hn :M 13''eB('.𳓇C3(F1qc9B.lkH:#pRHIXSZ.pS\n7P7R0^TD;#p ŅNALLC'gL sL`9,.f7M O̝i@f $}Ҷb')XTs]H7 a :SF9ȖBq>OaWd&9;Y(Vf-`X5,}d "B$PX`;?ȷ CtTΓPGpzXbwҚݴhPh҇I DUC<.p_ TaDC!)f ?U]LFa =*FV3tsgsˁ0#FF 4lZ"CFC9]p‰ ߡI3U"GtlN) a+AI8]f42Uہ> Ig~Lx &D&\YXh>x'O2-+b`"OGk0 Lem.[ p01xewUnhRam(V[L=VH:ǘGJ%DEn-P6O' H ;E w$h4v -p<3Xq"0M߅" +\q0K!Q$tҎ"ۈe$.+O`V(TˀLU4R!E龺Ƒ bc2@v 1 18żw,ۆ TtpȈS!un& A`y'AJBmC}ow( 0/yC4DX J\T8EK2F I x)!q9%N2#v7`PF(DW~$¦ ^_)+ $Fypn!D6NL nQvMj'L|ns!y0&lQT @$ \X@\*SZu4JExMZ(\Dsfd񰦄8#9zGnsNHn#?u"&CJ {A"佰QA쬨_' 2Z{HQeFŢ]@|Tre7s"b @pD/aG.)pƺAT )(JЎcꇏ6pDB  -ņ+W*uP+hEGtE G࢒ߖJb"AdOf1Hтk5'Ìnӱbe "VKEÐP9HyXMPO`T8?1;:.yPgЭ :vTcHTl`:-ڢp#J;4 :>ؘ,HŖ*BW^l,mS7- &h\N$ Ypb并_ \Q ٶ*9tweZ0@r) KA=RI `6rwjF Da ! CTa|Of'XU R:vlŁ zDā*:Ohl`6ZkgT^qRQI*"1a cũb4b>0r%VW#VÒ /lOd^ػﶠ'G6*2 21ơF Y|Pa~1\8%yi1v<ڶ=jOx?b: V/8®6]ˋbI6_{$`B U&qP1 = pq$ `eBxMtLsĿsŔ8m*7r߶|qH(uw9}붇>[p7Ѫ<.Sa]7 û p+&C5*X"iQ'D9nוް۫n\^ S~%Wd.]Rז~pWYnԂB^Q҄J2z3͂YMGpXs>GdEat$iCUR_ \IijXBDEB")1Dm:C? =2O(>Y\ ~=X.|P_IM~a"^Y( ?%0_QA8c0(dm^ Z_X+aSً21ȮY8wiCdg! ܘ&*Ɨ!#RVǬ_jǎYHj7aZmƿUR0O61/;TU*|PzaV)}* $y~@@WH&?>$V" EUUD*{@a*Ȼ=t.-)'w J\4JSO^5 ºW)aRx˜*;S,tÄhE61G)R|1@>ė9m3jMGq5wQ9rF|q^3hh8s[eE>=MΝV4XjpĈCt>3v껊vś^iU_^Gƈ l>AbBX2#<Q+woQ=zwE (RY>E|\ Xqw8=mO~7)[ȮR?il,jwwseZtxBqO;BAٵ״ECu( dkH޴/W^ZKO[7ھuoϓFUfU;݆ΣGuK{GxƗ>74;FY:&!DU6i 3C8t5yKV+OqBۋ#Ie \jHfq#:(seKerpDzo?c{t|ug7w#xm2+mfOJ\tuhpǞ7K Č̍WՍǴߌB8E[`}[7@5S [) %Qtm5W_q̘ۮR4S=Hvuӑ {U mG{SE7fLK]bYw.LXrX =k|FثcMщE<K&duԃAa}@ ´^؏=: 0b6iLՑ)Ck姒Swo{ezw} t6ULw7IZ6x{z}"GOb)V$ѵlnӸӝ) "+ D v RY55R7niٗx/<2z+qZ+}>vJ(Ч4vɟ9D4$@2f' i=)T)/ژJH( d;.'A.hxӇp"H@5@LIrJs:$0nIB)^8H~Le@:@hCG,鬑G<uJ:'ӡj1zU$Ǥn0mԆB/z!.mܰ+F1f# @ xpQ횯:=~n\^zgK7f +V<D$P \0SJzZ {zDS#^v[ GYtؓl\̋SWb)P@H~3i$>Hw.z꾪g4׮LpoQ2i/W^ k#)n^ n&,ywpCE /輄."BzH#7GfbqGwD-tkaq1$b2j뀜O |:]m=6Ş?2ޔ¢Ҁ*T)-H1P il!Gg6PS Vaw>ﺁnxб-]r ̦%•.=|(l4JP; %-8ϿrmE]vh2l)HK?j3Yw}Xށsp?lnݧF8#~~?hvmW;,~YO['| F Ptf[S;JHKlIsxz $Bϧ ˘%7!OnX(1  QlB,q; h2A|JywP]n̒#aUO 86:Rw3>䴹W=`á~}EB͖0 SuC} N6 ߑs:m@sBCM %I…W /9n#M;'`H`[+.S6G{wv_1_i؅L5k zV?mMb:чE5JR1竷OPJ;Pagő3 +Ƽ8wI:3t (CD!)3L*TZ?.'!!@ !!+-?8P["R8u\[ {oNa9{K%$x^q|ވ;~ @6 MF3G͚qŤyɧrEG0zFݐ:dOzF<Ak";-Op 2_(gQ؀%$+'ks8ۗ?x~w]wHg< z_RrU?~7_IED^{BJۢHL'$#Q.ig0cW?tƦ=u7hT `jJ!Ӂۀ-PLH:J@cyR+" K*(nJ^ kWuW;Xifym ˗dZeݼ, ì$X(chy𖞭kgs|s? Qc2BJ߶MYR$)XRE ~6y%nl_oRhsztBc]eqsCl+>hzu摮XRa)C}+ ;ihi[BՏJQJ76۶˚-ZDoȇ7w"ߗ|ѷʠB/hqXX13 .RDЛ3x! }Q`lNPeH@n ǼLZذZp%&z0TGpq喯v ɧFYi>|9g㈳#'IΊy,ڛb[Q׮je-F/'"uRhaX&sKnj޹eč3p,*SPGƼbpJGrnQ[YZy+2D EKKqTm-]KXƺԇ6ZnbOA <$>B(f . ٢gkRAG'P)_wO8u#њM͗yh\.F7d+(, ojĭmEz2͑\{U`ˬlgB9,TQ״taC69B߉L lG;;`l!J}M|Vŗ9EWL4%>| O9up*=B/llH=!ϸr3,n2#%u'w+AJcbW֎-8W]Hp `'N%BX# b~w*B(=14+j GJD{ϕ@= u LR$Šxhd HٗOA6)~6珉qL.nz 5.iM*AdS1fT0+H@<%aFj,/x H%D 3;HGQ?*F@nE3n|- EH5-6฀|ᯬ K3>B*̡R*:0HY@f|P矏*ix( @O P3 G~ 1x RkǴudW`?xrwF vP8t!dF ;&D>b$Y[QTQDՄ4TED_) Vhl 35<h9XxzȷC$| Pb$wh1c8{6h3Z3ag(rqE[:=Q<<P!g5ؐp4"j _$6t4,NKvib@g]`"z G H9M X(4#4Y #NP_ 2-A$)0p٪BzSCBUC 575]5C0a R q|KS]Aj]SB4h-˃Ah)DlO42T{(^/f| R0[P ǁKo(wЎ)?=A݈s P=SP(% D5T-/ zT<8iW./D0|>ut7j .Ê.9 5⁜2=|!F9s`GY D)P_ sDL"ܝU8/s)L~t DX 1?X8TE8ĀSϺE8.*r$)M2 9 $.+ =m"Prf`^^Sc̘І0c8UTGJ[*Eۍ|.M1?%pA%] CӢL>JpstIS p(`D<@d藉(%-32$B ^(g*7OT%b nw40mIA[|' Fz:tOlxC,d|Dϭ[{6oƧ #Љ0@̬Z6>OÅ T*+o6MN]s&0]< Qk:d ~/{V_\Q¸;xi_i][_F?\гćT2ŀE X],sN(qlR`IYz \={bPql Ga fhu[؄ã\+L[ 5%^-ᾒ0 (Oׂl}abpa]ةCw)e @ǽy"ڀ&3 ߜFp9]S4~܋q-Yt]VbÚ͚ ~>u;ij[qtx=i猭չj_*##KPõfE_gO?"PFFu!B1hK^VԴ5H 99O$hWКd}>9x:$ = َlA[P\{wfNA~>mڏyrQT+ʟHQH\o|HG&./>p>RCHb[yAe !57ÜH&;&?pZG+ds8 '=0Ϥ@i #3ȓ#7E/N/ \d.&XLxp G!>Lǣѓ qz:{49@@ 'ǔM(wXw`/X`,Ț®~, Wy#uC^PlͱG!~SZk&M:Y%3:V׬yyz_u/$ܐ8eSillrT"! DNjm00DjЍffXԆ za* _Ead ݨN/K)l˳i_}#_Zۛ~u%0|p{ 鮌._u-'k#foYWmIU1g*Ȍ?@=gIl>9hqt&T8=7{JNչ@Ѹ3564 } եiM%Γ/Ue}7lyWJT'yScu9ܚUu_< m#J7Ch{G8ct6W}SvR^8q-w<$Uu}÷>I1L#8 }ߺi ־1iOɑqy3- qDE+k͇LwC: EQ xN3 )|Ɛ:?Zx~߀|s_/zwҽ+'z.3+7>D{Dr3ΙsOxڤYU@44 \-#PH"hGlo(rpd.sZخF+I[ȓO?su9glӣS0vN>=L^iJA'̀,D͕X?_Psg2.N'i0-.j98ٗmKNl5m$h^ 5[(Ɏ5ݝfq17O:'&Q= :x @c1*g"+S%S /|n:$tX\GjwFD0?QڏoUJw+ \GMs|!,9GIUiv(^un3取5%?)گ#}@05+GzJ5 )k2ɨV,YRJ44~?v·o`;kǺ() &P(D.#ʋ` _ekW~XV-C0*?v̕hQ+DPrQI]hd  v{b=HAA=Hiڥ474ȗ#zB LSt47mw;5ۏPK)?[nY!D`'{:χzkTpjjK%xԁ>ΦPCr8Բb M H~NP ZRȵP+JrNxRXR2:̷7ģ= UX73.  ͯdvc11dy{NJ̣RV.|lMA7-@ I "J4`2Q:fKrk6V\C3 <MIk[UjBV>G3*\vG2Tvgp~4U | Y z:ux[;ڇ ֙UՁyD3E <qRه(B"?ZqcTÎdUN5PB2td$sR:P>PbCDi ! D =sԁR"nb  5碄$1}JJ&,|%jU.$-)rp0@A?׿, .ʰBjYI iCX&?([A+IgFrJy+ Rȉ-9dXj sR\0|TĉyoS刀&h0dEsyCc4|& g#~.Yֱ}Ce/Ha" O.rQO K.ʫuG|sF\mD]%raNM^w B zJ!/\`xvIifE G`YoLURn4xNκN a/JB$=f-U3P*"*(kwFkP%n !l/O1G9Q)w-BB,1LwA A"cC&1d2Zb%a d_D%/D_L\%plxfUHn9N!KWT3J@^2iz(P19Ê ݙ>pW8 O:~ Y_0pY`*0X[Yz-p!Cp+](E2A HE?*$) 쩭Í>Є 0tCBFFIf/O[*(jUp{|]E%L JvE/? `Uxn<˾;A}aEi- =o?t‹E^bjv*2Vx'Oe<{I o톷LT+lR<${$I*2߭͐CF9,pH / 3A R`_nxA R`IdRH灷aà459S5d|Ch@Y.cXTq)}[_YHߋY+s1N@hԙ?ࡻ?>|7U/~Hs?uj'z?>b{{$ ?i"XZ}F =ƞHIvܪ`Ϻ^t7=fwسvZOO.kS]q1O2OoU|+x~87\]|bqoiX$K@(W׃,f۟'Ro)e̥H =/hߋx,|Ԋ؟SK :`8h[ I6({X7c^\`ZB!mPH}hK;{,\W-%g=dW^U3ITPRa-YObxGHk`_B |A7SN5|Ԧ-ց>TMR՞n&j6ٙpL.I˃2P)NPӸ!ruA@>եsTڂyVyK <*ѩspԘiF ƃ1f2Wcq=&កuh&8G@g<H&#Ȉ OPw6 kD:)I;E-QmycS#.lcXaxğ`T[/{Kӻjbp`հ(cjg9 CFx-5<ox":aUD0 _` dT8-8a์K +3żXK$hi>ejѰA8,n+pbJDiLZ&ʓNh 2=T<$ z x= C0k!R15cZ1T } > E$v0}B0xjwƀUer0^a%  KYp#>C-)BINGbx K"8$:t ɌL у8 ؘ >)C &@:|/!55t6K(I҄H4 L&)c[HzxsS!K00CP~jL{*X5G6J__Ӂ>i08f|G4{{%wRShs$ 0ЎAC>ʠh^\؈ '!JOQNe1^f԰S"x8kjܑ|]p-Q]3rj# h c "B|'2 W܅^M K"|<S>65Ro>$,'AIhI}L)a{|0}$73 &Dž!hjh%K k-rF#!!ͮIͨj 9 F;8t>OҐ9ܟ,3jK ̀x@h?XLHa{L_p&ڧ8Z$݊{iSJIJC~`hO0=5ܚid~: ` `cx))4<'9ᶸadc*!A0CN 1 {5)Qe ] Ǝ?j%CvX}$Ӱj͚ZQ"<ӷvN-@]>}:9:&NAh0&ubaɽ85zy&ƺP2F%{L-hpFݽ=A?LQd .Чl=<j¸1 N51`ptXY'ojl^)Gߔ|D#f&TY8ސ=UqK`a$q-"IjC7ġ]Vl%`?)C a4_HR38 X. uw7f fe#VjaCS$\eeaHp+ z:{q+\XcR4sDV> ZoO<YrA64À6`۠xw~ځX$1NJ(p $nөil1 cDK>)?xAo@H}lj+O{(4Z%i3[ gZ9 L1$])I/`t./r9ˉdAC L 8pL [C4 sjP]RB %gm)Iv`$t0Bw߾yX5Lѧ1``aZ5n] c%\OLaڡ0ApIɧ?V~Uéa1ґ5bW@;6 N($b$po`bU#75L8(E&i0`xZ&P0t4Q*c˨5\a y BK`y'JOBÕ=g:ZFoaAҡ,&%p +㜘/U*&:݉JؤВ18"Abj M ;{"&Nj $°O ;ˊ>X]f vȉnL>IX !H3fl&h=|V "A`ؘX2+DBvCJ88;kEK^/<< 8J`H;H&|)X|TڧMqNKHzɤ=dPǶۚnaXN5WؼQw}X0aNJJMJ ZZq$kypQ6$fHFl.v*p8Nh-܁!nbA\Dǣn{F"ۍ t~ 8eXGqrH)Ha a&^A@06<:c[g KӁ@?5"X!DbO*(mtC:rRVStbbib/ցă[ɴHa@F@ʲn2@L-Cb- DYnydHV<; }Q" 0jl0xbtLpEFh%"AS1/ܓ'-Ae`U9vzB,IJr+NI -i+=-Raؒ bl^U.X2|Gh i@GXE! D5͈R]ʡƻv[S!͓`zh"yP.s>aLEhqii`-,$5 zoJeɴB.B,)~9) ȸޣ bR,1<9$ ~SS+hN,(p}btUXNؙ"zYy8OR cS#Վ5_ ZJآnx3 2CNFLЪ# JZ&yRq~ e}1Ty9 /oDg9nyy4g2My2d7'jSC`fzt8CþcaH ]1В׉=$(ӪoS^?)P*U0Sz^P:ۋSŠFâ` HGv}_`yr$5@ x,!)$J#$E- U*޲[XC,R} RL@ C mD0d4&nqPsP{Mw4 qGk尛*6\Ai(!4 ca0و싙8/EIb>"M% i=}Џ5[?wnŹ͝loDD :. f̙Cg8xtma0i=D,QK4:QJ^}vXsfI^xy͟Z6? YL^%A%[pRI@O0tP^)>cA\uȓC\!5SYߴ%%/sRK*}>%x^TDM&"2ו;NozNW8į;*s&"ɮHU 1T,"X[ 'vJUhߊ@?.(% x:Y[V;-Xvn*?7E^b챾.>!7581}/ c!|:žGm QU k Ys`c 05 z 4$X6@FYx{á0,=mhvj $n_pta-:CCG +aP8XSAv)tr.&b$ 4qhÂFO^9S&T`rEmtͱߜNJڑ`I, CJ ŋE{h,TQ;ÄVx8} R%MMGU-b;]ؘdG]K,\gR~1N aSC=vз khi6D 6 ,-?Dz3M,dj-w Lf (M <ξؽNO'9s;}?fr)D"^hCqXD#gFƇAͼ CwzwA|BxքsRD~sFɥWBr@AG"Gy9sowtJhڙuG4v2I K-EgB+.CX>\i<4\ C yv")ٹjYKPi&EúP)V#B8VחzʾOd[O)ԝNU]ц #SSTZiF ږn4kjbEu3lވGv)8Έ 9=\Q .Lp !gUQ3>#{⦺;khZ]Q{$v$^,T; kkTd:b!Ɏuwb$f{R5EԏM͓lg(_-gk3*|KS\|kKpi6-ʎQ¾4늒&U9! V@EMO1@0 x(l5OEc8ϽP(jY/BJɳC{#h~d%I+cm6RRs|'ujFȩ #׋lQS2`*RyU4𝶰$,KZ*ӌ^$+ҹI,9cL.o ~ŭ?Y-&gSa])"FUd85U/'Q薸$ Pnk҂׉+Z*]3TACBAW/fd$E|؎M pvmﻉpqmӼ̷6_m7e5ZaDX$ǩwjvnD>bZf 5f]4/h3oD[ᒩܒnd=Y yUÜZkHB5̳% IZLYz}ְ61G$M1Դdܐ6rIn(VbTvψ,GZp׵S"㒝4Sefy *r '+z:U qj8~6v4V44Uav@0 ũE!84X[)->>\N{CvY`GD{7-5tmc(bb`$HbOe&MI)ס)5NO!Fv.ZCRk$^s;?t횥 \k.LUUo6۱9K^u]tftyrc뚆lil]/|SsFؐfv 7k{GsƝc/$ZU歳ڇ4D4weZCs~JvtZSĺ&CV3be~i5;NhmQ7i& Sv^ב^9A޵KP[{JOlnm2p]'>P?9HT%UZ=ܞc({v5M#Vֶٸcˍ*]GvV6D7eMwT'{,fycλTmSYk.jo9o׮S6K߷|o{[Gi[RӶ6Vkꚸq˴+mM5m2=.klw{L E3X+B~7x޶ڃvBUu=4j;yKНm1u[vŷ4{:Om[ciG~EoAMKicgծ5\4,!M϶3?)7?&C]qu;֤oh/xL4ibvujFοٴsmѺhMk\aW{Y[fx4ѮhKlizoI]Ǫ81;3}?O} rmM̺hSÐ԰.Z\jxU} v4 W̍MSdΚܻ9ґjZCx| #S%X=ϧ1ճL"7("3iGamC{h)䍴Ƿiip%cx+z-U7힚eBmuC8wxdvvj>n~ʢO!rQfql5:>E_1;:HwZ;'VD5shx+׭:7v 4sNJ DW.H2#!H ;XE,pɏܵ齦E6a%;u,m{r1U9:+9{HްӒl>J s?&+*;z~|yt FQRu2gʴ6Ôh>ܹ^Qs;1 >[L><9}J~¥Ι*jTE7Q?`?~tmQH!~^,=P$Q o׊,]dPsIUT$[bk-w=FZ$ƣKL9$ȍ~.7qcА~= J<_cz32bβ%r%wOmꔃ9GH(1ɧt釖 X)߶ږi- C#lR$)_X&G]ܛWSg'07u@V|(7}fyH73BKWg.YuGhejf>65AXeCR55u悚F‚ަK?B\3xxZ98d{xm޼:mǃ}Sί譪U i9;X۵n{xyޅ3נ 8P K}bEKpU|09yx}<'GoyL4I-IQ+],?qZ48a%cKgI .MSt";otΛS)Hũw 5i˖:k:#gm-a3e]v]"쐐afw?{e")N~÷&O?o$C`jKv0.V}Λ7Cr JU-~Q1%pE-_a,~oE4&Z.;hzwQ.C}0{a׭dwٻm]ĺʅS%I5u-RȻG2cv9*QE+N1fHtבK5E$%b1m<~ұ/~m[DeϼSw"sLU/]Vˌn\W.7E_ũoh%p#ij. 1HnO6jHNAS T9ҴCՋ"thmbZđ7еays&Dx^|05y.PU CiEWdW>슋e?-.;K^cS-Ss*W,RZϺ𧢰9\d iW̽hFD#L6?b޼ iEDI׵y_z$~#BWucÅ珒dwOF (n}<<백Wj=.W[ֽR3Xer;/QGMc~`%ې0>gƼ)R90ߩ{(DVG|ӺV^xEUМM-o4~7lPK =5QmVx缹CijHC_{-N`|酵s.8JT=ÞnGpב/ r,տlB6Jǟ>ug^؅|iy dH8VAl9H$𫟻kAg'kC8*?6^xݤ|~=Fo[ E%c_gϣ:uhp_r“ɶ );AJ 0,T|&JKP 'ADmQʲ&guQA0? K\f5H)Q{X 2BdHG%70ƷGHr>yF]8?Ó6*̠y"rEvN05fA%(+w ')2(€Q87FtkojֈԱ~;Ndnprn4MOE\F"|t`DlhĬ`u\r*m\{FdQ2aN$y;gLPpۦa6;P^H4+aB=Y %9]h`6ʓzķ++2-o7Q5;rw7\$RPy>2huzU'L{  &jl+Q:ީm4*LM~=e:ɞr2ԳP2FoT<_Y3280tTU(lqR5]_@ *KY%tcW8h[}NJɿHcHN#X8隕rĊqHc޳$r$ ^&G\vgS"8{9T hJK:Je 찧J7ZmIR !!:0:YQ\dA=`3 饀7LsPKqA.tr!T6%l44 l~؊%]mQ˂>ezq )9iˎپq`^ VA:PW` l}TN<&eP;x9TхpTP2 1Ŗ<9$G+b:+^w'L0>_Th&Pr,X 0e>{V rtr0ة%@% 6Z #l@&I2 >< ĺ\E,r 9|(P\"j-AEZR(F3m\T,O<7dO;w.I3EC4i3g5Uj..F 2rPcg1~jH@i/t%Ȕ0!1}-\," {w6O!zA-k%dM%b1/?R[ʲp(@Хt@@)s$?1 gA2,S/XDh+27z7ӄ6dK1 /]!@&đwa8KS8y\PE vfV󐠃<7Dȥ~gtү>T*8mH(!zaOizFI5 bb<"n}w`+(鰳ʐ.&^DaDf34X5 56]4h װID V XI YW :$Ơdh_ : `t'oĵC#DgyL1 A!zvɈ[QOȢ& , m~VۋčUXʡeR,EZ xx"{Ĩ K$%P.)JAAızW4^Zj&,o ~ 9N>kl.Nv0@2U*c՘ϓ2¬PW(1Pcf^Atmp@gDKLIF{>n{eM-7lܲeZYSS}opB1/dbP2K Nί?*ۇ^'Ղ2Qh^ 4/}A2u΃YJ`g_gWXbK2c9ߧ}>wE:[ݫli^A'aJ(-}?|sH, ǂB$Pg V*: !5 ULkaӟ`(`+ĽM{u^q*Z-?.g[6l zWV TQhC _ nyA+X8Kc+mO,Rqj#K"1143 'U7;H]|]LfՕգF.)/9jԐCo?H*,(++5Ly뇯_ da$\oh^, ׃,ׯsO#Ld3( 7O{ d84)3i|P^ǺPn~\%g-q7jʞda((R,L5<p|jb"v;#X`gjßAa^c`eċ)`e ~OX>+Mw= uVc ҙ>_~bL^֢ 5)W]`M`b's 09L"^n"&GbH ^d+Dkz#67Ӂ;@ yL]z١EdP&>glb=p0S DW@=geQmĜzR F D@RS4gbN L K?|,o]qTȡUÇK$cU^^6jaC{cq,PQՍ3g "8^턡_Q[`QP: &LW/CIbH L VE ੄Ë*U11|%h׻[;cQ?7MTбEgE& <%}o8wA' %yZ5BScg iA28I'3֧ ,!:vG%[^3c=-I,- 6f&e=3Ec>)+`/M2bV= [:]`ƒ}巊BWKNd %zp[#m ֋@~1AC+ׁy:L[ |!# H`ƁۛhI**ZVaD H@鯊}8Ax6te}b`1N7 רꯄU1QgyhHyvDA LMlB+" GV/ UA!]R[[ooop`c 9J- \ujRYZJf}/ ,M@d^BdAKie龮a0"EW|z{ ϻJYj~✏}ƒ}ŷ[0g`3pxA;8AP+Y^jqs۫^hvaK `}ˤ6a^2W+( @u(:ӾX$uP'Ғ>e680bh$ C=Ƃ(|tj&1>c=۷{=E,W@`6PiOd/PGNùoOyA "O_bSzm vqD{Fml/6hdyPۻQ48f_櫪AЦ|cFL $o EQgD@ _N}~#0nO3X͔1B@ k ܽ_sr殠!n1oWulw8Ss="~A$ճXX2, ,ݒeVX/P#:k)+ г eTCgl9 r'Y ;Q_υmQ!pR"4a |SAGY) '@,# 4p%F"H(L @5X!j,og>;Pc"W*XE}IēM`>>5/`jpzDسXnO0T*0%ŔHhT`[G*:W "L\J:`W.l8R:?;a&OV@MEÖ@ӻ^~k9ldѴ:e1*g 0ʯr^bޖψraümh?J@{BG3pM+yL\T#TP\t {,(yN#rnPuAw@ZRxVo HjE@C@&+C[4p2FqQBGB"@(@op2-E Kax >’#<ڷ5sA~`} h/=4|`۠n0ᢗ<Ӿ+A[Z_-$N8 U0fj"`Ea L~+®f&)9_O@e8=<;SH!|:Nn(UkrkT%8E+1P~ ,$֩1ojƷGٍQIXKsC/y5,V0zrBB^/pþFd̔A8p:KE`CXX .Y5HO-qR__~A< ˂5:H5/810. u`A+ =H&"a.[/8~Ml[KTm$I4jYDxl}M!s?IUiAB65;Kvٸo:Ta/s\=K`-0/;%0< *鴋RE/Fb-+#iW>Ql$z?r-8S 2mExl 8?Uf@`jzplZM@Vj">0."!*#I%^""0N@' &#P2tk7\QYֲZA׆!&͗ SAK3F)b=Ͽ0V\&*N/Eb뮿^xlX2V&@h_PIR]oA 4twJBlX.Po]OD;7  aw #0&y(zPG;3)(rT$z.˘a/lYXlA;̉х/8/g=4(,uR 4m,(l>tuC'G^ Wq7%a׉8$doP+zQ2o><d!) ~g޷xKrEM}Qʭ r4jgawZJ hE?MSg 4;@YE1ZA QI%JЮr0F7$*/#WN=od4ĚjsT'VP{jw\kJ&\E.Z`كCR55KʛݗZ޽1t$[ οh; ^ogn)ѡw+ O Afhp TdtڵpSN{Yrhbx]`/ <H5I{$x ,#&/hx+-hfXhPA3m3 5B,+%]PvYѦhP"%>G,tR2a%W>AM91p]+b Pk(ЖlF @!74bE w@jn~-[4bz1Q$̴rBPW$Zȃ8ق4MeeE "S1t.P|meÒ|cj^)p%y$y# ȑ<̔JdG/hD$2:9W^uUp.R at5 :@95JPAn XY #Х" K^-). pyM+ V.|B=е/9Hw.7s|g#E_mZ :b S#.~d_kIFkʱ߅?kMտĸw8mw­Xʲ9ߠQ2F,,Rc$콌txՆmۚahM'8t.KhL_etA0w,H t:Ž<HC`@o`_BL=z7~a:XOvOtETb@hIC(EQ;x  dv+]ui'&dR7QymY6RC 5FN^M /n=(]]Y)8uRpWj:Bk$Zȷ8Z-ke~JP͢y3ZI7BJQ?.yg_^x%)13JK_{)j{KfoRu)|Sҫ%?RO#3s2kn WtM8-%I,bKW_[:tu~m;\u"S췵Su?>#9f1 Rcwlhy[/IϾl9a7rgDZ}e˧q&s~g)gh|^~3tekwtʙfo蛛;_(DyE}l=Jvϝ#b1-f)~y3x[ߜwѲLV"C%a~/Mι+"KJ7gmuvO;|R&y&$ >M^,t\Ց{WS>)tAwmGgK9;s]'o:mLE0n ]FY`\yDG[g<$ 3m+Ow!3KQa z_~rYm QDt#<BW\qo7W V,|? SZ#;u-'JCO;gp̦Dc3m?qʕK%G6x ߀C*-V]I{QscԱ7':zf1Ux#w1]~gdd<7|U9]jz{͖Wvt۩BhyMR *c6+U{7ywisc^mv;.Ӵg;B??.4$lT}=H*Yk׉6Ai$˼vġQZDPaAxb%' &I5ϼpwϖvj[? 4!19Ƒ-9I M%fb9஗9C ;ueT͖DÞxou x芥<ᬳ.0; i_bN s=6ֺ|AJwd2":̛ S@{N7bޚ?`6_yU/ j07\\xm]=h۴vquxoxiuf,5.H9˟wat{wx͖λP !ם=w5k/VLH,z9&zlK'${x!h1X)}R{ ~0z&C椓a헾n'w}>ē?5軐ո :, ']̯+Trnu69EKC&'T}}܋yC|p˯ϜSU Suk/Z.iG1=-5^L>媫.UM7zÍ7a\UT<87l6kWx57UW]}5v236H=-3'>wM?w`N~O?WQ-w.@͸uGCHI&S(|3}ߙ0ߜu\FCS'^;eb/<̹l䡇ʓ>MsH:֊]xY.T#[)cƊtWܚ{ r[.YYPw߻ 8M;lf7?>o6=lM_N.icsWMLΡCܯ< 6:<93"s`Jw~:l)?x?蘰rٛ\u}[ڎ8p_v_vs"VuB%9?Ys^dJ=`ԋO׽`~Gyn%iHLub锵!O\2>{gq]#qO=bqJ.I;F0t>RZ2FN Qg +ּ=#5o$U+Wd '  /H>[cN9'"Xtt@y ;]z镗_v57w*èdu_%:2p>7-!)lok?ȣzIzp ȗ kŴFexΫ8/{2M!tO=vmՎJzk\=C͛#b}Mnc"[DCvYMuC^JVf͉9ʊ23mEc!<繿<~C6O@L:!d>bܫ#9`Urj?`8 OCS+p"Wdͥr]Mc<㯟u߲LuG3 f{s P )((tf܍7>_K.#diĽX AP0y]s5y@g:|+`]{5W_} ~Au > >||/2Gy55: 8 #,3u|Қȅ^3k]?{ZKL8E2~Ԟ"6LG>i7wYwQψ#O=ygu2^̠jekVeD8o ;Ogp 3!5$}mP[+SO<Ϳ_?vǺRwL4^vެVp}^OޅU-:u[[" .XwȐ#ls[o뮽ڛnԌPԢAEYoݷ8jt[]'~UFLIڕdzB((`'܉ɮ Ihgu5q=ɑefj>V*ƺS=.j),ktr/3Cry(<s* AoPtS427݆|pe3="ᒱ(ɺokw_YX*SS;[|j,\q闯]̙@0 -;|=Mx?Ađbk^{-\! 3_d2aO}EA ~ʎ5HROPr =p0@mcAP Ni!ou\w˭6F@uA=&b=gR,gfwFAY/ܛs}{ޏV_><~EkXJV,<'g]B:jx<u *K=H8|//8{^;h/=c?DfM?:ev!ˆtI-k@٦#w+Rmk(zL9휙z]rAL\4Z?UH,_|ģM{i": N p+ RKq{KZ <@%vP# .m6݌mJN+ʹQIpŹSc 0uBEa54\:$ Y i)ИH x A^ ('X]vOa7R3<ē Hf.&~041][W afQiAPylrljP+a!9[:TPSQX d=3y'%. 7)J'Vhܾ@WE8o>x/$2EḬ3*eгe{UVRRHIanɶ ֲXz9KA%+n+'-)/*Y˟o\p}jg]դa{O=lYoQlӣXP@.\Re|~W UXR[Ys~(pi1jPԼL$gG=>z+풋9kv`NcTCy^Q h"Gl>g\TqGH%{|D)f aBpԬ_$u/N>3Uk?)2?Gmj ~#ngl]rKzWP̉O~9׭;g߹])@=dji1ϩ(?tۦKK9SsBTȜV^}gƏ7-hZ_:ބuo[?:|:H`TqR+CU-`NGl WJp1GcеQpcpA(p\|o |rgٲeAE6T)F?AG]deO(8Ky0x9I)@ B'_LZ/tcokG V 'm1xjجxTNtOmM*~kܸ'g{gw ك-{}:FpFV`M3KN4{,05s.~ƼhXtu]xԩ|L-C/}yWO=)ОSjgGZ7͗7 ^ްKkr#ș!IVdt#dIe^c4˹網!=ma_%Kl>vo|X;jѢQ7MqD-x+^^UƈūSk߹|Dc9H'p˦?{ 6fEu\fg65F{f}I}(ps/xO M|{l=oYіܾsrgo胮g|ݠ[G^xN; GJ9ݡcW!v]6$*"+@j'*55;px MM ;vlCC1P kcp4va9L_cUpg Kc|ZRJdYU+ṡ=]ŧ~ްlqX@̊E=>%;g{,դnQ{0Jmqج&q,%?@ooώ3u˓QCZ Cqad"xw EySD2>nZQ/>3b]#a oY? >hb_ /x;j\g4nskw~~΢u;W_'KbtV.ʆF|Ųg%Os! &jچ9s&vϓMR kw1 2F3eLb))x IGy6er &O6gιhP8.]zGWrswNUE'Qr@RggaS*ꈍ];h\4$tw)fQZDQ2qq.Rbpq@vbdx,: D$u0dՔLẆ第]7,&)?4KaWCȥHȁ·Z| %//8N.jve)V…lH|KKGU!edVPI%Jۦ#kCV-6+[Ip& ;x1 U=u [P k]Ts-225T~Glcu6 ]k#d~UTEp񩨱ےkEkDLKOnZ+>g}5&̿3oHm NFSrj/,w#aS Í``| ip!(BpRh ~ƚ"͉-7@1S Av}mȸ'v UFˊooĸ+|'ܕyyU*N -@{@:r k/ fAYgC!/+s'/ÑF(v#HN?xiܷۄRDe}/a7s\\uYR+LgD-dviY1iqHZa[9m8g}#<^i[1|!`*MuR< p^Қm' .>!wD^4]uMfyaa3nو'yhh >h*U.p7,<7!ˍj!<9a lĐa? p $Zy+;qŜ 3bx`)`yp.yRl-NaXuQ\h"o<匱{xU8HV H 21 %Ii`Ru4k \+..&T. {0:߃8* Cg$*t2?d?9xjp4s%[ b̴! 7L @aXp"istD|u$Đ) (eapIYБ R0lc "vc<91I98a!a(rǴCKMPQZ0wfEv9Eyss:#w 7[L8d^8`aQa U5bg}]NPP   uԻ8ސ3ц] H%uH_?:~[D@L,ZbG0rKVj,g'i0C) dG] SmIZ=!zz5F28ހqV/"ض#Ft 146^Jor+c^2{2SG:CSx!;9 hG&-L|\,J^}DGfZ0{_dTܶt0<]-$0AVAhϡhv<|6bƨd\b:3! ie7xsU'&%t8v'H$_( ϥEPT&EFҟ)q#놣bg&m~uLBf#%QHCr VkcC3T05KFVZ-KbB^ s,Wq)Ӎjqi(%aދ((Ga d]#r^`ȪnP/q-$*tJJt'Y2@2*MDz >JBH 9Vѡ&Ц|ohjC¤hI.lcSgI0C[s"[ Y)Ce< @ح v C('AԂi' d:^ ~I+HXe|+G5[*Uڈe7@^c= T!Ǚ1U$HXFb_HHCGT"U٠ QpjJ'#q >#ۉ9<kl<S)Bhi+˂0MEM<`.Y=Cv(`C+˦ar/%aQ@R C(wa"j$-;`Q!-75T)X`a_Vg68ƂӬwaUtMs).hŷI`%]]]xS.:aZ7 t@#.YOtcO g5.o+4Q7\ļv4VID->(BGC 'K~Уh߶ E!ۧ{d;6e"e>ׁRHLw3X3z>.?{rԏ?"Ywۃs]6"._'.V?s{̷8䓴*>ȥ7Fj}w/1d'HO]?Cz[q|CS⛽@|[|a'[nA R`A$2m )0HcQ ?x>C )TĀ#`V/?NR`_@0 sp  a* jsp2 A* R` jkrp" 3}MjIENDB`>Dd-  nAZ?Screen capture of banner page of OncoTraX V2Picture 10Description: Screen capture of banner page of OncoTraX V2.11P47 of the <site name> - KEA 420 window" b<-@-S}ۋ^<A=n<-@-S}ۋ^PNG  IHDRtW,BsRGB pHYs+<IDATx^ $U]t0`4gPuVVijgYe= 8ڶ .U͌("Ӄ3 Y*qF匌T؈=*2gb""_fFfEF䉊|{/ƍ7Vw{'_iy#ZȾֶ!kt -camkr(ra/!̉q6t\=4xGNk jʼn(Fß%є yiNtt d/"\mⶶM-iJ8/r}_HiIƣR,Xpsl3[H MHٵFm~W[/`,Hŕ?6;:C q?bAi[ҹkaŊIoxqfɕqN3 =8;qqO}VsO?sϽuW ^q%ڬcн&~{}`{C {+;\}oW?05w6@E\̭ONҗ7\vUW]ve]tGX16oyio>O_ow/{ӫ^oyӫN} G;^ 65[cvN|7Woy/_$מ5߿l|qk5'z -zĿp9g\u: <~޲yI웵<  @@6o:[F. goO=t2>]eGY㎛Yhdo/Izb_wԷz;~V ܵ<»ܻ?9`wkzW<'So[[qoß?O?i?m?~𕷕lwxW1f|uefe&3 Oso_u'{lF}K \qEn?_./\_ep+xsO?u/_ }o5]^|tB}^xʰ"zOmy,f inRήo:ʛwrnƝݎKn=kѻhi}$>מ~9ï~ϙZoIl8nզ= nWn-t+s}G=j˽׺u뮻:eW/ڏ| /ߜ[xʽ(?[W|뿖P98Ҳ.K98']Qb]h]%ar6kr.?x_d W}IZPEʭ~P>.B(" GqE薁)o[\ 8JM$i.Ʊ8*缕5om\] ]Aum>uj-x׸ȳ2r.O\u7sȇ- .S6_Z"AuӖ\]~b}=Ԇ[YsuzVްH[vWۑww|E1Ą1hw߲\Yr&Ba܀ZC=quzQ]9eڷ:v)_hxw Rݨm- ִpuq5K[K,y,CorBrmbXNhy:z^mSҚŻ=MF<`IEcS\ {S"c]\ܿ@`fJ֠+ 's~+ +drQt! PDzǮ%=5u1'攖 F5i@.{~q۸R \=zW/=W=7} $6c[fg4슙~}b; yy˖-/)@Uv|ע%A+y=w|Ёn]|9l>E z _n߾f͚ө?\YvG?/}ɟWb O.rNHP:&3kDV -{|ֹ5s+a[{?0f@n]jwo3pss'70]T[W3ys}ٳխ!7<`(qsW߭h}vY4eRMGy[R~A@?H\|{KjQyoų]`V3%g!Y(߳+N=/ާ=C9ety(pk~ZZietԅ/$Mٸ2<Ȋ5~ﰷ6^1k%8|Au܆{!P4愧?Y^Wn K M箝7NNeO [-ow{iw={vL&j~zr䣯x h0n}jjW~ٯzjSU -.Std|ztoxb^(CyMeZnXS> ʹKU<q+? TgvCTDZf=~c~A? O{xP7l WK'Y̗Ⱥ$lm<0k}t.'w7d$R]ڗo|Kvwe]R(NPE'\fN܊ӉHuicll'';i2N(v#s5j'CUvْEr뚸N}HT[gI\)xhs%0brF}oS6(/ԁ@n}ꬳ[*+ջ(oc?eկXK ׮鲜Ą`}*f/ ʹs^Qvqdkkh1-WCзo߮vusv!8o;;5z꬞F/r>XV*5"{ɦہ;^tɃ>x 7ȹӖm!QCWG?I@֨ק1uؑʾ^3$q 5sNex6HO ' #P[_jGPbӽwWH, /gzaxE]8QN{gyRBVHo-zg`\;v<[׸6r$tہΗn9?Џx $e7/K숡s:({; e'\]ܢӖNnr_}qn@:T?;:hʭ1{ĎO=;]Bqr/ #P[Wde_ggyw"q6ˢqwp5Ph,A_IV-ֳ-[\nvrjޱvb C7n čGic6R{bst>N{]UVhԃڗk OOTf4 MUVF߹8$_Ɨ[#Wt _clAܗpm޴#)n]?rzZd(kB N@~]y@x׭cu׈nG%,;o,Juc\] {:4 4('P֋N7Ur?n_i]t/wjwֱg S.'ޮMujc] P+RV SrJ0>zZVg(:iHp@n5D++oGGp:NnU&)Ox]@Z۽6ʱSsj͋5a\PL ݥ> 'F>Y=bg_8zFMG@#zGD4 0J*fFW@%[ob 0pc9 4nseXc4 \-AcI>ӎ@s ֛;X%zXH@VbEPH 4G>|uַm{`nFXL`MM=‹/yy羞zlG x`='`z nyEXc< <)AcA@C:X[H@y:{O[o\c |zYlƸO?B#|-7onGbS 02t;ң)Rwnno 0#3( @{w|_U_{C,̧ :  !p޹GK>2ӉN8>eĭ@EGf.Q_ 4~?$LsK [g (5@: F ި@ 4FM'@ 6@Qȭ7j:1@ j¤P  Zi-% TESUD Zi-% TESUD Z ^i@ @U ^I@r뵘 PrUD Z ^i@ @U ^I@BQ@2e (2mtb  N @hN6j:1u@"@nQӉ1ȭ @hr덚N @nm@[otb  rlEzc W %@NbP@U8eZI@NbP@U8eZI@r뵘 PrUD Z ^i@ @U ^I@r뵘 PrUD Z ^i@ @U ^I@BQ@2e (2mtb  N @hN6j:1u@"@nQӉ1ȭ @hr덚N @nm@[otb  rlEzc W %@NbP@U8eZI@NbP@U8eZI@r뵘 PrUD Z ^i@ @U ^I@r뵘 PrUD !@񀑙* )S@")FM'@) Fic [g (5@ %Ν{zvXgb7~~r6F`Z>w>r]cZUsXltk`8UAFN LLpܱRL}k8q;8 X3}ZGUS aYtm*1rà<1lY??GZYFf7^Y:-ghsvZ6M}Affi*j<r덟b @@qvxAh?;u)hHɭZ8)݂MƅZoL]1Qhd:%ozCvnvSP|6/^ 4fq8Rh'oY?a%>n8qt]ܹo[_n_V_SS{U+Hp&ن N8:> 8e &ܹey55 Б@)ӕ۶=07wRGq4 %y.zՇ,K=0;G@ 2M!ԟB@Jn$L@i @`y ܎D坣S*[ťVVjD[u}&K}Q+uCrr@uTK}%êh:>b^U׭s%P @nx5R*. Yt}f_ŅRJ}Q+uhWk0 0DqaR_ )5Yb9euNlK MjJ}VH@= pz=R*[InPkDOƀRjZ}J/W_l%rZ ^\ {G%=]sMsXX3#DFkFj #_ r?&,0^s//Efoͳ.)z Wc $)wKۑ;':Lsj@`$ ܎Dڠn]R+(fݪU+ih=.eW΄Wor{Պʌ-J}5vꭂ3ϊ| jfYZbZ{XoUU+@X( ة,VOI)c ,4ezwo]in[QW,&pP );xxMH())J ]A ߺ-ą5qAnX]qt[aV= cm~3ͬzlH F% @)S&!'JtYJ PU/;ϠLf ]H]BSK}տ,3ǭOXvUU_u%$@/Kt {kl*_꒝H9eJ^B @ P3#Z@!)uNЄ* 0iܷF %NްI@R[Ws {kT/&~Q! {ٍHԾ>Z2mm\91@rk|R_\ Ӝ]r-!\=w:?:]ώON! }DZB*\^ѐ[/+54en#פ"'dXX&e,@r+G:{+ed^Pq85R_E%{MSb 022O@V2.]b%eq)@9SO"etUD/9.eg l2('FRnG2N@x>PrBSԸVoRJɿ#Ü/ZF2]F ]% rVZ1 s" iRN W & TG %)x#  Pk@`RrDÝF )wd-ewTYKwl\@C}p~Be#@eC_:Y饾ivſ]/eC׭=Y;XkpdANPUt%9и@n̪ڧ_؝> T魰W XrJ/ER?'"4On+^\^ L[]DWJƒ5z!R`ԗiOU)OS3|倜״ʢ:6wMUFJ\BG )ny>)q~o*0WJ/] UBJp;G /:,48X,,nm5˷s F0t[]=Q@n>8}զv17ٝJj%3X\_㟅J+@@)SJ}@BQ@)ȭP  !@n}d E!Hɭsc I@[4J ʺn7էSU%gk`]R娗5H%En)k('@n-$$or׀{ r^)pce{\2=N<+iu\^ I$LGʘtvXw7ys5fXH+7U`ƿ_X6ʐwihQUJH)[B>J}ŽR%R_&'ԕL6w*)$U #pptf;{++e"ba9LF ǥiicG.X}W\2l:3H9eJ,ۚv$ $NSp1K*kZrz  Hlu'r|i%~V~uJ# 4RrD#1( @ #@/@"[FM9@&u͞_Ǝ@Jnh}6 F@uLNN9wk'CEٽ`寗5ݸZЧ[Y+c7Dlt&;Vk4̀C8ce1/l efVK]EGBmbRQYޚeuc>![[/ ?])rBnaWx1MfY0O8e?q+ѕUZ׍J\+EsZuJ}-oͲ1D~pʴzc7 z9Y ƭxKQ|ukQ1T @)S0aq!W Vkyk#*O v$Ϲ z+rXq,!FTg n {i>R_A8sPd#nRrDH@!@pE* e"[2MB׭wόjL %N^ D5@R[[MH WK\!^E:հccˁ B YѲ@PKEuWK}<5}q[aMBbEr5ثXXNH°a]*\\U~,}HNJ{ɩW.6Ai:+Zb{(er*d]S 65nӾW|{@TU/U2c(Sc8՘W5 X$rʔ$ UJZOrNN\2_c]/o5W,gD܎YMiWsq/) C}lz3uT+d]E: -Z{>ɗpR_@Fe6ѳ&Rrd (ՙ- r#4Y @3rHɭsM(BN uJ}VbXKrv>$VʈR_1̧8H)ŕ0%koTY,ݖu 7vLrGTJi dor%(RMNszy.$̨0O)%ױreWK} 06$NN)eT r cESc5465@4 "rʔ$ Kera胎FGԗF6F vFOpK)%R!48GH8e:V-g2w.s1.A*mݝdѭt9%uU%{Y^rg8=+oQl~.n GK%cϛJR)okryh`{ۉ6W1fpʴ>1MGZsQHkRk#; [CH\c5e{Y|V,'u.,-N9"2!4?FHjOL$#jgmۚS;Q 0N6v-[qnk@@qY3d -k i&J. ʉ'@%rǽ+ rSə j"Q8e44WT%M2ܟ` SuvX[߃>ӲȭvjQLQayVZt削4P[@TNDv,U#%Z;.jJzM'2|7m_qi~Ft>dQsQ/KDA}+QfѺ?D"n8?>0Ume0w)6t+'@nsԝ5fQwvrϚYφF rorKMmaS7߬6=DEDD2ڹi 'M>]IHɭ޶큹F0T-" ӏ, Ps7='.^}vO"AX"@n}Br 3l1h::IoM8BLۑFy@DSlESN )S@"@nQӉ1ȭ @hr덚N @nm@[otb  rlƎn1]2ݹCs@98ef5{b]l` )2@&ن+ztW|s,'*\)dh)Agz>KcP=;zb[׆S݃{kZ-]K6#ݓK%tVTESU 9ggt48P-f筁)09y_@K=3^TZu̢u)69Lӿc` [:ܻpܱ_jX,`Ly.^]mBu6hKq޾fo t0}xA`8ȭsGQPZ~Y+`YTcn֞Sý$M]͐uE2'p{cE~JZ˃C5lqљ!BS.my w[0}Ɛ1MT,;=N̪,r)zqme߇"@8glL";jq%X@)}&''w߻JDPrܥt^ssw>Ė kK,d<ʿ~GI4ɒm5^I(~\Fw@8}^pc1m;! 1'y.zՇ,|#|@`[BW@ Z#B  @)S0f1 TBۑ*@u!Hu  P NV!Bz]f= TBz%@.ȭe&@%ȭW!Bz]f= TBz%@.ȭe&@%ȭW!F5aFis2 !Ss̢7cng~NK XzSQY oHf'S8eh'ay٠OB_z(s%6J8*nEߖ/*ճ NcME3 ǜh߻ncݺDTe{Wfơhoi -LeX0o7cCrk=ݭHҜ=8psQk%A3ߩL,?#7pdk{ F-EѺY1Ѻ 9iE-r˭,Ī,e+rɱR'&}y f55ƙz\8G_i &.*6nr\K2B@Psl\rڶުK:J4ĭaZO Nר5^5{{Mų~T+QjΏ[)XԅϾu4Hd)٘|ߴ(\^tF7s_1XP+WN?wʊȶ.Lx"TBࢋ.uM~Czyڵ -]P)SXU;5 K8"͈;(XC)z?!Kyn\bh'Pj5[AB3$++4@g;MHߦUڹb #"B6; LKLpQ, ?'uy翥Gޭ+b2i ֛geז!u׸vެHXpZWwk ejSr],i%jLjrt^00-HJ1=1\%W@rKřryv0`vvsۆ^9==mss' A 3r=+J|sfX5VB`]d\i_z;#2 qt`}g!zܳn}g' {UY \FsT |{M' iO-Gu"#+j>ql@ $0MZl  Y}\8JӉX5k\#> CD`j͛^+ܼl04 @1w:  ${-h[Di@_'4plFt:0WoM'B[ɟ:ql @/Mn Pɭ@ ܎? V=y)DP0>>δLSoz~ғt̊ LFu <זZz֜h ?_pٻw[Xo9{AeumlO>'@]6L=S \3Xd»U8 m 0tl߾Sw98.t^EvZe=ϷV깑.s)ix|.eN=s\ggG&_1`[^TʖQ>)ԭc w%c;'ܦ2 g9>r_/C K_"8O̮~vC $.>RkoU,i&ν95Xgδ*_S@aA2-չ4͛i456q|5.3k+Pjfj/\PjkpBנޒc6vÛp&7[i Xh[JS,EZu%E\i<9>! ̮4E @2 OYHxJB3UV]Vx}[]Ѩދ1lzk+Pb[9,u͡ NQ7M[XYZ݆w' ;VRg,-wr|4K.mr%@rs&ZXPL6~d[O hSl!e$:Nw{Ib% a[itfɝ;=~Qv>DѮoA>];?Du1p+!mp&'xʓ?9gۇ7#Zg 02\E)Z#}ȘƕK߰aqH`w@0 H: 4nYc7 PN,fAJ>3@C :+ - KEA 420 windowPicture 11Description: Screen capture of the Edit User Characteristics screen of the <site name> - KEA 420 window" bNDH jcגzN3=nrNDH jcגPNG  IHDRuFsRGB pHYs+NIDATx^} eWUfwG$ р I@' AL'hC e+Ic HG3(vWJ lY wj׮sϹ}߫޺u>sws.>'(a-l1 2sS~?Bq[Y7ʷ}?3ɯ>pѯ=^|~_觾[׏~&. eWq%[/ FܟUuh腀eFUwzo0OӿWU:E+og>+^84K]yU5;WKzֿg6_rʱ׿l3h9Tl ! !;~u'3;pЏ<௸7ވ[/~(Njwz^orkuO#c8 ?I3?0O{q/j;U?AuDc/a߲o|z~~';CMv|#OOB b4gi{~+a,8o~q~[o[wKZa/I [Ϯ<X?EXwz,h)$kuUP4~~4u—?ǰI3/;/so|fEf]fxִײ#ꍠt_y[2;;k Ç9fݬvl@@222ev\=eW:n)޾hq%whsk\UM9xퟠdÿ&W89k%[;yk!,V%!r 0)Cb0Nr2ºG/.ɻqmW3k:5fSaGǚ nTXvV%3!]k(1+! *5@(K ! F \B@!Pe+7LZM &J@I)΢B``m%I*d%1F4.AL^T$U% 6ȬthHG jW[bVskm][`:m(ۭhҲi/j,v$̽ 8b g JW[{TB@L9Y V)\uT[MaE|V7jͺgE &粤9XhZ%dIX?F{8S>4(֍m\5ws ϐxiģ?)l[[#0L:a]T$&|М[[?h? H01?c>;.8Œ{i%=E)X쿱IŊ4^س-ĪXd/e$d .oBJ_W+Ri ! خHHb( 8^E&@-2@!o%m$B`L(B@w}=RgsTAO,M~:Q ! Ploz󲷶|N<)J! Z Ы:f(rg/Ȭ^!j4Д>Qv*W!f:\ }Z&ݟ|q{ұ0Jx#{^VWKYT{cOX/OUA`VrQz븣 /cJh+$11/x .0rjJ-4)ջbX`~c춥FWǐFʬZ{=gR [!fo7}/񫺊w|fo}G?af6 gǺz5s7g3#?j sӟSp1+3MޕY#Y*Kr^^Yٶ:ÅLu}}ߛD߽e1羭UhAkKKw_ p(t0+o}fZh8~'ڭs)Wh04\7VyZN&C־e/fzF.V3T<+ЌW}pXl:op|S1=LڝTص,]܍ R Ḍ_pQ=ɨ r^{ ["}ȃE7'>Wp8e&H,Q( ~y7~o?x(l:TM7lq^^=u-Z޾Z;mX ݻ6|<1s^~!|^[N.>)&U¸CT8q>_'>S>.ozϻAcAx̉'}{]'yC >s`O4G[ *"ȤAOH88쳳Ǭ#cӅ#|.TDeq޸%ȬKu&H_=<>񱿁Tg?YVI>0 g6o}em{c_@ @YOkcqaa.;iN]wuٓ3 !0GPZ׵77G~" e1Yx^jڸ[̬snsCk)xNSΉ`!ѣwfpD`>3c>xzpoYWx%@ zٲ01%ĝz_zT7IEw [ ~ă&F:;Ќ8/}pFXg}b`?n0/NЇAU>jզD?㖏ۿ؅cͦKOGqB (Ȅ̬O߻wXu,0\'A΢|f󸳐:V}RgG]@z*şձuB {ym>{.1gP1drZeu>Ҿt  NlbAn}6Ԃ^h9l:㱏wo^8q/G[~A"F u#رcG]xTx_a\p{Dnv?Vd@V )[ᾁ FHupcYٚ A}kLU̇\UuO-pD0dټcϻT8۪X["tin)p jJztS'swĺ}"fz/--[VmA\42 jM@j\^hփu렡e'{6]^@4f=ZWG(Dxd/5$ώ ZS9ֿav$:Fked' ^x< ]^hoh^ cջC>`Q@-eFCJ @X3WPȬB$! VB0[Ii*/2[i&T" >./2[i&T" >./2[i&T" >./2[i&T" >./ۑM:UY ! z,3}ej)ń}Axa1e\7¬+ӗޖB@L 7+kZ:7<ųpחZZ:iyBWXk)Rz>&/4 8{>l+\XSQm,R >5jC[~zY+u20" 7;v܌gWZiCCy,4IL:!k$['[CFKӠb% -i<&RAOPVmS̺08:`,|׮'Ƀ! 1[fpdC`Ӭ^ o409I;A Ip1 aD&]s/1 %~-%@ ?cW:;r.*2&Z!Na* ݤf= kA`q$&xH-t!J T}J8?Zrck]Tq8 Gf}zjڈZXbvYL\#NM2))G@PwŧEӪ2Uxe1ke'F(Z`8Da %gЃ.jz-)mj4Wb1 5!^O2fyEYl ݦ?`V.S ^ǜj9 F)$AC_Ң R|Z4*=@@fXxC&-٣g8-NVA_ᇒ$BX$ޡ+ 3,np 4g#~dhMjTOȟ{\e]o*R#\=|MOCv"ܱ/Lƌ~4sO\X={|lJ ͮ|qsKXbgfB s^rCt!O صŒ?epcCǗI@#ӎ|vЇ?'>N'$B <l41(8$A(hd#+|@N36 -ΪFT&~4qrjhvZʔz kaZ}P?<&jfv\xᅅUX`aS ]+z2V$6ײrSĄl$0>+xmZUV&VKi"j)TgFJS٧~{> 0ߙ7-n|8&A #$ @U#X,0Fj@,gݬ{ 'ŭ>S4ZX!ztSSBVL7֜1*4BLB@T @]e6 ]e3 zn7d(L41:ZJWɄ~셺*T?1B ئ1Z+\9%N46jqlN G9:7 YxS Bn5gpLh 0)359 !-6Ͳ8B**ӵ`*)sYo1Ȉ қv ZHCoӭVNNVf! 5#  -?h 6XfBSv*y[f}rFm:)3~6, Id o}x}aȬT ]!;)f]-jP!)S語B`4ێ4vԠB@4CvfE-EvքB7KB@ G@ 'hbB`Pl};H ! !z3D-pRbېY]Ea۶܂IZ [ծjWjj]-H<< lk8Uk'd ໰;x]_*~c? %B`rPNI& 3"`V!=2SqB@l")S7ԴBڎ /Q ! &mGxB@f( /Q ! &'$B7KB@ G@ 'hbB`Pl};H ! !z3D-pRb88=6STDmh:{wrP鼢tBF)Sy[ncgwaO)Ą =##O94[o֡UPHVzf}OkC7O ?8P⇓^i)uMvxR`ۇ0 :>8F ʇ@6 1R VR+Vi>S,2~:>){Ov1))Z'/V[WSOֆeL0DHqCh_x߫ρo)l0zڎ4z۶ЉeOjńc:\u%(+B W_)Xs|4?OMX[ [UC^L]&1,yY,,Y0^x!)2_"qx>P[2K Ր1VvΠ۩\;??8UioRbGr=xpc{)re,-__]WСG8-9_#X X]Rg*QkӤMWOZmyylT&Vb㇖#\ Z+Ƨ{h!ێ4 vo8~F!B On~jbvSN^ʈV>8ƿZ%H_޶y[oܖua\Hv[OAI4B@t:(D %.o]etHգHW+^ơ<@G׋,Mv h8kX=gOL)M#=sV1>W' Cfj]:5c}ǭL( W(Y2GlG}.BE9~7F۪'ǃtKdUb AaJ .6^H_)eHw ux ̒synO,RFe0΃S~ <4)S;0e+OU#(1UW]Q^uҀxXণ߯06ZYa4VbRb2ÎDaVrxb$FB\N[CZ 81֦¦e{3rVJQjik]?خ獡f}>-8J֮b> {am2-;8-=T_Z!/1s̋ SjĜ=fZ\f}uHbohiXF :z%DŽhV">Dk=ifQ偸> _gۥ@2SB,n~"8"u/GӧL'Wx*OQ%^Ս)ujz!lȴŔ^йn݈j[g[V,qBc}I8͈պIɗA'[t\j[,ز֕kv{֕kGB@4E eTzSTE/Z">qئ˜l b1U4,om!B_9aq[YcBgjCLfoe/@ݦ=òȱ<<%4d1J6D%Ƃ@n"hs;{N45Ż: N` ka0:i5HʔrE>rƂLR}!3WL`Rn$[Yl}C`z;%ۥ*k+ R32㳏1eXJC@ZJ5.'lҷHe acAq&HPt5E T_B``8]*՗ ,{^BvjQl}jZnCg"sl&sDc Y a:s[&Z̔غR}MtJ^"sxУ/ Zb8i.Y>lC9L*)W4t꫗WS֭uS4B SB7hzoR!RL@|Xɶ{HUuKM&WfIV 3dU$d\*d%8A. `"kp7f]6T",]m2O^fNa;nKX2MNlH"o Teb U StQZ6QURb2.0Sjk|2Bk<*=%9 ̍]~"5a@j|>}Co X)Z`T_-@*OTwH#,]ҒRy&kTx;H)*W?_Jl]b YI,jY- f\A.cRXQdJ5AT_[ !5J u]1B@غvӂ@J[ =)S2=h  HS)A@ۑӂ@ʔ02=@@tTB@#غFBW(ޫ2B@5B@^uB@(1 ;B@u! !HSRXLnIr! @2հB@ M;B@SB@^!zS! [B@ {՝RF!غƀBW(ޫ2B@5B@^uB@ַݻw߾ﯬ&p\m qCІC~ŏT__#2eڽ>;{mKK'-/Leų1 Sz|QMk Ȍn,!;|L5c(ԮPB4`4 D%=Dqg [_XX[_$Y.//"-,--x\yBZo{pnڅg{v%y"rx`I}COaU0D37x cveNHd;QL6 <㞣ww݉op]K7; vga vܗIcuԂK\ XL0eZA_,Įfk@s'|# 0;`}9 :n;b(ƍ@ʔif oVxӨFeyf}؉86]k4kM*d'c°0)hhbmG0ނwy -0㍽$,2!0ֻ7*t*=MC-`BMM-Zy(ܘXa;εMBGƲZϺ]vòC_>g!6a;YXrv= Oazs99+uRdW0VS y7FrNv%ǿ );p@֢B#9ۑSY1A0 z_4AS{mz` Ji•pKGy'*:iz|* iF`b뜺4tymu|ނ0f v[. bN6@՜\QJ^hN/yɾ.k%aM{͏_bu)y֏vވ;tNÂj3uA_ ^^8efrVYl9t8X9`4| % Ġl` Vd{8mݺC0ܜ̦L}a9MoT-=ꔓbDc +׭w&m1<`u݊lGJdB@L&)S'ﶢT[[ߊ2kl?۠:B@E`sL'I MH%a,^es|.$=,?rx|S,w|ŞR1+ٳ+dPƈڪn.խ9rx& izE @5iV 㱧$22˜\]q3f+˶U[+cnb6;Ug e.+-b,cJ~_bvV9:ɗ 3I ¤GIG$GS*}b!/3(To* [)q% S<.<-s.dZXPH&HV+h9K|8'+j(T[M؎`DxHu^KfPA6E9fK3E |څdAg,fҠNhX۬ Rvq_Hkc_{]8/wN¨.6yOg:֪èV4AjgO'(&-6&:gƗ'v[P*Z&p` RX%0 }0jHg)@M%S!n]D 8KX|?F[2RXEbBA|6qu._xOQ6 )kW(2%ַ1b ,&C 1van^R08HLqfCijZ{\,BOO4y`N50&N1|P,p["zFLe2%j1J9Z64"-HU+h=j iT_$e#|S>ayKFbW3}b0W!=SLeˌLB>d<ȵn=jztRu֭ kH&K$B`RLkU#o]" o}rF ! Z 2e*oCU+1/-b?,({ٞϸKM&'Aܚ3bk YPBs1yr` 1)J8B'P]V)b))޺z'0}:ܘ}^(R})'Ab/PZ/H^=u.󹮂}Fg{yl"OYUz8&!T_|e݁ĖxWۙ6t]T_@kf)jwoU`[&ޟZ&qH&! mGj+qcQ]E `Az uVራ-T4qDRvyE b))ޱjPt@Jl]ǽGױͽ%Mǵ S}ղMr"`T?}OL5T,&q> _aAX&Όc{e7_:As3} LJP!)w9-]y˜zuEB<1FZMݏԠ;s)nkYbl-pkKn\cKqW`6izxٲ¯i2=#xWCN@I!0ZRbJ5>(N阠0EW?OH.̎3.C@u{Vy]>V2||-ӪNժwHl4k,0J F@v$G j@!)Se#9GB@)Sy=gQ m6gY-~ʒd4:՗O VŠi U3*Պs(-! @.^0Z||mxf(X  dq{a/w3Ț+Ke9غղd3}5{=P7g"B`PJ$Ya S}ŻC cn߯T֪{C@a-U5! :B@ۑ: t b,sZMŦ-9Wno`Z~[SN}qB % Zmrf[tan4lbPOZD -T1ߵM`7is@ʻ<{ (Z@I[.)孷/aH^g縱&c-8He^Nt!0<*4xD&7՜!qJ/<ɿps$AYwq 26NYB5)u7e+ˍ~d^-Bx#2g6d2VU'O#~P_~Y~Cb/WpB(WX !0]lGRl}ƄB`K#2e]['J$(T$ Vviaհ*o}XU_!0QL[Ϻ,H+H]I, $N2 V7VdGxw/^=//ۑ $ֲ_䀬9SGHEZӫLuodQB@b<@T5zymsRu 0F¾8d[܍)LU2̙0՗E+Zqβ,f~u:oh͸=$q7i\&ƇǠWndp[^ӴH֐[\`"N2qī)khTCBz[\=jb*.]ӭ  Jb5;{[<`kʼnFꋯQWH#]vج'i=mi28= | 뒀7 Ч~Yx;Idm18ZĄ/!! ;7P u֢mGMuMF8iR}0aǁn-zӴ:iT› MkDOV3iĤqţ]jhWE<$)u-pl9l}i+NEKX e%~0chE/x S|_xs$B(J |RS-e(VC][]#B@kHYi+ \Z>:Kd ^),c>ҏ.Em" N*=Z [A4xj#1Z ,QVwjk?Q[oZa-Jf LQF eݺRx[gڊ9!꠹q^8%U[T_`8`5ZDokejFu)[,!T_N3VDΞfP}C4kU7+$3m [&X4ya/&]qsv٫3Yb*]N CɁޝXVhmڲ1(asN1l&:6Ϝ mc#xb FbjR!H+ Ui t>WH]++;* =`-%%baXjd|d^5]LdgoX_Cc0h%(_YY9t={$C& (/<<[x]x&3j񜽨9ZqP%<uMW5PB@B|nMَz@B`<L[O_! @[DB@L)S LNI! @ ڎ!")uyr)#@v~B`Pl}\ !o[wJ;! ֧˥F@~B`Pl}\ !o[wJ;! @Za!2httB@ )D#2LfoGzC>y^÷=͙~(yL J c]tř&#yBíCHQ%,%VX! Pک=B@t@ۑ=v9Mབྷxe+Sa,M?h1`@`@d`%l%Dj5Vs6r0yٗYIw/<>gJUB) ǟy=G<߻8˘!# ]9cVC+XsAqȆB\_eb fw`1i̞v?V=?A-ӷⵢ_{4w<@-@`JU }[A+]V- !0<cE_7/~ x670){7 a:*l8$(acG0_ad[ ދ{LSE6>ye/ Z njS@Jl=у/B@@@ ! ֻBR|b B!w! &'$B+[ IB@lktB@hTc@!+4eګ2B@Mj ! zLoe#B !wdO>"p5o_z;\: !w.8<38Y{K?! wjh_)p(@8OWf]-n[B@mG]J!! 3q1P~~Ef/̈́ W2k{3]K!! z@YV^# TYuK9! si,@/X-=WHf+%2sMG?a'>|ae֧BvּL'ymi# ?Z2h,>C@* !/, wOFNX]}v1۱֭y=e\׽wd֛,j!  4۷qY177w޺g@}#Y'(YX~yddqIa-8m>BPߔKHvmv/mH5R]x{բ*]{3O"V#..:CO}ꃎ, yi?s޺ݔJ/O`qq7ڋKhn ,ǁŏdP+b Z .=^$o`Jơ.2gHMͪTI[)}!)iW{1vA)0,KFA'].nFФ"J!0`+F;ϒJbA%$q ,[#K$G]Oq a ^$w~`IIӔl%bylWc~ Ë%u7<7 d>F o]a$>BC`#W-_n\C\~q' 0c,qc Pʫ_|MA)-K5J|~Z 9 czE[~o1`IS 2Ǚ*N,fgGU^L9pj3V,1̚/b\~7)o~bŠ9ASda$XhuIPȭVU uTǁ/uѢ*6]cp0Sk1fw,K5::غĄOe+J范'yLz.+!0<v+ Xv]``2p$ U Uee'j2o˜hrµމp3s e< O_YCkIoo31] !0;N[ȺQX)$x>VoeUB`4>3ᙙTtyT흢ޓB@WJ! ֧-)/xd'$B 2MB`Y.B@&Ȭ7AKB@G@f}H !  - ! &;BJ@! HEmdIENDB`}KDd  A`?Screen capture ofthe banner page of OncoTraX V2Picture 12Description: Screen capture ofthe banner page of OncoTraX V2.11P47 of the <site name> - KEA 420 window with a list of functions" bKI\YDҖs'I)=nI\YDҖsPNG  IHDRt-AsRGB pHYs+HIDATx^ %Uu%`Ę &"AJ>AWV@! A# B I L2*OMKmZ%:Ę-csNU[խ?ܮ{>{N]vٵ.X}_O{W~-0buE {> ʖ.:tpGuϰaղqUMLMU]M6n1JcD3qkB(Eπ`֊#e ̌Vf*Ϋv*KipuWqw:g'3&#MVh]UvR8&(Un+&(D!"{cro[1 y{;yџɘ[ wqC'z||yfݺyg=O{gOg.ȧǎ=?s3:/--y+\U^ =5 W-?yK쵰0G^FO$MD@F>=Z\\ zqd%}|>~]t_Wnz ^uvOC=u~WG?-}soy] x?|3O[7~~c>~)$ѝw/;q#6,9|sn%rwڳN~`۩\ )," "' ?,w"w|w|f?ZgmܸOܳg0!3]_x{>x^w߻_qՇyߊ[?z /_^Ė9O>;K=] ?p?ֿ[sv>v靟^ mܻt{p{w8t~uמp?9#+(M>N<{>EwW%ٚ^{ ߽S_" 1~ύ'5?_Ӿ7a]zȻ#O|K[!Ny ^[_[A܂,oÉo:=1j/" YϞCQˏ_%x䒳Ud^y%3D"HUwħ]Wъ;w[~| ޿0uAw̽0 sί8j/" OG{ Axk3nzޟwnz뭷"˾᰿ck7N _x^7|^d!”_Eob%2K^W>z x# ޱw\ sGB:^ _nKD3Wn:?^t_ 36- mE*{7Wn{VXn +twqDilhO,}wEd7z1s?8+{WHݐw~1[݋C?dDOy{횭9zy?.pZn#>DKkVv[kV~Ϊ/[ Zs4n=ѿ#<_zַ|o\/;^tʪO &[bh0:՟֑ߌb&:go8 eV:`ˊ[vͻϑ[6C2Ƿ2elwʶpxG-ϒ F2W! w,K0<+L-N6ơ3 2& atLqc챽 2Wt\a'._QSf!B@D@2tCc.Zh2s?L:\ä>_>\K5p%" !^XƷJ*9;S[Y AY,,rƬjL:J|O'GE@IN=}wyCRh,[// WgZwje 7jȟfݲ"v!!iu|3ǒK֞Y|AeD( 'ue fj "   |̘"EE@D'zO `WlY3;P>}칹|9Z@:YeJ^+.iKtRW D@D @鈗16}I#WB3vF=#FM£'kUe*"a{ElGki}?E9%Ȍ5.72կY7 v3;cc4In>SC3g)j~S;>Skz)?{&JwKM{8NC\|[DYǺ7>tވt#[=?s3iN=_;灶G?jd8*?0@6>5G}G|;.ݱ:ī+,ÏCWCoMc^raOXLNe{G{Y7|;irmxoKKKQ9.[Nqg}?[g jyyazAdrtYá///5_x-z-o~-uoFj{o:ˣ;v$FFק_d١*F4;*]8l,Ϡ1>`No=6g~/z1޽ԛ,d <\ 9Gl)! "C+GS> oFw!+xo]V`ܕ 9-#%~쥘|0,Bgm\Z9nii|m4G էh݅ x__L /lrpH3_1=ttqR 1fL3C^to+qǿPsJ6vB_fj\s}|:!aKN ozտy/|2H:t[mݺs .|)xekkO9G;םX2~_ e(Nq3QvqAܘu]fqf+NpzPQG>a ?;0N)~<3{1rWԇO=q~c%qaxxو]*:'(h=q4C~d|es۲ !YK|;(F-Ν;u7g}V/&#Bܭpzm\qwutn"t o^@sj瞻s{\^lҙt s|h`֠%")Kǧs&$(|:  R" lO<>5^:r3e_.95v(1np6 FxvsR4gu;cRG HElg!8l{^}9q Xl{Mj)Ȼ?=(_Z4&X"ہeo7b uuQ7-tu+퇹+u:~8@=ǁh|rQR|,O=cyk2EBܾ̎ʚbo$ ǟw u9!pgϺ?%OJq5l*"B ӧgRRKo^77$gʄt emp*g=W>i1W%7`ſR79p!$>R(} YhnN#0D n)YNn3[R~j#TM# =H-o gf^{](MyqA-*H%JOJĮW+"C@>]tdwtnY"" ]$ YM" }% י" ]$ YM" }% י" ]$ YM" }% י" ]$ YM" }%O[D@F`=f뚭GD@:M>ktj-q" "{dVQ[>Y.Ll>{o޽!07w/.@}n Yp {ViBmZnAGIi")gtF%*N.iaa6>{[OMfMFZn |zLQ>"E@>}&;ϲ-ܹmy'mm^mj90ah݊issy[={6m R(mtvyx4ӵ{*D8y"ދPǐ[x?_άޝ&=Z>}V!%Z@8[W 0 (Oc'"n4gu`1eK goZqK@4Oe|9nBPR̡s+za[̎ᖰW0*4M#fc׊-g藽)rچH@9}΍%ګmB+!ca{`h^A|wK!.o@Io-ß~O]bz#we]-^mZ \Ǭ?=2l {y[Bm%}zE`ƏyG=aS>o{?X&p+r xGO " "b/ 3֗ʧj" M ˛sG||lO|R0Fڝ-t^+ Uh.*VJT+R GT3 !5ʧŹr+ve̚=a1} +v%nVX+Z,qD5(^SWfԬuy,}Rjo"'JKmDvʧ׎T׆koTJT\ Wpj&(̧iRZb*̚,FUjxMS%m&{Q>s7n)6&5:Ċ5aLD5^)c4A@&Wf^њY4 ),} +v%\WXj&u(̧6@]"\ hͬ¸>n*r녅N@ /xg4O̚&3BUV1=jJ[jx U% $+NN"" 3C@5ff5BDj " 3CO" "PHHWma /Wc"h. g-Mh,*=ԩJ^zU/ (F8}R>Kb5-^G+vyтY!pKT%Uk $':2ZՋntmdXE˽5: bٖ"p?VJ՜>9KB (iLt[^0٫U`a /ULD0DXjxRt `-Wږ zA^^)F (Ϊ/- ksh-a[nRF&-)52Vu!dY%^:s[D@BFBD@C@H3DD@tTt@#dĭ K(w֥ kx++Ksk]+gc-Zbd.!"^6*V Wֺ kxTXVےXI"| MڨVڲ{͉jo Lj\a,9ֺjx QnUx"mu/ZzZhT!ʧdEհ֕Wë Zbd-$)*(̧WE]@5묻ފb5.W. "t⟑ qBVXëmey薰Wjig(>sS 3 wah /6/q4 k]5րBѐjxm1"(̧Mj(P[%uW[\LW+ ͬ0OPZhZ 겶|eS?|NF TD@ZN@H[>AROD@& kRSh9k?3(D@D`@#pzUŊ]aW9Ȫi,@=ܘ"'*3-jWarWo WouyAQ0WhfчyL9a9)J.}&|zgnU*50].δaͬ)zD / 2gӘT1OyMÚYS.YU㚉^a-ٜ|i=%tS$"J O_L(E`VYVXËlZbU7m!7,'>+%y@b.z1nB+œ`9MS5Oqm?m֊[yѻPYZ#AXbZ؉`\M[^)[xx0Q ڱH`i&0-ږu f5^L%b^b-W(Ӕ Q} U>(F8ϻl15c&uE@D jP ̥,|ON"" 3C@kffP>P>}fJ@!  gfP>@w^̥,<]#@5ML<]#@5ML<;?2PDGOdTP>#S<|57woC&%ZeU>! q30ͳSUa)cB. XpK*tYcH`]ӕ[úC~+2p`y|&(MLV-;F@5flBxs J٥P>Gk6Yk-U qv60Q.mj5GFڪ]?$EE@ZL@H[<9RMD@&$kYK̲M]D`!D@D; Fڝɖ%" '^b("#ʧhe@ ()" ="|z&[j!k33URTD@ i!"5!k33URTD@ i!"5!|LBʧ"RʧTIQ($|z!"5!PO?d~~~hݾvU(x۽KɞQ{5r܊əЮMΏd ǿ#L=g}Vr%@pc8R:k<4<85ՖOڻؽD:^g(A]d΋^:Ova/\lX% ˤAuz!!A@vC'`pJlޑpغrl;, ܲBu7lȮa?GM^xA<BÐ/pdu* ʧWL0][K GiH$ߖK NUEt[ep B0q< "PH@k #2$D[+7=RfQp\1>pn6P[~(mEfZ:@p͑{,8M9^F^+NP>(D@D`D@D; ʽtge@ hQX=l*"yʧw~e@(ޣɖ" '|zX*AD@fTIQ($k@D@fTIQ($k@D@f33URTD@ (^H D@D`f(>3S%EE@D酈@D@f@GP zp;g{ s)ТIW 5!ᓩ#.TI D`:OߵMssa|Y<\mÔKO, ~n)1z.xuַ.9(#!"P/ٮ Gwϲ'ycM 6!wӋg=OgQ5n~a636G9Ãdqͮ;wm,Ԅ@ݱʙosjl8365ўdBޔ|U4)ܺg9=&;G-tjزgf ym[^&!!Ylf P6ƜݗkqQB<9Q ?$3^nƆsjD*e!i|l,ۋk 驁&k(/{lq|(g!G3^; ųNQ;5ps$m@H>gFJSh>PaPC, A19̚wQ /sUG($kDP-.n|Oz5p.ݨ8>1jTAv0q5t)嚣M]]W .2NFgcLd6HetlYHQQJ&L % W3BtC3ޙ%['ζ9VfYKiypK xzR+6ȟi6|cs;Fsfx#d6Bc(r &a ;1eʸp.Њ @J(̧߱cǵ~kiե:8V^>D%4S#I{D;^A\N xc8-meout!KLi"wS #"  ӫCܟ>%FD@֔@a>]qΏZ ȧ׊SD@DI_s$:5Mt4:u5MO/NE@DuOoݔH!(M@QD@ZG@MO/NE@DuOoݔH!(M@QD@ZG@MWsl%YD@j&k58XCF5L@Hk*q" "tt kh58XCʧ!| -" 5P>f'" kH@5E@Dfʧ TD@D` (5L|ܽ 7E_FM&rIj'ek5Kt;t2)F2fw_<7ҳ,,8?ss-xz9]ބ^ԧ3JE>LiPMMu "0Cڹ,6l0޳^\܌onEdKfN zYwKgyBDg!+ YӊQ> ?! M\%j&}#5RC{ 2gs/'!^zj[ȕc ̍yr2&n~PښE{ptݨ r0-9H㤸zy6Цg/:tΥ'EE@FJQa8tc)6Lu;QWáC'yFP {:Ж_{a6fl$fu^DYJ"0f1Dx2\хm]L#DMxhD?n%NYFJ[r`{xjxRK  Y/ׄfh+je,*`%J_'Wx4JG3^3˔"P@a>]ʁmW31UE@ZO@5Z?ERPD@ 4OOD ' zۮ@LJkNm," }$5>" " VmQj-Pe+ݛ@QdJ6KI)'e8rTx4!3e\0Xs4VD,NgQ^jCujf8"yDG("Ưr-=Jt5t|cjӡ[)h ? R_j\3іejo%.Rܟ^V̫uo*y' ďV2E @t.o(&r5Bc;ch 6l`rXYZ`wFV WTBlXdC3HU2ZDʄ9r(̧װ?i[A|oτyjӅ׀rhX1,.v̌. q Q@N7_9in+&VL\h)ƶg~t@kԌ9$+T!-ڔ8mrnޥJ+`Q Ͱt|ά_ecһ@ rr,-DDjN<*EJ߽bBXJ,FX6l\<}N#Ȫ."ZA"yJ8 x[j[M.S K@ 27sD`[1KDbf)Fg᫡ ?gΚGvt kQ+~2%@L#1d6'(ɲND|zHh?f_zGDc* #" -'5Җ/D@Dc Vwwx4}r%B9램+:&ݍDo)A`R^D%s^7-|zhdt)|s,pg^bq|5Bw..6XWś&y db8K@{s@}Y,oRfΤJƿV ½b3ۆݓC_FV&[/.VIAw=fp;Irpl~ҝME%xPS\ #e[+fa*MVΚ*ъ]6ZN:j/3A8}6/.װ Uf3 cEsrhA( '=w} ãE=Y fziE}E`m [o _}זl,tظf,G|В/"PoO?4%^p=JpsUHIL3^kFu~OGY(^p˯ĺWU69<UۭUEPS9tV=c584~-0H]94ʐUƢFZrQ+=$ +|C&LʦZkx}{ȧ/--5Ҷa5ZlOw7J98{]ޫMfƭ>KIg"O\} On E@:B^ٽwx)N p#t/@&t{0}/.C?cʧwoe@g Ͽ-6HO0X^>-zs:,EݛtY$"eYĸs5.Ol6,5Sqz']։tuݜoY%"apȞG O4nO'͓O*7ws|zZܺR7be@O2??w๹{x|P{YIJ|4uc}q@(~.T?  MvgRNssGP=F#_o',j%"7~/:RQ#fJK_QPçRm$N g9eq1\lY6ۓ"H#ꍺußqk}1XikƯah jEJana& p?ZfwiCod!myt+N2kC"nݑ1k?e{7;Uj)"\#ǭ|~N?xFѯZ!bQ0;gqi)&bóm9p_[0 19JQj#"0xoGx Z1wWYZJ76!ŸKq%4tۍ$%-eR'%FٙHYk?}"LV FXp\~2L^.\3綅Qě daޜÑs02C%Wg Ew/c'=! 7M9 - KEA 420 windowPicture 13Description: Screen capture of the Annual Report Options screen (before) of the<site name> - KEA 420 window" b.4f.]*Rj-=n-4f.]*RjPNG  IHDRuFsRGB pHYs+-xIDATx^ ]ey3C^@PBP\T! A6)"VhW $i#ef\D"Zn[V?SDV0)4% s쯳=wu>{g?>{z;b,p{́%v;t;- naBd}ϰ!flʴ8i{z_OJq8 \PO8" .Ta{}.9W I~Mnp-G3 -{z4kր7kwz 3u N; =8'n oklj<}}~}. v|:uP76;c%+{V>00;6nxu-Yryfzek=훛y}c aiy?YtU^}||ݶm7~╧\Sys4ɻ/俽nlǖ?>2ery眨MG6=ܳo,/:7듫Z4X@"j m;6+>'5o[pHM2+zkw?gvӫ~պ;c]mGvw#9p;Ӈ>ijOɃWi?~3OE^+nO{S\\3 M=mn޵~ޓ}4zzӟo8?z.s PtjQ[VX ^Y4B^{,U]閭S?[mCy?7w5r$ؾ^x={{nanw\b~-vDyֳSV?U N;yLLC"mixdo'xO\.;GSkQ>/H,3U_*U껮==sO^כzw _^.[|tH//satSUZ#n\%ݻW{}7q뇼ג%Kn6U{7kg 8twu;.w\SEuU]ں>=x>vU]w/7oe:Ou5uUcTѻ+q҆;뽟v6ީwt(afYjz`˧(-FU`rSI}G 3$⺯{üQ|o]~lֽ[wszoI>}ݪxgeױG'>`M%5^ʪks$[_;}닔6LhaQ COa>K?XH]H)J?Gzn|llk{3?>_ &Bija?{ ċ_|;:W2ԑuJ{omr L|V;!ՍL&cBbG[n8 #[L&yL0!53"QLm=\Jr@GT36&Qlx_}2Dl $ L=<@7<؇ M ~6!@ /\MOAPĔYr= }6 jms1]5ߧ %O_"b͐ήSOc? q m ٺJV%nϏ>.zkӾNW n1ݴ}Ujkb^G+8n;I "|~k=JK@ ú%~Q)̥N  s@c uw 4 _՘&99v:qX41+khǝM').F 3[w,KwzkJ$XhT1|vI;-xA@;a3鋲՗o`0٠5MMp߂Mdž/Z^R  a~BMu*E [ÒVkoUr^qN+S<1Njl*.1 m\NtI=?IΣژ Ht N2d WAM ֛" Dym}&Y@-Y@Sdί=zrc % ,+v"G}EZ@ :YA u~~CnjsQSjuk[^m׳e-mSTt–Oۯ|ZV-!dfO?Eߖ,䤽o#Dg ]b'0Gŗ+9댢6 n_ j4ts4qjT^yYVE`(2MG>DZP݊/=?üg`%6 g{GGG4쬑)};Jb; qyxxx/^\v¶'g-*1YbqwGE^vmF{=?Ϛ?n+vJ jh##VS&XMRs86=rئ6ȢE+?+ B暵y`^]nìf KB3?F;.q(\+X(M#t;y(p־|HCsZTA:7FR#V }9feESyNGVsnM琵w[~{XI4ydw`8}M9jʝg}{G2+鎭vלeΎ=#Y_ 2MѠ A?yi ?^ZN8KզG gSҧH^CCCMAfzcW_tr^oV95z^>*Ei]wQT%#?||Owu|ޕѫlO?ਗ4;z /]T4&_-dWԳX)9dks9DYצSg?Nu~pL̦I֭seϟAK*}Ɣ5T@ aÃm|`yXLfw'T8餓ϟw9򠮋oCgѹa"QPfºZھºJ-X,,8+Lg.5wηΞsK{}}5i l3Vdwڸqct%^֥Xj4s !CjϪqm>-MqNHa]uN5u;I~eot1dZoH͞Rt5iDp01rT{{͛¦ۤw;m$VW3BK夵0tޛ&4ԠnZzV2/}Obe[nvݝ/\ \u7īHlhWrr ~m=nQTRo|kї33v/uyz=KRZe pɱzEO\mݮ]mIJU@7nłGikG~M^)\1݄ϬS|IYރK_|Ur3 J3L778w''Oϩ$oK}F$=6Du_1n'jYj7+u}ioj5VIA}n5g~]~j\#: Q *YnyuU4E.rnp)DEҥHL"2zrS%kQƷd|UZ4ma]Vj& jT\~gRzunrܵyֳ.4129KI70O /ceu~IEKG?uIӰn k,4Ts$1ܫN @G=&:*@Zom`QoThx&^>A7DA"+"GJ訰^E݋ Q_-# Дa)"@I*f&:as}e@W w1\-A]Iޕnh@s ;׷Xt%zW!%@X\b Е]v:@t:d, б֬0 ׿<6c0@B`e5k?NS@w8;Wy 1q5BA~J@so=fa\A@wXb wEXc% Y'mYczgk b퐭w۱J+ݎ$#|HzdUW~"-ZC]Iǟ;wAq~?Lj zWN f&g|94/goJ{~L'wh@ w{1,/9zgk &*q0=Aiݯg@6L:r'@ Qw;1u "@m܉13 tjN @m9@𨯮s9C3K3wh@ KL @E%ӎr'@`ɔ9@P[(wb  j@EzGc P[g@(;ʝ@:s@GQ@֙:c0 0s dZwO;l<՚"^YA }ܾv]G6iOۜdw͗?o[WSIXIU)C%鍏o``[U pj.i?b^YGb ؑXLJ6\,9 d͎(HZM`p>޷֬ANSXܠ?ܲarb$Iaij`3JeE)2̐T9IJ{,fx,2##GQwE5:ڻ^YG|9jTq*9Y[j$ӺYX4ua4uvlݎ-tgd;d^IMeVGCA39vaJ2&<&9"s&9RLlƦJ.6Cf~oeTB%1 k٢؎  v$+/g 7W }*NGgO:lЬRYK; ]^vLk.&Upݩ͙͟{Y{νϙϚAӢ4"_[\z8TvmKl]б gk ɔMK%WF&[ؠj:gfEIft0c4AC :uл֬>5˝0mwKxZб( PRHS\ݮw"WRNѫjc󃵝;ӫmrw[WɦX=Y|O*ZwA.jS7T[STLz@AKi#@mМU, &- б٪Ʈ*}Y^Ieٮ^+:brKήX)wMզA(R[g```ݻv-& Wc!jdO1ǭ+^8Gͺך%Ӄ(>vH˖}{bx/S5Qn`c&Gڎb)/f!N_`Mh(C$3!P@ W{Uc(Y2-Γ]A-v9 ?͞s];ۗA,44P~]da@< P[gf@`\i=0 P@%Sz4 @E9RE @ , PjD  0P[h@"+@a@EW1 @m= ? P[$b Az~@ @m$3a #i9~ Ls@(G%r @ 0,ԁ Pr @ 0s@(Gz9~ j9u #@m?zC:^!Fz`A@OG}M?cF PL+@a`4 ? dZH@Ka- TDzE @ Z@@"@ PjD  0P[h@"+@aU񵱭[I`7JG}7A(C`jKl rtzI~ ֶRXMikSĺL> Ɋ  EȒi/?ğRz{H Eu<7<|Eŝ-T͗ڨ)TH~k*Q&֠w=Pmv>-E-GIA䤓>;h٨bQ&5IfrYL忖Z2w+[eBOVo,^+`G,ʔjmk)[wP.C렩4bU*w8p9W]144J(r>[=Wsv8}6.jd+/Au}}mbEMH[ф>QxF,lMX ?6\&I 5(5WWޡp(x#46]u9.7dzI{O~O9Mwt9=.]Q>[尦|ϴa!U;Ud'֧0[B@m0Yw 7T.lPȁ"PN^m@vkVtQ_ P"Kh#ϑ] rsrAȒ)Evx1 TBz%@ Cz@J0"@(  P j`D PP[@+@'@sf @e dZ !E%Ӡ܁2`ɴ,ACKAe %@m,AC܁2^ !EzP@@e P[/K"@m=(w  %H@A;P@;vPf @`ɴ  LCz@K`D Pd'@%W!B!@m=O JP[#B Bz(@@^ F@P<F 5A(K%Ӳ@ (, PKe @PX2 (@,je @P P@ (փr@(KzY jAe %@m,AC܁2AG}2c@K`D Pd'@%X2#B B%P<*!@m  jx= TBz%@ Cz@J0"@(  P j`D PP[@mxWP3 X2-K"iP@@e dZ !E%Ӡ܁2^ !EzP@@e P[/K"@m=(w  %H@A;P@Y? P[(@xW;(3 JdZ F@Kx= TB%J0"@(X2 @+@'@%W!B!@m=O JP[#B Bz(@@^ F@P<FG} 5A(K%Ӳ@ (, PKe @PX2 (@,je @P P@ (փr@(KzY jAe %@m,AC܁2AG}2c@K`D Pd'@%X2#B B%P<*!@m  jx= TBz%@ Cz@J0"@(  P j`D PP[@mxWP3 X2-K"iP@@e dZ !E%Ӡ܁2^ !EzP@@e P[/K"@m=(w  %H@A;P@Y? P[(@xW;(3 JdZ F@Kx= TB%J0"@(X2 @+@'@%W!B!@m=O JP[#B Bz(@@^ F@P<FG} 5A(K%Ӳ@ (, PKe @PX2 (@,je @P P@ (փr@(KzY jAe %@m,AC܁2AG}2c@K`D Pd'@%X2#B B%P<*!@m  jx= TBz%@ Cz@J0"@(  P j`D PP[@mxWP3 X2-K"iP@@e dZ !E@K۷o9c[nփr@#l}Q6u 3 <JS7l}y! 3= $}-wfٸ{⋄ΞXt92ݰaiL\1@z*)`;~`  uֻ tѻw-"w.v\p ~:⸢yQdń:t3Ҋ01 ?0bET0b́ 0I#1 9ROd;66vՕ3c܉n:77A@3… ^ _(   Pݽ} kFXO@8qEX/"[{ @(C` M)”aH_@z.O_vXr2tےraK_@&1Uxx@]xZ&wW_9ݿM=[lynocO`_ߓZi*@^ F@a=O J+@  P z%@ P<*!@X#B BG E ?;SNpIMBIENDB`)TDd-  A?Screen capture of the Annual Report Options screen (after) of the<site name> - KEA 420 windowPicture 14Description: Screen capture of the Annual Report Options screen (after) of the<site name> - KEA 420 window" bQDqlgpv,"Q`M=nQDqlgpv,"PNG  IHDRuFsRGB pHYs+Q-IDATx^ %WU;2 DT`(I1G f-tS$F>×AI'QdFFA4GpMbАGȬ4߻߾T:>]wW}]vwOٷW>l^gy-P|Ql->Ci-ca[*O09jkl,31fSN J! ㉨?AhJ$$oI4SGc`=1 \jmrWIڞCL*ἌUL?1!oqTU{`C#͋MHM3#:COG>Ì$WCdZF[bCo`[>vٶmōu.;wperrtNv ΂rY]ww{?ر{VW|+?.," KA[o|O۝{ȑ#T'n;wނ }ee>uW_}^{_tI'm۶;wm^'5g<]W*ڧ|^kOWo~__{SSy?ϰW>/U|MW<;/y/}?ϿEGYW/\3vc^糇Vy|~{zq9xaW>s~i?|_`߹g=," ".|X% ]\?Ļ5+;hG`gqơC6efwÇ>׿1Ͼwލw|++߃tF37+g>c/K1_KoK?p㋿^ >Ë>׾烇_w!3)+-|Oǿ/wC8y黰kozBnp5ox^un-( c:T<~ď ZჟTq:u|im{{߇?W{/@WW_3=G?x!Г{}훯) 'E>.uL: A{Os9s{!_aD_z"fFii::›cϿ{5xE#Gog[$a#uͫv&akU[E@D+Xn}~_tww{:\? xa?T׽|sm<^^Go>̭HPQ;YQ;97 _ݍ:h$ap}~pb:?|?շ" "PG^qD$[z|>='aY6I|>?7:-\6ݣzn}b-I =^WU~pϸW.hYq8nߎwJg}? Oַ\Z*5oxܾ$$rY叻ۉfs..B??..^ ִDz#UI(/G.___߳g=4;zS_pUZlu@nsSn]n]n.*ӊcW>S6㵶\)Q?X)2Ƃ[&]7.&am oٸPg#k2^CXmrK! 1#&u$F-sr&NLI9UcɈlXd<w)':lw [_oNX`ꬰsrgpcu8UG &ET@F:Rr44*!rژ^ۍ=b5>An""GAE@D@4-mHcm>mR&P~uڋ nQ9@BW6˚LAK4f>-ij^4$j4'M sFmD@ :RxٺUi^LS\tXNqS[UNk ,`k̏C̡g%Xkи FRD` n2pXhD@|v7ݺU Ԧ亢9=%)f!]+_(r]_Ν'^iGOӷmkOޭr~ \[[C`L'~:އ1/-J<{o^v`ۛpe ߮1srP;{n6#1Y@;^T\*:Cn*OoPc#ׯh <Kr .H¼W'jQ¼v,0W< \gG}(r t-|:O1|g(y[ mwkEAظ8AP#x |)_?\xE5/?m3<ָaw bpAsCwpvDbPrOs~VVвΧtce;580ڑ Ql[L#:5\@3~ǎ#M_%q!胧oAF=|CF?ҩὶ.vܡ*FA8}|W>.k׽o##Gc|f3??siĠN Oݳh|$C>}YJd9 \!_\fw7SMnEw 72@fxTr_eۧwoՓO}]r N߳ݕmo[߿mf5.rzVWWױ0Ofc<я>npȼ="cA!sqng$2H7LshpH3OGhV\<#L39ayǟ|!h@I(vƪwW_]\I|NsP9!r\}Nʙ Da:O| D_ ߹e s>rӷC_BbPy Я[_{x#oǑ'?pC"ю銜==1 j:lLxm~-޹tāa~A|qy! ;zj-iT7`'HV> bd;w{ù㝟!SC>@v;Oӷ1qQʾ+4$s 4# t? NJcTw8pIېش=F,<ΝH'=/dS'Wn?8C⸍Z8뮻λuˁDnteK~֙_;:яx $Q'<=FXwm9/?[j\Kb:1pD2͊_(RS A?VGB V}J ԺM/"6W7yhۺn:Nhi\$/Uug6o|nC#iI)<ѭau: FMKGVyn c,«J^ğѳrF`jxC<W˃kmxJh`qMޗ>=ʑn@;"=—(H`zG<셫Wk("H@nV"ۓ0[h*" K@n}qV,%v-"wneR[_i" K@n}qV,%v-"wneR[_i" K`; V,D@D`a \vs ~U^_?{aa" "(]rY+^ $̶̢XwFWy֗cG" KC@n}iZ,gY)"p\MPɭ/T  p`(?Y)"XSb5[_5" A|:?(Z_i" KI@ˑre$H:Q2e/M%aJk$~n׮]{~ރg>h})w -"5 '} Mmif)Zߚs+E@8LGǟ֗r"  M@BOX,߼kJerKp0˽zF>6iWD@ 薩X(ʭ/tPn],j:e(}@D@r 52FD@[> "  E@N#" ʭk#R_K72XD`-ӭ;w\D@*薩v X(eP)cD@D@LBPn}SƈrD@D`(P)cD@D@u" "P[_1" "ܺX(ʭ/tPn],Z)" [nv={>_]&7Ľɑ fz3>;^~ +翭 I-~n?rһ6.1؜^b)#ޠc}f89j6]i{zǎMU>-{m z pK4cTɉL]/|Qi֌_-Miv-~nQ&?rjPN@2no$+bi4LY>mgr=RN@GC@Ls(U9p\zCN{^иn^u[SԮMc-9Qp:2ki;v0|l)7gݹү=/1+G|zk*/e(<OY>{LVJC&ʝqՠe9YFpA%U)=laqKB@˾kkЕd䴟kkCVC?`.*/;|x>^MDaTdL̦*=3_7VrrU^_?pU tx0 7dwl)Bw+ٝٞ͂A,cѺVVoez^`:P瀆m$= &QzQ[uב3'p٥Փ03N^ƒ + J#*K>$$ ]XN}!1|z_ؗMr6E#t q=RNZwAN)r?B rpf2-U3 ֵ'4`pHik$ؙYcTʡ/ D˔ha/ӾX ~oY]A CcpRB]F`i ֏[YY9|ѣ Gx}wy7ow9+/;GcY,4 F/^T'=FS@6hT/f Oo! =P s3N?^>?u4Z.eȭF`u<'<n3 -ӭ6w`s" ċ@5ֵg,4uOu h}>AZ@[r DD@惀J}|̃(H |̃(H |̃(H |̃(H |̃PMP" "Ѝnv" "0gtt&Dꈀ@7eڍz-9#" (ލzPn}&Dꈀ@7ʭw" "0g[ :" "ЍrlBt#z7~-" sF@9#" Pk艀nRbD@D`>|̃iO %FD@惀noʱc?;vǺ Y]s8F z (60-N,5ܒd `M s:зKw ) vڙ铉HDcO~ʓ|[ >Χ )D+~i^Ȟ=7x['`cqoQwHqC}ԋNQ|( >wzf!S*Pam^oLoa/L c .n T@g/n7 N`A\ 3-=\BD)*ommaOlDf?1?u[J[lei+͇x/ ,Rf&ʰ# aPIԶ-8}d2 CH 6sN9&ʛF4,kL GylsƆ(Lz![gj Q|kQ2̱Z4uh --gBo+͆ӌ !zD^W!ghrHCՌihK/БrT@>UXw5C8w."Ѕˑx`W\#س@4aWFiiթMlfm vم&[*u_al 4cOt$0\߻́l<{]G7x5/_-E_X̓-pXe3Xi3W_}$N||uu o 0lۍ|-u(6B>: WEwA̹EvM_p{/#ͭ҉XPiA'2mH4 qn7>c`>pˌ4i8J2;U_e*,cCɌ!ӂn%)i|,y:Cmnrhr\^=$acHz-}h;Cd_iH]ɭwznrn`'=YL I5+lP+~5Nnf[L[1}E>z)P/eJ-ca26MA!z!1J&`B8x̃ er|"bSfy:T2$M!z!hOT{@ xnZ|\c_b|谥~M'zh} X/_z%-0l@pNzT:>~/St*XD@D .'-aϭwA}E@D@L1Ҕk$^lR_`eLI x`$ WQ2d'L141jWɰF+@%0[f7x3o ENKoQccvkq+-$QnH9ʟ5Hȹe) SYOs<āx4hV3_ .J&Y Erk9Is}BBe16n\׈q?~ߩlC,^@zٌ` '1a#aZW.`RSڸWd 9fƊWVH<:3>o]+zUœVYꋎ8}8'RV Mz#R5ͭ*u2{6+`*wXfrgy!đeWDWe,&I;T?%3/hlP MT`xn ;,*_Ye.pXP|_K}We.U  쳫5Q1-˱ҥ Я]”7'S.{Ze54RCL-,[7h}IT@D5[o:@#>?3Ŀ$d'0ln]E`PL$ DE @ϭgf" " ) J}؆+0-[y[t32d5pqZW,1m*C }xt ]TB,n՗pWcq.(ES4?5qhW)OYPdKlMV 9~?X2ѱ`/g te^7L?G.m64ո,*XIml=N26qY3 5lX!*ͅu7ɁV~:'XM\ g6=A3,U.^ujɞ}7v鸊Yy|!6 L i_GbCIe4\n 0!0,ÌBѺ16bϺxp 87Kx&4>A}%h}\hTR;,c ~O:W^T>.h? LCKEm }Wsۭu >GqOr~GS?nR_|0BEQ@\hVac7^$A뮻l!d\b\PJUEn1*`z3/cah9)'49ev`D}c+N`Цn^2f:e[󴹥̏^'mИ%v3:ؒmʂ\*VWdWpfd_SUgӆ z eK,M(0xpqYkivۻE?b W]l"8^dtolִ׹?(_$'J: 2ڴ@^R_(}+s-U/ Jth@DcPEDUF )'QY * Y WfYw ۟̐7ės` W?cT3h~,7,[Cm'XHtWo%sOAЛJ lu]z/OڊN8nu@_D@#m-VD@:aonu:_D@orA+޼W,T+GKc%)ofVJϔPy{ WxMbb=sڴ>=ʒa9;CԷVOY2csbF>ldBkEdƚ2aczTك  4NS:nOe+L[6'3A-S0O`zh+α}ќR_bU/͏{a_\KtMjiiwAix0Yeb{[/J׈MLƁXʠ;Ұx؟PV,U !ݗI(--) 6XpTo:z'aAp QѺ)A-4FmNAMVR &lfcJ_URkyW|h1ifDTؐ}Q8ޞ(٨U: BZlk;j{_)S=n(Zyֵr9t7]5UE%9fIsJ}b YLV46/$YlX3z.j.I^zHTcY%RnJ/ #KNȧ7#U}{S" "07e:7fJX9L;2cXl]!slk*rc`E.oZ^YS.wL?7zؒh`{_jV 33ܓDKɭwr)x>#񚳀 Q~ޜulw%xq?ueZ̩ie PSC߄xK3ey ^Km%:נv 3'iK}AUP$g/LI"49%r!Ϥǒ*f!F?ˌ̈́;"\ `e?mx 3[5rr=DA׻7 |c1lٗT1vz fRDE%Rqc+|3Q6\9NF+mK4Yν?R^ ^!91*m^jxCDW(l@WWxy8Y+/myl`67#nL) ? jӊchŹ:J\;k' 0 2Uoyh72qHX fO`R_fn;(篡Cd Y+(F46(v@%PFjYngOfc˭Fk ]:s4g$G7_vpJY@Be=eC0Yӂ64$؈-RՂ̆@Nn*S1,: i8/FDLUOݠPf$݌O5Pg_H+l&ױ {rﱔF*mf(-<~ǎbBN,fT.d+5bD_vj\jTc˾kf9 u%rԎuz}X"N/ oVmc26#U1QTl{PC!>q; 'NۅНK7ԥkcK8EX{ݍ%M W>yoig } #ʧnz_)ߤn m/!#-!S," H`ˑ6< -" F`[Tȹei&A8An7Q{+QPM K+R_eLTޘ*q5eS;R9VfU|=r [gRMbO !2(@u7fcT|cJkM%qZ11v)fm$ I`:o_\R_*|A#އ`=F,H(!?P*}D1l+vU.۩+f T ZG@}w|*bˎkryc@M BP2ɭ[ecClپxMROư*X<m΂j -eKmͷgmEUom`(M`maBRv1̺Wo3Ea'~01?j =I"WK;2/[sb|+e hiub䋈U:SFǘ6,uЀҬҙ-^p\9lrDyya-`f{ॾ*ueaIJ}8[lg:"#5RX˩,2n,.v'VmnA\"(f%^aAk5C䥾#g+ `5N3ؠlVk,y*|riلA09("Wc,q}"TgGK4M7s<(f5A.&֗u5 3"`/n5 zI.oF$@ x%:FqS@/bA0*kpe3S1]CDa;xAE%+UYJRnT%nn,5p#ڠ]x{M`*+YD8"}RY &+ЖL}M)K|[}v|OؕSVY ,Аs_T/(h:żS[͑؞i40G`Nگ!IJeF_$" " $0rYD@D@6ᖩ G`[u)d[w/_;WƇρʛu U9:䷻;)Z_gW_Ns`v> n."04oƅY&WߕR_vs/Nf67 $Q)&L>puPKhG W$L;kI8?ue I^H`[h%$0-%d*E@D` ~S{ vZmH5j{!G|ZaF5Q _-Jl[,9p|cEwou{Z$bL-S$0-`-&xmq>^~ӎh%$s^7h⃀K(5}FՈ?JpҠ B +E=|gkApqKġ169[(&$.)6۹2(F4.dॾx)nK@Ѭ1>eC(}P.Tڢ9f}m͡ VHAw -O~[ jjqw]T C4^ ſ̴y݂6^2uq6ֶvA!ϧ- ^+Y*Rrrlgj[3&(|< 3U UzXIҳik__隧~ . 7ӊSQL rv}T8Ĭ4^.4:m(7@0^ƋYn̠>l2-cSVh!X :4Z4*6VoEh4K/V@,^^U٪Ǩ!]ڿ@+f0|,;xqQŴ'8_0|hcPL굡^CRYrrlڔP ƃV D M`5E!0=9qX[z֯G8A+jeZ` R%VU ϪTqn:Ʀq&yMgJD@ɭw;_՜HCϳ^)?Xq9QrPoW,' ax]U[Ń ,Rns}i 䮯nvWVlZ-WZ:Vm e`#bZA|K̨9.U:_NMElN(6XG>."Ѕॾ*VBZbʙ +'.}ʑ6ﭳ $ЧQ!@/f:eTG *f84 3d&"FBp9dR3;%arj]̢H_ $g>>?YA]_ŬdXL Y-!̧D-_D%<|~)hOX[?^Yj}}g9N=iiO(h*SHPXe΂]>D܊uS[XYi˞OG ̧iǦ2hM`[kMh *)7sOl[D,n6E@D@z#0-4  9L;= F`s#LPn]{,j:e(}@D@r 52FD@[> "  E@N#" ʭk"BMZeCImD@D`.\L*qkiQp苀nERrD@D`.Lw?zWt_:eGZ[릵kP ""PG _uշ?R*bעٴ^|^Cc[?tlRpMK6hFNՠOb9 vt*j,"X]=)O ;O[o+\x-Gϋ2f4jV+W)Ut0h?_̟Hf])$bfqlKәN3`K ѨWW%%5&'`o>^27z{+1ziS" ]'u|(l?6-NN`uz1ҧ;+khjӥ/2,K@c1=ëd66CbFhѫ"PI`%w}T 'ƞ Nq0ej}؎X8p|삍>Z*b$L٬u-ާP0ާ@x1dR i]@TNK *%a3Ox6t|Z [Iz"d`_<++E B4߮?A7hG:7v;L ,8F417fv!JLDGS<|uc[]efpʓOpC\hR,W]`Z T~%X8]{ m}ҼQ٤փ@#Fſ W^zz𿁿[2sF-p[{@(f^ݼ Jgנ14F*lDUI>16.qH>4hG VVV>v.DG;8rv0gFvA{_o-{F>h_((?|5֧h`_Y,-m- O>$w\Z]Hiral](̎?cCbnNWW?;p'%"@{ӏ1x>ѓ0gmJd'a+IK}eIۮR_py:i kJ`[+a"P%."  Lq˴H." "09LDhtˑSRD@D@#`h%XD@6rA]c`[ fPn}3kLr냡` ʭou)" Pn}0," A@͠1E@D`S h" "0 2ڊ-ӹ")(" -ih=21f{ð@F)(" cO=`u%ED@/Zh}ͨ4u" "Vh_uշJfIWXJw߰{-ȭ/!E@&}uuuW_vsٚs+E@[_T֗uא"  J@n}A'Vf,4+&ʭ/8%ͭγX&o~ӕ0r4UD`A ux[_Y" "PPn];,-GZ1" M౏ƣGw[n}Y'"PVWON2=x%ajeʋ2PD`(Z_)" A`"Ř_Y!"\wp{Ss[_闵"  F~޼(E 62GD` NL˭/ E@_y=^Ib#" I{lX}֩0[f:>|xW"u'" "eqg=u~r[f.dP JD@D`^~GLn}^Iz@>c_Kn=Z|Q[Y6" "Ѕe>h$L+" O yE?@D@wň(ޅ XUQYOva'-lu{[" " 'pﱽ253{U4@/[[" " ^0J y !" [[" " ^0J ;/H?5f<IENDB`@$$If!vh#v:V l t65-yt-$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l4 t0$65h5f4pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#v#v!:V l t0$65h5pyt%$$If!vh#vI#v#v#v3:V l44 t0$65 58f4p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#vI#v#v#v3:V l t0$65 58p(yt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#v #vt:V l t0$65 5tpyt%$$If!vh#vk#v#v#v:V l4 t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l4 t0$65Z f4p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vk#v#v#v:V l t0$65Z p(yt%$$If!vh#vt#v #v#vA :V l t0$65t5 55A ytw$$If!vh#vt#v #v#vA :V l t0$65t5 55A ytw$$If!vh#vt#v #v#vA :V l t0$65t5 55A ytw^ 2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH D`D ONormal <<CJ_HmH sH tH Z@Z )@ Heading 11$@&5CJ KH OJQJ\^JaJ d@d l)@ Heading 2$@& 56CJOJQJ\]^JaJR@R r)@ Heading 3$@&5OJQJ\^JaJZ@Z })@ Heading 4$@&56CJOJQJ\D@D )@ Heading 5$@&5CJB@B  Heading 6$@&a$5\B@B  Heading 7 $@&a$ 5CJ\B@B  Heading 8$@&^p`5\: @:  Heading 9 $@&5\DA`D Default Paragraph FontRi@R 0 Table Normal4 l4a (k ( 0No List V`VWTOC 2 $ ^CJ_HaJmHnHsH tH uR@RSaTOC 1$ B*\aJmHnHphuB@B uDTOC 3$ ^]aJ:@: , TOC 4^XCJaJ6@6 TOC 5^ aJ6@6 TOC 6^aJ6@6 TOC 7^aJ6@6 TOC 8^xaJ6@6 TOC 9^@aJ6U`6 Hyperlink >*B*phr>`r)|Title$dh@&a$75B* CJ(KHOJQJ^J_HmHnHphsH tH u.)@. Page NumberVOV TOC BasedP a$@CJOJQJJOJ TOC$$B*CJ$OJQJ^Jph33FOF z\$ Note Text]^X`xaJvOv 0Screen CaptureM 'CJOJPJQJ^JaJmHnHtHuPOPC9Screen xxa$CJOJQJaJmHnHuH@H  Balloon Text CJOJQJ^JaJ>> Normal Indent 1!^Z.O". Step" F5\F@2F ,Header#!P5CJJ @BJ  Footer$!N CJOJQJRoQR Note Text CharB* _HaJmH phsH tH PZ@bP J Plain Text &OJPJQJ^JnHtHFV`qF FollowedHyperlink >*B* ph*W`* Strong5\r`r J Table Grid7:V)0 )<<66 F Footnote Text*@&`@ FFootnote ReferenceH*NY@N  Document Map,M OJQJ^JB'`B nq,Comment ReferenceCJaJ4@4 nq, Comment Text.@j@@ nq,Comment Subject/5\DD "wBullet0 Fx]h^<T< NN Block Text1x]^6B"6 q d Body Text 26P26 d Body Text 23>Q@B> NN Body Text 34xCJaJLM!RL NNBody Text First Indent5`HCbH HpBody Text Indent6^hPNarP NNBody Text First Indent 27`NRN NNBody Text Indent 28dx^hPS@P NNBody Text Indent 3 9x^hCJaJ0"@0 NNCaption:5\.?. tNNClosing;^$L$ NNDate<<[< NNE-mail Signature=4+4 NN Endnote Text>j$@j NNEnvelope Address ?&#$+D/^@ OJQJ^JaJF%@F NNEnvelope Return@ OJQJ^J:`@: NN HTML AddressA6]Je@"J NNHTML PreformattedB OJQJ^J> @> 2I.Index 1C^`CJ> @> 2I.Index 2D^`CJ> @> 2I.Index 3E^`CJ> @> NNIndex 4F^`CJ>@> NNIndex 5G^`CJ>@> NNIndex 6H^`CJ>@> NNIndex 7I^`CJ>@> NNIndex 8J^`CJ>@> NNIndex 9K^p`CJN!@2N NN Index Heading Lxx56CJ\],/, NNList M^h`020 NNList 2 N^`030 NNList 3 O^8`040 NNList 4 P^`050 NNList 5 Q^`60@"6 o List BulletR F$:6@2: NN List Bullet 2S F:7@B: NN List Bullet 3T F:8R: NN List Bullet 4U F:9b: NN List Bullet 5V F>Dr> NN List Continue Wx^hBEB NNList Continue 2 Xx^BFB NNList Continue 3 Yx^8BGB NNList Continue 4 Zx^BHB NNList Continue 5 [x^>1@> {q List Number\ F::@: ~|o List Number 2] F:;@: # List Number 3^ F:<@: NN List Number 4_ F6=6 NN List Number 5`t-`t NN Macro Text*a  ` @ <<OJQJ^J_HmH sH tH I@" NNMessage HeaderCbM NOPQ^8`OJQJ^JaJ8^@28 NN Normal (Web)caJ:B: NN Normal Indentd^4O4 NN Note Headinge0K0 NN Salutationf2@r2 NN Signatureg^FJ@FjIGSubtitlehd@& 5CJaJL,L NNTable of Authorities i^`8<#< NNTable of FiguresjL.@L NN TOA Headingkx5OJQJ\^JaJdod )@Heading 2 Char056CJOJQJ\]^J_HaJmH sH tH NN n DText+m$$ h7$8$H$]:o: m D Text Char_HmH sH tH LoL RList Bullet CharCJ_HmH sH tH >O2> `V6Style1 p5OJQJ\HoH 2 dBody Text CharCJ_HmH sH tH ^o!^ )@Heading 3 Char*5CJOJQJ\^J_HaJmH sH tH Lo2L w{ Table Text s((CJ_HmH sH tH DoAD ;Fm Closing CharCJ_HmH sH tH 8O8 vRk table note u^`xJoaJ uRktable note CharCJ_HmH sH tH JoqJ s{Table Text CharCJ_HmH sH tH o yocodejx Mh8p @ xHP X !(#((^`OJQJ_HaJmH sH tH FoF xo code CharOJQJ_HaJmH sH tH NoN 8Note Text Char1CJ_HaJmH sH tH LoL \qList Number CharCJ_HmH sH tH 8O8 OM>code2|8^``ZoZ )@Heading 4 Char%56CJOJQJ\_HmH sH tH PoP ]List Number 2 CharCJ_HmH sH tH 0O0 $screena$CJLoL )@Heading 5 Char5CJ_HmH sH tH 2O2 'courierOJ QJ 4O"4 u'courier2OJ QJ Lo1L ' courier CharOJ QJ _HaJmH sH tH 0OB0 Bcgwarn]^`boQb oHeading 1 Char.5CJ KH OJQJ\^J_HaJ mH sH tH PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] (/xFJ& 7& n& & & ' Q' '   Dw/K6 D2!="]#$&(*,-T/s02 6+9;#=?BDHM@PQ{S*UWYZ]p`bcegCiEkdmnojqrsBvv.x*{t}eҁt<Fݚx?V&_|"[/S5rNZi Q 4Q| *$%J')+r-/m124y68:=?YA#C|DGCIKSwWt[l^Iadfi/km0pqsv(zd}FeŊH`#:B]N'{I> F $^+0K6:<I6lq  \^cdefghiklmnopqstuvwxy{|}~    !"$%&()*,-.014679;<>@ACDEGIJLNOPQRTUVYZ[]^abdeghijlmnoqrsuvx 'Ej0Rn o  )0;CYQjRRwSUEVXhYZ\]n_*abdhkqLwxQy5ȯ(ػ?XCct/m >"'.f68;AGM RWV[%ae_hWlq5v{V/qEg=z`P@eM#qIwA k2A7p/|ZS$#IkDf 0Tl<f-F]x-Aw#Gl9Qv(Im0Eh&I`9[}Fd|8Tl +Pp+Ni+NqC[tBe?f0TtAc4If/a.b~LqR#N S~7[, P     O     H     J }    O     Aq,\)d1c4mBxGj%[+L~2c(_7c+` 'U~8p2h >q,X G ~    !B!x!!!"D"w""""0#b###$<$o$$$%J%x%%%&D&s&&&& 'M'y'''(D(|(((!)Y))))-*d***+(+]++++,>,m,,,-A-q---.;.k.../>/v///0L0000'1W11112K22223H3333 4C4{4445C5o55556N6|666"7S7777 88c88888889L9999 :7:c:::C;;;<1<n<<<=BFKiPX]einLruv]vvvw@wXwmwwxUxx1y~yyezzS{{{{|(|o|||:}a}}} ~;~_~~~~ <_(JbzĀ܀iԇǕ >ݬ*3ðٱ,p͵A    ]_`abjrz  #'+/2358:=?BFHKMSWX\_`cfkptwyz{|}~     !"#$%&()*+,-./0123456789:;<=>?@ABCDFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghiklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./123456789:;<=>?@ABCDEFGHIJKLMNOPQSTUVWXYZ[\]^_`abcdefghijklmopqrstuvwxyz{|}~  []+GIJLk~%ACDFe{ 79:<[~&Oknoq%ADEGf4Uqtuw:=>@_    > g  0 3 4 6 U m 0 L O P R q    % H d g h j  + . / 1 P q #?BCEd&Qmpqs/235Tf'CFGIh 1Plopr+./1Pp6RUVXw !#BiHdghj!=@ACb8Vruvx2568Ws ">ABDc~%B^abd!@c-ILMOn "Ag.JMNPo . 1 2 4 S p !!! !(!>!Z!]!^!`!!!!!!!! "%"(")"+"J"s"""""""""""##4#7#8#:#Y#|###########$($D$G$H$J$i$}$$$$$$$ % % %%.%S%o%r%s%u%%%%%%%%&5&8&9&;&Z&g&&&&&&&&&&&&'!'$'%'''F'T'p's't'v''''''''( (#($(&(E(O(k(n(o(q(E9|991:l::;;;<J<p<<=+====o????@5@s@@@ACAwAAABC8CaCC D?D~DDD0EiEEEF8FFFGGGG"j]jjssssttttttuuTutuuuuu$vDvhvpvvv@bj5Uy4PS8TW3ORE]r|B^a=Y\vĂRxݲ$ @t6؟FJC4 X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%̕XXXXXXXXXXXXXXXXXXXX%X%X%X%X%X%%%%X%%%%XXXXXXXXX 2LYt!!T # @H 0(  0(  B S  ? _Toc456598586 _Toc456600917 _Toc39994668 _Ref126744247 _Toc127843923 _Toc518198529 _Toc151451031 _Ref154459908 _Ref165274819 _Toc173658689 _Toc42857001 _Toc42909246 _Toc127843924 _Toc151451032 _Toc173658690 _Toc518201381 _Toc42857002 _Toc42909247 _Toc127843925 _Toc151451033_Related_Manuals _Ref154459963 _Toc173658691 _Toc149545511 _Toc173658692 _Ref20552131 _Toc42857003 _Toc42909248 _Ref162679760 _Toc173658693 _Toc173658694 _Toc149545516 _Toc173658695 _Toc149545517 _Toc173658696 _Toc149545518 _Toc173658697 _Toc173658698 _Toc173658699 _Toc173658700 _Toc173658701_SE__Add/Edit/Delete _Ref164476214 _Toc173658702 _Toc173658703 _Toc173658704_Deleting_a_VA _Ref164474433 _Toc173658705 _Toc173658706 _Toc173658707 _Toc149545519 _Toc173658708 _Toc173658709 _Toc149545521 _Toc173658710 _Toc173658711 _Toc173658712 _Toc173658713 _Toc173658714 _Toc173658715 _Toc173658716 _Toc173658717 _Toc173658718 _Toc173658719 _Toc173658720_PF__Post/Edit _Toc149545528 _Ref164475280 _Toc173658721_RF__Recurrence/Sub _Toc149545529 _Ref164475161 _Toc173658722 _Toc173658723 _Toc173658724 _Toc173658725 _Toc173658726 _Toc149545531 _Toc173658727 _Toc149545532 _Toc149545533 _Toc173658728 _Toc173658729 _Toc173658730 _Toc173658731 _Toc173658732 _Toc173658733 _Toc173658734 _Toc173658735 _Toc173658736 _Toc173658737 _Toc149545534 _Toc173658738 _Toc173658739 _Toc173658740 _Toc173658741 _Toc173658742 _Toc173658743 _Toc173658744 _Toc173658745 _Toc173658746 _Toc173658747 _Toc149545535 _Toc173658748 _Toc173658749 _Toc149545537 _Toc173658750 _Toc149545538 _Toc173658751 _Toc173658752 _Toc173658753 _Toc173658754 _Toc149545539 _Toc173658755 _Toc149545540 _Toc173658756 _Toc149545541 _Toc173658757 _Toc173658758 _Toc173658759 _Toc173658760 _Toc173658761 _Toc173658762 _Toc173658763 _Toc173658764 _Toc173658765 _Toc173658766 _Toc173658767 _Toc173658768 _Toc173658769 _Toc173658770 _Toc173658771 _Toc149545542 _Toc173658772 _Toc173658773 _Toc173658774 _Toc173658775 _Toc173658776 _Toc149545543 _Toc173658777 _Toc149545544 _Toc173658778 _Toc173658779 _Toc149545545 _Toc173658780 _Toc149545546 _Toc173658781 _Toc173658782 _Toc149545547 _Toc173658783 _Toc149545548 _Toc173658784 _Toc149545549 _Toc173658785 _Toc173658786 _Toc149545550 _Toc173658787 _Toc149545556 _Toc173658788 _Toc173658789 _Ref165274786 _Ref165274852 _Ref165274885 _Ref165275024 _Ref165275074 _Ref165275118 _Toc173658790 _Toc173658791 _Toc157386516 _Toc173658792 _Toc151451064t(t(t(((((3333333333(4(4(4;;;;;AHAHZ|_|_ddLoMox~ΐΐΐI̦ͦmnPR<<<< e<NNN"#%%')t*+r18393k69Q<b?ACKOUVV(YZZdqd?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~t(t(t(((((((33333(464747474747474;;UHUHZ__eerorox:~ʊΐ^զߦ6qt5<[[['2Y^^o"#B%(<)* ,1U3U369{<?6ACKP9U/V/VIYZZ*ddQe)fi,k,knn=rex$zz{|}~#Hlc`xƋƋIX..ϯϯݷ(]]{ckfo*o*o*o*w*w*w*w*w*w*w*/ןKzb{b|b}b~bbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb¨bèbĨbŨbƨbǨbȨbɨbʨb˨b̨bͨbΨbϨbШbѨbҨbӨbԨbըb֨bרbبb٨bڨbۨbܨbݨbިbߨbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb"*"*+*U.U.^.<<<===H]N]NeN.Shh!hhhh ww<^^mm~eefXX-"-"3~}~}}44;|| *c7G77CCZZ77UUyy}*}**]+i+l+l+t+11)C)CCCCC1LgLgL.M.MNRNRCYCYHYssssssssK      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~**2*2*].e.e.<<<===HdNkNkN1S h)h)hhhh &Geeuu wwk^^2"2"3}}}:@@/h<L  CCKKbb==aa***h+k+s+z+z+11/C/CCCCC:LqLqL7M7MSRSRGYLYLYssssssssK   !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~8R*urn:schemas-microsoft-com:office:smarttagsCity9i*urn:schemas-microsoft-com:office:smarttagsStateBk*urn:schemas-microsoft-com:office:smarttagscountry-region:n*urn:schemas-microsoft-com:office:smarttagsStreet;o*urn:schemas-microsoft-com:office:smarttagsaddress9*urn:schemas-microsoft-com:office:smarttagsplace=*urn:schemas-microsoft-com:office:smarttags PlaceType=*urn:schemas-microsoft-com:office:smarttags PlaceName ;1onkikonikonononRRkonononononononononononononRiRkkkRiRRiRiRiR8@hn((@*D*++,,------. ...114 4 6699XG\GAHIH[HcHHHHHHHPPPPPPPPsR~RRR;S?SgSkSST+T-TNTPTWWZZ[ [[#[p[x[[[*\2\&].]^ ^__````b!bxbbbb.c2cEcIc dd:dBdhh ppppttyy}}~Հ׀āȁ 8;VZ@HNjҋőΗܗ8@Н՝Ξݞoۤ^fFN'4 /= 1>8D dl=K FT OQm8ICRj~dt47}7>  / 1 2 5 6 8 T ^ _ m fk 0?<@u""#$h$l$7%;%H%X%_%c%%%%%'(7(N)^)**,",,,11g3t33344444444555555X6_6w6{6666677889999::9:=:1=B=??@@@@@@ A A-A/AOA`AlAnAAACCCDDD@DBDKKKKL!LMMOO&P9PQQ.R0R1R4R5R8RQRSRFUUU?OPQRGHT_̮׮K^r(sttuuupvvj4T8X3S|Bb=]ٖږ9:jkjk|}`a>?OPQR؟GHJKMNPQST_a̮׮BCDHK}(7_~H\g^,]^V>#>oURfT |S _dRIm`F L0| !B>+)<"r.H3p\[ YM30\E=U"3zSexjOP'VjlF}/m0~xĎ^`.88^8`o(.^`o(. ^`OJQJo( ^`OJQJo( 88^8`OJQJo( ^`OJQJo(hh^h`.   ^ `OJQJo(  ^ `OJQJ^Jo(o   ^ `OJQJo( xx^x`OJQJo(HH^H`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o ^`OJQJo(Ph^`P5o(.^`5OJQJo(pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.^`.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L. hh^h`OJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo(^`.  ^ `. L ^ `L.xx^x`.HH^H`.L^`L.^`.^`.L^`L.hh^h`o(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.Ph^`P56CJOJQJo(.^`5OJQJo(pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L. Ph^`POJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo(^`.  ^ `. L ^ `L.xx^x`.HH^H`.L^`L.^`.^`.L^`L. hh^h`OJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo( hh^h`OJQJo( XX^X`OJQJo( pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo( hh^h`OJQJo( hh^h`OJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo(3>+)F}/m}~P'Vj~xzSe[ YMr.r.r.r.r.r.r.r.r.r.r.r.r.r.r.r.r.r.r.r._r.r.r.r.r.r.\E=U !F Im`2                 VDK                 4}        GVDK       l                 VDK        VDK'       enr         @ @ @ @ @ DB  =B]M6eELeEK2-]M6r@U|j`c w N0*3+2735aI `gVs!tJ| b"&2q(yrG*DVMVgboq~; $'0q47dITk}=v,9Mcm{~ AHO~ 3#,:68IXXowX 5$=FRTX0^ df|Z%NY4kk} * 4 }B QO =j j q  g+ : ); < @ C P u l x   6 : !O ` k q .{  i   , . ! ( > RR W d w @y |  b w ' 1 # %& * lQ n] _ _ b j i} K~ J #Z&,34}@fFN\XYZ^X^'.E1EHPUV(`E *0abfn}? f'_)>-@NVMV[agFtvx3@*%)*1f337+HPO[[+\heh!j (;)*18:>s?L'MbAJ c"M)+-B7<J>>pETU>Z^a  $*8:CZb  n13>=?#A\GeIR]fopDxZ W./A|HoL-"-.NPe[f_lw;zf_{469>MPQ ]{F*6<P`]iaa#kxy %#s4V9DFMLNZm uw# ^ ^*788;B6]j =>Glc3et5S f&90>sABMNPy%|1o8c $:,2C9MUxD~y F } 3 < H Z 8w !r !t)!-!m6!@!H!^!{"*","U"*_"`"Mm"9 #c#i.#A/#D#D#W#^#$$$z)$7$G$fc$r$w$? %< %%)%%%g:%D%Z_%p%u%{%&p&# &&&[(&-&UA&L&#O&S&v&''' ' 'R'T'|X'c'2c'h'u'(K(x(d(r(&(&(t'('(K(h(n()M ))))3 )X+).)/)>)D)nI)Y)]Z)r)Qu)Y*V*%*?W*Z*g** + +++ +v%+.+1+<+o@+\A+%V+^+B^+ j+Dr+r+r+#u+c{+ ,: ,,,',(,+@,wF,J,T,b,nq,q,g--V--))-R)- ,-75-K-Q-CS-]-c-vi-m-p-|- .....<.=.2I.O.|.T8/J/b^/ij/q/f 00$0H80 <0SQ0U0Z0k0Nw0x0}001 01-H1O1O1PV1p12 222.2O23$34&3B43U3]3$|34 4j04;48A4nB4H4@P4d4Z5 5&5)5M,5;5OJ5W5 r5u5fz5/6}6666#6=6`V6L\6{t6~67x)707-67;7W7Y7c7f7l7|78#8 :8:8L8Z8l8m8G 9_)9!+9=09J9 a9 ':+8:v::D:L:t:_ ;;-;/;W; [;d;iv;?y;S}; <)<5<#=<@< C<N<0`<|=={=i4=6K=s=w=>p >>>F>'>>/>0>M>>%E>4G>lK>L>OM>TZ>k>|>8?? D?lM?X? @@@(@@@F@7V@9V@a@v@g~@SAA"Ak#A<$A4A9A>A9_AlAwA(BJAJ[J0\JdJ`jJ?mJGnJvJ}JFK7Kh`KhKVrKrKLC-L{=LALLL OLOLdTL]L_LxlLSsL5|L Mv9M>MAMfCMHM9hMjM6mM yMCNgNN#NO*Nw*NNNPNPNeNtNCO7O+O/9OGOLOlRO=TO@P P)P+P5P^8PUQPRPUP XPiPdmPpPxP3QQQT.Q$@QHQIQ\Q\dQSyQ(R RRBRSRVRWRfRSS!SU&S+Ss,S ]]]},]8]Y]^/^3B^U^i^q^ _` __!_}9_9_L_O_YX_X[___a_ih_,i_p_x``y.`/1`T`j`'t`0t`aSa(alRaVa]abCbbb.bBbVb fb"bbi(c5*c!2c3cQ8c@cEcXcjcrctcwcd[d7dWdwddxod*udB|dee5ee')e+e/e MeWPeUeXe[eG\e%ceeekeqeresefefffjfUqfxf~fg#gAgLg0agBcgVfgNh.hMh-Nh]hagh~phcshGibi`i$ii%iz-i7iCi*FiTi\ivhijinih'j3jR9j@jEj"Ij]SjTj`[j^jej-wjkskk(kM2k:k=k->kEk6HkOkPkESk]lkK~k l lIll "l[0lg6l 7l/Jl VlVl_|l`m5 m mmm\m2m'@mEmMmPm[moemnm3vmwmnnn?n DnLndn*in*sno o0oZEoIohjouo~o3ppxp;#p8pHp[Xp9]pbplp q qqL qs"q7qDqoqHrr93rI>rNrW[rK`rdlrrqrLs ss*s-s:sRs8]sdsdsjs1ssttOt/ t t3wEwxpx2x'5xYxRbxdxkx9oxux yyLy[`ygyiyjyrqyuyzz"z7)z11zAzhzxz~z {0{%{J<{?{o{t{t{z{{{-|| ||h|$|)|g<|8I|J|Q[l ,2F:G\JO[QbwefRn5=ILNT@Yhp~_\hy"&&+,)@CXN2d'+;NIirT|~. U #*+6>VHIIKQaivW T) .;wBOGV|oot\*o7}X[Rkw| `**28BYd 7@>)HR_E~ 146?4XlDp59G TATKZ[wy:z~zHX_2bjzpJX  TMEX~[bo\wq)o?EbGZKN8c"ns=z%{ DLRYkl2mg #+Z`^hDFL[hqq5}Y$ "!/-;?FR%\a<||cR , )"$827p;gmusw b'c+0012'EQ`dklo t5(CJ\jnxW&^Fm)ps~rU %M=LkEzJ#+/9MT?cxl0_v&*d`w3RT4WBW}WYaSjzklvsxx. O3PTvV]& (,h66<hK[~^u% /0v>b3syN$!",@KKat424^Xmv23dI.dgv_| 6Ag!%a&*9@Ao\lAl ./ 0617p:z;^~/{6}>AD_GPxV,h[ /;=3A!JNKaSz\xvzz} G*,<NvYc/ d 9#/9Ee|w~N,a40l ov|8*a*0sITj{|; 03uIS`atk0"#8;9)I`v+4//6AeE_\8_m?CK5LN RZftvJ{H )5~[h8pwz7')+oKV \!\s\n{y < =\CSdnu5{ 1zH[m,nu~|)/I_aOd#hik8l8w)#(7MX_l{M ;88 ;"=>>H_Yciy({ Z7eFgTjs{s$&^0::@EFI(KMUDdIgchYkXoy}jNa48[E^ `g@l?tvwz-" x!{26I6BCuj !e%0(>O]_boyz{~f)n/Hwxw34x>INP}UfBoqX%(0:mAACCRUcdAJkRUhZ p+s"t! "U)e*567?,@B{H K(YY_Nwr| c$%g@KM&Zd7hvwsTg7<d{&*YJYeu&.DHcgqLU-25;PYUp\PilWtv F!R%:\<*Anoucvvy , {l""'7KAMgIi>!!)*~46@y/266=:hBCSlxtuvi5 IKlNe^ck~v@ 6b9LA'G]M~NO^ bu{Z[,2=?bDJ]TVYaldnqv^!#)!:;=8>DEJLAN4QXrAw%z2 ;;C5TZO`ej,kst zE&(:sIvI9_,tx!~053QY}2-B2>?"DC`l0u "-/IZY7ZjnrKxA)-BRG{$/emgg|hdj`+i-5KQn6pz+:BNoV_adCgqMLJ),2 8+_cin}T p&$&D\'*5+i3_KTw $I_^|2}Q%%3-KW[1Q8v@Zgvv~i#E'5+6JRhLY$:`hmuyb| n*.-;OGLiZM[Kgp9 .AS.rtp":CK Q>d &&[*\V@m{## `9|Md/ASgk|69J?PSLT+`z+Mhdf{HJ@xxxx|````QJ@<@H@l@x@0@Unknown G*Ax Times New Roman5Symbol3. *Cx ArialG=  jMS Mincho-3 fg?= *Cx Courier New;WingdingsI Arial Unicode MS; Batang5" Tahoma71 CourierACambria Math#1hxBgxBgʴfnfG^nfG^!r0NKX ?%E>.! xx OncoTraX: Cancer Registry User Manual#Oncology, GenEDITS, Cancer RegistryProvider Systems Sanders, John`                Oh+'04 LX x   OncoTraX: Cancer Registry User ManualProvider Systems$Oncology, GenEDITS, Cancer RegistryONCOTRAXMANUAL_2012Sanders, John2Microsoft Office Word@F#@L@mu@munfG՜.+,D՜.+,xx  $, 4 ZPatch ONC*2.11*47(Health Systems Design and Development Department of Veterans Affairs^ OncoTraX: Cancer Registry TitleH2 8@ _PID_HLINKSA26!! https://web.facs.org/datalinks/\]&http://www.facs.org/cancer/index.htmlmjLftp://ftp.cdc.gov/pub/Software/RegistryPlus/EDITS/Program/edits11152001.exeFChttp://www.naaccr.org/index.asp?Col_SectionKey=7&Col_ContentID=136216http://www.facs.org/cancer/ncdb/NCD_110B_09202006.exe[8Ehttp://www.facs.org/cancer/ncdb/install_1985_1990_1995_2000_2005.pdfv.+http://www.facs.org/cancer/ncdb/edits.html\]&http://www.facs.org/cancer/index.html!@http://www.va.gov/vdl/documents/Clinical/Oncology/onc211_tm.docBd_VistAFs_Deleting_a_VABo_SE__Add/Edit/DeleteFs_Deleting_a_VAq_PF__Post/Edit|_RF__Recurrence/SubFs_Deleting_a_VAPP-http://vaww.va.gov/cstage/cgi-bin/cstage.exe~70http://www.facs.org/cancer/coc/fordsmanual.htmlw87http://www.facs.org/cancer/coc/cocprogramstandards.pdfp*0http://seer.cancer.gov/manuals/EOD10Dig.pub.pdfnq+http://seer.cancer.gov/manuals/codeman.pdf[F2http://cancerstaging.org/cstage/CSPart2Manual.pdf\6http://www.cancerstaging.org/cstage/csmanualpart1.pdfQ)http://www.seer.cancer.gov/tools/seerrx/%http://www.training.seer.cancer.gov/x/4http://vaww.medicalsurgical.va.gov/cancer/index.aspF-http://cancerstaging.org/cstage/manuals.htmlWhttp://www.cancerstaging.org/N|http://www.ncra-usa.org/3:y$http://web.facs.org/coc/default.htmc:v0http://www.facs.org/cancer/cocflash/june02.html\]s&http://www.facs.org/cancer/index.htmlh-phttp://cancer.gov/Em-http://www.seer.cancer.gov/training/manuals/Qj)http://www.seer.cancer.gov/tools/seerrx/0c_Toc1736587900]_Toc1736587890W_Toc1736587880Q_Toc1736587870K_Toc1736587860E_Toc1736587850?_Toc17365878409_Toc17365878303_Toc1736587820-_Toc1736587810'_Toc1736587800!_Toc1736587790_Toc1736587780_Toc1736587770_Toc1736587760 _Toc1736587750_Toc1736587740_Toc1736587730_Toc1736587720_Toc1736587710_Toc1736587700_Toc1736587690_Toc1736587680_Toc1736587670_Toc1736587660_Toc1736587650_Toc1736587640_Toc1736587630_Toc1736587620_Toc1736587610_Toc1736587600_Toc1736587590_Toc1736587580_Toc1736587570_Toc1736587560_Toc1736587550_Toc1736587540_Toc1736587530_Toc1736587520y_Toc1736587510s_Toc1736587500m_Toc1736587490g_Toc1736587480a_Toc1736587470[_Toc1736587460U_Toc1736587450O_Toc1736587440I_Toc1736587430C_Toc1736587420=_Toc17365874107_Toc17365874001_Toc1736587390+_Toc1736587380%_Toc1736587370_Toc1736587360_Toc1736587350_Toc1736587340 _Toc1736587330_Toc1736587320_Toc1736587310_Toc1736587300_Toc1736587290_Toc1736587280_Toc1736587270_Toc1736587260_Toc1736587250_Toc1736587240_Toc1736587230_Toc1736587220_Toc1736587210_Toc1736587200_Toc1736587190_Toc1736587180_Toc1736587170_Toc1736587160_Toc1736587150_Toc1736587140_Toc1736587130_Toc1736587120_Toc1736587110_Toc1736587100}_Toc1736587090w_Toc1736587080q_Toc1736587070k_Toc1736587060e_Toc1736587050__Toc1736587040Y_Toc1736587030S_Toc1736587020M_Toc1736587010G_Toc1736587001A_Toc1736586991;_Toc17365869815_Toc1736586971/_Toc1736586961)_Toc1736586951#_Toc1736586941_Toc1736586931_Toc1736586921_Toc1736586911 _Toc1736586901_Toc173658689  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  Root Entry Fmu Data L1Table; 1WordDocument' SummaryInformation( DocumentSummaryInformation8 4CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q